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GENETIC AND ENVIRONMENTAL FACTORS INFLUENCING
SUSCEPTIBILITY TO INFECTIOUS AGENTS
"Much more attention should be given to the combined effects of blood group and secretor
status on susceptibility to bacterial infection."
A.E. Mourant, FRS (Blood Relations')
INTRODUCTION
Almost as soon as the ABO blood groups had been identified in 1900, publications appeared
on the distribution of these antigenic phenotypes among patients with a variety of diseases
and conditions. In the introductory chapter of Blood Groups and Diseases. Mourant
emphasized that it was only in 1953 that the first convincing evidence was found for an
association between group A and carcinoma of the stomach. Additional studies by C.A.
Clarke and R.B. McConnell found associations between other forms of cancer and ulcers with
ABO blood groups and with the ABIT secretor status.
Much of the earlier work was severely criticised by Wiener on the basis that if a hypothesis
could not be put forward to explain the observed associations, they were probably due to
chance. The associations reported for ABO blood groups and infectious diseases were
excluded from these criticisms because many microorganisms express antigens cross-reactive
with A,B and H (the antigen of blood group O). It was suggested that anti-A and anti-B
isohaemagglutinins might act as "natural" antibodies in a non-immune host against organisms
expressing these antigens.
Although the ABO blood groups and secretor status are stable, easily and inexpensively
determined genetic markers, further investigations of the initial epidemiological findings
were not pursued for a variety of reasons. Different groups found different ABO blood group
associations for the same infectious disease. These might be explained by antigenic variation
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in the strains causing the outbreaks studied or differences in populations, environmental
factors, size or classification of patient categories. Statistical methods used might also be
important considerations as some environmental factors can mask the contribution of blood
group or secretor status which can only be identified by use of multivariate analyses [45].
The interest in the genes of the major histocompatibility group (MHC) generated by the
advent of tissue and organ transplantation very much overshadowed studies of blood group
antigens with reference to immunity and infection. I think the main reason these observations
were not pursued is that only one hypothesis, that anti-A and anti-B could act as "natural"
antimicrobial antibodies, was put forward to explain the epidemiological observations.
Research begun in the 1970's identified the important role of protein-carbohydrate
interactions in phagocytosis of microorganisms by non-immune hosts and the lectin-mediated
binding of potentially pathogenic microorganisms to carbohydrate receptors on host epithelial
cells. These studies, in conjunction with the hypothesis that infectious diseases might
contribute to the differences in distributions of blood group antigens among different
populations, were the starting points for my work on the role of blood groups and secretor
status in susceptibility to infectious agents. In addition to ABO blood groups and secretor
status, epidemiological data for large patient and control populations collected in my studies
have provided a means to examine important environmental factors proposed to contribute to
susceptibility to infectious agents, e.g.. smoking and passive exposure to cigarette smoke.
As new data suggested that microorganisms might be involved in conditions other than
classical infectious diseases such as peptic ulcers and insulin dependent diabetes, I have
been invited by clinical colleagues from a number of disciplines to join in their
investigations. Most recently I have applied the techniques developed for studies on
bacterial meningitis to examination of sudden infant death syndrome (SIDS) as it has been
suggested that microorganisms might play a role in some cot deaths.
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ABO BLOOD GROUPS AND SUSCEPTIBILITY TO INFECTION
The model chosen to examine the role of ABO blood groups and susceptibility to infection was
the increased proportion of group B individuals among those with gonorrhoea [1,4,6-14,16].
Three hypotheses were tested:
1. The anti-B isohaemagglutinins found among O and A individuals are bactericidal
antibodies for some strains of Neisseria gonorrhoeae.
2. The anti-B isohaemagglutinins enhance opsonization of gonococci by neutrophils or
mononuclear phagocytes.
3. The epithelial cells from group B individuals bind greater numbers of gonococci
compared with cells from groups A or O.
Bactericidal activity of normal human serum and isohaemagglutinins
Although gonococci adsorbed isohaemagglutinins, natural bactericidal activity of normal
human serum was not associated with either anti-A or anti-B. The important factor was the
lipopolysaccharide (LPS) structure of the bacteria. Strains could be divided into those with
"simple" or "complex" LPS structure based on sensitivity to R type pyocins from Pseudomonas
aeruginosa [1], Those with the complex LPS obtained from localized genital infections were
killed equally efficiently by sera from donors of blood groups A or B while those with the
"simple" LPS were uniformly resistant [8]. This observation was exploited with colleagues
from Birmingham in studies of induced serum resistance of gonococci [14], These studies
were the first indication that alteration in LPS was involved in this phenomenon. Some
isolates from disseminated gonococcal infections expressed the complex LPS, but they were
resistant to normal sera, indicating that there were at least 2 mechanisms of serum resistance
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in these bacteria.
Mice inoculated with strains expressing either simple or complex LPS produced bactericidal
antibodies to the strains of the same LPS type used for inoculation and also to those with the
opposite LPS type. This did not occur in humans. Patients with gonorrhoea infections had
substantial bactericidal titres to strains with the complex LPS; however, there was no
significant activity against 2 strains with the simple LPS tested [12]. This observation
emphasized that the immune responses of humans and laboratory animals to microorganisms
that are strictly human pathogens might differ significantly; consequently, all studies on the
immune responses were examined with human sera or saliva samples.
Opsonizing activity of isohaemagglutinins
Gonococci can be bound to neutrophils and monocytes in the absence of serum by lectin-like
interactions that can be inhibited with simple sugars [13]. Following opsonization of the
bacteria with sera from donors of different blood groups, there was no difference in
attachment of the gonococci to neutrophils [7],
There was no difference in binding of unopsonized bacteria to monocytes from the 4 ABO
blood groups. There was, however, a significant increase in binding of gonococci opsonized
with sera from donors of blood groups A, B or O but not with sera from AB donors. Group B
monocytes bound the greatest number of bacteria; and adsorption of isohaemagglutinins
reduced binding to that observed for unopsonized bacteria [9].
Novotny and his colleagues suggested gonorrhoea is a "disease of the human macrophage." In
their studies, gonococci were found in pus surrounded by debris and granules derived from
monocytes. It was suggested that these materials protect the bacteria from serum and
phagocytic activity, and these "infectious units" are important in the survival of the
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bacteria in the host. In the context of this hypothesis, our results suggested that the
increased association of gonococci with B monocytes might result in the increased probability
of formation of infectious units in group B individuals and that this might contribute to the
excess of group B among patients with gonorrhoea [11].
Binding of gonococci to epithelial cells of blood group A or B
Although the binding of gonococci to uroepithelial cells varied with different quarters of the
menstrual cycle, cells from group B women bound more gonococci than those of A. This
suggests that the B antigen might be one of the receptors for some of these bacteria [16].
These studies on gonorrhoea have not been pursued further as at this stage outbreaks of
meningococcal disease had appeared in Western Europe and I was urgently persuaded by
colleagues working in infectious diseases to apply these methods and techniques developed to
the problem of bacterial meningitis.
SECRETOR STATUS AND SUSCEFriBILITY TO INFECTIOUS AGENTS
There are two phenotypes associated with the secretor (Se) gene. Secretors have in their body
fluids such as saliva or nasal secretions the carbohydrate determinants of their ABO blood
group antigens, much of which is bound to protein molecules. Non-secretors do not express
these antigens in their body fluids. The secretor gene is found on chromosome 19, and it is
inherited in a Mendelian dominant pattern. Approximately 75-80% of most populations are
secretors and 20-25% express the recessive non-secretor phenotype. There can be significant
variations from these proportions in different ethnic groups such as Lapps, Eskimos and
American Indians in which over 95% are secretors. The genetics and biochemistry of the
ABO blood groups and the interactions between the secretor and Lewis blood group genes
have been studied in great detail. The expression of these antigens on cells and in body
fluids of secretors and non-secretors is summarized in the table on next page.
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Blood group antigens on cells and in body fluids
of secretors and non-secretors
Secretors Non-secretors
BG antigen cells secretions cells secretions
H (A/B) + + +
Lewis® +/- +/- + +
Lewisb + +
It was the differences in the distributions of these antigens that suggested some of the
hypotheses proposed to explain susceptibility of non-secretors to a variety of bacterial and
yeast infections.
Epidemiological Studies
When Mourant and his colleagues published Blood Groups and Diseases in 1978, almost 25
pages were devoted to the studies on ABO blood groups and infectious diseases. Less than 1
page covered the studies on secretor status and infection, mainly the excellent studies from
the 1950's and 1960's on rheumatic fever by Glynn and Holborow. With the exception of
gonorrhoea [6], among patients with the bacterial diseases investigated, my studies have found
a significant excess of non-secretors: recurrent urinary tract infections [5]; kidney scarring
associated with urinary tract infection [32]; meningococcal disease [18]; invasive disease
due to pneumococci [18]; invasive disease due to type b Haemophilus influenzae [19]. A
similar pattern was found among patients with oral or vaginal infections due to yeasts [34].
Patients with diabetes often have problems due to yeast infection and were studied as a model
for these infections in the immunocompromised host. The large cohort of diabetic patients
examined and multivariate analyses allowed dissection of the very different genetic and
6
environmental factors contributing to carriage of yeasts [54] and to oral disease in
individuals with insulin dependent compared with those with non-insulin dependent diabetes
[45],
Respiratory virus infections have been suggested to be one of the factors associated with
bacterial meningitis. When my group tested the hypothesis that non-secretors would also be
over-represented among patients with respiratory virus diseases, the first associations
between secretion of blood group antigens and disease susceptibility were identified:
respiratory disease caused by influenza A and B, rhinovirus, respiratory syncytial virus
(RSV), ECHO viruses [46]; and heterosexual transmission of the human immunodeficiency
virus [47],
The suggestion that autoimmune diseases might be triggered by infectious agents led to
surveys of secretor status among patients with conditions for which infectious triggers had
been postulated. A significantly higher proportion of non-secretors were found among
patients with some rheumatic conditions [21], insulin dependent diabetes mellitus (IDDM) but
not among those with non-insulin dependent diabetes (NIDDM) [23], and Graves' disease [26].
Studies by other groups that identified Helicobacter pylori in patients with peptic ulcer
resulted in reassessment of blood groups and secretor status with reference to presence of
these bacteria [44],
Susceptibility of non-secretors to infectious agents
Since there were no apparent associations between ABO blood groups and the bacterial or
fungal diseases for which there was an association with non-secretion, the following
hypotheses proposed were limited to factors common to all blood groups.
1. If H antigen found on the epithelial cells of all individuals except the very rare Bombay
phenotype can act as a receptor for some microorganisms, the H antigen and Lewisb
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antigens found in body fluids of secretors might bind to the bacterial adhesin, reducing
the probability of colonization of secretors.
2. The Lewis3 antigen found in consistantly greater amounts on the epithelial cells of
non-secretors might act as a receptor for some microoganisms, enhancing the probability
of colonization of non-secretors.
3. As the gene for the third component of complement is found in the same linkage group
as that of the secretor gene, there might be differences in levels of C3 in the sera of
secretors compared with non-secretors.
4. The lower levels of secretory IgA reported for non-secretors might reflect impaired
mucosal responses and contribute to a compromise of epithelial defences.
The role of H as a receptor.
Although boiled saliva from secretors did reduce binding of Candida to epithelial cells [34],
there is little evidence to support the hypothesis that H antigen is a receptor. Binding of
Candida blastospores to cells of non-secretors was greater; therefore, the binding of the
blastospores to epithelial cells could not be proportional to the amount of H expressed.
Cells of non-secretors express significantly lower levels of H than cells of secretors due to
the presence of H type 1 adsorbed from body fluids [42]. A similar pattern of increased
binding to non-secretor cells has been observed for staphylococci [56],
The role of Lewis3 antigen as a receptor.
Although Lewis3 antigen is found on cells of >95% of individuals, it is usually present in
greater quantities on those of non-secretors. Binding of Candida blastospores [35] and some
toxigenic strains of Staphylococcus aureus to cells of non-secretors was greater than to that
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of secretors [51]. Polyclonal antibodies to Lewis3 antigen inhibited binding of the yeast to
cells of non-secretors but not to those of secretors; but, pretreatment of cells of secretors
or non-secretors with polyclonal anti-Lewisb had no effect on binding of the blastospores
[35]. Binding of staphylococci was inhibited by pre-treatment of host cells with monoclonal
anti-Lewis3 antibody; and binding of staphylococci to epithelial of secretors and
non-secretors was significantly correlated with the amount of Lewis3 detected on the
epithelial cells [57].
The amount of Lewis3 expressed on the cells of an individual appears to be constant.
Although epithelial cells of non-secretors usually bind high quantities of anti-Lewis3
antibody and those from individuals who lack the Lewis gene bind very low amounts, the
amount of Lewis3 detected on epithelial cells from secretors is highly variable [51]. This
might explain why studies comparing binding of microorganisms to secretor and non-secretor
cells have given non-significant results in many cases. Even if the microorganism had an
adhesin that recognized Lewis3, differences in binding would not be detected if donors were
matched only for sex and age but not the amount of Lewis3 expressed. If there are adhesins
that bind to Lewis3 present on a variety of microorganisms, one of the factors contributing
to susceptibility of infants to colonization by potentially pathogenic bacteria could be the
fact that both secretors and non-secretors express easily detectable quantities of Lewis3
during the first few months of life [46,51],
Complement levels of secretors and non-secretors
Among healthy participants in a large survey for meningococcal carriage [24], the levels of C3
were lower among non-secretors, but not significantly so; however, among the 8 donors whose
C3 levels were below the lower limits of the normal range, 7 were non-secretors [30]. It had
been reported that among patients with insulin dependent diabetes mellitus (IDDM), but not
those with non-insulin dependent diabetes (NIDDM), the levels of C3 and C4 were lower than
that of non-diabetic individuals. As my studies had found a higher proportion of
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non-secretors among patients with IDDM [23], C3 and C4 levels of these patients were
examined. Both these components were significantly lower among non-secretors with IDDM
[22], The implications of these findings are unresolved, as I have not had resources to
investigate the biological activities of C3 from these individuals or the prevelence of the F
and S variants.
The humoral immune responses of secretors and non-secretors
Based on early reports that non-secretors had lower levels of secretory IgA and serum IgA and
IgG, we examined the hypothesis that these lower levels of IgA might reflect an impaired
immune response to some microorganisms. None of our studies have found evidence to
confirm the earlier reports. Among women treated for 20 years or more for recurrent urinary
tract infections, the levels of total serum IgA and IgG of non-secretors were significantly
higher than those of secretors [20,38]. Among saliva specimens from children examined in the
Stonehouse survey, we found no association between secretor status and total salivary IgA;
there were, however, significantly higher levels of IgA among those children who were
carriers of meningococci, but not those from whom Neisseria lactamica was isolated [36].
Material collected in association with the outbreak of meningococcal disease at the Airdrie
Academy [39] provided the opportunity to measure both total salivary and serum levels of IgA,
IgG and IgM and the amounts of antibodies specific for the neisseriae. Again, we found no
evidence for differences in levels of total or specific serum immunoglobulin between secretors
and non-secretors. There were no differences in the levels of total or specific salivary IgA
or IgG; however, there were significant differences in both total and specific levels of
salivary IgM. Non-secretors had lower levels compared with secretors. Although
immunoglobulin levels were raised among carriers, the effect of secretor status was still
significant [53]. As children under the age of 12 months have little secretory IgA and are
dependent on their secretory IgM for protection of their mucosal surfaces, these differences
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in IgM levels might contribute to the apparent increased susceptibility of non-secretor
infants to colonization or disease.
ENVIRONMENTAL FACTORS CONTRIBUTING TO SUSCEPTIBILITY TO INFECTION
The epidemiological studies of secretor status and oral candidiasis and secretor status and
meningococcal disease have also identified environmental factors that contribute to increased
carriage of these two potential pathogens.
Oral candidiasis and carriage of yeasts
Because non-secretors were found to be over-represented among patients with oral or vaginal
yeast infections [34], the role of secretor status in susceptibility to these infections
among immunocompromised individuals was investigated. Patients with diabetes were chosen
as a model because the prevalence of these infections have been reported to be increased in
this group. They could be assessed more easily and safely than those undergoing
immunosuppressive therapy or those with HIV infection; and there is a large enough
population to obtain statistically relevant numbers, particularly as 18 genetic and
environmental variables were examined. The aetiology and pathogenesis of IDDM and
NIDDM differ significantly, and these studies were the first designed to assess risk factors
leading to oral candidiasis and carriage of yeasts in these two groups of patients. One of
the important observations was that oral candidiasis is not always associated with the
presence of Candida albicans [45],
The risk factors for both disease and carriage differed significantly for patients with IDDM
compared with those with NIDDM. Non-secretion was a significant factor associated with
disease and carriage, but only among patients with NIDDM. In addition, the studies identified
other factors such as the importance of glycaemic control and emphasized the importance of
multivariate analyses in these studies [45,54],
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Bacterial meningitis
Smoking and passive exposure to cigarette smoke
Smoking was identified as a risk factor for meningococcal carriage among the children in the
survey of the Airdrie Academy [39]. As smoking and passive exposure to cigarette smoke
have both been implicated as contributing to meningococcal carriage, studies were carried out
in Greece where there are fewer social restrictions on smoking than in the United Kingdom.
Among the Greek military recruits smoking was a highly significant factor associated with
carriage. Smoking was found to be associated with socioeconomic category; the pattern was
similar to that observed in the United Kingdom. Among men, those in professional classes
were less likely to smoke than those with fewest years of formal education [49].
In a study of carriage of meningococci among Greek school children, the mother's smoking
was significantly associated with carriage of these bacteria. In contrast to the pattern
observed for women in the United Kingdom where smoking is associated with socioeconomic
group as it is for men, approximately a third of Greek women in all socioeconomic groups
smoked. This might explain the observation that carriage rates for meningococci were similar
in the two areas of Athens, one in which socioeconomic indicators were high and one in which
they were significantly lower [58,59].
Gonococcal infection and meningococcal disease
As there appeared to be significant cross-reactivity between meningococci and gonococci, it
was suggested that gonococcal infection might increase bactericidal activity against
meningococci. The results refuted this hypothesis. Compared with sera from women
attending antenatal clinics (a population in which the prevalence of gonorrhoea is very low),
there was little bactericidal activity detected against serogroupable meningococci in the sera
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of patients of both sexes with gonorrhoea. This might be a factor contributing to the
secondary peak of invasive meningococcal disease among teenagers and young adults,
particularly military recruits [10].
Viral infections as predisposing factors for bacterial diseases
Another factor suggested to contribute to susceptibility to bacterial meningitis is
respiratory viral infection. The studies of Greek military recruits suggested that virus
infections in general did not increase carriage of meningococci. Although the proportion of
recruits with respiratory infections was greatly increased during the winter screening
(approximately 34-46%), the proportion of carriers of meningococci (24-31%) was not
significantly increased compared with that observed during the summer (18-30%) when the
proportion of recruits with symptoms of respiratory infection was much lower (approximately
5-7%) [59]. If the general effects of viral infection did not enhance carriage, another
hypothesis is that some viruses induce specific antigens in the epithelial cells of the host
that act as additional receptors for meningococci, enhances their binding to the virus
infected cells.
Several observations led to the use of respiratory syncytial virus (RSV) as a model. It
affects most children by the age of 2 years; and, it occurs most frequently during the winter
months when meningitis is also most common. To test the hypothesis that RSV might be
involved in these diseases, binding of several strains of meningococci and of type b IT
influenzae to uninfected HEp-2 cells and these cells infected with RSV was compared. There
was a significant increase in binding of these bacteria to the virus infected cells [56]; and,
this pattern was also observed for both toxigenic and non-toxigenic strains of S.aureus [56,
57].
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Sudden Infant Death Syndrome (SIDS)
The methods developed for the study of bacterial meningitis have recently been applied to cot
deaths. Analysis of epidemiological studies by other groups with reference to our laboratory
studies suggest the following hypothesis. SIDS occurs during the vulnerable period when
maternal antibodies are declining and the infants's immune system is immature. It has been
suggested that colonization by toxigenic bacteria during this period might be responsible for
some of these infant deaths. Staphylococci and group A Streptococcus pyogenes produce
pyrogenic toxins that result in high fever; and they are "superantigens" having a number of
other physiological effects including induction of powerful cytokines such as TNF and
interleukin 1.
The coincidence of the peak of cot deaths with the reported peak in the proportion of infants
expressing Lewis3 antigen prompted studies on the role of this antigen as a receptor for
toxigenic staphylococci. The enhanced binding of staphylococci to RSV-infected cells
suggested a second factor that might contribute to colonization or density of colonization of
infants by these bacteria [51,56],
These findings assessed in the context of epidemiological studies on cot deaths suggested a
scheme by which various factors might contribute to SIDS. The pyrogenic toxins are
produced by these bacteria between 37-40°C; and the amount of toxin is increased at higher
temperatures. If the infant is colonized by toxigenic bacteria and its body temperature is
increased by viral infection, over-wrapping with clothing or bedding or by being placed in
the prone sleeping position, this might result in significantly increased toxin production.
The toxin could contribute to some of the mechanisms proposed to be involved in these deaths:
heat shock; or, through interleukin 1 induction, the deep sleep state associated in some
instances with apnoea [51,56,57],
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The studies summarized in this introduction have identified both genetic and environmental
factors that contribute to susceptibility to infectious agents. The hypotheses proposed to
explain the epidemiological studies have provided several new insights into the host-parasite
interactions involved in some infectious diseases and provided new approaches to examination
of cot deaths.
Perhaps the major contribution of the work on blood group and secretor status will be
identification and characterization of glycoprotein adhesins that use these carbohydrate cell
surface components as receptors. One of the major problems in development of vaccines
against encapsulated bacteria that cause disease in young children is that infants and
children under the age of 5 do not make long-lasting or effective immune responses to
polysaccharide antigens. Serotype protein antigens of meningococci are under investigation
as vaccines, but will be of limited value. Work in progress in my laboratory has isolated
from outer membranes of meningococci and staphylococci protein components with a
molecular weight of approximately 60,000 daltons reactive with Lewis3. If the material can





1. Blackwell, C.C., Young, H. and Anderson, I.S. 1979. Sensitivity of Neisseria gonorrhoeae
to partially purified pyocines of Pseudomonas aeruginosa and a possible approach to
epidemiological typing. Journal of Medical Microbiology, 12: 321-335.
2. Blackwell, C.C. and Law, J.A. 1981. Typing of non-serogroupable Neisseria meningitidis
by means of sensitivity to R-type pyocines of Pseudomonas aeruginosa. Jouunal of
Infection, 3: 370-378.
3. Blackwell, C.C., Winstanley, F.P. and Telfer Brunton, W.A. 1981. Sensitivity of
thermophilic bacteria Campylobacters to R-type pyocines of Pseudomonas aeruginosa.
Journal of Medical Microbiology, 15: 247-251.
4. Kinane, D.F., Blackwell, C.C., Weir, D.M. and Winstanley, F.P. 1982. Phagocyte
recognition of Neisseria gonorrhoeae. Journal of Clinical and Laboratory Immunology, 9:
168-172.
5. Kinane, D.F., Blackwell, C.C., Brettle, R.P., Weir, D.M., Winstanley, F.P. and Elton, R.A.
1982. Blood group, secretor state and susceptibility to recurrent urinary tract infection
in women. British Medical Journal, 285: 7-9.
6. Kinane, D.F., Blackwell, C.C., Winstanley, F.P. and Weir, D.M. 1983. Blood group,
secretor status and susceptibility to infection by Neisseria gonorrhoeae. British
Journal of Venereal Diseases, 59: 44-46.
7. Blackwell, C.C., Kowolik, M.J., Winstanley, F.P., Kinane, D.F. Weir, D. M., Law, J.A.
and Ho Wang Chok, Y.L. 1983. ABO blood groups and susceptibility to gonococcal
infection I. Factors affecting phagocytosis of Neisseria gonorrhoeae. Journal of Clinical
and Laboratory Immunology, 10: 173-178.
8. Winstanley, F.P., Blackwell, C.C., Weir, D.M. and Kinane, D.F. 1983. ABO blood groups
and susceptibility to gonococcal infection. II. The relationship of lipopolysaccharide
type to gonococcal sensitivity to the bactericidal activity of normal human serum.
Journal of Clinical and Laboratory Immunology, 11: 27-32.
9. Kinane, D.F., Blackwell, C.C., Winstanley, F.P., Weir, D.M. and Elton, R.A. 1983. ABO
blood groups and susceptibility to gonococcal infection. III. role of isohaemagglutinins
in increased association of Neisseria gonorrhoeae to monocytes from blood group B
individuals. Journal of Clinical and Laboratory Immunology, 12: 83-86.
10. Winstanley, F.P., Blackwell, C.C., Weir, D.M. and Kinane, D.F. 1983. Gonorrhoea: a
predisposing factor for meningococcal disease? Lancet ii: 1134-1135.
11. Blackwell, C.C., Kinane, D.F., Winstanley, F.P., Kowolik, M.J. and Weir, D.M. 1984. The
role of the monocyte in gonococcal infection. Proceedings of the Tissue Culture and
Reticuloendothelial Society. Akademia Kaido, pp 199-203.
12. Blackwell, C.C., Winstanley, F.P. and Weir, D.M. 1984. Absence of bactericidal antibodies
against group I lipopolysaccharide determinants of Neisseria gonorrhoeae during human
infection. Journal of Medical Microbiology, 17: 353-356.
16
13. Kinane, D.F., Weir, D.M., Blackwell, C.C. and Winstanley, F.P. 1984. Binding of
Neisseria gonorrhoeae by lectin-like receptors on human phagocytic cells. Journal of
Clinical and Laboratory Immunology, 13: 107-110.
14. Winstanley, F.P., Blackwell, C.C., Tan, E.L., Patel, P.V., Parsons, N. J., Martin, P.V.M.
and Smith, H. 1984. Alteration of pyocin-sensitivity pattern of Neisseria gonorrhoeae is
associated with induced resistance to killing by human serum. Journal of General
Microbiology, 130: 1303-1306.
15. Blackwell, C.C., Andrew, S., May, S.J., Weir, D.M., MacCallum, C. and Brettle, R.P. 1984.
ABO blood group and susceptibility to urinary tract infection: no evidence for
involvement of isohaemagglutinins. Journal of Clinical and Laboratory Immunology 15:
191-194.
16. Blackwell, C.C., Winstanley, F.P., Weir, D.M. and Kinane, D.F. 1985. Host-parasite
interactions influencing susceptibility to diseases caused by the pathogenic Neisseria
species. Fourth International Symposium on the Pathogenic Neisseria Species. American
Society for Microbiology, Washington, D.C. 452-455.
17. Winstanley, F.P., Blackwell, C.C. and Weir, D.M. 1985. Factors influencing susceptibility
to meningococcal disease. Biomedicine and Pharmacotherapie, 39: 167-170.
18. Blackwell, C.C., Jonsdottir, K., Hanson, M.F., Weir, D.M., Brettle, R.P., Todd, W.T.A.,
Chaudhuri, A.K.R. and Mathew, B. 1986. Non-secretion of ABO blood group antigens
and susceptibility to infection with Neisseria meningitidis and Streptococcus pneumoniae.
Lancet, ii: 284-285.
19. Blackwell, C.C., Jonsdottir, K., Weir, D.M. and Hanson, M.F. 1986. Non-secretion of
ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet,
ii: 687.
20. Blackwell, C.C., May, S.J., Brettle, R.P., MacCallum, C.J. and Weir, D.M. 1987. Secretor
state and immunoglobulin levels among women with recurrent urinary tract infections.
Journal of Clinical and Laboratory Immunology, 22: 133-137.
21. Shinebaum, R., Blackwell, C.C., Forster, P., Hurst, N.P., Weir, D.M. and Nuki, G. 1987.
Non-secretion of ABO blood group antigens: a new host susceptibility marker for the
spondarthropathies. British Medical Journal 294: 208-210.
22. Blackwell, C.C., Winstanley, F.P., Weir, D.M. and Kinane, D.F. 1987. Lipopolysaccharide
structure and serum sensitivity of non-serogroupable Neisseria meningitidis. Journal of
Clinical and Laboratory Immunology 24: 29-32.
23. Blackwell, C.C., James, V.S. and Weir, D.M. Gemmill, J.D., Patrick, A. W., Collier, A.,
Clarke, B.F. 1987. Secretor state of patients with type 1 or type 2 diabetes mellitus.
British Medical Journal 295: 1024-1025.
24. Stuart, J.M., Cartwright, K.A.V., Jones, D.M., Noah, N.D., Wall, R.J., Blackwell, C.C.,
Jephcott, A.E. and Ferguson, I.R. 1987. An outbreak of meningococcal disease in
Stonehouse: planning and execution of a large scale survey. Epidemiology and Infection
99: 579-589.
25. Blackwell, C.C., Jonsdottir, K., Mohammed, I. and Weir, D.M. Non-secretion of blood
group antigens. A genetic factor predisposing to infection by Neisseria meningitidis in
J.T. Poolman et al (eds). Gonococci and Meningococci. Kluwer Publishers, dordrecht
1988 pp. 633-636.
17
26. Collier, A., Patrick, A.W., Toft, A.D., Blackwell, C.C., James, V.S. and Weir, D.M. 1988.
Increased prevalence of non-secretors in patients with Graves' disease - evidence for an
infective aetiology? British Medical Journal 296: 1162.
27. Blackwell, C.C., Collier, A., Patrick, A.W., Weir, D.M. and Clarke, B.F. 1988. Secretor
state and complement levels (C3 and C4) among patients with insulin dependent diabetes
mellitus. Diabetes Research 9: 117-119.
28. Blackwell, C.C. 1989. Genetic susceptibility to infectious agents. (Leading Article).
Proceedings of the Royal College of Physicians, Edinburgh, 19: 129-138.
29. Blackwell, C.C., Weir, D.M., James, V.S., Cartwright, K.A.V., Stuart, J.M. and Jones,
D.M. 1989. The Stonehouse study: Secretor status and carriage of Neisseria meningitidis
and Neisseria lactamica. Epidemiology and Infection 102: 1-10.
30. Blackwell, C.C., 1989. The role of ABO blood groups and secretor status in host defences.
FEMS Microbiology Immunology 47: 341-50.
31. Blackwell, C.C. 1989. A.E. Mourant: A biographical note in celebration of his 85th
birthday. FEMS Microbiology Immunology, 47: 315-316.
32. May, S.J., Blackwell, C.C., Brettle, R.P., MacCallum, C.J. and Weir, D.M. 1989.
Non-secretion of ABO blood group antigens: a host factor predisposing to recurrent
urinary tract infections and renal scarring. FEMS Microbiology Immunology 47: 383-388.
33. May, S.J., Rahat, A., Blackwell, C.C., MacCallum, C.J., Brettle, R.P. and Weir, D.M.
1989. Characterization of Escherichia coli strains evaluated from infected urine of
secretor and non-secretor women. FEMS Microbiology Immunology 47: 377-382.
34. Thorn, S.M., Blackwell, C.C., McCallum C.J., Weir, D.M., Brettle, R.P. Kinane, D.F. and
Wray, D. 1989. Non-secretion of blood group antigens and susceptibility to infection by
Candida species. FEMS Microbiology Immunology 47: 401-406.
35. May, S.J., Blackwell, C.C. and Weir, D.M 1989. Lewis3 blood group antigen as a receptor
for Candida species. FEMS Microbiology Immunology 47: 407-410.
36. Blackwell, C.C., Jonsdottir, K., Hanson, M.F., Weir, D.M., Mohammed, I., Cartwright,
K.A.V., Stewart, J.M. and Jones, D.M. 1989. Blood group,secretor status and susceptibility
to bacterial meningitis. FEMS Microbiology Immunology 47: 351-356.
37. Blackwell, C.C., Aly, F.Z.M., James, V.S., Weir, D.M., Collier, A. Patrick, A.W.,
Cumming, C.G. and Clarke, B.F. 1989. Blood group, secretor status and oral carriage of
Candida and other fungal species among patients with diabetes mellitus. Diabetes
Research, 12: 101-104.
38. Blackwell, C.C., May, S.J., MacCallum, C.J., Brettle, R.P. and Weir, D.M. 1989. Secretor
state and susceptibility to recurrent urinary tract infections pp 234-240. In
Host-parasite interactions in urinary tract infections. [Ed. E.H. Kass and C.
Svanborg-Eden].
39. Blackwell, C.C., Weir, D.M., James, V.S., Todd, W.T.A., Banatvala, N, Chaudhuri,
A.K.R., Gray, FI.G., Thomson, E.J. and Fallon, R.J. 1990. Secretor status, smoking and
carriage of Neisseria meningitidis. Epidemiology and Infection 104: 203-209.
40. Blackwell, C.C. and Weir D.M. 1990. Meningococcal disease: high virulence and low
tranmsission? Lancet 336: 53.
18
41. Toft, A.D., Blackwell, C.C., Saadi, A.T., Wu, P., Lymberi, P., Soudjidelli, M. and Weir
D.M. 1990. Secretor status and infection in patients with Graves' disease.
Autoimmunity, 7: 279-289.
42. Rahat, A., Stewart, J., Blackwell, C.C. and Weir, D.M. 1990. A semi-quantitative method
for measurement of H type 1 and H type 2 on buccal cells and in saliva of secretors and
non-secretors. Vox Sanguinis, 59: 101-105.
43. Mentis, A., Tzouvelekis, L., Spilliades, C, Blackwell, C.C. and Weir, D.M. 1990.
Inhibition of Helicobacter pylori haemagglutination activity by human salivary mucins.
FEMS Microbiol Immunol, 64: 125-128.
44. Mentis, A., Blackwell, C.C., Weir, D.M., Spiliades, G., Dailianas, A. and Skandalis, N.
1991. ABO blood group, secretor status and detection of Helicobacter pylori among
patients with gastric or duodenal ulcers. Epidemiology and Infection 106: 221-229.
45. Aly, F.Z., Blackwell, C.C., Mackenzie, D.A.C., Weir D.M., Elton, R.A., Sofaer, J.A. and
Clarke, B.F. (1991). Chronic atrophic oral candidiasis among patients with diabetes
mellitus - the role of secretor status. Epidemiology and Infection 106: 355-363.
46. Raza, M.W., Blackwell, C.C., Molyneaux, P., James, V.S., Ogilvie, M.M., Inglis, J.M. and
Weir, D.M. 1991. Association between secretor status and respiratory viral illness.
British Medical Journal 303: 815-818.
47. Blackwell, C.C., James, V.S., Davidson, S., Wyld, R., Brettle, R.P., Robertson, R.J. and
Weir D.M. 1991. Secretor status and heterosexual transmission of HIV. British Medical
Journal 303: 825-826.
48. Tzouvelekis, L.S., Mentis, A.F., Makris, A.M., Spiliadis, C., Blackwell, C.C., and Weir,
D.M. 1991. In vitro binding of Helicobacter pylori to human gastric mucin. Infection and
Immunity 59: 4252-4254.
49. Blackwell, C.C., Tzanakaki, G., Kremastinou, J., Weir, D.M., Vakalis, N., Elton, R.A and
Mentis, A 1992. Factors affecting carriage of Neisseria meningitidis among Greek
military recruits. Epidemiology and Infection 108: 441-448.
50. Tzanakaki G, Blackwell CC, Kremastinou J, Kallergi C and Weir DM. Antibiotic
sensitivities of meningococcal isolates obtained from patients and carriers in Greece.
Epidemiology and Infection 108: 449-456.
51. Blackwell, C.C., Saadi, A.T., Raza, M.W., Stewart, J., Ogilvie, M.M., and Weir, D.M.
Susceptibility to infection in relation to sudden infant death syndrome. Journal of
Clinical Pathology 45 (supplement): 20-24.
52. Tzanakaki, G., Blackwell, C.C., Kremastinou, J., Kallergi, C., Fallon, R.J. and Weir, D.M.
1993. Serogroups, serotypes and subtypes of Neisseria meningitidis isolated from patients
and carriers in Greece. Journal of Medical Microbiology 38: 19-22.
53. Zorgani, A.A., Stewart, J., Blackwell, C.C., Elton, R.A. and Weir, D.M. 1992. Secretor
status and humoral immune responses to Neisseria lactamica and Neisseria meningitidis.
Epidemiology and Infection 109: 445-452.
54. Aly, F.Z.M., Blackwell, C.C., Mackenzie, D.A.C., Weir, D.M. and Clarke, B.F. 1992.
Factors influencing oral carriage of yeasts among individuals with diabetes mellitus.
Epidemiology and Infection 109: 507-518.
19
55. Raza, M.W., Ogilvie, M.M., Blackwell, C.C., Stewart, J., Elton, R.A. and Weir, D.M. 1993.
Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and
Haemophilus influenzae type b to a human epithelial cell line (Hep-2). Epidemiology and
Infection (in press).
56. Saadi, A.T., Blackwell, C.C., Raza, M.W., James, V.S., Stewart, J., Elton, R.A. and Weir,
D.M. Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells
and their possible role in sudden infant death syndrome. Epidemiology and
Infection (in press).
57. Blackwell, C.C., Saada, A.T., Raza, M.W., Weir, D.M. and Busuttil, A. The potential role
of bacterial toxins in sudden infant death syndrome (SIDS). International Journal of
Legal Medicine (in press).
58. Kremastinou, J., Blackwell, C.C., Tzanakaki, G., Kallergi, C., Chronas, G., Elton, R.A.,
Mentis, A. and Weir, D.M. Parental smoking and carriage of Neisseria meningitidis
among school children. Eighth International Pathogenic Neisseria Conference (in
press).
59. Kremastinou, J., Tzanakaki, G., Mentis, A., Blackwell, C.C.and Weir, D.M. Carriage of
Neisseria meningitidis among military recruits and school-age children in Greece. Eighth
International Pathogenic Neisseria Conference (in press).
ref: ccb/mc/c/cv/ccb-dsc
20
SENSITIVITY OF NEISSERIA GONORRHOEAE TO
PARTIALLY PURIFIED R-TYPE PYOCINES AND A
POSSIBLE APPROACH TO EPIDEMIOLOGICAL TYPING
C. Caroline Blackwell, H. Young and Isabel Anderson*
Department of Bacteriology, Edinburgh University Medical School, Teviot Place. Edinburgh
EH8 9AG. and 'Westminster Medical School, Horseferry Road, London SWIP 2AR _
A rapid, inexpensive typing system for Neisseria gonorrhoeae would be of use
in epidemiological studies, for distinguishing failures of treatment from cases
of reinfection, and in the early recognition of strains that might have special
pathogenic features such as those associated with disseminated infection
(Knapp and Holmes, 1975; Morello, Lerner and Bohnoff, 1976; Schoolnick,
Buchanan and Holmes, 1976; Eisenstein, Lee and Sparling, 1977). Previous
efforts to type gonococcal strains have involved the serological detection of
antigenic differences (Glynn and Ward, 1970; Maeland, Kristoffersen and
Hofstad, 1971; Apicella, 1974; Johnston, Holmes and Gotschlich, 1976; Tra-
mont et al., 1976; Wang et al., 1977), differences in nutritional requirements
(Carifo and Catlin, 1973) and variations in sensitivity to bacteriocines (Flynn
and McEntegart, 1972; Walstad, Reitz and Sparling, 1974; Knapp, Falkow
and Holmes, 1975; Lawton et al., 1976).
Observations on the production of pyocines and demonstration of sensitiv¬
ity to these bacteriocines have been us«i as the basis of typing systems for
Pseudomonas aeruginosa (Farmer and Herman, 1969; Govan and Gillies,
1969). Sensitivity to R-type pyocines has been reported for strains of N.
gonorrhoeae (Morse et al., 1976) and the possible use of pyocines as a typing
tool has been investigated (Sidberry and Sadoff, 1977). Three types ofbacterio¬
cines have been described in Ps. aeruginosa: soluble bacteriocines (S-type)
similar to the colicines of Escherichia coli (Ito, Kageyama and Egami, 1970),
rod-type (R-type) particles resembling defective bacteriophages (Kageyama,
1964), and the flexuous F-type bacteriocines (Govan, 1974i). The R-type and
F-type pyocines were chosen for the present study because they can be sedi-
mented by ultracentrifugation and are visible in electron micrographs; these
qualities allow their partial purification and separation from the S-type pyo¬
cines and other soluble inhibitory substances produced by Ps. aeruginosa.
Using 23 pyocine preparations, Sidberry and Sadoff (1977) obtained 30
sensitivity patterns among 106 strains of N. gonorrhoeae but the majority of the
strains fell into two groups and further evaluation of the method with gonococ¬
cal isolates from several sources was suggested by the authors.
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Matejuaxj and methods
Micro-organisms and culture media. Strains of Ps aeruginosa producing the R-type pyocines
listed in table I were obtained from Dr John Govan of this department. Kageyama (1975)
classified many R-type pyocines on the basis of their spectrum of activity, and strains from
groups Rl, R2, R3 and R5 were specifically chosen for use in this study. The Kageyama
classification for the R-type pyocines produced by these strains is given when known. Strains of
Ps. aeruginosa from which F-type pyocines were obtained werepp430, Fl, R186, Ep520, Epl 11,
R34, R7095, Ep274, Ru84, and Ep 397. Strains of Pseudomonas were maintained by subculture
on nutrient agar every 7 days. N. gonorrhoeae strains were supplied by the Center for Disease
Control (CDC), Atlanta, Ga, USA and the Royal Infirmary, Edinburgh (RIE). Organisms from
disseminated infections were obtained from Dr Joan S. Knapp, Neisseria Reference Laboratory,
Table I
Pyocine-producing strains of Pseudomonas aeru¬

















R5 ISC IS4, IS5
Unclassified R205 ISC
. .. = Not available for examination.
United States Public Health Service, Seattle, Washington; these included prototrophic strains
and strains of different auxotypes from three geographic areas: Atlanta, Indianapolis, and
Seattle. All RIE organisms had been identified as N. gonorrhoeae on the basis of Gram stain,
oxidase reaction and sugar utilisation. On arrival at our laboratory each was retested for oxidase
reaction and Gram staining. Strains were stored in skimmed milk at — 20°C. The gonococcal
strains were maintained on either Thayer Martin medium (TM) or modified New York City
medium (MNYC; Young, 1978). When needed, colony types Tl, T2, T3 and T4 were selected
from GC Medium (Difco) with the aid of a stereoscopic microscope with a double system of
substage lighting (Jephcott and Reyn, 1971).
Sensitivities to antibiotics were determined on clear GC Medium (Difco) with the following
additions per 960 ml after autoclaving: 0-5% (w.v) ferric nitrate (British Drug Houses) 10 ml, GC
supplement* 20 ml, 20% (w.v) glucose 10 ml. Antibiotics were added to GC agar at the following
concentrations: penicillin G (Glaxo) sodium salt: 0-015,0-03,0-06,0-125,0-25,0-5,1,2 units/ml;
tetracyline hydrochloride (Achromycin, Lederle Ltd): 0-05,0-1, 0-25,0-5, 1 /ig/ml; spectinomy-
cin hydrochloride (Trobicin, Upjohn Ltd): 2, 4, 8, 16 /ig/ml; chloramphenicol (Chloromycetin.
Parke-Davis Ltd): 0-1,0-2,0-4,0-8, 1-6 /ig/ml; lincomycin hydrochloride (Upjohn Ltd): 4, 8, 16,
32 /ig/ml.
• GC supplement: L glutamine (Koch Light Chemicals) 0-5 g, cocarboxylase (British Drug Houses) 0-01
g, water to 100 ml 20%.
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Antibiotic-sensitivity testing Visibly turbid suspensions (approximately 1 x lC-3 x 101
colony-forming units/ml) of gonococci were made in NaG 0-85% (w/v) containing soluble
starch 1% (starch-saline). Portions of the suspension were placed in the wells of a Steers
replicator which delivered approximately 0 0025 ml of the suspension to the antibiotic plates
(Steers, Foltz and Graves, 1959). The same suspensions were also used for the assay of sensitivity
to pyocines. The plates were then incubated for 48 h at 37°C with 10% COj in a Searle Quabtemp
(80 TQ CO- incubator. Minimal inhibitory concentration (MIC) was recorded as the lowest
concentration of antibiotic at which there were five or fewer colonies per spot inoculated.
Induction andpreparation ofpyocines. Pyocine preparations were obtained by a modification
of the method of Govan (1974a). From an overnight nutrient-broth culture, 2 ml was added to
25 ml ofsodium glutamate broth (SG B) which contained sodium glutamate20g, glucose (20% w/v
solution) M "mT.ThaJnesmm^ulphateTMgSUrTHjOrtriHg, Hisodium hydrogen~phosphate
fNa^H Kl. 1 -iti-Pl yii g. potassium dihydrogcn phosphaTeTKHyPOj) 025 g, calcium nitrate
10 mg. veast extract 1 g and distilledwaTerlo I lure The sterile gTuCOseln solution (Seitz filtered)
was added to the cooled autoclaved medium before use (Kageyama and Egami, 1962).
The pseudomonads were incubated at 30°C in an orbital incubator (Gallenkamp) at 100
r.p.m. for 2-5 h. Mitomycin C (1 -5 pg/ml) was added at this point and the cultures were incubated
for another 2-5-3 h. The lysates were centrifuged at 10 000 g for30min. to remove bacterial cells
and debris; each supernatant was decanted, shaken with chloroform 5% (v/v) and stored at 4°C.
This preparation was the crude pyocine lysate.
The crude lysate (12-5 ml) was ultracentrifuged at 100 000 g for 3 h and the supernatant
containing S-type pyocine activity and other soluble inhibitory substances was discarded. The
pellet containing the R-type activity was resuspended in 10 ml 0 01m Tris buffer (pH 7-5)
containing 0-OIm MgG^H^D and 0 01m MgSOtTH-O (referred to hereafter as Tris buffer). This
partially purified pyocine preparation was stored at 4°C.
Assay ofpyocine activity against Ps. aeruginosa and N. gonorrhoeae. Pyocine activities of the
crude lysates and the partially purified preparations were assayed by spotting doubling dilutions
on nutrient-agar (NA) plates and MNYC plates and allowing the spots to dry. The NA plates
were then flooded with the appropriate standard strains of Ps. aeruginosa (indicator strains)
known to be sensitive to the particular test pyocine. Sensitive and resistant gonococcal strains,
identified in pilot studies, were tested on MNYC.
Partially purified pyocine lysates were diluted 1 in 2 in Tris buffer and spotted with a dropper
pipette calibrated to debver 0 02 ml on plates of GC, MNYC orTM medium and allowed to dry.
Overnight plate cultures of gonococci were suspended in starch-saline and used to flood the
plates to produce a confluent lawn. The plates were allowed to dry and incubated overnight at
37°C aerobically with 10% CO2. Some gonococci grew more slowly and were incubated for an
additional 24 h. Results were recorded as + = inhibition, + = inhibition with some over¬
growth, — = no inhibition. Ps. aeruginosa indicator strains were included in each test as well as
the gonococcal strains CDC486 or CDC046, which were sensitive to most pyocines tested, and
strain 879 which was resistant to most pyocines tested. The sensitivity of a gonococcal strain to
each pyocine was examined at least three times. Preparations were assayed regularly to monitor
levels of active pyocines. Those with low litres usually gave equivocal or negative results. Table
III includes representative data of pyocine titres and sensitivities of sensitive strains CDC486,
CDC046 and resistant strain 879.
Serotyping of meningococci and sulphadiazine sensitivity testing were done by Dr R. J.
Fallon, Department of Laboratory Medicine, Ruchill Hospital, Glasgow.
Results
Preliminary studies
None of the F-type pyocines listed (see Methods) inhibited any of 84
gonococcal strains against which they were tested in pilot studies. Several of
the R-type pyocines were able to inhibit 94-5% (104/110) of the gonococcal
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strains selectively. Inhibition was observed on clear GC, TM, or MNYC or
media; the darker background of the TM and MNYC plates facilitated read¬
ings and these media were less subject to contamination. Addition of 1%
soluble starch or 2% bovine serum albumin to the GC plates did not affect
inhibition of gonococci by the pyocines.
Comparison ofsensitivities ofdifferent indicators to the test pyocines
Two types of zones of inhibition corresponding to those found for soluble
(S-type) and rod-type (R-type) pyocines were observed with the gonococci.
The S-type zones resembled those found with soluble bacteriocines (Fredericq,
1957) or other inhibitory substances that diffuse readily into agar away from
the site of inoculation. Large zones of this type were observed with crude
lysates. Typical R-type zones—smaller, discrete zones of inhibition limited to
the site of inoculation (Ito et al.. 1970)—were found with the partially purified
ultracentrifuged preparations. Table II illustrates the differences in inhibition
produced by crude lysates and the partially purified pyocines. These were
titrated against the appropriate Pseudomonas indicators and two gonococcal
strains, one that had appeared to be resistant to pyocines tested in the pilot
studies and one that appeared to be sensitive to many of the pyocines. Ultra-
centrifugation separated the heavier R-type particles from the S-type pyocines,
pigments, and other soluble substances that had an inhibitory effect on the
gonococci. The pyocines in table II were selected as examples of this effect
because the partially purified pyocines of Kageyama groups R2 and R3 did not
inhibit gonococci under the conditions used in the survey but the crude lysates
did. These observations are of importance when our results are compared with
those of other workers.
The concentration of the gonococcal inoculum usually made little differ¬
ence to the inhibition observed with a series of twofold dilutions of pyocines up
to 1 in 8192. Undiluted gonococcal inocula and tenfold dilutions up to 1 in 100
Table II




Titre of the stated pyocine, preparation in tests with
Pseudomonas sensitise resistant
indicator gonococci gonococci
Crude Ultracentri- Crude Ultracentri- Crude Ultracentri-





1024 128 128 1* 8 0»
8192 4096 128 4 8 0
8192 8192 32 1 8 0
8192 8192 32 1 8 0
* 1 = Undiluted preparation; 0 = do inhibition.
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were tested. A more dilute suspension occasionally gave a clearer zone of
inhibition; strains were retested with diluted suspensions when only faint
reactions (±) were obtained with undiluted preparations. The partially puri¬
fied pyocine preparations were diluted in twofold steps to 1 in 8192 and each
dilution was spotted on to appropriate plates for assay of inhibitory activity
against a known standard sensitive strain of Ps. aeruginosa, a sensitive gono¬
coccal strain and a resistant gonococcal strain. The titres of inhibitory activity
for the pyocines of Kageyama groups R1, R2, R3, and R5 and the pyocine that
is unclassified are outlined in table III.
Tabu 111
Comparative. sensitivities of Ps. aeruginosa and N.
gonorrhoeae to partially purifiedpyocines
R-type pyocines
from Titre of the partially purified pyocine
preparation in tests with
Kageyma Ps. aeruginosa sensitive resistant
group strain indicator gonococci gonococci
Rl IS4 8192 1024 0
IS6 8192 1024 0
IS8 8192 1024 0
2285 8192 1024 1
ISD 1024 128 0
R2 ISB 128 0 0
pp430 8192 1 0
R21 40% 4 0
R3 ISE 8192 1 0
R4
R5 ISC 2048 1024 0
Unclassified R205 8192 1025 0
Footnote as in table 11.
Group Rl. Preparations of pyocines in this group were potent in tests
gainst the sensitive Pseudomonas indicator strain, and less potent against
ensitive gonococci strain CDC486 or CDC046, usually by three dilution
ubes. There was only a slight inhibition of the "resistant" strain 879 by the
tndiluted strain 2285 pyocine.
Group R2. Although the titres for pyocines pp430 and R21 on sensitive
trains of Ps. aeruginosa were similar to those for pyocines for group Rl, the
snsitivity of gonococci to these pyocines was dramatically lower and not
sliably reproducible. The titre for pyocine ISB determined with Ps. aeruginosa
:>r this set of tests was lower than that of pp430 or R21 and no inhibition of
onococci was noted. Slight inhibition of the sensitive gonococcal strain was
bserved with another preparation ofpyocine ISB that had a higher titre on the
:nsitive Pseudomonas indicator, but this was only with the undiluted pyocine.
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Group R3. The only example of this group, pyocine ISE, yielded results
similar to those observed with pyocines of group R2—high titres on tests
against the sensitive Ps. aeruginosa indicator strain but little or no reproducible
activity against gonococci tested.
Group R4. Our collection did not include a member of this group.
Group R5. Results obtained for pyocine ISC were similar to those found for
pyocines of group R1 —high titres on sensitive Ps aeruginosa strain and slightly
lower titres for sensitive gonococci.
Unclassified. Pyocine R205 was not classifiable in any of the Kageyama
groups. Its titres on sensitive strains of Pseudomonas and gonococci were
similar to those found for groups R1 and R5.
At the higher dilutions of each pyocine, areas of inhibition of growth
became increasingly turbid. Morse etal. (1976) made similar observations and
suggested that this was evidence for a non-replicating inhibitory substance.
Not all strains were sensitive at the same dilutions of the pyocines; therefore a
dilution of 1 in 2 was chosen for the screening procedure. This dilution would
provide a large number of pyocine particles and correspond to the dilution
used by Sidberry and Sadoff (1977).
Typing ofNeisseria spp. with partially purifiedpyocine preparations
Isolates from different sites of individual patients as well as isolates from
known consorts were tested for sensitivity to pyocines and antibiotics. A
typical set of results is presented in table IV. Sensitivities to penicillin G,
lincomycin, tetracycline, chloramphenicol, and spectinomycin were deter¬
mined for each isolate with the same culture suspension that was used for
determining pyocine sensitivities. These "matched" isolates usually had very
similar pyocine patterns and identical patterns of sensitivities to the above
antibiotics. We observed no correlation between patterns of pyocine sensitivi¬
ties and sensitivity to any particular antibiotic.
In table V pyocine-sensitivity patterns for CDC and RIE strains are
compared. There was a broader distribution of strains than that found by
Sidberry and Sadoff (1977). Although there were differences in numbers per
pyocine type in the two groups, there were only five small patterns—F, G, I, J
and M—that were found among the CDC isolates but not the RIE ones.
Table VI presents pyocine-sensitivity patterns for strains from disse-
infections. There were no extraordinary sensitivities, e.g., to pyocines of
Kageyama groups R2 or R3. Patterns of sensitivity were not associated with
particular sites of isolation, penicillin sensitivity or auxotypes. The majority of
strains from each of the three geographic regions had similar patterns.
Strains of Neisseria meningitidis from patients attending the Department of
Venereology were also collected and several were tested for sensitivity to
pyocines. Only two of those sent for typing were serotypable; strain 1042B was
of serotype W135 and strain 1055A was of type Z'. The majority were serologi¬
cally nontypable but were of different pyocine types. There were two patients
from whom meningococci were isolated from genital sites. Strain 330B was
TableIV
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found in a cervical culture and strains 9102 A, B, C, and D from cervix, urethra,
rectum, and throat respectively. The genital isolates from these two patients
were non-typable serologically and had different pyocine types. Three of the
four isolates from patient 9102 had similar patterns of pyocine sensitivity and
similar sensitivities to sulphadiazine (1-5 mg/mJ). Strain 9102A was less sensi¬
tive to sulphadiazine (5-10 mg/ml) than the other three isolates and had a
different pyocine-sensitive pattern (table VII). Further studies are in progress
with a larger group of meningococci from different serological groups and
sources.
Discussion
These results are additional evidence that tests for sensitivity of gonococci
to R-type pyocines may provide a rapid, simple, inexpensive method for typing
N. gonorrhoeae (Sidberry and Sadoff, 1977). Isolates from consorts or from
different body sites of individual patients could generally be identified as being
similar strains. Patterns of antibiotic sensitivities for these matched isolates
agreed with the findings for pyocine sensitivities. Sensitivity to pyocines
appears to be a stable characteristic. A fresh local isolate and a strain from a
disseminated infection, both subcultured twice a week for over a year, have
maintained their original patterns of sensitivity to the pyocines tested.
Preliminary results with organisms from several sources (CDC collection)
and local isolates indicated that there is a broader distribution among the
pyocine sensitivity types of gonococci observed than that found by Sidberry
and Sadoff (1977) with their isolates from limited geographical locations.
Using 23 pyocine lysates they found 30 types; but a majority of their strains
48% (51/106) fell into one group and 18% (19/106) into a second group. We
found 15 types in tests with 11 pyocines and there are several more types to be
defined with the additional pyocines being used in our present studies.
Table VIII presents an analysis of our results compared with those of
Sidberry and SadofT (1977). The analysis is based on the schematic represen¬
tation of pyocine receptors in Ps. aeruginosa proposed by Kageyama (1975). It
was observed in our study that if a gonococcal strain was sensitive to any of the
pyocines, it was sensitive to ISC, a pyocine of Kageyama group R5; the
gonococcal strains in both studies were most often sensitive to members of this
group. Fewer strains were inhibited by pyocines of group R1 and the propor¬
tions of strains inhibited by this group of pyocines were similar in both studies.
Our results differed in that we were unable to detect reproducible inhibition by
R2 and R3 pyocines among the gonococcal strains tested. Crude lysates of R2
and R3 pyocines produced large S-type zones of inhibition on the "sensitive"
(CDC486) and "resistant" (879) standard strains of gonococci, but the ultra-
centrifuged preparations did not inhibit either strain. Because the preparations
used in Sidberry and SadofFs studies were equivalent to our crude lysates,
some of the inhibition by R2 and R3 pyocines that they observed with a few
gonococcal strains may have been due to the presence of material other than
the R-type pyocines.
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Table VIII
Inhibition of N. gonorrhoeae by pyocines ofKageyama
groups RI-R5; comparison of results with those of Sid-
bery and Sadoff (1977)
Percentage of N. gonorrhoeae isolate! of indicated strain
inhibited by pyocines of Kageyama group
R3* R4* R2* Rl* R5*
1-9-4 H = 21 -8 D = 0-9 K =74 A-100
F = 2 8 L = 19 B = 100
1 =16-4 M = 74-5 C = 100
U = . . . N =76-8 E = 99-1





(Sidberry sod Sadoff, 1977) T =61-4
1SE = 0 ... ISB =0 ISD =84-5 ISC = 94 5
R21 =0 IS4 =72-7
430 =0 IS6 =67-3
ISS =32-7
(This study) 2285 = 42-7
* Arranged in the order of the receptor sites on the lipo-
polysacchande fractioo of Pi aeruginosa suggested by
Kageyama (1975); the receptor for R5 is nearest to and that
for R.3 is furthest from the cytoplasm.
The receptor site for the R-type pyocines is in the lipopolysaccharide (LPS)
(LPS) of Pseudomonas (Ikeda and Egarai, 1973; Govan, 1974a; Koval and
Meadow, 1977) and a similar location has been suggested for Neisseria (Sid-
berry and Sadoff, 1977). Table VIII is based on Kageyama's (1975) proposed
pyocine receptor sites for his groups R1-R5 in the LPS of Pseudomonas. The
receptor for R5 is in the portion of the LPS nearest the cytoplasm. The other
receptors, in order towards the most distal portions of the LPS, are R1, R2, R4,
R3. The "R" numbers correspond to sites thought to be essential for sensitivity
to each pyocine; e.g., mutants lacking the receptor for R3 were resistant to
pyocines of the R3 group but sensitive to those of groups Rl, R2, R4, and R5.
If the receptors for R-type pyocines in Pseudomonas and in gonococci are in the
LPS, this analysis suggests a similarity in the "deeper" portions of the LPS of
Neisseria and Pseudomonas. Other workers have also found that colony types
T1 and T4 of the same strain showed no difference in sensitivity to the pyocine
R-type 611, 131 (Morse el al., 1976), indicating that pili probably do not form
part of the receptor sites for the pyocines examined. The receptors for F-type
pyocines are not found in the LPS fractions of Pseudomonas (Govan, 1974b)
and, significantly, we did not find any inhibition of gonococci with the 10
F-type pyocines tested.
Gonococci from disseminated infections did not have unique pyocine
sensitivities differing from those found for strains from localised infections.
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The sensitivity of Salmonella typhimurium to some bacteriophages depends on
the presence of receptor sites in the O repeat units of the LPS. Mutants that
have lost these outer portions, rough or R-mutants, are less virulent than the
smooth wild type. They are also insensitive to bacteriophages that attack the
wild type because they lack the receptor (Rapin and Kalckar, 1971). If there
were a unique portion in the outer LPS of the strains from disseminated
gonococcal infection that resulted in serum resistance, or increased resistance
to phagocytosis, it might be detectable with pyocines. Sensitivity was antici¬
pated to pyocines of Kageyama groups R2 and/or R3, but no reproducible
sensitivities were observed.
These findings are encouraging although further investigation with an
emphasis on purification, standardisation and storage of the pyocine prepa¬
rations used at present is clearly needed. Testing of other pyocines of the
various Kageyama groups would be of value. Partially purified preparations of
R2, R3 and R4 pyocines from other sources need to be examined to determine
whether there are LPS receptors for these groups or whether the inhibitory
effects reported by Sidberry and Sadoff (1977) were due to material other than
the R-type pyocines. Pyocines that are "unclassified" by the Kageyama scheme
may be useful because we have evidence for the selective inhibition of gono-
cocci by pyocine R205 in the present study. In addition, selection of gonococ¬
cal indicator strains will be necessary.
Preliminary experiments indicate that this system may be able to differen¬
tiate strains of Neisseria meningitidis that are nongroupable by present serolog¬
ical methods.
Summary
Strains of Neisseria gonorrhoeae from a variety of sources were examined
for sensitivity to 11 partially purified R-type pyocines from Pseudomonas
aeruginosa. Selective inhibition of gonococci by pyocines of Kageyama groups
R1 and R5 was observed. "Matched isolates", those from consorts or different
body sites of individual patients, usually had very similar pyocine-sensitivity
patterns and identical sensitivities to five antibiotics tested. This study included
local isolates, strains from diverse geographic regions, and strains from dissem¬
inated gonococcal infections. It also proposed a relationship between pyocine-
receptor sites in the lipopolysaccharide of Ps. aeruginosa and N. gonorrhoeae.
Topics needing further evaluation are discussed.
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Typing of non-serogroupable Neisseria meningitidis by
means of sensitivity to R-type pyocines of Pseudomonas
aeruginosa
C. Caroline Blackwell and Jacqueline A. Law
Department of Bacteriology, University of Edinburgh,
Medical School, Teviot Place, Edinburgh EH8 9AG
Summary
Thirty-three (66 per cent) of 50 non-serogroupable isolates of Neisseria meningitidis could be
typed on the basis of their sensitivities to partially purified rod-type (R-type) pyocines from
13 strains of Pseudomonas aeruginosa. Only seven (11 per cent) of 63 serogroupable
meningococci were sensitive to the test pyocines. The pyocine typing method is particularly
applicable to the labelling of strains in which autoagglutinability precludes the standard
agglutination typing procedure.
Introduction
Our interest in non-typable strains of meningococci was stimulated by
isolation of these organisms from the genitourinary tract and rectum of
several patients attending the Department of Genitourinary Medicine,
Royal Infirmary Edinburgh (Blackwell, Young and Bain, 1978).
Conventional serotyping of Neisseria meningitidis is based on bacterial
agglutination tests that detect differences in meningococcal capsular poly¬
saccharide antigens; nine major groups are recognised. Table I lists these
Table I Serogroups of N. meningitidis
Serogroup Group specific polysaccharide
A N-acetyl-3-O-acetyl mannosamine phosphate (al-6)
B N-acetyl neuraminic acid (<*2-8)
C N-acetyl and O-acetyl neuraminic acid (a2-9)
D Not determined
W135 4-0-a"D-galactopyranosyl-/?-D-N-acetyl neuraminic acid
X N-acetyl glucosamine phosphate (crl—t)
Y N-acetyl neuraminic acid: glucose
Z l-0-2-acetamido-2-deoxy-cr-D-galactopyranosyl-glycerol 3'-phosphate
Z' (29E) 3-deoxy-D-marmo-octulosonic acid
0163—1453/81/040370+ 09 $01 00/0 © 1981 The British Society for the Study of Infection
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groups and the chemical compositions of the specific polysaccharides that
have been determined (Bhattacharjee, Jennings, Kenny, Martin and Smith,
1976; WHO, Technical Report Series, 1976; Jennings, Rosell and Kenny,
1979). There are, however, a number of meningococcal isolates that are not
classifiable by this system, i.e. non-serogroupable strains. They are 'non-
agglutinable', reactive with none of the specific group antisera; 'polyagglu-
tinable', reactive with more than one specific group antiserum; or 'auto-
agglutinable' in diluent in the absence of serum. Non-groupable mening¬
ococci that we isolated from the urethra and cervix of patients were found
to be sensitive to partially purified rod-type pyocines produced by Pseudo-
monas aeruginosa (Blackwell, Young and Anderson, 1979). It seemed
important to follow up this finding as a possible aid to epidemiological
tracing.
Materials and methods
Standard serotypes, representative strains of each serogroup, and various
non-groupable strains of N. meningitidis were obtained from the following
sources: Bacteriology Laboratory, Royal Infirmary Edinburgh (RIE): Dr
R. J. Fallon, Ruchill Hospital, Glasgow; Professor J.-P. Albert and Dr J.
Etienne, Centre Collaborates, O.M.S. de Reference et de Recherche pour
les Meningocoques, Marseille-Armees, France. Dr W. D. Zollinger, Wal¬
ter Reed Army Medical Center, Washington, D.C. kindly supplied us with
meningococcal prototype LPS serotype strains. On receipt at our laboratory
each was retested for oxidase reaction and Gram stain. Strains were stored
in skimmed milk at —20°C or maintained on modified New York City
Medium (MNYC) (Young, 1978). Strain RIE 1339 of N. gonorrhoeae and
strain ZD9 39 of Ps. aeruginosa (from Dr M. Kageyama, Mitsubishi-Kasei
Institute of Life Sciences, Tokyo) were used as positive controls for each
test.
Strains of Ps. aeruginosa producing R-type pyocines listed in Table II
were obtained from Dr John Govan of this department. Kageyama (1975)
Table II Pyocine producing strains of Ps. aeruginosa
Kageyama classification of
R-type pyocines Pyocine producing strains
R1 ISD. 2285. IS4. IS6. IS8




Noogroupable R205 . 9579
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classified a number of R-type pyocines on the basis of spectrum of activity,
and strains from his groups Rl, R2, R3 and R5 were specifically chosen for
this study. A representative of group R4 was not available at the time.
Preparations of R-type pyocines were induced and partially purified as
described previously (Blackwell, Young and Anderson, 1979). Sensitivity
of meningococci to the pyocines was determined using the same method
employed for N. gonorrhoeae (Blackwell, Young and Anderson, 1979)
Serogrouping and sulphadiazine sensitivity tests of meningococcal isolates
from RIE were done by Dr R. J. Fallon.
Results
It was observed that if a meningococcal isolate was sensitive to any of the
pyocines tested, it was usually sensitive to the pyocines of group R5 and the
unclassified pyocine 9579. Those sensitive to pyocines of group Rl were
also sensitive to those of groups R5 (ISA and ISC) and 9579. N<
meningococcal isolate was sensitive to pyocines of groups R2 and R3. Ou
gonococcal isolates had similar patterns of sensitivity to the classifier
pyocines (Blackwell, Young and Anderson, 1979) and also to 9579
Standard pyocine sensitive strains of Ps. aeruginosa, N. gonorrhoeae and A
meningitidis were tested in each experiment to monitor the activity of the
pyocine preparations. As the pyocine preparations aged some of the -
reactions became ± reactions. This could be correlated with a fall in titre o
pyocine activity against the pseudomonas, gonococcal and meningococca
indicator strains.
Sensitivity to pyocines appears however to be a stable and reproducible
property. A non-serogroupable strain (468) has been subcultured,twice pe:
week for over two years and it has maintained its original pattern o
sensitivity to the pyocines tested. Over a six-week period, three othe:
isolates with three different patterns of pyocine sensitivity were subculturec
twice weekly and tested every two weeks. The patterns of pyocint
sensitivity had not altered during this time. Storage of isolates in skimmec
milk at — 20°C for a year did not affect the pyocine sensitivity patterns.
Five groups of meningococcal isolates were examined:
(a) reference strains and clinical isolates of each serogroup;
(b) non-groupable isolates from Marseilles, Edinburgh and Glasgow;
(c) prototype LPS serotype strains;
(d) pharyngeal isolates of patients attending the sexually transmitted
diseases clinic. Royal Infirmary, Edinburgh;
(e) genitourinary and rectal isolates from patients attending the sexualK
transmitted diseases clinic. Royal Infirmary, Edinburgh.
The reference strain for each serogroup and representatives of each
group obtained from Dr Fallon and from our clinical laboratory were tested
on at least three occasions for sensitivity to pyocines. Table III lists these
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Table III Numbers of serogroupable isolates sensitive to partially
purified pyocines
No sensitive to one










Percentage total sensitive "II.
• Two of the Frasch serotype strains M978 and M982 showed sensitivity to some of
the pyocines.
t The reference strain Z was the only available representative of this group.
reference strains, number of isolates of each serogroup tested, and the
number of isolates sensitive to one or more pyocines. Seven (11 per cent) of
the 63 serogroupable strains were reproducibly sensitive to one or more
pyocines. Serogrouping of these isolates confirmed that they were express¬
ing their group polysaccharide.




one or more pvocincs ()
Marseilles 12 4 33-3
Edinburgh 14 13 92K
Glasgow 24 16 66-7
Total 50 33 66*
* Percentage total sensitive.
Of the 50 non-groupable strains examined, 33 (66 per cent) were sensitive
to one or more pyocines (Table IV). There was no apparent difference in
sensitivity to the pyocines among the non-groupable, polyagglutinable or
autoagglutinable strains. Table V shows the types of patterns observed and
the distribution of these patterns among isolates from the three different
sources: Glasgow, Edinburgh and Marseilles. Five of the patterns
observed—A, B, L, N, O—are similar to those found for N. gonorrhoeae
(Blackwell, Young and Anderson, 1979).



















































































































*Letterscorr spondtsimilarpatternsobservedmongis lat fN.gon rrhoeae(B ckwell,Y ungndA d rson,1979).
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Table VI Pyocine sensitivities of LPS serotype strains
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Kageyama group
R1 Unclassified R3 R2 R5
Prototype
strain
Serotype (serogroup) ISD 2295 IS4 IS6 ISS R205 9579 ISE 1SB R21 430 ISA ISC
LI 1263 (C)





L7 6155 (B) - - + - - - - * -*■
L8 M978 (B) + + + + ♦ + — — - - ♦ +
L9 120M (A) - - -f — - — —
L10 7880 (A) — - - - - - + — — — — i ♦
+ » inhibition; ± * inhibition with some overgrowth; - » no inhibition.
Pyocine sensitivities of meningococcal strains with different LPS com¬
positions obtained from Dr W. D. Zollinger are shown in Table VI.
Serotypes LI, L3, L4, L5 and L6 were insensitive to the pyocines tested.
Serotypes L2, L7, L9 and L10 had similar sensitivities to pyocines ISA, ISC
and 9579. Strain M978, serotype L8, was sensitive to pyocines of groups R1
and R5 and also the two unclassified pyocines R205 and 9579.
Table VII Pyocine sensitivities ofN. meningitidis from pharyngeal
cultures
Kageyama group
R1 Unclassified R3 R2 R5
No. of





1 + + _ + + +
2 + - + + +
1 +- + + + + + -- -- -
3 + + + + - + + -- -- +
1 + + + + + + + -- -- +
+ « inhibition; ± » inhibition with some overgrowth; - » no inhibition.
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A group of 30 pharyngeal isolates was then tested for sensitivity to
pyocines. Eleven (36-7 per cent) were resistant to all the pyocines tested
Six of the 19 isolates showed a single pattern and the remainder fell into 1(
groups (Table VII). Seven of the 30 isolates, each with a different pattern
of sensitivity to the pyocines tested, were sent for serogrouping. Five were
non-groupable, one was group Z and one was group W135. The W135
strain was resistant to each of the pyocines tested.
Table VIII Pyocine sensitivities of N. meningitidis from rectal or
genitourinary cultures
Kagevama group






no. ISD 2285 IS4 IS6 IS8 ISB R21 430 ISE ISC
A NG 0-1-1 cervix + _ _ _
B NG urethra — - - - ------ -
CI NG 1-5 urethra +- + + + 4- — — — — — 4-
C2 NG 5-10 cervix + - - + + — — 4.
C3 NG 1-5 rectum + + +
C4 NG 1-5 throat + + + ■f ----- 4-
D NG 1-5 urethra -t- - + + •f ----- -r
E NG urethra -r - + + ■f — — — — — 4-
F NG urethra - - 4- + + - — - — - 4-
. . . = not done: + = inhibition: ± - inhibition with some overgrowth: - = no
inhibition.
Isolates of N. meningitidis cultured from throat, urethra, rectum or cervix
of patients attending the Department of Venereology, Royal Infirmarv.
Edinburgh were examined for serogroup, sulphadiazine sensitive and
sensitivity to pyocines. In Table VIII these data for isolates from six
patients are compared. Although the meningococcal isolates were non-
serogroupable, they could be separated into groups based on sensitivity to
pyocines. Among the isolates from patient C, those from the urethra,
rectum and throat had similar pyocine sensitivities and similar sensitivities
to sulphadiazine. The cervical isolate differed in its pyocine sensitivity
pattern and it was also more resistant than the other three to sulphadiazine.
Discussion
Sensitivity of Neisseria gonorrhoea to pyocines is thought to depend on the
presence of specific receptor sites within the lipopolysaccharide (LPS)
(Sidberry and Sadoff, 1977; Blackwell, Anderson and Young, 1979). A
number of investigations have reported similarities between the LPS
Pyocine typing of meningococci 377
structures of gonococci and meningococci (Tramont, Sadoff and Arten-
stein, 1974; Tramont, Griffiss, Rose, Brooks and Artenstein. 1976; Sadoff,
Zollinger and Sidberry, 1978). Since there is also evidence for differences in
the LPS components of different strains of meningococci (Davis and
Arnold, 1974; Zollinger, Pennington and Artenstein, 1977; Mandrell and
Zollinger, 1977), we extended our investigation on pyocine typing of N.
gonorrhoeae to include a number of strains of N. meningitidis that were not
serogroupable by their capsular antigens.
Among the 50 non-groupable isolates of N. meningitidis tested for
sensitivity to 12 selected pyocines. 33 (66 per cent) were sensitive to one or
more of the pyocines tested. As with the gonococcal strains tested,
meningococci sensitive to any of the pyocines were sensitive to those of
group R5 and the unclassified 9579. No strains were sensitive to pyocines of
group R1 only. None of our isolates were sensitive to pyocines of groups R2
and R3 (Blackwell. Young and Anderson, 1979). The same patterns of
sensitivity were observed for serogroupable isolates but only 11 per cent of
these isolates were sensitive to one or more pyocines. The presence of the
polysaccharide capsule may prevent the R-type pyocines from reaching the
attachment site within the LPS. In Table III it is noteworthy that three of
the seven serogroupable strains sensitive to pyocines (one from group A,
one from group C, and one from group Z') were not laboratory strains. The
other serotypable, pyocine sensitive strains were reference Z, reference
W135, and two Frasch serotype strains (Table III) and the LPS prototype
strains, 35E, 6155, 6275. M978 and 7880 (Table VI). The effect long term
subculture has on maintenance of the capsule is an important consideration
as this might affect the subsequent response to pyocines.
Only 5 per cent of gonococci tested in a previous study were insensitive to
all pyocines used (Blackwell. Young and Anderson 1979). A portion of the
34 per cent of non serogroupable meningococcal strains insensitive to
pyocines may possess capsular material that blocks the pyocine receptors in
the LPS. New serogroups might be determined by investigating the pyocine
insensitive strains.
Determination of pyocine sensitivities for non-serogroupable strains of
iV. meningitidis may be of value as an epidemiological tool in that the
majority (66 per cent) of the total number tested are sensitive and may be
typed by this method (Table IV). Three general patterns are apparent: (1)
those that are insensitive to pyocines tested, (2) those that are sensitive to
pyocines 9579, ISC and ISA. (3) those that are sensitive to pyocines 9579.
ISA, ISC and pyocines of group R1 (Table V). Five of the seven patterns of
sensitivity are similar to ones found with N. gonorrhoeae (Blackwell. Young
and Anderson, 1979). Since about 50 per cent of non serogroupable isolates
examined by one laboratory are autoagglutinable (R. J. Fallon, personal
communication), the pyocine sensitivity method might provide a useful
method for typing these strains even if new serogroups based on agglutina¬
tion of capsular antigens are determined.
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SENSITIVITY OF THERMOPHILIC CAMPYLOBACTERS TO
R-TYPE PYOCINES OF PSEUDOMONAS AERUGINOSA
C. Caroline Blackwell, F. P. Winstanley and W. a. Telfer Brunton
Department of Bacteriology, Edinburgh University Medical School.
Teviot Place, Edinburgh EH8 9AG
Summary. Strains of thermophilic Campylobacters of human origin were
examined for bactenocine activity and for susceptibility to R-type pyocines of
Pseudomonas aeruginosa. None of 50 strains inhibited the growth of any other
strain, but 13 of 80 strains (16%) were sensitive to R-type pyocines. Absorption of
one of the partially purified pyocine preparations with a sensitive strain resulted
in the removal of pyocine activity and a decrease in viable count of the organism
by 85%.
Introduction
The importance ofCampylobacters as animal pathogens has been recognised for many years.
Human Campylobacter infection was first reported by Vinzent. Dumas and Picard (1947). but
during the next decade only 15 cases were reported (King. 1957). More recently, the
thermophilic members of the genus have been shown to be commonly associated with diarrhoea!
disease in man (Butzlerer al.. 1973; Skirrow, 1977; Telfer Brunton and Heggie. 1977). Large
outbreaks have been attributed to ingestion ofcontaminated water (Trehan and Vogt, 1978) and
contaminated milk (Robinson et al.. 1979).
Studies of the epidemiology of Campylobacter enteritis in man have been hindered by
difficulties in classification and by the lack of simple methods for typing the causative organism.
Biotyping has provided useful information but is time consuming and exacting (Skirrow and
Benjamin, 1980). The development of serological methods has been hindered by difficulties in
detecting somatic antigens (Butzler and Skirrow, 1979; Watson. Kerr and McFadzean. 1979),
but they have now proved their value in epidemiology (Jones, Eldridge and Dale, 1980) and
taxonomy (Pennerand Hennessy, 1980). We have not found any reports ofsuccessful typing by
means of bacteriocines or bacteriophages in the literature.
In this study we examined two possible methods for typing thermophilic Campylobacters;
examining strains for bactenocine activity, and testing their sensitivity to partially purified
preparations of rod-type (R-type) pyocines of Pseudomonas aeruginosa, which are of use for
typing Neisseria gonorrhoeae (Blackwell. Young and Anderson, 1979), and non-serogroupable
strains of N. meningitidis (Blackwell and Law, 1981).
Materials and methods
Bacteria. Thermophilic strains of Campylobacter were isolated from the faeces of patients
or animals by the method of Skirrow (1977) and had the following characters; positive oxidase
and catalase reactions; sensitive to nalidixic acid; growth at 43°C but not at 25=C. In all. 80
strains, each representing a separate isolation, were used in the following experiments. They
were grown in an atmosphere containing c. 5% Oj and 5% CO? (Skirrow, 1977).
Strains of P. aeruginosa that produce R-type pyocines, listed in table I, were obtained from
Dr J. R. W. Govan of this department and Dr M. Kageyama. Mitsubishi-Kasei Institute of Life
Sciences. Tokyo. Kageyama (1975) classified many R-type pyocines into groups on the basis of
their spectra of activity; strains representing each of these groups were chosen for this study. P.
Received 26 May 1981; accepted 26 Aug. 1981.
247
248 C. CAROLINE BLACKWELL ET AL.
aeruginosa strain ZD8'38. also from Dr Kageyama and sensitive to all the pyocines tested, was
used as a positive indicator strain.
Screening of Campylobacter strains for bacteriocme activity. Fifty strains of thermophilic
Campylobacters were tested against one another for the production of bactenocines by the
method of Gillies and Govan (1966). "Producer strains" were grown overnight (18 h) at 37°C
on Tryptone Soya Agar (Oxotd) supplemented with 5% (v/'v) of defibrinated horse blood.
"Indicator strains" were grown overnight (18 h) in nutrient broth (Oxoid Nutrient Broth No. 2).
This experiment was repeated with producer strains (1) that had been grown overnight on
tryptone soya agar at 353C, and (2) log-phase cultures of which had been grown for 18 h at 37°C
in nutnent broth containing mitomycin C (1 pg ml) before being plated on to tryptone soya agar
and grown for 18 h at 37°C. Areas of inhibition of growth of the indicator strains by producer
strains were taken as evidence of bacteriocinc-like activity.
Assay ofpyocine activity against Campylobacter strains. The R-type pyocines were induced
and partially purified as described previously (Blackwell et al„ 1979). after the method of Govan
(1974). Sensitivity to R-type pyocines was determined by placing drops (15 >il) of a 1 in 2
dilution of each pyocine preparations on to plates of (1) tryptone soya agar supplemented with
5% (v/v) of defibrinated horse blood. (2) nutrient agar (Columbia Agar Base, Oxoid) containing
agar l", (w v), and (3) similar nutrient agar containing agar 2% (w/v). After the drops had been
absorbed into the agar, the plates were flooded with a 1 in 100 dilution of an overnight culture of
a Campylobacter strain in nutnent broth. Excess inoculum was removed by means of a sterile
pipette, and the plates were then incubated overnight at 37°C in microaerobic conditions as
descnbed above. Results were recorded as + = inhibition, ± = inhibition with some over¬
growth, — = no inhibition.
Preparation of electronmicrographs. A negative-staining technique described by Govan
(1974) was used.
Titration of pyocine activity. Twofold dilutions of the pyocine suspension were made in
Duibecco's Buffered Salt Solution (BSS; Dulbecco A. Oxoid) with 0-2% phenol red. A drop (15
pi) of each dilution was placed on a dried plate of nutnent agar (agar 2°„ w/v). When the drops
had been absorbed the plate was flooded with a suspension of P. aeruginosa strain ZD8/38 (107
cfu.ml). and incubated at 37CC for 18 h. The pyocine titre was the highest dilution that produced
a clear area of inhibition of the bacterial lawn.
Adsorption of pyocine activity by Campylobacter cultures. A turbid suspension of the
Campylobacter containing lOMO9 cfu/ml was made in BSS. Equal volumes of bacterial
suspension and pyocine preparation were mixed, incubated at "STC for 30 min and then
Table I
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centrifuged for 15 min at 5000 rpm. The supernatant fluid was titrated for pyocine activity as
described above. The pellet was resuspended to the original volume in BSS and the viable count
determined by the method of Miles. Misra and Irwin (1938).
Results
Production of bocleriocmes by Campylobacter strains
None of the 50 strains inhibited the growth of any other strain, whether it had been grown at
37;C or 35'C or pre-incubated with mitomycin C. Thus, none of them gave evidence of
bacteriocine-like activity in the conditions examined.
Sensitivity of Campylobacter strains to R-type pyocines
Of the 80 strains examined, 13 (I6°0) were sensitive to one or more of the pyocine
preparations. These were most often and most markedly sensitive to pyocines of strains 9579.
ISA and ISC. Two isolates were sensitive to these three and also to R205 (unclassified) and three
pyocines of group R1: ISD. IS6 and IS8. Sensitivity to any of the pyocines of groups R2, R3 or
R4 was not observed (table II).
In addition to the initial sensitivity tests on blood agar, the experiments were repeated on 1%
and 2% nutrient agar on which growth tended to be less mucoid, so that extracellular material
would be less likely to interfere with the attachment of pyocines. Identical results were obtained
on all three media.
Electronmicrographic studies
We were unable to demonstrate attachment of pyocine no. 9579 to Campylobacter strains
that were sensitive to its inhibitory activity.
Adsorption ofpyocine activity by Campylobacter strains
Absorption studies were performed with a preparation of pyocine no. 9579 (litre 256) and a
pyocine-sensitive Campylobacter strain (no. 13624) and a pvocine-resistant Campylobacter strain
(no. 01.T). After absorption with the resistant strain the litre of pyocine was 128 and after
absorption with the sensitive strain it was less than 4. The viable count of the two suspensions
used to adsorb the pyocine were determined before adding the pyocine suspension and at the end
of the experiment. There was no decrease in the viable count of the resistant isolate during
incubation with the pyocine but the viable count of the sensitive isolate was reduced by 85°0. i.e..
from 1-51 x 10* cfu/ml to 2-25 x 10* cfu/ml.
Table II
Inhibition of Campylobacter strains by extracts containing R-type pyocines
Inhibition of the stated number of Campylobacter strains*




R1 R2 R3 R4 R5 Unclassified





2 ± 1l 1l it1l itl 1l 1 1 1II 1 +l1 1+4 •4. -4>
+ = Inhibition of growth; + = partial inhibition of growth; — »no inhibition of growth
* Reference number of pyocine-producing strain (see table I).
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Discussion
Sensitivity to R-type pyocines has been found to be of value in typing strains of P. aeruginosa
(Gillies and Govan, 1966), strains of N. gonorrhoeae (Blackwell et aJ., 1979) and non-serogroup-
able N. meningitidis (Blackwell and Law, 1981). As far as we are aware, the sensitivity of
thermophilic Campylobacters to R-type pyocines has not been reported previously. We were
unable to demonstrate the attachment of pyocines to Campylobacter cells by electronmicros-
copy, possibly because of the instability of the Campylobacter cell envelope, but we were able to
remove the pyocine activity by absorption with suspensions of pyocine-sensitive Campylobacters
but not of pyocine-resistant Campylobacters.
Only a small minority of the cultures tested were sensitive to the pyocines used in this study.
Similar results were obtained with capsulate serogroupable meningococcal strains (Blackwell
and Law, 1981). The capsular material ofCampylobacter strains may prevent the pyocines from
penetrating to the receptor sites. Among 13 Campylobacter isolates sensitive to the pyocines
there were four distinct patterns of sensitivity (table II).
The receptor site for R-type pyocines is in the lipopolysaccharide (LPS) of the cell envelope
of P. aeruginosa (Ikeda and Egami. 1973: Govan. 1974; Kovaland Meadow, 1977) and a similar
location has been suggested in Neisseria (Sidberry and Sadoflf, 1977; Sadoff, Zollinger and
Sidberry, 1978; Blackwell et al., 1979). Because Campylobacter cell walls closely resemble those
of other gram-negative organisms, similar receptors for R-type pyocines may exist in the LPS of
Campylobacters. Our results suggest that some Campylobacter strains share similar cell-enve¬
lope components, and sensitivity to the various groups of pyocines may reflect this.
Sensitivity to pyocines occurs too infrequently among thermophilic Campylobacters to form
the basis of an independent typing scheme, but it might be of help in the further development of
serological typing schemes, in that it may provide a means of detecting differences in somatic
antigens. The different LPS types might be used to develop assay systems similar to the
microbactencidal assay used to classify N. meningitidis, group B (Frasch and Chapman, 1972),
or the haemagglutination inhibition (Mandrell and Zollinger, 1977) and radioimmunoassay
methods (Zollinger and Mandrell, 1977) used to determine LPS serotypes among capsulate
strains of meningococci.
We are grateful to Mrs Marilyn Cole and Mrs J. Mears for help in typing the manuscript and
to Professor J. G. Collee and Dr D. M. Weir for their advice in preparation of the manuscript.
This investigation was supported by grant no. K/MRS/50/C22 from the Biomedical Research
Committee, Scottish Home and Health Department, and Leo Laboratories Ltd.
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PHAGOCYTE RECOGNITION OF
NEISSERIA GONORRHOEAE
D. F. Kinase, C. C. Blackwell, D. M. Weir and F. P. Winstanley
Department of Bacteriology, University Medical School, Tevior Place,
Edinburgh EH8 9AG, Scotland, UK
(Received 15 February 1982)
SUMMARY Human monocytes show an increased ability to bind pilate rather than non-pilate
gonococci. Polymorphonuclear leucocytes (PMN) do not discriminate between pilate and non-pilate
variants. PMN, however, bind appreciably more gonococci (either pilate or non-pilate) than
monocytes. The results help to explain the role of pili on gonococci as virulence factors and in the
immune response.
DUCTION
:hment of Neisseria gonorrhoeae to mucosal cells
heir subsequent invasion are the initial steps in
itablishment of gonococcal infection. When the
isms have penetrated the mucosal barriers, the
me then largely depends on their interaction with
cytic cells. Attachment and uptake by polymorpho-
ir leucocytes (PMN) may lead to destruction of the
ism. Attachment to macrophages is likely to lead to
ion of an immune response by presentation of
bial antigen to the lymphoid cells. The interaction
:n phagocytes and bacteria is clearly an important
linant in the pathogenesis of the disease. Binding
phagocyte membrane is dependent on the presence
iropriate adhesin receptor interactions between
ia and phagocytes (1).
virulence of N. gonorrhoeae has been linked with
jlar colonial types, pilate types T, and T,. but not
lon-pilate types T3 and T4 (2). Pilate gonococci
jeen found to adhere more efficiently to certain
] tissues than non-pilate organisms, e.g. epithelial
I), sperm cells (4), buccal cells (5), erythrocytes (3)
,sue culture cells (6, 7). No difference in binding to
has been observed with pilate and non-pilate
xrei (7, 8); attachment of gonococci to PMN
s to be mediated by another surface component,
kocyte association factor (9).
iew of the different roles PMN and macrophages
i host defence, we sought differences in the ability
;e cells to bind pilate and non-pilate gonococci
y isolated from an infected patient.
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Materials and Methods
Bacterial Strain
Neisseria gonorrhoeae strain E757, recently isolated from a patient
attending the Department of Genitourinary Medicine was used through¬
out these experiments. Opaque colony types 2 (T2) and 3 (T3) were
differentiated with a Zeiss stereoscopic microscope with a double
system of substage lighting and selectively subcultured and maintained
on Difco GC base supplemented as described by Young 110) (GC agar).
T2 and T3 growths, with more than 95*. of the colonies stable, were
employed Bacteria were harvested from GC agar plates at 14-16 hr,
suspended in Dulbecco's phosphate buffered saline (D.PBS) by gentle
pipetting, washed and finally re-suspended gently in D PBS. The pili
were sheared by vortexing a suspension of gonococci in D PBS with a
Rotamixer Deluxe (Hook and Tucker Ltd., England) at maximum
setting for 5 min.
Grids negatively stained with phosphotungstic acid were examined
by electron microscopy (Hitachi HU 12Ak This confirmed the presence
of pili on type 2 gonococci and their absence on type 3 and vortexed
type 2 and 3 gonococci (3. 11).
Bacterial concentrations were determined at E650nm on a CE292
spectrophotometer (Cecil Instruments. Cambridge, England) by
reference to standards enumerated by microscope counts with a
counting chamber. Dose response experiments indicated that the
optimal concentration of gonococci for these assays was 10* organisms/
ml and this concentration was used throughout.
Phagocytes
Blood from healthy donors with no history of gonorrhoea was
collected in plastic tubes containing 10 units of heparin ml"'. Mono¬
cytes and PMN were separated on Ficoll-Hypaque cushions (Ficoll,
Pharmacia. London) —specific gravity 1-078- according to the method
of Boyum (12). After the interface cells (monocytes and lymphocytes I
were collected, the pellet containing granulocytes and red blood cells
w as re-suspended in 0 82 °„ ammonium chloride to lyse the erythrocytes
(13). The separated cells were finally washed twice with D PBS.
Preparation of Monoluvers
PMN and monocytes were re-suspended in Eagle's minimum essential
medium (MEM) without scrum, buffered at pH 7-3 with HEPES (final
concentration. 30 mM. Wellcome Research Laboratories. Reck en ham I.
and supplemented with penicillin/streptomycin (final concentration.
lOOu ml"' of each) and glutamine (final concentration. 2 mM) to give
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a total cell count of 3 < 10* ml Alic|uots ll ml) of the above cell
prepurutionv were Ijvered onto I 3 mm diameter I No 11 gl.iv> cocerdtp-.
in tiv.ue culture plates IS mm well diameter. iCostar, 2'>i Broadway.
Cambridge. Macs.) and incubated for I hr at 37°C to allow adhesion.
Non-adherent cells were removed by repeated washing with 0 PBS.
3indinq Assay
Coverxlips were overlaid with I ml of gonococci in D PBS containing
Ca * " and Mg"" ions (0-9 m.M and 0-5 mM. respectively) and
incubated for: |!) 30 mm at 37°C. and (3) 2 hr at 4°C. Non-attached
organisms were removed by repeated washing with D PBS. Coverslips
were air dried, fixed in methanol and stained with May Grunwald/
Giemsa. Bacterial binding was estimated by counting leucocytes with
bacteria attached at two or more discrete points. Duplicate coverslips
were used; for each coverslip. 300 leucocytes were counted and the
results expressed as the percentage of cells binding organisms.
Analysis of Results
Statistical analysis of the results was by paired sample t tests.
Results
Attachment of Pilate and Non-pilate Variants
Figure 1 summarises the results of three experiments
comparing the attachment of pilate (T2) and non-pilate
(Tj) gonococci to PMN and macrophages. There was no
significant difference in association of the two types to
PMN at either 4°C or 37°C (P > 0-5). The association of
T2 cells with monocytes was significantly greater than
that observed with T3 cells at both 4°C (P < 0 02)
and 37°C (P < 0 01). A significantly greater number of
PMN than monocytes bound both T, and T3 gonococci
(P < 0 01) (table 1).
Effect of Removal of Pili
Figure 2 shows that the difference in binding of T2 and
T3 cells to monocytes illustrated in Figure 1 was abolished
by removal of pili from T2 cells by mechanical shearing.
While there was a slight overall reduction in binding of
gonococci to the phagocytes following shearing treatment
(table 2), there was still a significantly greater number of
PMN than monocytes binding gonococci (P < 0 05).
Comparison of4°C and 37°C Assays
The results for the assays done at 4°C represent
attachment only as the monocytes and PMN do not
phagocytose at this temperature. The 37°C assays are for
attachment and phagocytosis, i.e. association. Differentia-
mvtttophrls
• 37°C for JO mo




Fig i. Association of pilate (t,) and non-pilate (T3) gonococ.
PMN and monocytes at 37°C and 4°C. Each point represents the
of three experiments.
tion between phagocytosis and attachment was not d
but the general trends in phagocyte/gonococcal ass>.
tion at 4°C and 37°C were consistent and suggest tha:
type of attachment seen at 4°C also occurs at ph;.
logical temperatures at which phagocytosis also occu:
Discussion
These results indicate that the recognition of
gonorrhoeae by PMN and monocytes differs. Our find:
agree with the observation of Swanson (7) that PMN
not appear to discriminate in their ability to bind pi!
and non-pilate variants of the strain used. Monocytes
contrast, showed an increased binding of pilate organs
similar to that observed for epithelial cells (3), sperm
buccal cells (5), erythrocytes (3) and tissue culture C;
(6, 7).
Two roles have been suggested for pili in the estabii:
ment of gonococcal infection: (1) pili assist the organi
in attaching to the mucosa (6,. 14); and (2) pili incre.





p.v/.v Monocytes difference P calue
ti 37*C 94 17 3117 73 <0431
4°C 97-33 23-67 64 <04)01
t3 37»C 93-17 7-00 36 <04)1
4°C 92 17 6.30 36 <04)1
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Fig. 2. The effect on binding of both T. and Tj gonococci to PMN
and monocytes following mechanical shearing treatment of the gono¬
cocci. Each point represents the mean of three experiments.
gonococcal resistance to phagocytosis by, PV1N (3, 15.
16, 17). Our findings suggest a third role in conjunction
with the hypothesis of Novotny and his colleagues (1977)
that "gonorrhoea appears to be a specific disease of
human macrophages".
Novotny and his colleagues observed "infectious units"
of gonococci in electron micrographs of pus from
more than 70 infected individuals. These are clusters of
organisms that appear to be undamaged and in an
exponential growth state. Surrounding the gonococci is a
coat made up of granules and remnants of mitochondria
that are thought to be derived from macrophages. There
is evidence, from labelled antibody studies, to suggest
that the dense accumulation of granules protects the
gonococci from humoral defences. These granular coats
also seem to allow the gonococci to gO unrecognised by
phagocy tic cells as long as the coat remains dense.
According to Novotny's hypothesis, a host is infected
with both free non-multiplying gonococci and multi¬
plying gonococci in the protective infectious units. The
multiplying organisms infiltrate the mucosa and sub-
mucosa of the genitourinary tract. Free gonococci phago-
cytosed by PMN are destroyed, but those ingested by
monocytes are believed to interfere with regulation of the
phagocytic cell and multiply within it. This results in the
destruction of the monocyte, the remnants of which
surround the gonococci to form a new infectious unit.
The results of the present study encourage us to postulate
that the presence of pilar antigen on the gonococcal
surface is a virulence factor that increases the probability
of the bacteria becoming attached to and subsequently
phagocytosed by monocytes.
The large difference we have shown in binding of gono¬
cocci (whether pilate, non-pilate or vortexed) between
PMN and monocytes is most striking and contrasts with
work done on Staph, albus in our department; in the
staphylococcal studies, binding to PMN and monocytes
showed no differences (19). Our results with gonococci
may also provide an explanation for gonorrhoeal recur¬
rence additional to the theory of broad heterogeneity
of the gonococcal antigens (20, 21, 22). An ineffective
immune response to gonococcal infection may be
explained by the much greater ability of PMN to take up
the organism in comparison with the smaller numbers
that are recognised and taken up by monocytes. If
these are largely incorporated into "infectious units" and
survive, the presentation of gonococcal antigen by the
monocytes to the lymphocytes will be reduced in com¬
parison with other types of antigens. Pili are not readily
demonstrated on gonococci in human tissues (23, 24). If
proteolytic enzymes in pus and tissues remove these from
the surface of the organism, the probability of attachment
to monocytes would be further reduced. As pili seem to
enhance attachment to epithelial cells and macrophages,
loss of pili would be likely to limit colonisation and to
reduce the possibility of the development of infectious
units in macrophages with a consequent reduction in
virulence.
ACKNOWLEDGEMENTS
We are grateful to Mrs. Marilyn Cole for help in typing the manuscript
and to Professor J. G. Collee for his advice in the preparation of
the manusenpt. This investigation was supported by Grant No.
K/MRS/50 C22 from the Biomedical Research Committee. Scottish
Home and Health Department and by Grants GSI 103311 SB and
G979,74 S from the Medical Research Council.
PHAGOCYTE RECOGNITION OF NEISSERIA GONORRHOEAE 171
CES
tl (19S01. Surface carbohydraies and lectins in cellular 13.
n. Immunology Tbda\. I. 45.
S Jr.. Peacock. W L Jr.. Deacon. W E. Brown. L and 14
I. (1963). Neisseria gonorrhoeae I. Virulence genetically
lonal sanation. J Bacterial.. 85. 1274.
. A P Jr. and Sawyer. W D (1973). Role of pili in the 15
>f Neisseria gonorrhoeae. Infect. Immun. 8. 255.
mquest. A. N.. Swanson. J, Buchanan. T. M.. Wende.
Williams. R P. (1974). Differential attachment by pilated 16
lilated Neisseria gonorrhoeae to human sperm. Infect.
897
E. M. and Wilson, C. (1977). Vanations in buccal cell
if Neisseria gonorrhoeae. Infect. Immun., 16, 709. 17.
I. (1973). Studies on gonococcus infection. IV Pili: their
achment of gonococci to tissue culture cells. J. Exp.
571. 18.
I, King. G and Zeligs, B. (1975). Studies on gonococcus
VIM. '"Iodine labelling of gonococci and studies on
ro interactions with eukaryotic cells. Infect. Immun., 11,
19.
I, Sparks, E., Zeligs, B., Siam, M. and Parrott. C. (1974).
l gonococcus infection. V. Observations on in vitro
s of gonococci and human neutrophils. Infect. Immun., 20.
Sparks, E., Young, O. and King, G. (1975). Studies on
s infection. X. Pili and leukocyte association factor as 21.
in interactions between gonococci and eukaryotic cells in
r. Immun., 11,1352.
. Patterson. I. C. and McDonald. D R. (1976). Rapid " 22.
He utilisation test for the identification of Neisseria
e. Brit J. Vener. Dis.. 52. 172.
R. S_ Fulbright. R. S . Eads. M E. and Sawyer, W. D. 23.
hvlenediamineletracetic acid-sensitive antiphagocytic
Veisseria gonorrhoeae Infect. Immun., 15. 817.
. (19681. Isolation of leucocytes from human blood. 24
bservation. Methyl cellulose dexiran and Ficoll as
erythrocyte aggregating agents J Clin Lah. hit est . 21. Suppl 97.
31
Boyle. W (1968). An extension of the "'Cr release assay for the
estimation of mouse cytotoxins. Transplantation. 67. 761.
Ward. M £_ Watt. P J and Robertson. J. N. (1974). The human
fallopian tube: a laboratory model for gonococcal infection.
J Infect Dis.. 129, 650
Swanson. J.. Kraus, S J. and Gotschlich. E. C. (1971). Studies on
gonococcus infection 1 Ptli and zones of adhesion their relation to
gonococcal growth patterns. J Exp. Med. 134. 886
Thongthai. C. and Sawyer. W D (1973). Studies on the virulence
of Neisseria gonorrhoeae 1. Relation of colonial morphology and
resistance to phagocytosis by polymorphonuclear leukocytes.
Infect Immun., 7, 373.
Ofek, I„ Beachey, E H. and Bisno, A. L (1974). Resistance of
Neisseria gonorrhoeae to phagocytosis: relationship to colonial
morphology and surface ptli. J. Infect. Dis-, 129, 310.
Novotny, P- Short, J. A, Hughes, M, Miler, J. J., Syrett, C, Turner,
W. H„ Harris, J. R. W. and Maclennan, I. P. B. (1977). Studies on
the mechanisms of pathogenicity of Neisseria gonorrhoeae. J. Med.
MicrobioL 10. 347.
Glass. E. J, Stewart, J. and Weir, D. M. (1981). Presence of
bacterial binding "lectin-like" receptors on phagocytes. Immunology,
44, 529.
Kasper. D L.. Rice. P. A. and McCormack, W. M. (1977). Bacteri¬
cidal antibody in genital infection due to Neisseria gonorrhoeae. J.
Infect. Dis.. 135, 243.
McMillan, A, McNeillage. G„ Young. H. and Bain, S. S. R. (1979).
Secretory antibody response of the cervix to infection with Neisseria
gonorrhoeae. Br. J. Vener. Dis., 55, 265.
McMillan. A-, McNeillage. G„ Young, H. and Bain, S. S. R. (1979).
Serum immunoglobulin response in uncomplicated gonorrhoea.
Br. J. Vener. Dis.. 55, 5.
Novotny. P, Short. J. A. and Walker, P D. (1975). An electron-
microscope study of naturally occurring and cultured cells of
Neisseria gonorrhoeae. J .Med Microbiol.. 8. 413.
Evans. B A. (1977). Ultrastructural study of cervical gonorrhoea.
J Infect. Dis.. 136. 248.
TTeviot Scientific Publications Lid31 Montpelier ParkEdinburgh EH10 4LX. UK
lEct al.
Reprinted from the BRITISH MEDICAL JOURNAL
3 July 1982, 285, 7-9
ABO blood group, secretor
state, and susceptibility to
recurrent urinary tract
infection in women
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Abstract
ABO blood group and secretor state was determined in
319 women with recurrent urinary tract infection and
compared with those of a control group of 334 women of
similar age ranges. Women of blood groups B and AB
who are non-secretors of blood group substances showed
a significant relative risk of recurrent urinary tract
infection of 312 (95% confidence limits, 149 and 6 52) in
comparison with other types. This appears to be a
genuine example of synergy in which absence of and-B
isohaemagglutinin and secretor substances combines to
give an increased risk of recurrent urinary tract infection.
Determination of blood group and secretor state may
provide additional information in identifying those at
risk.
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Introduction
Correlation between ABO blood group and susceptibility to
certain infectious diseases is well documented.1 "• In studies of a
Chilean population, patients of blood group B had 50% greater
probability than those of other blood groups of contracting
Escherichia coli urinary tract infections.'
The antigens of ABO blood groups are present in two forms:
(a) alcohol-soluble in tissues of all subjects, and (b) water-soluble
in most body fluids and organs of secretors. The non-secretor
state has been linked with the susceptibility to certain infectious
agents.'-" Haverkorn and Goslings' found that patients in
blood groups other than O and non-secretor patients were most
susceptible to rheumatic fever and rheumatic heart disease, and
carriage of group A streptococci was observed more often in
non-secretors.
We analysed the distribution of ABO blood groups and
secretor state among women with recurrent urinary tract
infections in Edinburgh.
Subjects
Regular attenders at the pyelonephritis clinic of the City Hospital,
Edinburgh, were asked to provide a specimen of blood and saliva for
determination of blood group and secretor state. All patients in this
survey were girls and women aged 10-80 (mean 49) years. None had
predisposing factors such as stones.
The patients were divided prospectively into two categories:
Patients with pyelonephritis—Those with unequivocal radiological
evidence of chronic pyelonephritis—that is, focal loss of parenchyma
associated with distortion of calyces—or those with a history and
clinical and laboratory findings consistent with acute pyelonephritis.
Patients with uncomplicated urinary tract infections—Those patients
with normal appearance on intravenous pyelograms, but with appreci¬
able bacteriuria (10s organisms/ml) and a history of recurrent urinary
tract infections.
Controls—Control data were produced by testing 334 samples of
plasma from female donors (age range 18-60) from the survey area
for the presence of secretor substances. Further control data for
distribution of blood groups were available for 6662 donors from the
same area as that from which our patients were drawn.10
Methods
Blood from each patient was collected at the clinic and stored in
heparinised tubes. The saliva from each patient was boiled for 20 min,
centrifuged at 5000 xg for 10 min, and the supernate stored briefly
at 4°C until tested for the presence of blood group antigen. Blood
group was determined by agglutination tests in plastic wells. Secretor
state was determined as described by Mollinson11 with saliva or
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plasma samples. Saliva or plasma from secretors and non-secretors
representative of the four blood groups were used as controls for each
experiment. Agglutinins used were anti-A and anti-B sera and Vlex
europaeus lectin. The red blood cells used were A21 B, and O.
Linear logistic multiple regression12 was used to compare the ABO
blood group and secretor state categories of the study and control
groups. This also gave estimates and confidence limits for relative risk
of urinary tract infection between categories. /2 tests were used for
analysis of two-way frequency tables.
Results
No significant differences in the proportion of secretors or the
distribution of ABO blood groups were found between the two
diagnostic categories of patients with urinary tract infections; all 319
patients were considered as one group for comparisons with controls.
The table shows the distribution of different blood groups and
secretor state for the study group and for the smaller series of controls
in whom secretor status had been determined. For the study group,
the table shows also the ratios of observed prevalences to those
expected from the pattern found in controls.
Distribution of blood groups in study group and in two groups of controls, those
in whom secretor state was determined (group I) and those in whom it was
unknown (group 2) (numbers in parentheses are ratios of distribution found in
study group to that expected from control data)
Blood group
O A B AB
Control group 1 (n = 334):
Secretors 124 74 35 12
Non-secretors 49 30 7 3
Study group (n = 319):
Secretors 110 (0-93) 63 (0 88) 32 (0-96) 7 (0-64)
Non-secretors 52 (111) 28 (0 98) 18 (2 69) 10 (3 49)
Control group 2 (n = 6662) 3323 2410 715 214
To test the dependence of risk of urinary tract infection on ABO
blood group or secretor state, a linear logistic multiple regression was
carried out on the two samples. This examines the influence of the
three main effects (anti-A, anti-B, and secretor state) and their inter¬
actions on the proportion of subjects with urinary tract infection, using
approximate y2 tests. Presence or absence of anti-A was found not to
have a significant effect, but there was a significant interaction between
the anti-B and secretor effects; subjects lacking both anti-B and
secretor substance—that is, those of blood groups B and AB who are
non-secretors—had a higher risk of recurrent urinary tract infection,
whereas subjects lacking only one of these two did not differ signifi-
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cantly in risk from those with both factors present. Thus the data fit
extremely well (x3 = 1 86, 6 df) to a model in which the non-secretor
in blood groups B and AB have a highly significant excess risk
(x' = 9T2, 1 df, p<0 01) over all other types. The relative risk of
urinary tract infection for these subjects as compared with other
types was estimated as 3-12, with 95°0 confidence limits of 1 49 and
6 52. This appears to be a genuine example of synergy with absence
of both anti-B and secretor substance being necessary to give an
increased risk of urinary tract infection. The ratios of observed to
expected prevalence in the table show this finding clearly, with only
those for non-secretors in blood groups B and AB differing substantially
from unity.
The larger series of controls (in whom only ABO group and not
secretor state was known) did not differ significantly from the smaller
series in their blood group frequencies, but showed a highly significant
difference (x* = 16 34, 3 df, p<0 001) from the patients wit l urinary
tract infections (table) (14% in blood groups B and AB v 21 %). This
confirms previous findings and is consistent with the suggested model
in which non-secretors in blood groups B and AB have an increased
likelihood of recurrent urinary tract infection. The proportion of
anti-B negative patients in the study group is inflated by the excess
prevalence of those who are also non-secretors, even though anti-B
negative secretors are not at a higher risk. Thus, absence of anti-B
when considered alone shows a significant risk relative to presence of
anti-B (95% confidence limits of 1-24 and 21-7 (table)). This risk is
lower than the threefold increase in risk found for non-secretors in
blood groups B and AB, because the anti-B negative group is "diluted"
with anti-B negative secretors.
Discussion
The highly significant excess of non-secretors in blood groups
B or AB in the study group strongly suggests a synergistic link
between the absence of anti-B isohaemagglutinin and secretor
substances and an increased risk of recurrent urinary tract
infection in women. In the controls the prevalence of non-
secretors of 26-6% reflects an increased incidence of non-
secretors found in Scottish and Irish ethnic groups compared
with that reported for other regions in the United Kingdom.13
This highlights the need to use local control groups in surveys
of this nature.
The association of infections with ABO blood group and
secretor state1 3 has led to investigation of the mechanisms
concerned." 11 15 Many bacteria cross-react with ABO blood
groups.14 30 Drach et al" found A and B blood group activity in
47% of 34 urinary tract pathogens. Isohaemagglutinins may have
an important protective role against these cross-reacting
bacteria.15 13 Our finding that individuals of blood groups B and
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AB with no anti-B isohaemagglutinins are more susceptible to
urinary tract infection is interesting in that Drach13 ■" found
antigens like those of blood groups A and B on urinary tract
pathogens, often with both group A and group B activity on the
same bacterium. These workers noted that anti-B titres were
sometimes raised in the disease but anti-A ones were not,
suggesting that the antigen to blood group A was less immuno¬
genic on the bacteria or that there were deficiencies in recognition
of antigens of blood group A. Springer et al16 found E coli 086
B:7 to be highly interactive with the blood group: thus growth
was retarded in the presence of anti-B sera; if complement was
added a bactericidal reaction ensued. Isohaemagglutinins may
also interact with blood group like antigens on bacterial cell walls
to inhibit attachment to uroepithelial or periurethral cells. Thus
persons capable of producing anti-B isohaemagglutinins may have
a greater degree of protection against urinary tract infection. In
general, the extent of bacterial cross-reaction with ABO blood
groups suggests that a selective advantage linked to ABO blood
group might operate in combating infections.
Secretor state is associated with certain differences in immuno¬
globulin concentrations in that anti-B serum IgA and (in white
people) serum IgG concentrations are lower in non-secretors
than in secretors.21 22 This suggests that non-secretors may have
less effective immune protection than secretors and is consistent
with our findings that non-secretors were more susceptible to
recurrent urinary tract infection. This probably entails the
participation of other factors, and the finding that excretion of
blood group substances in urine is an active process in the kidney
and not a simple filtration process22 suggests that these substances
may have a protective part to play in secretions. Boat et al24
found that ABH blood group substances of saliva inhibited
haemagglutination of influenza B virus and suggested that some
of these substances may interfere with access of influenza virus
to binding sites. One of the protective roles of these blood group
substances may be their ability to occupy or in some way
interfere with binding sites either on the bacterium or. on the
epithelial cell with possible effects on bacterial colonisation and
subsequent invasion and infection; this appeared to be the case
in our studies on diabetic mice.22
Determination of blood groups and secretor state may provide
additional information in identifying individuals who are at
risk. In children under the age of 5 the combination of infection
and vesicoureteral reflux predisposes to renal scarring.22 Few if
any tests are available for providing prognostic information for
adults with a normal urinary tract and a history of recurrent
infection. Blood group and secretor state may be of relatively
minor importance in relation to all other aspects of susceptibility.
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Nevertheless, it may be worthwhile for the clinician to take
account of ABO and secretor state in addition to already
established factors in the assessment of patients with urinary
tract infection when considering their long-term susceptibility
and management. Meanwhile, there is a good case for research
workers concerned with mechanisms of microbial pathogenicity
to add this consideration to an extending list of host factors that
bear on host-parasite interactions.
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Blood group, secretor status, and susceptibility to
infection by Neisseria gonorrhoeae
D FKINANE.C C BLACKWELL, F P WINSTANLEY, AND D M WEIR
From the Deportment of Bacteriology, University of Edinburgh Medical School, Edinburgh
SUMMARY To determine whether the presence or absence of anti-B isohaemagglutinin in
individuals of blood group B increases their susceptibility to gonococcal infections 567 new patients
attending a sexually transmitted disease clinic were screened for blood group and secretor status. Of
the patients with blood group B, 20-1% had gonorrhoea and \2% had not. A higher percentage
(20 • 9<7o) of patients with no anti-B isohaemagglutinin had gonorrhoea compared with those without
(12-1^7#). There was, however, no synergy between the absence of anti-B isohaemagglutin and non-
secretion of water-soluble blood group B antigen. Further research is needed to determine the
underlying host-parasite interactions responsible for the increased susceptibility to gonorrhoea in
these individuals.
Introduction
Over the past six years there have been reports of
increased susceptibility of individuals of blood group
B to infection with Neisseria gonorrhoeae.12 Foster
and Labrum1 suggested that the presence or absence of
anti-B isohaemagglutinin may be the causal factor for
the reported increase in susceptibility to gonorrhoea of
individuals with blood group B. In a recent study we
found that individuals of blood groups B and AB —
that is, those with no anti-B isohaemagglutinin — who
were also non-secretors of blood group antigen were
significantly more susceptible to urinary tract infec¬
tion.5 To determine whether there is a synergistic
effect between those two host factors and sus¬
ceptibility to gonococcal infection we screened
patients attending a department of genitourinary
medicine for blood group and secretor status, and we
related the data to the occurrence of gonorrhoea in
these patients.
Patients and methods
During a three-month period all new patients
attending the department of genitourinary medicine at
the Royal Infirmary, Edinburgh, were asked to
provide a specimen of blood and saliva for determina¬
tion of blood group and secretor status.
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Control data for blood group frequency were
available for 6662 donors from the same geographical
area.4 Secretor status control data were produced by
testing 334 plasma specimens from blood donors in the
survey area.
SCREENING PROCEDURES
Blood from each patient was collected at the clinic and
stored in heparinised tubes. The saliva from each
patient was boiled for 20 minutes, centrifuged at
500 x g for 10 minutes and the supernate stored briefly
at 4"C until tested for the presence of blood group
antigen.
Blood group was determined by agglutination tests
in plastic wells (WHO plates). Secretor status was
determined as described by Mollinson3 with saliva or
plasma samples. Samples of saliva or plasma from
secretors and non-secretors representative of the four
blood groups were used as controls for each experi¬
ment. Agglutinins used were anti-A and anti-B sera
and Ulex europaeus lectin. The red blood cells used
were of groups A,, B, and O. The Blood Transfusion
Service, Royal Infirmary, Edinburgh, kindly supplied
the reagents for blood grouping and determination of
secretor status and also performed random
verification tests on 50 selected saliva samples and 46
plasma samples.
Results
The distribution of blood groups of patients with and
without gonorrhoea and of the controls is given in
Blood group, secretor status, and susceptibility to infection by Neisseria gonorrhoeae
Table I Distribution of ABO blood groups in 567 patients with and without gonorrhoea and controls
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Culture results for N gonorrhoeae
Blood group Nonegative No(%) positive Total No!%) ofpatterns No 1%) ofcontrols*
o 247(30-3) 3*46 1) 32(49-7) 3323(49 9)
A 176(35-8) 23(30-3) 199(33-1) 2410(36-2)
B 39*12-0) 16*21-1) 73*13-2) 713*10-7)
AB 9*1 8) 2*2 6) 11*1 9) 214*3-2)
Total 491(99-9) 76*100-1) 367(99 9) 6662*100 0)
table I. The blood group frequencies of the controls
and the total number of patients attending the clinic
showed no significant differences (jf»5-864,
pX)-l). The frequency of blood group B in these
patients with gonorrhoea was 21 • 1*# compared with
'121* in those without. This difference was not,
however, significant 0^ = 5-103, pX)-l). When the
frequency of blood group B in the patients with
gonorrhoea was compared (21-lwo) with that of the
controls (10-797«) the difference (x2 = 8-404,
p<0■ 05) was significant.
The effect of the presence or absence of anti-B on
susceptibility to gonorrhoea is shown in table II. A
higher percentage (20-91*) of patients with no anti-B
isohaemagglutinin had gonorrhoea compared with
those with anti-B isohaemagglutinin (12-1%)
(^2 = 4-947, p<0-05). Using the relative risk method
of Woolf* we found that the relative risk ofgonorrhoea
was 1-93 for individuals without anti-B isohaem¬
agglutinin. This means that they are 931* more
susceptible to gonorrhoea than persons with anti-B
isohaemagglutinin.
The distribution of secretor status for patients with
and without gonorrhoea and controls is given in table
III. No significant differences were noted between the
total patients and the controls (x2 = 0-917, pX)-1) nor
between those patients with and without gonorrhoea
(r = 0-168, p>0-5).
table ll Analysis of data from table / by presence or
absence of anti-B isohaemagglutinin
Culture results for
N gonorrhoeae
No th) No t*N
Ann-B negative positive Total
Presern (O md A) 423(87-9) 58(12-1) 481(100)
Abseni (B »nd AB) 68*79-1) 18*20-9) 86(100)
To<»J 491 76 567
Discussion
Our findings confirm those of others'2 that
individuals of blood group B are more susceptible to
gonococcal infection and further suggest that the
absence of anti-B isohaemagglutinin is important.
An increase in the number of non-secretors among
patients with gonococcal infections had been
predicted, but this was not observed. Although there
was a significant increase in the number of blood
group B individuals among the infected patients, there
was no synergy between the absence of anti-B iso¬
haemagglutinin and non-secretion of water soluble
blood group B antigen comparable to that found in
patients with urinary tract infections.5
The underlying host-parasite interactions respon¬
sible for the increased susceptibility of individuals with
no anti-B isohaemagglutinin to gonococcal infection
are not yet known; they appear, however, to differ
from those involved with other Cram-negative,
urinary tract pathogens. Accordingly, we are currently-
investigating the role of anti-B isohaemagglutinin in
normal human serum acting as an opsonin or as
bactericidal antibody, gonococcal interactions with
human phagocytic cells of the different blood groups,
and differences fn the attachment of gonococcal
strains to epithelial cells from individuals with
different ABO blood groups.
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SUMMARY The effect of opsonization of Neisseria gonorrhoeae by isohaemagglutinins from normal
serum on attachment to humar. polymorphonuclear leukocytes (PMN) was investigated. No significant
differences between sera from blood groups O, A, B or AB were found. Differences in attachment of
gonococci were related to differences in lipopolysaccharidc detected by sensitivity to R-type pyocines of
Pseudomonas aeruginosa. Non-pilate variants of each test strain markedly stimulated nitroblue tetra-
zolium (NBT) reduction in PMN, but their pilate variants were essentially inactive in the NBT test
Introduction
The establishment of an infection by Neisseria
gonorrhoeae depends on a variety of factors including the
ability of the bacteria to attach to the appropriate target
cells, their uptake and destruction within phagocytic
cells, and the effects of serum components on their via¬
bility and opsonization. A higher incidence of gonor¬
rhoea among individuals of blood group B has been
reported (1, 2), and a theoretical explanation is that the
anti-A isohaemagglutinin characteristic of B serum may
be less effective as an opsonin than the anti-B isohaemag¬
glutinin which occurs in the sera of persons of groups A
andO(l).
In this study we have investigated the effects of isohae-
magglutinuins in the sera of individuals of groups A, B, AB
and O on the attachment to polymorphonuclear leuko¬
cytes (PMN) of gonococcal strains with different cell
envelope characteristics. The effects of differences in
bacterial cell envelope structure and composition as re¬
flected by variation in complexity of pyocine receptors of
the lipopolysaccharide (LPS) (3) have been examined as
factors that may affect attachment of non-opsonized
bacteria to the PMN membrane or the subsequent
phagocytosis and killing of the bacteria.
In an earlier study with one of the strains used here we
have shown that human PMN do not discriminate in
their binding ability between pilate and non-pilate
variants of the strain of N. gonorrhoeae tested (4),
though these variants differ in their infectivity. Either (1)
the binding mechanism studied does not reflect a more
Correspondence: Dr. G G Blackwefl, Department of Bacteriology,
University Medical School Teviot Place, Edinburgh.
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significant surface event in vivo, or (2) intracellular events
within the PMN significantly determine the outcome of
the challenge. To assess the effects of variation in the cell
surface of the organism on the metabolism of the PMN
with implications for the survival of the gonococci, we
have tested the NBT response induced by pilate and non-
pilate variants of various pyocine types.
Materials and Methods
Bacteria
The isolates of N. gonorrhoeae used are listed in Table 1. Strains 9 and
F62 are laboratory cultures; and strains 7422 and 7502 from dissemin¬
ated gonococcal infection were obtained from Dr. Joan S. ICnapp, Neis¬
seria Reference Laboratory, United States Public Health Service,
Seattle, Washington. Eight others are clinical isolates from patients
attending the Department of Genito-Urinary Medicine, Royal
Infirmary, Edinburgh. The pyocin types of these isolates were deter¬
mined by the method previously described (3). Pilate colooy type T1
and non-pilate colooy type T4 variants of these strains were differen¬
tiated with a Zeiss stereoscopic microscope with a double system of
substage lighting and selectively subcultured and maintained on Dtfco
GC agar base supplemented as described by Young et aL (5\ Bacteria
were harvested from these plates at 14-16 hr, suspended in Hanks'
balanced salt solution (HBSS) by gentle pipetting, washed and finally
resuspended in HBSS. ...
Sera •
Serum from individuals of groups A. B, O and AB with no history of
gonorrhoea was stored at -20°C in 05 ml aliquots and thawed
immediately before use. For some experiments sera inactivated by
beating at 56*C for 30 min were used.
Phagocytosis Assay ...... ;
Blood was collected from a healthy group O donor with no history of
gonorrhoea. Volumes of blood (7 ml) were collected in beparinized
(10 iu/ml) plastic tubes to which 2 ml of 5 % dextran (Sigma Chemicab)
in phosphate buffered saline (PBS) pH 7-2 was added.
. . .• j73
4 4smw i i' jKjs.ii* i> pci oi *v yuiiorrnotu*
Rf 1STam
Vnclassi/ied
strain RJ strain R3 strain US strain
ri. gonorrhoea*
strain ISD 2285 IS4 IS6 IS8 R205 9379 ISB R2I 430 ISE ISA ISC
Croup I
E757 - - - - - - 4- - - - - + ±
M9131 - - - - - - 4- - - - - 4* +
7302 ± —
Croup II
F62 + ± + 4* + + + - - - - 4- +
9 + - + + + + 4- - - - - 4- +
M8865 + ± + + + 4- - - - - 4- 4-
E760 + - + + + + 4- - - - - + 4-
PI 52 + - + + + 4- + - - - - + 4-
M6967 + - + + + + 4- - - - - 4- 4-
7422 + — + + + 4- + - - - - 4- 4-
+ inhibition.
+ inhibition with some growth.
— no inhibition.
Erythrocytes were sedimented at 37*C and the leukocyte rich portion
was centrifuged at 380 g for 10 nun. The leukocytes were washed twice
with hepanmzed saline and suspended in HBSS. The cell suspension
was counted in a haemocytotneter and the concentration adjusted to
approximately 10' PMN/mL
Bacterial suspensions (approximately lC/ml) were prepared in
HBSS. The numbers of viable organisms in suitable dilutions in HBSS
were determined by colony counts on GC agar.
The phagocytosis assay was essentially as described by van Furth and
co-workers (6V Leukocytes (lO'/ml) and bacteria (10*/ml) were mixed
in equal volumes in plastic tubes with 0-2 ml (10%) of the appropriate
serum and incubated at 37°C with rotation (16 rev/tnin). Abquots of
0-4 ml were removed at 0, 10 and 30min and added to 10 ml ice cold
HBSS to prevent further phagocytosis. The leukocytes were sedimented
by centrifugation at 380 g for lOmin.
Bacterial suspensions were opsonized for 30min with serum 10%
(v/v) from a healthy individual of blood group A, B or O with no history
of gonorrhoea. For the control, the serum was replaced by HBSS.
For tests at each time interval, 0-5 ml samples of the pelleted leuko¬
cytes were spun onto glass slides in a cytocentrifuge (Shandon Elliot
Cytospin) at 500 rpm. The slides were then studied by light microscopy.
The number of leukocytes containing bacteria in vacuoles or adherent
to the cell surface were expressed as a percentage of the 200 leukocytes
counted. The number of bactena per cell were calculated as a mean of 10
counts.
Nitroblue Tttrazolium Reduction (NBT)
The NBT reduction was assayed as previously described (7) with
PMN and bacteria from the phagocytosis experiments. For the stimu¬
lation test, 0-5 ml of the saline dextrose solution was replaced by an
equal volume of a suspension of the N. gonorrhoeae strain being tested.
Percentage positive counts (Le. cells containing formazan deposits) were
made of the preparations and the mean of 10 counts compared statis¬
tically by a paired r-test with the unstimulated control cells performed
at the same time.
Attachment Experiments
Blood from healthy donors with no history of gonorrhoea was col¬
lected in plastic tubes containing 10 units of heparin ml"'. Monocytes
and PMN were separated on Ficoll-Hypaque cushions (FicoU, Phar¬
macia, London; specific gravity 1-078) by the method of Boyum (8).
After the interface cells (monocytes and lymphocytes) were collected.
the pellet containing granulocytes and red blood cells was resuspende
in 0-8 % ammonium chloride to lyse the erythrocytes (9). The separate
cells were finally washed twice with Dulbecco's phosphate buffere
saline (DPBS) pH 7 1 PMN were resuspeoded in Eagles' minim:
essential medium (MEM) without serum, buffered with HEPES :
pH7-3 (final concentration, 30 mM; Wellcome Research Laboratone
Beckenham), and supplemented with penicillin/streptomycin (final coc
centration 100umJ"' of each) and glutaminc (final concentratiot
2mM) to give a total cell count of 2x 101 (3ml). Aliquots (1 ml) c
the above cell preparations were layered onto glass covers lips 13 mt
diameter in tissue culture plates with wells of 16 mm diameter (Costa
295 Broadway, Cambridge, Ma) and incubated for 1 hr at 37°C t
allow adhesion. Non-adherent cells were removed by repeated washin
in DPBS.
Covers lips were overlaid with 1 ml of gonococci (5 x 10*/ml) i
DPBS containing Ca** 0-9mM and Mg* * 05 mM and incubated fo
(a) 3hr at 4"C, or (b) 30min at 37°G Non-attached organisms wer
removed by repeated washing with DPBS. Coverslips were air-dnec
fixed in methanol and stamed with May Grunwald/Giemsa. Bacteria
binding was estimated by counting leukocytes with bacteria attached a
two or more discrete points. Duplicate coverslips were used; for eac
coverslip, 200 leukocytes were counted and the results expressed as th
percentage of cells binding organisms. The percentages of leukocyte
with 1,2-3,4-5,6 or 6 bacteria per cell were also determined-
Fresh normal sera were obtained from the same healthy donors c
blood groups A, B. O and AB from whom the leukocytes were isolated
A portion of each serum was inactivated at 56*C for 30 mm The effect c
opsonization on attachment was assayed as above by preincubating th<
bacterial suspensions with 0-1 ml of the homologous heat-inactivatei




Sera from individuals of blood groups A, B or O wen
used as a source of isohaemagglutinins; the control con
tained HBSS instead of serum. The titres of isohaemag
glutinin were 256 for anti-A and anti-B in the B and A
individuals respectively and 64 for anti-A and 32 for anti
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Fig. 1. Phagocytosis of N. gonorrhoea*
strains opsonized with A. B, or O
serum. •: no serum. O: A serum, A •" B
serum. X: O serum.
B in the O individual. Figure 1 shows the effect of these
various sera on attachment and phagocytosis (i.e.
association) of various strains of gonococci at 37°C.
The figure shows that association was independent of
the presence of the isohaemagglutinins; the variations
observed were dependent on strain differences. The
strains included a laboratory strain (F62) subcultured for
a number of years that showed the highest degree of
association; a freshly isolated clinical strain (M6967);
and two strains isolated from patients with disseminated
gonococcal infection (7422 and 7502).
Attachment to PMN of Strains with Different Lipopoly-
saccharide Composition Determined by Pyocin Type
The strains used can be subdivided according to the
complexity of their LPS as defined by sensitivity to R-
type pyocins. Group I strains can be simply regarded as
sensitive to the pyocins that attach to LPS structures
nearest the cytoplasmic membrane, whereas group II
strains are sensitive to the same pyocins as group I and
also to additional ones that attach to LPS components in
positions more distal from the cytoplasmic membrane. A
clinical isolate of group I (E757) and one of group II
(PI52) were examined for their ability to attach to PMN
from individuals of blood groups A, B, 0 and AB. At 4°C
and 37°C (data not shown) in the absence of homologous
serum, the group II organisms with the more complex
LPS associated with larger numbers of PMN than the
group I organism (fig. 2). The same differences in
association were apparent between the two groups when
the bacteria were preincubated with homologous heat-
inactivated serum (data not shown).
The numbers of gonococci associating with individual
PMN were determined for organisms of both groups (figs.
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Fkj. 3. Numbcn of pilate gooococci of group I associated with indivi¬
dual PMN of different blood groups at 4*C in the absence of serum.











Table 3 The effect of pUauoo oo NBT reduction with jooococa of
group I and group [1 (percentage PMN containing fonnazan)
Strain









E757 (T4) 2 3-8 (0-35) 24-2 (4)*
non-pilate
E757 (Tl) 2 3-8 (0-55) ^ <*5)t
pilate
Croup II
F62 1 10-6 254*
noo-pilate
F62 (Tl) 1 10-6 10-6f
pilate
E760 (T4) 5 6 (2 2) 27-6 (6-6)*
noo-pilate





Fig. 4. Numbers of pilate gonococci of group ii associated with indi¬
vidual PMN of different blood groups at 4*C in the absence of serum.
associated with individual PMN (fig. 3). Similar patterns
were observed in the presence of homologous heat-inacti¬
vated serum at 4°C and 37°C, although fewer organisms
of either group attached at 4°C
Factors Affecting NBT Reduction
Pilate and non-pilate variants of group I and group II
strains were assessed for their potential to stimulate NBT
reductase in PMN. Two strains of group I (M9131 and
E757) and 5 strains of group II (F62, M8865, M6967,
E760 and 9) were used. No differences in the number of
formazan-containing PMN were found in NBT tests with
Table 2 Stimulation of NBT reduction by non-pilate (T4) variants of
gonococci of groups I and II (percentage PMN containing fonnazan)
Mean percentage PMN containing
formazan (SE)
Number of Unstimulated Stimulated
Strain experiments (control) (test)
Croup I
M9131 3 3-1 (0-62) 8-87 (2-8)
E757 2 3-8 (0-55) - 24-2 (4)
Croup II
F62 3 5-9 (1-1) 24-03 (2 11)
M6967 2 8-4 (2-9) 22-4 (0-5)
9 2 3-9 (15) 13-9 (2-1)
M8865 3 3-1 (0-62) 19-3 (2-1)
E760 • 5 6-0 (21) 276 (6-6)
non-pilate variants of the two groups (table 2). In con¬
trast, for each strain tested, the presence of pili resulted in
a significantly lower number of PMN-containing
formazan deposits compared to results obtained with its
non-pilate variant (table 3).
Discussion
We have tested the hypothesis proposed by Foster and
Labrum (1) that the observed excess of blood group B
individuals among patients with gonococcal infection
may indicate that the anti-B isohaemagglutinin is a more
effective opsonin than the anti-A isohaemagglutinin. We
were unable to demonstrate any significant difference in
the association of individual strains of N. gonorrhoeae
opsonized with fresh sera from healthy A, B, O or AB
individuals to PMN of the respective blood groups.
Our results indicate that differences in association of
gonococcal strains with PMN from A, B, O or AB indi¬
viduals was independent of the serum and paralleled dif¬
ferences in LPS composition as detected by the sensitivity
of the strain to R-type pyocins of P. aeruginosa (10,3,11).
The strain of group II gonococci with the more complex
LPS was found to attach to a greater percentage of PMN
than the strain of group L The same pattern emerged
when the numbers of gonococci per individual PMN
were determined.
Differences in attachment of gonococci to PMN from
donors of all four blood groups appears to depend on the
LPS composition as determined by pyocin type, rather
than the presence of piH or opsonization by anti-B
antiserum.
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* Jo contrast to our observations on association with
PMN we found no differences in the NBT test with
pMu'when non-pilate strains of either group I or group
II were tested. Both groups were found to show an
increase in number of formazan-contaimng PMN com¬
pared with the control to which no bacteria were added.
Results for pilate variants of both groups were not signifi¬
cantly different from the unstimulated controls.
Densen and Mandell (12) reported that in the presence
of serum, pilate and non-pilate gonococci of their test
strain F62 stimulated specific granule release measured
by the appearance of lactoferrin in the medium, and that
both stimulated increases in oxidative metabolism. In
contrast, Kreiger, Schiller and Roberts (13) reported a
minimal increase in glucose oxidation and oxygen con¬
sumption of PMN to which pilate gonococci were
attached compared with the marked increase found with
non-pilate gonococci. It must be noted that the latter
workers were using a pilate strain and a non-pilate strain
obtained from two different patients with disseminated
infections. Our results in studies with pilate and non-
pilate variants of strain F62 and with isolates from
localized genital infections support the findings of
Kreiger et al. and not those of Densen and Mandell.
We conclude that in host parasite interactions between
PMN of the four different blood groups and N. gonor¬
rhoeae, the surface characteristics of the bacteria detected
by the pyocin typing system are the major determinants
of recognition. These surface characteristics appear to
have no effect on subsequent intracellular events that are
linked with the NBT assay. Our findings support pre¬
vious reports (13, 14) that gonococcal cells with pili, cell
surface components associated with virulence, provoke
less stimulation of intracellular bactericidal mechanisms
:r. human PMN than do non-pilate organisms. Although
antibodies against pilar proteins are produced during
gonococcal infection (15), electron microscopic studies of
infected material have prompted debate about their
physical presence on the bacteria in vivo (16, 17). It is
possible, however, that proteases present in the tissue
fluids and released by phagocytes may remove these
structures.
The greater ability of group II gonococci with more
complex LPS to adhere to PMN would be expected to
t to the disadvantage of the organism in establishing
infection. This would, however, be offset by any
advantage such organisms would have in attaching to
uroepithelial cells. Group II organisms are frequently
recovered from patients (3); thus, it will be necessary to
determine if the differences in attachment to PMN
observed for groups I and II are found also with
uroepithelial cells. Pili are already known to play a part
in mediating such attachment (18, 19) but, the relative
contributions of pili and LPS are not yet established.
The present report has concentrated on gonococcal-
PMN interactions. Novotny and colleagues (20) have
proposed that gonorrhoea is a disease of human mono¬
cytes. Whether or not the presence of pili or differences in
LPS have any significance as determinants of suscepti¬
bility in individuals of different blood groups has not yet
been elucidated. As a result of the present study and our
previous findings (4) that pili are an important deter¬
minant for attachment to monocytes, investigations are
underway to examine various factors, of both host and
parasite, affecting recognition of gonococcal strains by
monocytes of different ABO blood groups.
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BLOOD GROUPS AND SUSCEPTIBILITY TO GONOCOCCAL
INFECTION.
II. THE RELATIONSHIP OF LIPOPOLYSACCHARIDE TYPE TO
GONOCOCCAL SENSITIVITY TO THE BACTERICIDAL
ACTIVITY OF NORMAL HUMAN SERUM
F. P. Winstanley, C. C. Blackwell. D. M. Weir and D. F. Kinase
Department ofBacteriology. University of Edinburgh Medical School. Teviot Place. Edinburgh EH8 9AG, UK
(Received 2 August 1982)
SUMMARY This study examines the bactericidal activity of normal human sera from individuals of
blood groups A and B for gonococcal strains with simple and complex lipopolysaccharides (defined by
pyocin-sensitivity) isolated from localised and disseminated infection. The bactericidal activity did not
depend on A or B isohaemagglutinins. Resistance to normal human serum exhibited by strains from
localised infections appeared to be due to lack of part of the lipopolysaccharide antigen, whereas
resistance of strains from disseminated infection appeared to depend on a separate mechanism yet to be
defined.
Introduction
Individuals of blood group B are especially susceptible
to genito-urinary infections with Escherichia coli (1, 2)
and Neisseria gonorrhoeae (3. 4. 5). There is evidence that
the anti-B isohaemagglutinin found in individuals of
■blood groups A and O may play a role in host-protection
against infection by gram-negative bacteria (6).
In this study we investigated the sensitivity of a number
of strains of .Y. gonorrhoeae with different lipopolysac-
rharide (LPS) to "normal human serum" (NHS) from
ndividuals of blood groups A and B to determine
whether anti-B isohaemagglutinin is involved in a non¬
specific host defence mechanism against gonorrhoea.
Previous work from this laboratory has indicated that
attachment of gonococcal strains to polymorphonuclear
-eukocytes (PMN) varies according to differences in the
structure of the LPS (7) as detected by differences in
ensitivity to partially purified R-type pyocins of Pseudo-
nonas aeruginosa (8). Since LPS is one of the major anti¬
gens involved in bactericidal killing (9.10), strains of both
>f the pyocin-defined groups (7) were tested to determine
vhether differences in LPS structure could be correlated
vith differences in sensitivity to the bactericidal effects of
4HS and conventional immune sera prepared in mice.
'orrespondence Dr. D M. Weir. Department of Bacteriology




Ten gonococcal strains from localised infections were supplied by the
Department of Genito-unnary Medicine. Royal Infirmary of Edinburgh
iR.I.E.). Three 0-lactamase-producing strains were kindly supplied by
Dr. K. Shannon and Professor I. Phillips. St. Thomas's Hospital
Medical School. London, and two strains from disseminated infections
were obtained from Dr. Joan S. Knapp, Neisseria Reference
Laboratory. United States Public Health Service. Seattle, Washington.
All strains, together with the grouping based on pyocin sensitivity (?)
are listed in Table 1. They all conformed to the morphological and
biochemical characteristics of .V. gonorrhoeae and were of colony type 4
ill).
Culture
Strains were cultured on Modified New York City (MNYC) medium
(12) at 37°C in a humidified incubator with 10", C02 in air.
Isolation of Pyocin-resistant Mutant
Colonies grow ing within a zone of inhibition produced by pyocin IS8
were isolated and re-typed. One mutant strain lP280|i), sensitive to
Kageyama group R5 pyocins only, was used in the study.
Preparation of Immunising Antigens
An 18-hr growth of gonococci was harvested from MNYC plates
with sterile cotton swabs and suspended in 0-01M phosphate-buffered
saline (PBS) pH 7-2. An equal volume of PBS containing 2 4%
formaldehyde was added to the suspension which was stored overnight
at 4°C. The formaldehyde-treated organisms were centrifuged at 900 x
g for 1 hr and resuspended in PBS containing 0 01 formaldehyde to
the opacity of Brown's Tube No. 3 as judged by eye (13). This is equi¬
valent to 1 1 x 10' gonococci ml (14).
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Table 1 Pyocin type of gonococcal strains
Pvocins with Kageyama group
Rl
Gonococcal

























+ clear zone of inhibition.
X zone of partial inhibition.
- no inhibition.
• ^-lactamase producing strains.
+ strains from disseminated infection.
Immunisation Schedule
Female CF1 mice. 5-6 weeks old. caged in groups of 10, were given
0 25 ml of the standard suspension of formaldehyde-treated gonococci
(gonococcal antigen) intravenously, via the lateral tail veins. The mice
were immunised at day 0 and again on days 7 and 10. On day 14 a small
quantity of blood was taken from the retro-orbital plexus of each mouse
of the group and pooled: the serum obtained was inactivated by heating
to 56°C for 30min and then distributed into small tubes and stored at
— 20°C until required. The mice thereafter received booster doses
(0 25 ml) of the gonococcal antigen at 14-day intervals and blood was
obtained 5 days after each immunisation.
Complement
Human AB serum from a donor with no history of gonococcal
infection w as adsorbed for 24 hr at 4°C with a live suspension of the
gonococci used in the study, distributed in 200pi aliquots and stored at
- 70°C before use. The minimum haemolytic titre of the serum was
32-64.
Normal Human Sera from Individuals of Blood Groups A and B
Kindly supplied by Drs. S. Urbaniak and P. L. Yap of the Blood
Transfusion Service, R.I.E.
Screening Test for Bactericidal Activity ofNormal Human Serum
An 18-hr culture of gonococci was suspended in Dulbecco's Phos¬
phate Buffered Saline supplemented with Mg** and Oa** ions
<0-5 mM and 0 9 mM respectively) (DPBS + B) to give approximately
10*cfu/ml.
A series of two-fold dilutions, from 15 to 480, were made in a micro-
titre plate for each serum to be screened to give a final volume of 50pi
per dilution, 40 pi of gonococcal suspension and 10 pi of a two-fold
dilution of the complement source were added to each well and incu¬
bated at 37°C for 30min. Two drops of 20 pi from each well were plated
onto MNYC medium and incubated for 24 hr. The highest serum
dilution to give a reduction in viable count of 5 80 °„ was considered to
be the bactericidal titre of the serum.
Bactericidal Assay with Immune Mouse Serum
These were performed in round-bottomed glass tubes (15 mm x
75 mm). An 18-hr culture of gonococci was suspended in D PBS -r B to
give approximately 10" cfu ml. The assay mixture contained 160 pi of
bacterial suspension. 20 pi of a two-fold dilution of heat-inactivated
mouse serum and 20 pj of freshly thawed AB serum as the complement
source. Controls lacking serum and or complement were included for
each experiment. After static incubation at 37°C for 30min in a humidi¬
fied atmosphere with 10 °0 C02 in air. 25 pi volumes were removed
from each tube and viable counts were performed (15). A reduction in
viable count of 80 °0 or greater when compared with controls was
considered to be significant.
Results
The gonococcal strains were all typed by pyocin sensi¬
tivity and classified into two broad groups: Group I
strains were sensitive to Kageyama group R5 pyocine;
Group II strains were sensitive to Kageyama groups R5
and Rl pyocins (table 1).
The AB serum used as the exogenous complement
source for the bactericidal reactions was found to have
slight microbicidal activity against strains of Group II.
This activity was removed by absorption at 4°C with the
sensitive strains and the procedure had no effect on the
complement titres. Absorbed AB serum was used in all
the bactericidal tests.
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Table 2 Bactericidal titre of normal human serum from Group A individuals
Sera
Test strain of








M8865 15 240 60 60 60 30 120 120 30 120 120 60 30 30 15 60
P280 > > > > > > 240 240 240 60 120 30 120 120 30 120
E2590 < < 60 30 < 30 < < 30 30 120 60 60 60 15 60
P3290 15 15 30 30 30 30 15 60 120 120 15 15 15 60 30 120
•1560 < < < < < < < < < < < < < < < <
Group I
Group II
< less than 15.
> greater than 4S0.
* strains from disseminated infection.
Normal human sera from individuals of blood groups
A and B were found to be bactericidal to gonococcal
strains of Group II to a titre of >15, but no activity
towards Group I strains from localised infections or a
disseminated infection could be demonstrated at the
lowest serum dilution of 15. The titre of bactericidal anti¬
body against strains of Group II was slightly greater in
individuals of blood group A (tables 2 and 3). No bacteri¬
cidal activity could be demonstrated towards strain 1560
(Group II) from a disseminated infection (tables 2
and 3).
This bactericidal activity of NHS towards strains of
Group II is inhibited by 10 mM Mg-EGTA which
sequesters Ca " ions necessary for the classical pathway
of complement activation.
There was no discrimination between strains of Group
I and Group II by the microbicidal mechanism in
immune mouse serum. Serum raised against a strain from
Group I (M9131) killed other strains in Group I and also
strains in Group II. This same lack of discrimination was
shown by antiserum raised against a strain from Group II
(M8865) (table 4). Similar experiments with two
gonococcal strains from disseminated infections (1560
and 7425) showed no detectable microbicidal activity.
One serum from each of the blood groups A and B was
absorbed twice for 24 hr at 4°C with a heavy suspension
of erythrocytes expressing A or B antigens to remove the
iso-haemagglutinins. This absorption did not remove any
bactericidal activity from the sera. Absorption with a
heat-killed suspension of P. aeruginosa strain ZD8
slightly reduced the bactericidal activity of the sera (table
5).
Table 3 Bactericidal titre of normal human serum from Group B individuals
Sera
Test strain of















< < < < < < < < < < < < < < < <
15 30 30 30 > 15 120 30 15 15 < 30 < 15 30 15
< 15 < 15 240 15 15 30 120 60 60 60 240 60 120 60
< < < 15 60 < < < 30 30 30 60 30 60 30 30
< < < 30 60 < 120 60 120 30 30 15 15 120 30 60
< < < < < < < < < < < < < < < <
< titre less than 15.
> titre greater than 480.
* strains from disseminated infection.
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Table 4 Microbicidal action of immune mouse serum. Number of tests
out of 4 giving ? 80kill
Table 6 Relative positions of pyocin receptor sites on hpopolysaccha-
nde I LPS) of Pseudomonas aeruginosa
Antiserum
Gonococcal —
strains M913I (group I) M8865 (group III












Our findings suggest that the increased susceptibility of
individuals of blood group B to infection by N.
gonorrhoeae is not related to differences in susceptibility
of the organism to isohaemagglutinins. Although N.
gonorrhoeae isolates have been shown to absorb anti-A
and anti-B isohaemagglutinins (4) the bactericidal acti¬
vity of normal human serum (NHS) could not be re¬
moved by absorbtion with red blood cells expressing A
and B antigens.
Variations in the susceptibility of gonococci to the
bactericidal effects of NHS have been reported (9, 16.17).
Although the LPS has been found to be the target antigen
for "natural" antibody (16. 18). the particular com¬
ponents involved in the reaction had not been identified.
Classification of gonococcal isolates by the sensitivity-
pattern to partially-purified R-type pyocins of P. aeru¬
ginosa has provided a method for detecting differences in
LPS antigens. Clinical isolates of Group I which appear
to have a simpler LPS structure are resistant to NHS
while those with more complex LPS (Group II) are sensi¬
tive. The importance of LPS components in determining
the reaction with NHS is illustrated by the change from
sensitivity to resistance found in the mutant P280p
(Group I) derived from a NHS-sensitive clinical isolate,
P280 (Group II). Alterations in the LPS associated with
RJ' R4' R2' Rl' RJ'
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* Arranged in order of the receptor sites on the lipopolysaccharide
(LPS) fraction of P. aeruginosa suggested by Kageyama (1975).
The receptor for R5 is nearest to. and that for R3 furthest from the
cytoplasm.
this mutation was shown by gel-electrophoresis and gas-
liquid chromatography (unpublished data). These
findings are similar to those of Morse and Apicella (19)
for their gonococcal LPS mutant selected for resistance
to pyocin 611-131.
A schematic representation of the relative positions of
pyocin receptors on the LPS of P. aeruginosa proposed
by (20) is show n for our range of pyocins and those used
by Sidberry and Sadoff (21) in Table 6. The "natural"
antibody of NHS appears to be directed against either:
(1) the LPS structure(s) that form the receptor site(s) for
pyocins of Kageyama's group R1; or (2) to one or more
structures distal, but linked, to the receptor site for the R1
pyocins. Evidence for this second proposal comes from
the work of Sadoff and co-workers (22). Gonococcal iso¬
lates were typed with pyocins from their collection and
they found that the growth of serum-sensitive strains was
inhibited by pyocins D, H and I. These three pyocins
belong to Kageyama groups R2, R4 and R3 respectively
which attach to LPS receptors distal to those for R1
(table 6). In contrast, our pyocins of these three groups
Table 5 Titres of bactericidal antibody before and after absorption
N. gonorrhoeae Before Absorbed with Absorbed with
strain absorbtion erythrocytes P aeruginosa
P280 120 120 60
Group A serum M8865 120 120 60
(K) E2590 30 30-60 15
P280 120 120 15
Group B serum M8865 15 < 15
(xi) E2590 15 15 <
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had no activity against any of the gonococcal isolates
tested (8).
The putative "natural" antibody responsible for the
microbicidal activity of NHS differs in specificity com¬
pared with conventional immune sera raised in mice.
While the "natural" antibody recognises determinants
present only on organisms expressing the more complex
LPS, the immune sera had a wider specificity and were
bactericidal for strains of both Group I and Group II.
Previous work has suggested that resistance of
gonococci to NHS is not due to the presence of masked
antigens, blocking IgA antibodies, or deficiencies in com¬
plement function, but to the resistant organism's lack of
an LPS determinant that binds the "natural" antibody
(23); our findings support this view. The bactericidal acti¬
vity of NHS towards strains of Group II could be
absorbed in part by a heat-killed suspension of P.
aeruginosa strain ZD8, suggesting that the activity may
be due to "natural" antibody induced by commensal
flora.
One implication of our findings is that the more NHS-
sensitive Group II organisms should be restricted to
localised infections and that Group I should predominate
in disseminated infections. In an earlier study on pyocin
types of gonococci from a number of geographic sources
(8) 95 (86-4°0) of 110 isolates from localised infections
were of Group II compared with only 15 (13 6%) of
Group I. In contrast, of the 24 isolates from disseminated
infections, a higher percentage of Group I organisms
(41 -6%) were found. The proportion of isolates of Group
II was 58-3 %. Since organisms of Group II have been
isolated from disseminated infections, simplicity of LPS
does not appear to be the sole factor in determining the
characteristics of a "disseminated" strain.
A Group II isolate from a disseminated infection was
resistant to immune mouse serum in addition to NHS
and this finding is the subject of further studies. This
suggests that loss or masking of antigens can occur
without interfering with the receptor sites for the R-type
pyocins. This resistance to bactericidal antibody of a
strain from disseminated infections was not found to be
associated with anti-complementary activity of the
organism.
We conclude that the bactericidal effect of NHS on
strains of N. gonorrhoeae is mediated by antibodies that
bind to a LPS portion associated with the binding site of
R1 pyocins present in gonococci of Group II. Strains
lacking this portion of LPS —(Group I)—are resistant to
NHS. Thus "natural immunity" to gonorrhoea appears
to be directed at organisms of Group II.
The basis for the increased susceptibility of blood
group B individuals to gonorrhoea is still not established
but seems not to be due to isohaemagglutinins. There is
evidence in E. coli urinary tract infections that the anti-B
titres are raised during infection with organisms
expressing B-like antigens. This rise did not occur with
anti-A isohaemagglutinins in response to A-like
organisms (24). If this difference is reflected in other
"natural antibody" responses of B individuals a possible
basis for increased susceptibility to infection arises.
The sharing of antigens (galactose determinants) be¬
tween the LPS of gonococci and blood group B antigen
could also account for a diminished response in indi¬
viduals of blood group B.
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ABO BLOOD GROUPS AND SUSCEPTIBILITY TO
GONOCOCCAL INFECTION. III. ROLE OF
ISOHAEMAGGLUTININS IN INCREASED ASSOCIATION
OF NEISSERIA GONORRHOEAE TO MONOCYTES FROM
BLOOD GROUP B INDIVIDUALS
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SUMMARY The association of human monocytes of different ABO blood groups with gonococci
was examined under various conditions. Blood group B monocytes in the presence of autologous heat
inactivated serum (HIS) showed increased association over monocytes of the other ABO groups with
their autologous sera. No statistically significant trends in ABO monocyte association were noted for
assays carried out in the absence of autologous HIS. Absorption of isohaemagglutinins from sera
reduced the gonococcus-monocyte association level to that of controls.
Introduction
Increased susceptibility to various infectious diseases
has been linked to the ABO blood group of the individual
(1-8). Correlation between increased susceptibility to
infection with Neisseria gonorrhoeae and ABO blood
group B has been noted in patients of different racial
groups (5—7).
The underlying mechanisms of microbial patho¬
genicity involved in these host parasite interactions are not
understood. Man> bacteria cross-react with ABO blood
groups (9-11). Miler and co-workers (6) have shown that
infection with- N. gonorrhoeae may reduce the titre of
ABO blood group isohaemagglutinins and that
gonococci in vitro were capable of absorbing both anti-A
and anti-B isohaemagglutinins. This suggests that
gonococci have both A and B-like antigens present in
their cell walL The possible protective role of isohaem¬
agglutinins against these cross-reacting bacteria thus re¬
quires consideration. Anti-B isohaemagglutinin has been
shown to be both bactericidal to (10) and a significant
opsonin for (12) E. coli 086. Work in our laboratory,
however, suggests that anti-A and anti-B isohaem¬
agglutinins are not bactericidal for gonococci (13) and
they did not result in significant differences in association
with polymorphonuclear leucocytes (14). Further work
has been carried out to evaluate the role of isohaem-
Correspondence.* Dr. C C Blackwell Department of Bacteriology,
University Medical School, Teviot Place, Edinburgh EH8 9AG.
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Neisseria gonorrhoeae strains PI52 and E757 recently isolated from
pauents attending the Department of Genitourinary Medicine were
used throughout these experiments. P132 and E737 were of different
pyocin sensitivities which suggests differences in their lipopoly-
saccharide (LPS) (15). E757 was of "simple" LPS type (Group I)
whereas P1J2 was of "complex" LPS type (Group II) (14). Opaque
colony types 2 (pilate) (Tj) and 3 (ooo-pilate) (T5) were differentiated
with a Zeiss stereoscope microscope with a double system of substage
lighting and selectively subcuitured and maintained on Ddco GC base
supplemented as described by Young (16) (GC agar). T2 and Tj
growths, with more than 93 % of the colonies stable, were employed.
Bacteria were harvested from GC agar plates at 14-16 hr, suspended in
Dulbocco's phosphate buffered saline (DPBS) by gentle pipetting,
washed and finally resuspended gently in DPBS.
Bacterial concentrations were determined at E630nm on a CE292
spectrophotometer (cscxl instruments, Cambridge, England) by
reference to standards enumerated by microscope counts with a
counting chamber. a concentration of 10* organisms/ml was used in all
assays except those involving absorption of isohaemagglutinins where a
concentration of 10* organisms, ml was used.
Phagocytes
Blood from healthy donors with no history of gonorrhoea was
collected in plastic tubes containing 10 units of heparin ml"1. Mono¬
cytes were separated on FicoO-Hypaque cushions (noou, THaamacu,
London) specific gravity 1 -073 according to the method of Boyum (17).
After the interface ceils (monocytes and lymphocytes) were collected,




Autolofoui sera >u obtained at the same time as the Mood for the
orfls was taken, [a some experiments heat inactivated sera (HIS) was
used and this was obtained by inacbvabng sera in a water bath at 56*C
for 30 mm Fresh human sera (FHS) and heat inactivated sera (HIS)
wcsa used at a final coocentranoo of 10% in the appropriate well. The
ijohacmaggtotxnia levels of all sera were within normal limits.
200 leucocytes were counted and the results expressed as the percentage
of cells binding organisms.
Analysts ofRtvilts
Two factor -ualysu of variance was used to the dfects of
blood group and various coodiboas on gonococcal/'monocyte associa¬
tion.
Absorption ofABO Antibodies
The group O sera used for these experiments had both anb-A and
ano-B otres equal to 256. The isohaemagglutunas anb-A and ano-B
were absorbed by an equal mixture of A, and B washed RBC for 1 hr at
37"C and then overnight at 4*C The ahsorpboa mature of sera and
RBC eras approximately 50% (vol/vol). The anbbody btres were re-
checked after absorption and where necessary absorpboo eras repeated
until both. anb-A and and-8 btres were reduced to zero. Haem-
agglutmaboo tests to check original btres and btres after absorpbon
were carried out as described by Miler (6).
Preparation ofMonolayer]
Monocytes were resuspcnded in Eagle's minimum essential medium
(MEM) without serum buffered at pH 7-3 with HEPES (final concen¬
tration, 30oM; wellcome useaach laboaatoejes, Beckenham) and
supplemented with penicillin streptomycin (final concentration 100 nJ
ml ~1 of each) and glutamine (final concentration, 2 mM) to give a total
cell count of 2 x 101 ml"'. Aliquots (1 ml) of the above ceil preparations
were layered onto 13 mm diameter (No. 1) glass covers lips in tissue
culture plates 16 mm well diameter: (costa*. 295 Broadway,
Cambridge, Mass.) and incubated for 1 hr at 37*C to allow adhesion.
Non-adherent ceils were removed by repeated washing with DPBS.
Binding Assay
Coverslips were overlaid with 1 ml of gonococci in OPBS containing
Ca* * and Mg' * ions (0-9 mM and 0-5 mM, respectively) and incu¬
bated for: (1) 30 tnin at 37*C and (2) 2 hr at 4*G In those experiments
involving sera. 0-1 ml of the appropriate sera was added to the 0-9 ml of
gooocooa in DPBS. Non-attached organisms were removed by
repeated washing with DPBS. Covers lips were air dried, fixed in
methanol and stained with May Crunwaid Gicmsa. Bacterial binding
was estimated by counting monocytes with bacteria attached at two or
more discrete points. Duplicate covers lips were used: for each coverslip.
Results
Figure 1 shows the association of goaococci to mono¬
cytes of different ABO blood groups under various con¬
ditions ; Dulbecco's Phosphate Buffered Saline (DPBS) at
37°C for 30min, DPBS at 4°C for 2hr and autologous
heat inactivated serum (HIS) at 37°C for 30min. Each
bar represents the mean of 3 experiments, different indi¬
viduals were used for each experiment.
Two factor analysis of variance was used to examine
the effects of blood group and of the various conditions
on gonococcus-monocyte association for each strain
separately.
A significant interaction in this analysis indicates that
the effect of blood group on association varied between
the different conditions. When DPBS 37°C and 46C were
compared in this way, no significant interaction was
found for either strain, but when HIS was also included
there was a significant interaction for both E757 (p <
0-001) and P152 (p < 0-01). As Figure 1 shows this is
mainly due to the fact that association was greater for
group B subjects when HIS was used whereas there was
little difference in association between the blood groups
when DPBS was used.
A similar analysis was carried out to examine the
effects of blood group and strain on association for each
condition separately. There was a significant interaction
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case of HIS, strain E757 in addition to showing the
greater association with B monocytes shows more
association with group A subjects than with those of
groups O or AB, whereas strain P152, although likewise
associating to a greater extent with B monocytes, gives
tittle difference in association between the 3 other blood
groups (fig. IV
Thus LPS characteristics may not be important in
gonococcus-monocyte association in DPBS but may be
important when serum is present Experiments using
fresh human serum (FHS) were carried out but gave very
low association levels for PI52. We have noted
previously in our laboratory that PI52 was complement
sensitive and suggest that it is this sensitivity to com¬
plement that gives the low association levels for P152 in
FHS.
Comparing the association in HIS and DPBS at 37°C
there is an overall increase in association for HIS
throughout the blood groups with the exception of blood
group AB. This is interesting bearing in mind that blood
group AB homologous HIS contains no isohaem-
agglutinins in contrast to A, B and O homologous sera
which do.
Figure 2 shows the effect of removal of isohaem-
agglutinins on gonococcus-monocyte association at
37°C. Group O monocytes and serum from different
donors were used for each of 3 experiments. Absorption






Fn. 2. The effect of removal of »ohx£m»|jJutuimi on mociidoo at
fooococcj to moaocjrtei of blood (roup O at 37*C Each bar repraeot*
the mean ± ISEM at 3 expenmenu.
that of DPBS. It is likely therefore that although there are
differences in binding patterns between strains, the signi¬
ficant interaction or binding pattern mentioned
previously for HIS is due to the presence of isohaem¬
agglutinins in the homologous sera.
Discussion
Our results indicate that there are no differences in gono¬
coccal association to monocytes of different ABO blood
groups in the absence of autologous heat inactivated sera.
This suggests that differences in ABO blood group
antigen expression on monocytes does not influence
gonococcal attachment (4°C) or phagocytosis and/or
attachment (37°CV There were no significant differences
between strains P152 and E757 in their binding in DPBS
at both 4°C and 37°C. This coatrasts with earlier work on
P.VTN (14) which shows marked differences in binding
between strains.
The association of gonococci to monocytes of different
ABO blood groups in homologous heat inactivated sera
(fig I) showed a significant pattern of binding for each
strain, P152 (p < 0-01) and E757 (p < 0-001) with an
increased level of association for group B monocytes. A
further statistical analysis showed significant differences
in pattern of association to different ABO monocytes for
PI52 and E757 (p < 0-05V Thus LPS characteristics
seem to be important in gonococcus-monocytes associa¬
tion in autologous HIS. Heat inactivation was important,
as strain PI52 being complement sensitive, gave very low
association levels when autologous fresh serum assays
were carried out (not shown).
It is interesting to note that HIS increases the
association for both strains for monocytes of all blood
groups except AB, Le. the blood group with no isohaem¬
agglutinins. Miler (6) found that the isohaemagglutinins
induced by gonococci were predominantly of the
immunoglobulin M class as are isohaemagglutinins of
normal sera. Haegart (18) has demonstrated the presence
of IgM receptors on human peripheral monocytes. Our
experiments indicate that isohaemagglutinins were
responsible for the increased gonococcus-monocyte
association over that found in DPBS. This differs from
the findings for PMN where various isohaemagglutinins
gave no significant increase (14).
These results would seem to contradict predictions
that blood group B individuals may be more susceptible
to the disease due to the ineffectiveness of their isohaem¬
agglutinins in opsonizing bacteria for monocytes. In our
previous report on phagocyte recognition of gonococci
(19) we quoted "Novotoy's hypothesis" (20) that gonorr¬
hoea was a disease of human macrophages in which the
gonococci attach to and enter macrophages where they
multiply forming "infectious units" which go on to infect
other sites. We noted increased binding of pOate gono¬
cocci to monocytes and suggested that this may be
-
- < SUSCEPTIBILITY TO GONOCOCCAL INFECTION 85
virulence factor because increased affinity for monocytes
would result in more "infectious unit" formation. In the
light of these comments the results presented here suggest
that group B individuals may be even more susceptible
than individuals of other blood groups due to the
increased association found for group B monocytes
leading to the formation of more "infectious units".
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of chloracne (723 The ublt shows the morality figures of both
jubgroups stratified by year of birth. 25 men hive died, 8 from
mv0cardjj| infarction including sudden death and 8 from
neoplasms In contrast to the 8 who died from tumours, 7 of the 8
(nen who died from myocardial infarct ion/sudden death had had
c hioracne, 4 belonged to the group of 16 contract cleaners, who did
the dirtiest work and had severe chloracnc. These 16 men had many
o,her exposures to chemicals before and after the period concerned,
and alcohol consumption was relatively high among this group. The
neoplasms do not show an organ related pattern, and are nor
considered to represent any excess mortality expected number of
deaths 21 (SMR 1-19, 95% confidence interval 0-78-1-703
expected number malignant diseases 6-94 (SMR 1-15, 95%
confidence interval 0-49-2-09).
Morbidity data are being collected on 35 of the cohort, most of
them being employees of the factory concerned. The data are being
compared with those of a matched control group, and to date no
significant differences have been found. The study continues.
Ye (hank Prof F 4e Yaard and Dr H B Bur no dc Meaqutta, National
Institute for Public Health, BUthoven, for mimical calculations.
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GONORRHOEA, A PREDISPOSING FACTOR FOR
MENINGOCOCCAL DISEASE?
Six,—Immunity to meningococcal disease correlates with the
presence of bactericidal antibodies for Ntisima mtmngitvbs.
Development of protective antibodies in the absence of
meningococcal disease is associated with carriage of noo-
serogroupable strains of the organism which are also usually non¬
pathogenic. IJ Children not yet colonised by these strains are at
greater than usual risk of meningococcal disease. We have noted
abnormally low levels of antibody bactericidal for N merungithht
serogroup A and two noo-serogroupable strains among individuals
with gonorrhoea,3 and report here the bactericidal activity ofserum
from individuals with gonorrhoea against strains of N memngiiuJis
serogroups A, B, and C, those most frequently associated with
meningococcal disease, and against the two non-serogroupable
strains (0452 and NG846).
Strains of .V meningitidis were cultured on modified New York
City medium at 37*C in a humidified atmosphere enriched with
10% COj. Titration ofbactericidal antibody was done as described
previously (see table).4
The results demonstrate very low or undetectable levels of
antibodies bactericidal for the strains of meningococci serogroups
A, 8, or C in sera from patients with gonorrhoea. This contrasts
with the litres against a group A strain found in serum ofuninfected
"normal" individuals from the same geographical area (only 5/16
sera having titres below 4)3 and with litres against serogroups A, B,
and C reported by Craven et il.'
Absence of bactericidal antibody against serogroupable
meningococci is a common feature of individuals who contract
meningococcal disease and, as Artenstein and Ellis4 suggested,
"since meningococcal disease is a rare event compared to the carrier
state, it may well be that deficiencies in host defences may play a
major role in determining whether systemic invasion occurs".
1. Gwldachacidei L Gouchltcb EC. Artenwcto MS. Humjs wmut to the
mewmfocwcnm U: Devflopmrm of natural jububui J Exp SWT 1*6*. ISS:
1177-AS
2 Reiki LB. MacGrtgor RB, Bean, HN Bacttnadal tstibody a/las cMeiuiatioa with
Sxiuxrxx aniY'U, J tmfeti Ov 1*73,127: 3S-A2.
I Bturkwrll CC, V uwunky FT. tPeu DM. Lipopol, tactbar ida type aad acttsmvtty of
the pathogenic Vnaaarai to tba bancnodal actmey of normal human icrum to:
Proceeding tf tba fifth international con far, OCT oe ccrebroaptml Otea.af.ia
(MarueUka. Fraaca, 1*633
4. Wawtanky FT, BtacWell CC Weir DM, Rcoaoa DF ABO Mod groupa and
tuacept itelrry to fooorTboaa □: Tba ralauooabip of lipopolyiaccharidr rype to
fooocoacmf temsatiTiry to tba bactanctdal acutmy of normal human tarum J CJtm
Lot Imarana/ 14S3, II: 27-32.
5. Oman DF, Shan KT, FraarbCE. Natural bactericidal activity ofbumaoaarumasaioat
ft/iuamo meoiefiaXii oolatas of ddSrrrot trrogruupa and serotype, I.feci Immmm
1*42. *7: 132-37
* Anaoaaam ms, Ellai RE Tba rat of axpooura m a paocnr oak meningococcal
mcruogma. A4.hr MM I *64, IXS: *74-77
TITRE OF BACTERICIDAL ANTIBODY AGAINST S MENINGITIDIS
STRAINS Of Sf ROGROl'P A. B. AND C, AND TWO NON'GROC fABLE
STRAINS 0432 AND NGWS IN SEBA FROM PATIENTS WITH
GONORRHOEA
Pa(«n( A B C M32 NG846
1 <4 1-16 4-8 12-64 16-32
2 <4 <4 8-16 64-128 <4
) <4 1-16 8-16 64-128 8-16
4 <4 <4 <4 16-12 <4
5 8-16 8-16 16-32 64-128 32-64
6 <4 <4 8-16 >128 64-128
7 <4 <4 <4 >ia 4-8
1 <4 <4 <4 64-128 16-32
9 <4 <4 <4 16-12 <4
10 <4 <4 <4 64-128 4-8
11 <4 <4 4-8 >128 <4
12 <4 <4 4-8 >ia 128
13 >2-64 <4 4 >128 >128
14 <4 <4 <4 >128 1-16
15 «4 <4 8-16 64-128 64-129
16 4 4 4-8 >128 32-64
17 <4 4-8 >J2S >128
18 4-B <4 4-8 >128 >128
Meningococci and gonococci possess similar lipopolysaccharide
structures,7 and cross-reset ions ofmonoclonal antibodies have been
shown between hpopolysaccharide antigens of meningococci and
gonococci.1 Bactericidal antibodies against both these species
appear to be directed against lipopolysaccharide antigens. The low
litre of bactericidal antibody towards groups A, B, and C
meningococci in sera from patients with gonorrhoea could be due to
absorpitoo of cross-reactive antibodies by the infecting strain of
.V gonorrhotae.
We propose that gonorrhoea may compromise host defences
against meningococcal disease and that this may explain in part the
following observations:
(а) The age range most at risk of meningococcal disease is 0-4
years (ie, children lacking bactericidal antibodies') but the group
next most at risk is 15-19 years, the age when sexual activity begins
and when the incidence of gonorrhoea is high.*'10
(б) During outbreaks of meningococcal disease is military
establishments most patients are aged 18-24 years,11,11 the range in
which moat cases of gonorrhoea in servicemen are found.
(c) The incidence of meningococcal colonisation of the pharynx is
higher in patients with genital gonorrhoea (26%) than in those
without (11%). The relative risk ofharbouring meningococci when
infected with gonococci is 2-44 (95% confidence limits,
I-4-4-2313,14
A recent history of gonoccal infection or exposure to infection
may be one of the contributing factors to the increased susceptibility
of young adults to meningococcal disease.
Ye thank 0* H. Young and the staff of the STD diagnosis laboratory,
department of bactertoiogy. foe aupplyinf sera and Mn M Cole for help m
preparation of the report. The work vaa supported by grants frees the Medical
Research Council
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THE ROLE OF THE MONOCYTE IN 60N0C0CCAL INFECTION
C.C. BLACKWELL, D.F. KINANE, P.P. WINSTANLEY,
M.J. KOWOLIK and D.M. WEIR
Department of Bacteriology, University of Edinburgh
Medical School, and Department of Oral Medicine and Oral
Pathology, School of Dental Surgery, University of
Edinburgh, Teviot Place, Edinburgh, Scotland
Studies on the pathogenicity of gonorrhoea have been severely United
by the lack of an experimental model since the causative organism,
neisseria gonorrhoeae, has only humans as its host. Epidemiological
studies have been hampered by lack of a typing system for the bacteria as
well as the social problems attached to contact tracing. One of the few
relatively easily Investigated host factors associated with susceptibility
to gonorrhoea is the increased incidence of blood group B individuals
among those infected (1,2). Even in an area such as Edinburgh where
there is a high incidence of blood group B (10%) we found that more than
20% of gonorrhoea patients were blood group B (3).
Two hypotheses have been proposed to explain this increased suscept¬
ibility: (I) As with type 0:86 strain of Escherichia coll (4), anti-B
isohaemagglutinin of groups A and 0 is a "natural* bactericidal antibody
for seme strains of gonococcl; OR (II) Anti-B isohaemagglutinin of groups
A and 0 is a more effective opsonin for some strains of gonococci (1).
Although gonococci had been shorn to absorb isohaemagglutinins (2),
we found that the natural antibody directed against them in normal human
serum was not associated with either the anti-A or anti-B Isohaemagglutinin.
Bactericidal activity was found in all the sera tested. Killing depended
on the lipopolysaccharide (LPS) structure of the bacteria t those with a
complex LPS were serial sensitive, those with a simple LPS were serum
resistant (S).
Having eliminated the first hypothesis, we examined the second - the
role of lsohaenagglutlnins as opsonins. Based on their observed increase
in the proportion of blood group B among women with gonorrhoea, Poster and
Labrum suggested that the anti-B Isohaemagglutinin may be a sore effective
opsonin than anti-A (1). We opsonized different strains of gonococci
with serum from A, 0 and B individuals with no history of gonococcal in¬
fection and determined the percentage of bacteria bound to the polymorpho¬
nuclear leukocytes (Ml) of a group 0 donor.
There was no significant difference in association of PMN with gono¬
cocci opsonized by anti-A or anti-B isohaemagglutinin! however, as in the
experiment screening for serum bactericidal activity, difference in
association depended on LPS type. Those with the complex LPS were bound
in greater numbers than those with the simple LPS to the FMN of each of
the ABO blood groups in the absence or presence of the autologous serum.
We examined strains with the two LPS types for differences in stimu¬
lation of bactericidal activity with the nitroblue tetrazolium (NBT) test.
Non-pilate strains of both LPS types significantly stimulated the NBT
reaction as measured by the increase in the percentage of containing
the reduced formazan. Pilate variants of the same strains inhibited the
NBT reaction. The percentage of formazan containing PMN did not rise
above the control in which no bacteria were present (Table 1) (6).
Table 1 i The effect of pilation on NBT reduction with gonococci
of group I and group II (percentage PMN containing
formazan).


































Similar association studies were carried out with strains of gono¬
cocci of simple and complex LPS and peripheral blood monocytes of groups
A,B,0 and AB.
In the absence of autologous heat inactivated serum (HIS), there were
no significant differences in gonococcal association to monocytes of
different ABO blood groups at 4* and 37*. There were no significant
differences between simple and complex LPS types in contrast to our
findings vith PMN. This association of gonococci with monocytes is
inhibited by sugars; therefore, it is probably mediatedby the lectin-
like receptor described by Weir and co-workers (7). (Fig.1.)
In the presence of HIS, there was an increase in binding of both
strains to monocytes of A, 8 and 0, but not AB, the blood group with no
isohaemagglutinins. The greatest increase was observed for the group B
monocytes. Absorption of 0 serum with A and B cells reduced the associ¬
ation to the level observed in the absence of serum (8), (Fig.2.)
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Figure 1. Association of gooococci to monocytes of different ABO bloo-
groups under various conditions.
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Figure 2. The effect of removal of isohaemagglutinins on association

















We have recently done setae preliminary experiments to determine NBT
reduction in monocytes exposed to N« gonorrhoeae, Neisseria meningitidis
and Neisseria lactamica. The results shown in Table 2 indicate that
opsonization of all three species with the fresh autologous serum from the
monocyte donor lowered the percentage of NBT positive cells in comparison
with results obtained with unopsooized cells. In contrast to our find¬
ings with PMN, pilate forms stimulated NBT reduction in monocytes, and the
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SHORT ARTICLE
ABSENCE OF BACTERICIDAL ANTIBODIES AGAINST
GROUP-I LIPOPOLYSACCHARIDE DETERMINANTS OF
NEISSERIA GONORRHOEAE DURING HUMAN INFECTION
C. Caroline Blackwell, F. P. Winstanley, D. M. Weir and D. F. Kinane
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place. Edinburgh
EH8 9AG
Summary. None of 34 sera from patients with gonorrhoea contained antibodies
bactericidal for strains of Neisseria gonorrhoeae with Group-I lipopolysaccharide
(LPS). All contained antibodies against a strain with Group-II LPS, as do sera
from uninfected controls. The absence of Group I-LPS antibodies in infected
humans contrasts with previous findings that mice immunised with strains from
either of the LPS groups produced bactericidal antibody to Group I. Our hope
that detection of antibodies to Group-I strains would provide a screening test for
gonorrhoea was, therefore, not realised.
Introduction
Gonococcal isolates from uncomplicated genital infections and disseminated infections have
been divided into two broad groups based upon their pyocin-sensitivity spectrum. This
classification has been shown to correlate with interactions of strains from localised genital
infections with both humoral and phagocytic components of the human immune system.
Briefly, gonococcal strains sensitive to pyocins of Kageyama's group R5, lipopolysaccharide
(LPS) Group I, are resistant to normal human serum and they bind in lower numbers to
polymorphonuclear leukocytes than strains of Group II (Blackweil et al.. 1983). This second
group is sensitive to pyocins of Kageyama's group R1 in addition to R5 and strains of this group
are killed by the majority of normal human sera tested (Kageyama. 1975; Blackwell, Young and
Anderson, 1979; Winstanley et al., 1983). Strains of Group II are thought to have extra LPS
components, absent or cryptic in strains of Group I, to which there are bactericidal antibodies in
the majority of normal human sera (Schneider et al., 1982; Winstanley et al., 1983).
Earlier studies revealed that specific antisera raised in mice against strains of Group I or II
were bactericidal for other strains of the homologous group. They were also active against
strains of the heterologous group (Winstanley et al., 1983). In that study we also screened sera
from a control population of women attending a postnatal clinic for bactericidal antibodies to
both groups of gonococci. Antibodies against Group II only were found. This is a population
in which there is a very low incidence of gonorrhoea. We have now screened sera from
individuals with gonorrhoea for bactericidal activity against strains of LPS Groups I and II.
Our hypothesis was that individuals exposed to or infected with N. gonorrhoeae would, like the
mouse model, have antibodies to both groups and that detection of bactericidal activity for
Group I might be used as a serological screening test for gonococcal infection.
Materials and methods
Bacteria. Strains of LPS Group I (E757 and M9131) and Group II (P280) were isolated
from patients attending the Department of Genitourinary Medicine, Royal Infirmary,
Edinburgh. All were from localised genital infections (Winstanley et al., 1983). They were
Received 5 Sep. 1983; revised version accepted 2 Dec. 1983.
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and uninfected patients; utres were C 4. The litres to strain P280 were similar to those recorded
in the table.
Discussion
The absence or extremely low titres of bactericidal antibodies against strains M913I and
E757 in sera from patients with gonorrhoea refutes our hypothesis, based on results obtained
with immune mouse sera (Winstanley et a/., 1983). that infection with N. gonorrhoeae in man
would result in the production of antibodies bactericidal for strains of Group I. This failure
may result from the stimulation by Group-I antigens of antibodies of classes that do not activate
the classical complement pathway, e.g., classes IgA and lgG4. or by failure of the human
immune system to respond to antigens of the gonococcal LPS associated with the binding site for
R5 pyocins.
It has been suggested recently that susceptibility and resistance to gonorrhoea of a group of
Chinese prostitutes was associated with differences in the major histocompatibility complex
genes. The HLA "haplotype" A11. B15 appeared to be associated with resistance to the disease
amongst these women who were at very high risk of exposure to infection (Chan and Rajan,
1982). Similarly, the ability to respond immunologically to LPS antigens associated with the
binding site of R5 pyocins might depend upon the genetic constitution of the individual.
Bactericidal antibody is an important host defence that prevents the dissemination of
gonococci from the mucosa (Brooks. Ingwer and Peterson. 1978). The majority (c 85°0) of
gonococcal strains isolated from localised genital infection are of Group II (Winstanley el al..
1983) and are thought to be prevented from dissemination by "natural" bactericidal antibodies
and complement. Strains of Group I, however, being resistant to normal human serum, have a
greater predisposition to cause bacteraemia: they are isolated from approximately 42% of
disseminated infections (Winstanley et al.. 1983).
The apparent inability of man to produce antibodies bactericidal for gonococcal strains of
Group I may be a host factor that retards recovery from disseminated gonococcal infection and
it may also pose difficulties in the immunoprophylaxis of gonorrhoea. These results indicate
that. like other attempts to identify antibodies against gonococcal LPS (Ward and Glynn. 197!
and 1972; Watt. Ward and Glynn. 1971; Maeland and Matre. 1975), screening of sera for
bactericidal activity against LPS-group-I strains will not be of use as a diagnostic test.
We are grateful to Dr H. Young and the staff of the Serology Laboratory . Department of
Bacteriology, for supplying us with sera and to Mrs M. Cole for help in preparation of the
manuscript. The work was supported by grants G81/103811/SB and G979'64'S from the
Medical Research Council. Mr D.F. Kinane was a recipient of the Davidson Research
Fellowship, Faculty of Medicine. University of Edinburgh.
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SUMMARY The adherence of gonococci to phagocytes was examined for the presence of "lectin-like"
receptors capable of binding these bacteria. The data suggests such "lectin-like" receptors are present
on PMN and monocytes that recognize sugars present in the gonococcal cell wall and that there are
quantitative and qualitative differences in expression of these receptors. These findings may have
importance in investigation of the interaction of gonococci with phagocytes and with the subsequent
induction of immunity in the disease.
Introduction
Attachment of Neisseria gonorrhoeae to mucosal cells
and their subsequent invasion are the initial steps in
the establishment of gonococcal infection. Once the
organisms have penetrated the mucosal barriers, their
survival largely depends on their interaction with phago¬
cytic cells. Attachment and uptake by polymorphonuclear
leucocytes (PMN) may lead to destruction of the
organism. Attachment to macrophages is likely to lead to
initiation of an immune response by presentation of
microbial antigen to the lymphoid cells. The interaction
between phagocytes and bacteria is clearly an important
determinant in the pathogenesis of the disease. Binding
to the phagocyte membrane is dependent on the presence
of appropriate adhesin-receptor interactions between
bacteria and phagocytes.
Interaction between gonococci and PMN or mono¬
cytes may be mediated by lectins present either on the
bacterium or the leukocyte. These lectins, or sugar-
binding proteins, can be demonstrated by inhibition of
binding reactions after preincubation of cells or bacteria
with sugars. Various workers have attempted to demon¬
strate lectins on gonococci involved in binding to host
cells. Punsalang and Sawyer (1) were unable to inhibit
the binding of pili to rabbit erythrocytes with eleven
simple sugars. Trust et al. (2) were also unable to inhibit
attachment of gonococci to buccal cells with ten simple
sugars. They did however find evidence to suggest that an
oligosaccharide on the surface of the epithelial cell may
act as a pilus receptor. Buchanan et al. (3) came to a
similar conclusion as did Lambden et al. (4). King and
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Swanson (5) were unable to block gonococcal binding to
PMN with four simple sugars but found that pretreatment
of gonococci with periodate reduced the binding of
gonococci to PMN. Watt et al. (6) investigated the
possibility that gonococcal surface lectins may bind
to sugar groups of human fallopian tube cells. They
found no inhibition of binding with lectins specific for
the following sugars—N-acetyl-galactosamine, galactose,
fucose and N-acetyl-glucosamine. They did, however,
present evidence suggesting that sugar groups of gono¬
coccal LPS can bind to HEp-2 cells and concluded that
sugars on the gonococcal surface are likely to be involved
in attachment to mucosal cells but that appropriate
inhibition experiments were required.
Preliminary experiments with gonococci and leuko¬
cytes supported the findings of other workers (2,5) and
indicated the absence of simple sugar-inhibitable lectins
on gonococci. Efforts were therefore directed at examining
sugar-inhibitable lectins on phagocytes that might recog¬
nize gonococcal cell wall sugars. Phagocytes have been
shown by previous work in the authors' laboratory to
express lectins that bind a variety of bacterial species (7).
Materials and Methods
Bacteria
N. gonorrhoeae strain E757, recently isolated from a patient attending
the Department of Genitourinary Medicine was used throughout these
experiments. Opaque colonies of type 2 (t2), differentiated by means of
a Zeiss stereoscopic microscope with a double system of substage
lighting, were selectively subcultured and maintained on Difco GC base
supplemented as described by Young (8) (GC agar). Suspensions were
made from plates with more than 95 % of t2 colonies. Bacteria were
harvested from GC agar plates at 14-16hr, suspended in Dulbecco's
phosphate buffered saline (D.PBS) by gentle pipetting, washed and
finally re-suspended gently in D.PBS.





spectrophotometer icecil instilments. Camondge. England l by refer¬
ence to standards enumerated by microscope counts with a counting
chamber.
Phagocytes
Blood from healthy donors with no history of gonorrhoea was
collected m plasuc tubes containing 10u of heparin ml*1. Monocytes
and PMN were separated oo Ficoll-Hypague cushions at 400 g for
30 tnin according to the method of Boyum (9). After the interface cells
(monocytes and lymphocytes) were collected, the pellet containing
granulocytes and red blood cells was re-suspended in 0-J2 % ammonium
chloride to lyse the erythrocytes (10). The separated ceils were finally
washed twice in D-PBS.
Preparation of Monolayers
PMN and monocytes were re-suspended in Eagle's MEM to gsvc a
total cell count of 2 * 10J/mL One millilitre of the above cell preparations
was layered onto 13 mm diameter (No. 1) glass covershps in 16 mm well
diameter assue culture plates (coma, 295 Broadway, Cambridge,
Mass.) and incubated for 1 hr at 37*C. Non-adherent cells were removed
by washing seven times with D-PBS.
Binding Assay
Covers lips with monolayers of PMN or monocytes were overlaid
with 1 mi of gooococd in D.PBS containing Ca** and Mg* " ions
(0-9mM and 0-5 mM, respectively) and incubated for 2hr at «*C-
Non-attached organisms were removed by repeated washing with
D.PBS. Covers lips were air dried, fixed in methanol and stained with ^
May GrunwaJd for 3 min, rinsed and stained by Giemsa for 3 min. —
Bacterial binding was estimated by counting monocytes with bacteria JT
attached at two or more discrete points. Duplicatecoverslips were used; I
for each coverslip. 200 leucocytes were counted and the results expressed o
as the percentage of cells binding organisms. §
2
Sugar Inhibition of Gonococcal Binding to Phagocytes ■§
Monocytes and PMN monolayers were prepared as described above.
Cell monolayers were preincubated with 0-5 ml of the appropriate sugar
solution for 20 mm at 4*C. The sugar solutions used were: D-galactose,
N-acetyl-D-galactosanune. D-galactosamine, N-acetyl-D-glucosamine,
D-glucose. E-fucose and 0-giucosamine. These sugar solutions were
used at 5 mmol 1"'. lOmmol 1"1 and 20 mmol 1'' concentrations in
D.PBS with 0-9 mmol 1"1 Ca * * and 0-5 mmol I"1 Mg * * ions. The cells
were then washed and the binding assay performed at 4*C for 2 hr. Pilate
gooococci were used at a concentration which gave approximately 50%
binding for both monocyte and PMN controls.
Results
Figures 1 to 4 show the results of sugar inhibition studies
on binding of the pilate variant of strain E757 to phago¬
cytes of blood group O. Each figure shows the effect on
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Figs. 1—4. These figures show the effect of preincubation of phagocytes
with the named monosaccharide on the binding of pilate gooococd of
strain E757. The assays were carried out with PMN («X) and mono¬
cytes (- •) of blood group O at 4*C for 2 hr. Each point represents the
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sugar at three different concentrations. Binding of gono¬
cocci to PMN and monocytes can be inhibited by
£>-galactose, N-acetyl-D-galactosamine, D-galactosamine
and D-giucosamine. Each of these inhibitions follows a
dose dependent pattern, with the highest concentration
20mmoll~l giving the greatest inhibition. N-acetyl-D-
glucosamine and D-glucose had no effect on the binding
of gonococci to either PMN or monocytes. L-fucose
inhibited binding of gonococci to monocytes in a dose
dependent fashion but did not inhibit binding of gono¬
cocci to PMN. Differences in inhibition for PMN and
monocytes were also seen with 0-glucosamine. with the
dose response inhibition of each of these sugars at a lower
level for monocytes than PMN.
Discussion
The results reveal that phagocytes are capable of bind¬
ing gonococci by various sugar-inhibiiable "lectin-like"
interactions. Each of the four sugars giving clear dose
dependent inhibition—D-galaaose, D-galactosamine. N-
acetyl-D-galactosamine and D-glucosamine—are present
in the gonococcal outer surface (11,12,13).
0-glucose has been detected on the gonococcal outer
surface but did not inhibit binding. Work in our labora¬
tory (14) has shown that D-glucose did not inhibit
binding of Staphylococcus albus to human or guinea pig
PMN, indicating the absence of a D-glucose specific
lectin on the phagocytes. In contrast, human monocytes
do express a D-glucose specific lectin and the failure to
inhibit gonococcal attachment to these cells by D-glucose
suggests that the D-giucose present on the gonococcal
outer surface was somehow shielded or not exposed
exteriorly. There was a notable difference in the ability of
L-fucose to inhibit binding of gonococci in that inhibition
occurred with monocytes but not with PMN. L-fucose
has the same orientation at C.» as D-giucose and this
orientation appears to be important in binding of glyco-
conjugates to rat alveolar macrophages (15). Thus the
differences noted between PMN and monocytes with
L-fucose may be due to the absence of the D-glucose-
specific lectin on PMN. Furthermore, quantitative differ¬
ences are seen with D-galactosamine and D-glucosamine
in their binding to PMN and monocytes. In both cases
PMN were more readily inhibited than monocytes, pre¬
sumably reflecting the numbers of **!ectin-like" receptors
on the two cell types.
D-glucosamine does inhibit binding of gonococci to
human PMN in contrast to the lack of inhibition by D-
glucose. Thus the amino group on C2 appears to de¬
termine recognition. Previous work on the mannosyl,
fucosyl, N-acetyl-glucosaminyi receptor on rat alveolar
macrophages had also implicated C2 as a determinant of
specificity (15). The failure of N-acetyl-D-glucosamine to
inhibit binding of gonococci to either PMN or monocytes
may reflect either the absence of this sugar from the
gonococcal cell wall or the inhibition of recognition on
adding the acetyl group to D-glucosamine. D-galactose,
D-galactosamine and N-acetyl-D-galactosamine in con¬
trast are found in the gonococcal cell wall and inhibit
binding of gonococci to both PMN and monocytes.
The details of the specificity of phagocyte lectins for
different sugars are not understood. Whilst showing
preferential specificity for particular sugars, lectins can
also interact to a lesser degree with other sugars, e.g.,
concanavalin A with its main specificity for a-methyl
mannoside can also interact with D-mannose, D-fructose,
maltose, isomaltose, trehalose and various lipopoly-
saccharides and bacterial polysaccharides.
The recent finding in our laboratories that there is
an association between the mouse phagocyte lectin that
recognizes cell wall sugars of Staphylococcus albus and la
antigens of the major histocompatibility complex (16)
further suggests that lectins may show a degree of
polygamy in their ability to recognize carbohydrate
determinants. Only a small number of genes code for the
I-region antigens and, whilst there is extensive poly¬
morphism in a species, polymorphism in an individual is
necessarily limited. The I-region antigens of macrophages
are thought to be involved in antigen presentation to
T-lymphocytes. To carry out this function the I region
must be able to recognize a wide range of determinants
(17).
Little is known of the role of the human major histo¬
compatibility complex (MHC) in determining suscepti¬
bility or resistance to gonorrhoea. A recent study in
Singapore indicates that certain HLA haplotypes (All
and B15) are associated with resistance to gonorrhoea
and syphilis amongst Chinese prostitutes. The haplotype
HLA-B17 associated with susceptibility is found in 26%
of prostitutes with combined infections of syphilis and
gonorrhoea compared to 7% in the control population.
This haplotype was absent in the prostitutes who were
resistant to these infections (18). Compared to the resis¬
tant group the susceptible group were found to have
poor blastogenic responses in lymphocyte transformation
assays to treponemal and gonococcal antigens. So far
there is no evidence of any association with the HLA-D
region (equivalent to the mouse I region). The importance
of the class II MHC antigens in generation of the immune
response to bacteria is widely accepted with T-belper
cells recognizing bacterial antigens in association with
class II antigens on macrophages. The findings in the
present study point to the need to explore further the
recognition of gonococci by phagocytes and possible
association with class II MHC antigens as determinants
of susceptibility.
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A laboratory-grown strain of Neisseria gonorrhoeae, selected in vivo, BS4 (agar), is susceptible to
complement-mediated killing by fresh human serum but is relatively resistant to killing by
human phagocytes. It can be induced to scrum resistance by incubation with a small molecular
weight fraction of guinea pig serum. The serum-susceptible and induced-resistant forms show
differences in pyocin sensitivity tests. This indicates either differences in the structure of their
lipopolysaccharides or masking of some dcterminant(s). The pyocin sensitivity pattern of
BS4 (agar) is only slightly different from that of a closely related strain, BSSH, which is more
susceptible to killing by human phagocytes.
INTRODUCTION
A strain of Neisseria gonorrhoeae selected from a small colony forming, pilate laboratory strain
(BS) by three or four passages through plastic chambers implanted subcutaneously in guinea
pigs was resistant to killing by human serum and human phagocytes when examined without
subculture (Penn et al., 1976, 1977). When cultured in laboratory media, the in Wro-selected
strain, BS4 (agar), lost its serum resistance but retained its resistance to killing by phagocytes
(Penn et al., 1976,1977). The serum resistance could be restored phcnotypically to BS4 (agar) by
incubating it for 3 h at 37 "C in a defined medium (DM) containing 01% (w/v) bovine serum
albumin (BSA) and small molecular weight fractions of either guinea pig or some human sera
(Veale et al., 1981; Martin et al., 1981).
The determinant(s) of the induced resistance of BS4 (agar) to killing by human serum has not
yet been investigated. The limited supply of host-derived inducer has prevented the production
of sufficient organisms for investigation of outer membrane proteins (OMP) and lipopolysac¬
charides (LPS) comparable to those studies on the culture-stable type of serum resistance shown
by strains from disseminated gonorrhoea (Brooks et aI., 1978; Lambden et al., 1979; James et al.,
1982). An investigation of the LPS of susceptible and induced-resistant forms of BS4(agar)
seems particularly relevant because LPS appears to be the target antigen for the 'natural'
antibody responsible for the bactericidal activity of normal human serum (Brooks et al., 1978;
Schneider et al., 1982). A method for indicating changes in LPS of N. gonorrhoeae became
available when it was shown that partially purified, Kageyama R-type pyocins from
Pseudomonas aeruginosa (Kageyama. 1975), the receptor sites for which reside on the LPS
(Meadow & Wells, 1978), reacted with gonococci and could form the basis of a typing system
(Morse et al., 1976; Sidberry & Sadoff, 1977; Blackwell et al., 1979). Only small numbers of
gonococci are required and the pyocin method has been used to indicate LPS differences in
mutational and epidemiological studies on gonococcal sensitivity to serum killing and
attachment to polymorphonuclear leucocytes (Guymon et al., 1982; Blackwell et al., 1983;
00:2-1287,84.0001-1764 S02.00 © 19M SGM
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Winstanley et al, 1983) This paper reports tests with a range of R-type pyocins on strain
BS4 (agar) before and after induction to serum resistance by the low molecular weight fraction
from guinea pig serum.
The determinants of the resistance of strain BS4 (agar) to killing by phagocytes have been
investigated by comparing it with a closely related phagocyte-susceptible strain, BSSH, selected
in vitro by colonial appearance from the original parent strain BS (Peon era/, 1977). In this case,
sufficient organisms could be obtained for biochemical examination. The putative determinant
of resistance was not pili and resided in outer membrane vesicles (OMV) (Parsons et al., 1981).
Examination of the proteins of purified OMV from BS4 (agar) and BSSH on sodium dodecyt
sulphate polyacrylamide gel electrophoresis associated three OMP with the resistance of
BS4 (agar) to killing by phagocytes (Parsons etal., 1982). However, it was thought interesting to
include in the pyocin tests a comparison of the phagocyte-resistant [BS4 (agar)] and phagocyte-
susceptible (BSSH) strains.
METHODS
\eisseria gonorrhoeae. Strains BS4 (agar) and BSSH were derived, stored, cultured and counted as described
previously (Penn et a!.. 1976, 1977, Parsons et al., 1981, 1982).
Induction of BS4 (agar) to serum resistance. The method used was described by Veale et al. (1981): lOMO3
gonococci were incubated for 3 h at 37 *C in equal volumes of DM containing 0-1 % (w/v) BSA and an ultrafiltrate
of guinea pig serum containing molecules of less than 5000 daltons (Veale ef al., 1980; Martin et al., 1981). The
serum-susceptible BS4 (agar) used for comparison with the resistant organisms in the pyocin tests (Table I) had
been incubated in DM containing 01% BSA for 3 h at 37 *C without the inducer.
Pyocins. Representatives of four of the five groups (R1-R5) of R-type pyocins described by Kageyama (1975)
were prepared from the following strains of P aeruginosa and partially purified and stored as described by
Blackwell et al. (1979). These included: R1 pyocins from strains ISD, 2285, IS6 and IS8; R2 pyocin from strain
1SB, R3 pyocin from strain ISE; R5 pyocins from strains ISA and ISC; and two unclassified pyocins from strains
R205 and 9579
Tests for pyocin sensitivity A suspension (15 nl) of partially purified pyocin was added to a suspension of
gonococci (100pi; Hy-103 c.f.u. ml"' in DM (Veale et al., 1981) in a sterile plastic test tube (10 ml capacity).
Control tubes received DM (15 pi) but no pyocin. After 30 min incubation at 37 'C, DM (0-5 ml) was added to
each tube. The gonococci were deposited by centrifugatioa (1500g, 15 min, 37 *C) and the supernatant was
removed. The gonococci were resuspended in 0-3 ml DM, which was plated out on haemoglobin agar. After
incubation at 37 *C in candle extinction cans the colonies were counted. Results of the experimental samples were
recorded as +, ± and - when the viable counts were < 5%, < 20% (but > 5%), and > 20%, respectively, of the
colony counts for the control tubes. All gonococcal strains were tested against the 10 different pyocins in many
tests (see Table 1).
RESULTS
The results are summarized in Table 1. During the 3 h induction period to resistance the
serum-susceptible form of BS4 (agar) had lost its sensitivity to the pyocin produced by strain
R205 and its partial sensitivity to that produced by strain IS8; also its full sensitivity to the R5
pyocin produced by strain ISC became partial. The serum- and phagocyte-susceptible strain
BSSH (Penn et al., 1976, 1977) showed a partial sensitivity to the R1 pyocin from strain IS6 in
contrast to the insensitivity of the two forms of BS4 (agar), both of which were relatively
resistant to killing by phagocytes (Penn et al., 1976, 1977; N. J. Parsons & H. Smith,
unpublished observations). In reactions with the pyocins from strains IS8 and ISC, BSSH
behaved similarly to the serum-susceptible form of BS4 (agar). With the pyocin from strain
R205, BSSH was less sensitive than the serum-susceptible form of BS4 (agar), whereas the
serum-resistant form of BS4 (agar) was fully resistant to this pyocin.
DISCUSSION
The pyocin sensitivity tests suggest that a change in LPS occurs when the serum-susceptible
gonococcal strain BS4 (agar) is converted to serum resistance by the low molecular weight
inducer from guinea pig serum in the short time of 3 h at 37 °C. Overall, a loss of sensitivity to
three pyocins accompanied the increase in serum resistance and this indicates that the LPS
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Table 1. Activity of 10 different pyocins on strain BS4 (agar) before and after induction to serum
resistance and on strain BSSH
Each result was obtained on at least four different tests with each pyoctn and at least eight different tests
with pyocins from strains IS6,1S8. R205, 9579 and ISC The differences between the serum-susceptible
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• Results were recorded as + . + and - when the viable counts were <5*.. <20*,(but >5*J,and >20*.
respectively, of the counts of the control tubes not containing pyocin.
structure had been altered, since three receptor sites appear to have been removed or modified or
masked by a new component. This result complements recent correlations made between the
susceptibility of clinical isolates to serum killing and the presence of LPS receptors for the Rl
pyocins (Winstanley et a!., 1983). Any speculation on the precise changes in LPS structure which
accompanied the increase in serum resistance depends on the assumption that observations on
pyocin reactions with the LPS of P. aeruginosa apply to the LPS of N. gonorrhoeae. Mutants of
gonococci selected for resistance to Rl pyocins remain sensitive to R5 pyocins, indicating that
the receptor for the R5 pyocins is in the portion of the LPS nearest to the cytoplasm and those for
Rl pyocins are more distal (Winstanley era/., 1983). These are similar to the results obtained for
P aeruginosa (Kageyama, 1975). Little can be drawn from the most marked change in pyocin
sensitivity accompanying the increase in serum resistance, namely the complete loss of
sensitivity to the unclassified pyocin from strain R205, since its receptor site is unknown even
for the LPS of P. aeruginosa. It should be noted that in the majority of clinical isolates of
gonococci, if the strain is sensitive to Rl pyocins it is also sensitive to the pyocin produced by
strain R205 (Blackwell etal., 1979). The smaller losses in sensitivity to the Rl pyocin from strain
IS8 and the R5 pyocin from strain ISC suggest that receptor sites both in the polysaccharide side
chain and in or near the core of the LPS may have been affected. The receptor sites may not have
been produced, or they may have been modified, or even obscured by new structures such as
proteins under the influence of the small molecular weight inducing factor whose mechanism of
action is unknown. However, one possible masking agency, the formation of a capsule under the
influence of the inducer, does not occur; in electron microscopy similar to that which
demonstrated capsules on some gonococci (Demarco de Hormaeche et at., 1978), capsules could
not be seen on BS4 (agar) organisms either before or after being induced to resistance (P. M. V.
Martin, unpublished observations).
It is tempting to suggest that changes in pyocin sensitivity which occur as the result of the
action of the small molecular weight inducer indicate changes in LPS which are responsible for
the increased resistance to serum killing. However, the evidence at present is only that of
association (Smith, 1983) and can only be strengthened by deeper investigations on the
connections with serum resistance of the LPS and any other bacterial components (for example,
OMP) that may be formed under the influence of the inducer.
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SUMMARY Investigations of the possible mechanisms under¬
lying the increased susceptibility of women who are blood
group B and non-secretors ofwater-soluble blood group antigen
to recurrent urinary tract infection (UTI) revealed that iso-
haemagglutinins are not involved in bactericidal killing or
agglutination of 8 serotypes (1,2) of Escherichia coli frequently
associated with UTL The implications of these results and
possible areas for future studies are discussed.
Key words: Blood group, urinary tract infection, isohaemag-
glutinins
Introduction
There have been a number of reports linking suscepti¬
bility to certain infectious diseases with ABO blood
group, particularly those involving Gram-negative bac¬
teria such as cholera (3), enteric infections (4,5) and
gonorrhoea (6-8). The antigens of the ABO blood groups
are present in two forms: an alcohol soluble form found
in tissues and a water soluble form in the body fluids of
individuals with the genetically controlled ability to
secrete blood group substance (9). Non-secretion of
blood group substances has also been linked to suscepti¬
bility to certain infections including cholera (10) and
rheumatic fever (11).
A survey of women attending a clinic for investigation
of recurrent urinary tract infections revealed that those of
blood groups B and AB who were also non-secretors
showed a significant relative risk of infection of 3-12 This
appeared to be a genuine example of synergy in which
absence of anti-B isohaemagglutinin and secretor sub¬
stance combined to give an increased risk of recurrent
UTI (12).
Because antigens that cross-react with blood group
substances are found on a number of Gram-negative
bacteria (7, 13-15), we investigated whether the anti-A
and anti-B isohaemagglutimns might contribute to pro¬
tective humoral immunity to UTI. In the presence of
complement, anti-B antibody had been found to be
Correspondence: Dr. Caroline C Black-well, Department ofBacteriology,
The Medical School, University of Edinburgh, Teviot Place; Edinburgh
EH8 9AG.UK.
bactericidal for Escherichia coli serotype 086 (16). It has
also been shown to be an opsonin for serotype 086 (17).
Antibodies bactericidal for Gram-negative organisms are
often directed toward the lipopolysaccharide (LPS) com¬
ponents (15,18). These LPS antigens are also the basis
for classification of E. coli strains into their various
serotypes.
We postulated that, as in the case of serogroup 086, the
anti-B isohaemagglutinin in subjects of blood groups A
and O might be bactericidal for serotypes of E. coli
associated with UTI, or perhaps they might function as
agglutinating or opsonizing antibodies for these strains.
The hypothesis is tested in the study reported here.
Materials and Methods
Bacteria
Strains of £. coli of scrogroups Ol. 02, 04, 06, 07, 025, 050, and
075 commonly isolated from UTI (1,2) were obtained from the
national typfi culture collection, public health laboratories.
Colindale, London.
They were maintained on nutrient agar (Columbia agar base, Oxoid)
and their identity checked by agglutination tests with their respective
typing sera (difco laboratories. Detroit. MI). a serum sensitive strain
of Neisseria gonorrhoeae, P280 (15), maintained on modified New York
City medium (MNYC; Young, 1978) was included in all assays for
bactericidal activity as a positive control
Subjects
Control sera were obtained from healthy women attending a post¬
natal clinic and from women in the Department of Bacteriology. Sera
from patients with histories of recurrent UTI were obtained from
women attending the outpatient clinic of the City Hospital Edinburgh.
Each sample was heat-inactivated at 56*C (or 30min and stored at
— 20*C until tested.
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Methods
Micro-bactericidal assays were performed by the method described
by Winstanley et al. (15). Human AB serum was used as the complement
source. It was absorbed for 24 hr at 4°C with a live suspension of each
of the E. coli serogroups used in the study to remove any cross-reacting
antibodies. The absorbed serum was distributed into 200 pi aliquots,
and stored at — 70°C until needed. The haemolytic titre of the com¬
plement source was 32-64.
An 18-hr culture of each strain was suspended in Dulbecco's
phosphate-buffered saline supplemented with Mg+t and Ca++ ions
(0-5mmol and 0-9 mmol respectively) to give approximately 104 colony
forming units per ml. Serial two-fold dilutions of the sera to be tested
were made in microtitre plates and to each was added 40 pi of one of the
bacterial suspensions and 10 pi of the human complement source. After
incubation at 37°C for 30 min, the numbers of viable organisms in each
well were determined by culturing 3 20 pi drops from each on nutrient
agar. The bactericidal titre of a serum was the highest dilution causing
a reduction in viable count of ^ 80 % as compared with that of a control
to which no complement was added.
Agglutination of the 8 serogroups by serum from women of blood
groups A and B was assayed as follows. For each strain, bacterial
suspensions were prepared from 5-7 colonies of an overnight growth
on nutrient agar in 2 ml of sterile saline and vortexed. For each strain
3 nutrient agar plates were seeded with 0-5 ml of the bacterial suspension
and incubated overnight at 37°C. The contents of the plates were
harvested in 6 ml sterile saline and this suspension boiled in a glass
universal tube for 30 min. The suspensions were stored at 4°C until
needed.
Slide agglutination tests were performed by thoroughly mixing 10 pi
of serum with 10 pi of one of the bacterial suspensions on a glass
microscope slide. The slide was rocked gently for 2 min and the results
recorded visually with a good light as follows: — = no agglutination;
+ = slight agglutination; + + = clear agglutination; + + + = very
strong agglutination.
Heat-inactivated sera from individuals of blood groups A and B were
absorbed with suspensions of each of the 8 serotypes associated with
UTI and also with 086. The sera were mixed with the bacterial
suspensions at 37°C for 30 min. They were then incubated overnight at
4°C with fresh bacteria. The bacteria were removed by centrifugation at
approximately 2,000 x g in a Sorvall RT 6000 centrifuge. Control sera
were treated in a similar fashion, but an equivalent volume of saline was
substituted for the bacterial suspension. Titre of isohaemagglutinins
was determined by the addition of the appropriate erythrocyte suspen¬
sion to serial two-fold dilutions of the absorbed sera and the control
sera. The highest dilution at which there was visible agglutination of the
red blood cells was noted.
Absorption of blood group substance of E. coli was performed by
incubating saliva from secretors of blood groups A, B, and O with each
individual serotype. Approximately 107cfu/ml of boiled bacteria was
incubated with 0-5 ml of saliva for 30 min at 37°C. The suspended
bacteria were pelleted at 2,000 x g in a Sorvall RT 6000 centrifuge. The
supernates were tested for their ability to inhibit haemagglutination of
A. B. and O cells by anti-A, anti-B isohaemagglutinins and the lectin of
Ulex europeus respectively (20).
Results
Bactericidal Activity of Isohaemagglutinins
The E. coli strains of serogroups Ol, 02, 04, 06, 07,
025, O50, and 075 were tested in bactericidal assays
against a panel of sera from women who had been
referred to the UTI clinic at the City Hospital and
against a control panel of sera from a population with
no recent history of infection. Among the UTI patients
there were 13 of blood group A, 32 of group B and 10 of
Table 1 Agglutination of E. coli strains by sera from patients with
UTI
% ofsera with agglutinating antibodies
Blood group
E. coli A B
serogroup N = 19 SII
Ol 84-2 45







group O. Among the controls there were 6 of group A
and 6 of group B. Although each of the sera killed the
serum-sensitive gonococcal strain P280, there was no
significant bactericidal activity against any of the 8 E. coli
serogroups.
Agglutinating Activity of Isohaemagglutinins
Twenty group B sera and 19 group A sera obtained
from women attending the UTI clinic were examined
for their ability to agglutinate the 8 serogroups asso¬
ciated with infection (table 1). Agglutinating activity was
observed for each serogroup. Although there were differ¬
ences in the reactions observed with A and B sera, e.g. for
Ol and 02, these differences were not dependent on
isohaemagglutinins. Absorption of serum from A and B
individuals with each of the 8 strains did not reduce the
titre of either anti-A or anti-B antibodies. Absorption
of group A serum with strain 086 removed all the
anti-B isohaemagglutinin. In addition, serum samples
from 8 controls of blood group AB were found to
agglutinate each of the 8 serotypes tested.
Because these 8 serogroups did not absorb isohaemag¬
glutinins, they were not tested for differences in opsoniza¬
tion by autologous serum in phagocytosis experiments
with polymorphonuclear leukocytes and monocytes ob¬
tained from donors of blood groups A and B.
Absorption of A, B, and H antigens from the saliva of
secretors by the 8 serotypes was tested. None of the
serotypes was able to remove any of the blood group
antigens.
Discussion
Although individuals of blood group B appear to be
more susceptible to genitourinary infections by Gram-
negative bacteria, the host-parasite interactions under¬
lying these observations remain unclear. In this study we
have eliminated any contribution to susceptibility or
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resistance to recurrent urinary tract infections by iso-
haemagglutinms, at least for 8 serotypes commonly
associated with these infections.
The target antigen for bactericidal antibodies against
Gram-negative bacteria is LPS. Anti-B isohaemagglutinin
is bactericidal for serotype 086, but there was no activity
directed by anti-A or anti-B antibodies against the LPS
structures of the 8 serotypes tested. A number of studies
on the bactericidal activity of human serum for the
O serotypes of £. coli have been undertaken with small
numbers of individual sera or pooled sera from a small
number of healthy donors. Although there were variations
in sensitivities to these sera among different strains of
the O serotypes, there was no information regarding the
blood group of the individuals tested (2,21,22). In each
of these studies, serotypes associated with UTI were
found to be resistant to the sera tested. Our study
confirms these observations for 54 individuals of known
blood groups. The K antigens of our strains were not
determined because they had been found not to affect
serum sensitivity (2).
Since none of the 8 strains absorbed the isohaemag-
glutinins, these were not the antibodies responsible for
the agglutinating activity observed in the sera of the UTI
patients. Absorption of the Ulex lectin by the £. coli
strains was not tested because anu-H antibodies are not
normally present in humans.
A long-term survey of UTI patients is in progress. We
will be examimng the serotypes of their £. coli isolates to
determine if there is a correlation between blood group
and serotype: e.g. group B and strains of serotype 02
(table 1).
Since there do not appear to be antigens cross-reacting
with blood group A or B antigens on the bacteria tested,
an alternative hypothesis was suggested: there are recep¬
tors on the bacterial surface that recognize blood group
antigens or other antigens containing galactose, fucose.
and/or N-acetyl galactosamine on the host's epithelial
cells. In this case, water soluble blood group substances
in secretions and in urine could block these receptors,
reducing the probability of binding by this mechanism.
Our experiments with boiled bacterial cells or cells
vortexed to remove fimbriae revealed that the different
serotypes did not absorb blood group antigen from the
saliva of secretors. This suggests that the LPS does
not form part of the hypothetical binding mechanism
proposed above. The ability of mannose-sensitive and
mannose-resistant fimbriae to absorb blood group anti¬
gens and the possible role of these interactions in estab¬
lishment of infection are being investigated.
These results suggest that the increased susceptibility
of women of blood groups B and AB who are non-
secretors is not related to the absence of anti-B iso¬
haemagglutinin. These serum-resistant O serotypes most
frequently isolated from UTI patients are those most
frequently found as part of the normal faecal flora (2). We
would agree with these authors that the association of
these serogroups with bacteraemia and also with UTI
probably reflects a greater opportunity to colonize the
urinary tract rather than any particular virulence factor such
as an attachment mechanism associated with LPS com¬
position. Our future investigations will concentrate on
interaction of the blood group antigens in secretions with
protein and glycoprotein components of the bacterial
surface.
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Host-Parasite Interactions Influencing Susceptibility to
Diseases Caused by the Pathogenic Neisseria Species
C C BLACKWELL, F. P. WINSTANLEY, D. M. WEIR, and D. F. KINANE
Department ofBacteriology. The Medical School. University ofEdinburgh. Edinburgh EH8 9AG. Scotland
Evidence from a number of sources suggests that individuals of blood group B are
more susceptible than individuals from other blood groups to infections by the pathogenic
Neisseria species. We have examined humoral and phagocytic immune responses of individ¬
uals of the four ABO blood groups to N. gonorrhoeae as well as attachment of these
bacteria to target epithelial cells of groups A and B. The results provide evidence that
might explain, at least in part, some of the host-parasite interactions underlying the epidemi¬
ological observations.
Our epidemiological studies have confirmed that
there is a significant increase in the proportion of
individuals who are blood group B among patients
with localized genital gonorrhea (11, 16, 20). There
is also indirect evidence to suggest that there may
be a similar association for susceptibility to menin¬
gococcal disease. The meningitis belt of Africa (24)
is found in an area where the incidence of the B
gene is highest, 15 to 20% (20).
We have examined three hypotheses that might
explain, at least in part, the host-parasite interac¬
tions underlying the apparent increased susceptibil¬
ity of people of blood group B to gonococcal
infection, (i) Humoral defenses: As has been re¬
ported for Escherichia coli 086, anti-B isohemag-
glutinin of blood groups A and O is bactericidal
for certain strains of Neisseria gonorrhoeae, (ii) Cel¬
lular defenses: As has been reported for £. coli
086, anti-B isohemagglutinin is an effective opso¬
nin for certain strains of N. gonorrhoeae (8, 22).
(iii) Attachment to target epithelial cells: Some
strains of gonococci attach in greater numbers to
target epithelial cells of group B individuals.
HUMORAL DEFENSES
One of the principal target antigens for bacteri¬
cidal antibodies is the lipopolysaccharide (LPS) of
the goncococcus (12, 27). It is also the receptor
for the rod-type (R-type) pyocins of Pseudomonas
aeruginosa (16). With our pyocin typing system
(5) we were able to divide gonococci isolated from
both localized genital infections and disseminated
gonococcal infections into two categories. For sim¬
plicity we refer to group I as those strains with a
"simple" LPS, inhibited only by pyocins of the R5
class as defined by Kageyama (14). Strains of group
II were those with a "complex" LPS, inhibited by
pyocins of the R5 class and also those of class Rl.
There were, therefore, two different types of LPS
target antigen to examine.
"Natural" serum bactericidal activity. Our con¬
trols consisted of women attending postnatal clin¬
ics, a population with a very low incidence of
gonorrhea and high titers of isohemagglutinins.
Although gonococci have been shown to absorb
isohemagglutinins (20), we found that natural bac¬
tericidal activity of normal human serum directed
against isolates from localized genital infections was
not associated with either anti-A or anti-B isohe¬
magglutinins. The important factor was the LPS
structure: those strains with a complex LPS were
serum sensitive and those with a simple LPS were
uniformly resistant (32). This supported the finding
of Schneider and co-workers (27), who found that
serum resistance in gonococci was not due to mask¬
ing of antigens, blocking antibodies, or deficiencies
in complement, but to lack of an LPS determinant.
One implication of these findings is that the se¬
rum-sensitive group II organisms would be re¬
stricted to localized infections and the group I
strains would be found more frequently among iso¬
lates from disseminated gonococcal infections. In
an earlier study on pyocin types of gonococci from
a number of geographic sources, 95 of 110 isolates
(86.4%) from localized infections were group II
and 15 (13.6%) were group I. In contrast, of the
24 isolates from disseminated gonococcal infec¬
tions, 10 (41.6%) were group I. Since group II
isolates from disseminated gonococcal infections
are also serum resistant, this implies that there are
at least two different mechanisms of serum resist¬
ance (5, 32).
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Iramun< responses to N. gonorrhoeae Experi¬
mental immunization of mice with strains of either'
LPS group 1 or group II resulted in production
of bactericidal antibodies that cross-reacted with
strains of the homologous or heterologous LPS type
(32). Since normal uninfected individuals have anti¬
bodies bactericidal only for group II strains, we
examined sera from patients with gonorrhea to de¬
termine whether infection resulted in bactericidal
activity against group I strains.
Among the 34 sera from infected patients, titers
to group II stram P280 ranged from 16 to 280.
Very low titers (4 to 8) of antibodies bactericidal
for group I strain E757 were detected in sera from
3 patients, but not among the other 31 samples
(4).
This lack of production ofbactericidal antibodies
against group I LPS may result from its stimulation
of antibodies that do not activate the classical com¬
plement system (immunoglobulin A or G4) or from
the failure of the human immune system to respond
to that portion of the gonococcal LPS associated
with the binding site for R5 pyocins. It has been
reported that among Chinese prostitutes suscepti¬
bility and resistance to gonorrhea were associated
with differences in major histocompatibility com¬
plex genes. Resistance was associated with haplo-
type All, B15, and susceptibility was associated
with B17 (7). Recognition of the group 1 antigens
might depend on the genetic constitution of the
individual.
Although we were able to divide nonserogroupa-
ble meningococci into the same two groups by the
pyocin typing system (2). the same patterns of se¬
rum sensitivity and resistance were not found when
we tested our control sera for activity against poly-
agglutinable. autoagglutinable, and nonagglutina-
ble strains. Most of the 48 sera contained
bactericidal antibodies for each of the 10 nonsero-
groupable strains and for strains of serogroups B
and W135 but none against a strain of group Y
(3; manuscript in preparation).
Sihce the LPS of gonococci and meningococci
are structurally similar (2, 28), it was predicted
that gonococcal infection might act as a stimulus
for bactericidal antibodies against N. meningitidis.
In contrast to the control population, there were
very low titers of these antibodies in the sera of
patients with gonorrhea for serogroups A, B, and
C. The titers obtained with nonserogroupable
strains were similar to the controls (33).
Although the age range at greatest risk of menin¬
gococcal disease is 0 to 4 years, the group next
most at risk is 15 to 19 years, the age when sexual
activity begins and the incidence of gonorrhea is
high (15, 25). Outbreaks of meningococcal disease
in military establishments occur in the 18- to 24-
year age group, also the group with the highest
incidence of gonorrhea (4, 30). This suggests that
a recent history of gonorrhea may be ooe of the
factors contributing to the increased susceptibility
of young adults to diseases caused by N. meningi¬
tidis (33).
CELLULAR DEFENSES
In our first studies on binding of gonococci by
phagocytes (16), it became clear that neutrophils
and monocytes interact in very different ways with
these bacteria. Gonococci bind to a higher propor¬
tion of neutrophils, and the presence or absence
of pili does not significantly affect this binding. As
with epithelial cells and spermatozoa, a higher pro¬
portion of piliated variants of a strain bound to
monocytes when compared with the nonpiliated
form (13, 29).
There was no significant difference in association
of neutrophils with gonococci opsonized by sera
containing anti-A or anti-B isohemagglutinins;
however, larger numbers of those strains with the
complex LPS (group II) than of those strains with
the simple LPS (group I) were associated with the
neutrophils of each ABO blood group (1).
There were no differences m association of unop-
sonized gonococci with monocytes from donors of
the four ABO groups. When bacteria were opso¬
nized with autologous serum from the donor, there
was a significant increase m association with mono¬
cytes of groups A, B, and O, but not AB. Group
B monocytes bound the greatest number. Absorp¬
tion of isohemagglutinins from the serum reduced
the levels of binding to that observed for unopso-
nized bacteru (17).
Our original hypothesis was not proved, but if
the hypothesis of Novotny and colleagues is correct,
that gonorrhea is a "disease of the human macro¬
phage" (23), these results may explain the increased
susceptibility of group B individuals to infection.
If gonococci ingested by mononuclear phagocytes
are able to inhibit the bactericidal activities of the
cell and grow within it, when the cell eventually
lyses. the bacteria are released as "infectious units,"
protected by a coat of debris. The findings of Witt
et al. (34) and Veale et al. (31) indicated that gono¬
cocci are capable of survival and growth within
both neutrophils and monocytes.
The increased association of gonococci with B
monocytes may result in an increased probability
of forming the infectious units in which the bacteria
are shielded from both cellular and humoral im¬
mune mechanisms.
ATTACHMENT TO TARGET EPITHELIAL
CELLS
Attachment of gonococci to susceptible epithelial
surfaces is the first step in the initiation of disease.
In these experiments we examined the adherence
of two strains from disseminated gonococcal disease
to uroepithelial cells from women of blood groups
A and B to test our hypothesis. The two strains
were obtained from Joan S. Knapp, Neisseria Ref-
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erence Laboratory, U.S. Public Health Service, Se¬
attle, Wash. Strain 6354 was LPS group I.
prototrophic, serotype WI; strain 7423 was LPS
group It, prototrophic, serogroup WI. For both,
the MIC of penicillin was 0.125 U/ml.
The bacteria were grown on chocolate blood agar
in an atmosphere of 5 to 10% COi, harvested at
12 to 13 h in Dulbecco phosphate-buffered saline
containing Ca1* and Mg1* (0.9 mM and 0.5 mM.
respectively), and adjusted to 5 x 10* cells per
ne¬
uroepithelial cells were collected at midmorning
from women (ages 22 to 26 years) of blood groups
A and B, washed three times in saline, and adjusted
to 2 x 10* cells per ml in Dulbecco phosphate-
buffered saline.
Duplicate samples of equal volumes of cells and
bacteria were gently mixed and incubated for f h
at 37®C and 50 rpm in an orbital incubator. The
mixtures were washed three times with saline and
resuspended to the original volume of the reaction
mixture. Slides of the washed mixture were pre¬
pared from 0.1-ml volumes with a cytospin (Shan-
don). The slides were fixed with methanol. Gram
stained, and examined by light microscopy (Leitz
Laborlux). For each slide 40 epithelial cells with
adherent bacteria were counted; those cells that
could not be counted accurately, those in clumps
or that had a distorted morphology, were not in¬
cluded. When there were more than 50 bacteria
per cell, the number was recorded as 50.
The experiments were performed once a week
over a 4-month penod to determine any effects of
the menstrual cycle on attachment.
The results in Fig. 1 indicate that more bacteria
of both strains attached to the blood group B cells
than to the group A cells. There were two to four
experiments for each quarter of the cycle except
for the first, for which there was only one set of
data.
These results agree with those found for attach¬
ment of gonococci to vaginal epithelial cells at dif¬
ferent stages of the menstrual cycle. More
gonococci were found to attach to cells obtained
during the postmenstrual phase than to those ob¬
tained during the premenstrual phase (10). In a
later study Forsiin and Danielsson reported no vari¬
ation in adherence of gonococci to uroepithelial
cells during the menstrual cycle (9), but their meth¬
ods were different from ours in that our subjects
were followed over approximately four cycles. The
differences in attachment to ceils of different blood
groups may, in conjunction with the hormonal ef¬
fects reported by Forsiin and co-workers (10), ac¬
count for the variations observed among different
donors by other investigators (29).
These are preliminary experiments that must be
repeated with more individuals and also with
strains from localized infections. If these observa¬
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FIG. 1. Attachment of two strains from disseminated
gonococcal infections (DGI) to uroepuhelial cells ob¬
tained from women of blood groups A and B
the factors underlying the increased incidence of
group B individuals among gonorrhea patients.
There are lectmlike receptors on human phago¬
cytic cells that bind gonococci by means of sugars
in their cell envelope (19). We are investigating
the suggestion that differences in attachment to tar¬
get cells of the ABO blood groups may be due to
recognition of an adhesin(s) on the bacteria by a
similar mechanism.
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FACTORS INFLUENCING HOST SUSCEPTI¬
BILITY TO MENINGOCOCCAL DISEASE
by F. P. Winstanley, C. C. BUckwell and D. M. Weir
(Department of Bacteriology. The Medical School,
University of Edinburgh*. Edinburgh)
abstract
Host-parasite interactions influencing the develop¬
ment of the protective humoral immune response to
Neisseria meningitidis are briefly reviewed. Possible
consequences of the observed decreased til res of bacte¬
ricidal activitv specific for meningococcal serogroups A.
B and C among patients with gonorrhoea arc discussed
with reference to I the epidemiology of the two
diseases. 2 > the protective role of« natural » antibodies
to the Neisseria species and 3 •' the carriage rate of
serogroupable strains ofS. meningitidis among patients
with gonorrhoea and a control population.
aBREcE
Les interactions hote-porasne infiuengant le dcvelop-
pement des repor.ses immunes humorales protectrices
cis-a-vis dc Neisseria meningitidis sont paswes en revue.
Les consequences eventuelles des litres bas d'activite
bactericide specifiquc des serogroupes de meninges-
coquc A. B et C observes chc: les patients aiteinis dc
gonorrhec sont discutees en function / dc /'epide¬
miologic des deux maladies ; 2, du role protectcur des
artticorps " ncturels » vis-a-vis des souches dc Neisseria :
3 ■ de la frequence de fetal porteur de souches dc
N. meningitidis serogroupubles chez les patients
alteinis de gonorrhee et dans la population temoin.
Current knowledge of the factors thai determine
the susceptibility of individuals to meningococcal
disease is scanty, but a number of predisposing condi¬
tions nave been suggested. These faciors include
overcrowding, poor general health and iiving condi¬
tions. influenza and absence of serum bactericidal
activity against the meningococcus (24). The study
of Goldschneider and colleagues :9i shewed that
• Tevioi Place. Edinburgh EH8 9AG. L k
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immunit) 10 meningococcal d'.scase is related to the
titre of serum bactericidal antibody reactive with
polysaccharide antigens of Seisseric meningitidis.
Their evidence was as follows
1) The incidence of meningococcal disease is age-
dependent. Great susceptibility in the early years of
life is followed by an increase ir. resistance, directly
related to the increase in titre of serum antibodies
bactericidal for A', meningitidis.
2t Low litres or absence of these bactericidal
antibodies were shown to correlate with susceptibility
of army recruits to meningococcal disease.
3) Passive immunisation with group-specific anti-
meningococcal serum had been shown to reduce the
case fatality rate in meningococcal disease t7i.
These bactericidal antibodies are generally absent
or of low titre during the first two years of life, the
period of greatest susceptibility io the disease. As
the litres of serogroup-specific antibodies increase
in older children, the incidence of meningococcal
disease decreases The antigenic stimuli responsible
for these antibodies are thought to include contribu¬
tions from the normal bacteria! flora of the body.
Carriage of S'eisseria laetaniica. a bacterium closely
related to the meningococcus, can proveke the deve¬
lopment of cross-reacting bactericidal antibodies
to serogroups A. B and C. Gold and co-workers <8)
suggested that since this organism is acquired by most
infants during the first two years of life, it may be
a mayor stimulant of bactericidal antibodies that
cross-react with A. meningitidis. Asymptomatic
carriage of serogroupable and nor-serogrcupable
meningococci has also been show-p io stimulate
production of bactericidal antibodies i)0. 26>. Cross-
reactions between meningococci of groups A and C
and enteric bacteria have also been observed '27).
This evidence suggests that natural immunity to
meningococcal disease may be attributable to for¬
tuitous cross-reactions of antibodies stimulated by
both generically related and unrelaied bacteria.
Artenstein and Ellis (3) pointed out that the high
rate of carriage of meningococci compared with the
rarity of meningococcal disease suggests that deficien¬
cies ir, host defence may play a major role in deter¬
mining systemic invasion. For example, recurrent
meningococcal meningitis (18) and gonccoccaemia (25)
occur frequently in indiv iduals with congenital absence
of the terminal components of the complement sys¬
tem. Another genetic factor associated with susceptibi-
MENINGOCOCCI DISEASE
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Companion of '.h< meningitis belt of Africa with areas of the continent
in which there is a high incidence 115-DO *'.) of the blood group B gene in the population.
lity to infectious diseases is ABO blood group (21).
Individuals of biood group B appear to be more
susceptible to infection by Seisseria gonorrhoeae
than individuals of other ABO blood groups (17);
they might also be at greater risk of infection with
meningococci.
The congruity between the ■< meningitis belt »
of Africa and the large region of that continent that
has a high incidence (15-20 *,) of the B gene has
not escaped our notice (Figure) (24, 20). A combi¬
nation of environmental and genetic factors present
in this region might be responsible for the high preval¬
ence of meningococcal disease.
In the course of studies on serum-sensitivity among
the pathogenic Neisseria species, we found that in
individuals with active gonorrhoea the levels of anti¬
bodies bactericidal for serogroups A. B and C of
.V. meningitidis were much lower than those from
an uninfected control population. The markedly
reduced litres of bactericidal activity were restricted
to the three serogroupable strains tested; the titres
against two non-serogroupable strains (0452 and
NG$46> were similar to those from <c normal »
individuals from the same geographical area (51).
We suggested that the absence or low ture of bacteri¬
cidal antibody reactive with serogroups A, B and C
in patients with gonorrhoea might result in their
resistance to meningococcal disease being compro¬
mised.
The following epidemiological observations also
suggest a link between susceptibility to meningococcal
disease and to gonorrhoea:
a) During an outbreak of meningococcal disease
the age range in which greatest morbidity occurs is
0-4 years. These are children who have not yet deve¬
loped bactericidal antibodies against meningo¬
cocci (10). The group in whicht he next highest incid¬
ence occurs is the 15-19 year olds, an age range
corresponding to the onset of sexual activity and in
which there is a high incidence of gonorrhoea (16. 23).
i) Outbreaks of meningococcal disease in military
institutes occur predominantly among recruits. 30 *.
of infections developing within 5-6 weeks of their
entry (4. 29). The majority of patients with menin¬
gococcal disease in an outbreak in a military esta¬
blishment fell into the age range of 18-24 years which
is identical to that in which most military cases of
gonorrhoea are to be found (18. 30).
c) The incidence of meningococcal colonisation
of the phary nx is higher in patients with genital gonor¬
rhoea (approximately 26 %) than in those without
(approximately 11 The relative risk of harbouring
meningococci when infected with gonococci is 2.44
(95 confidence limits. 1.4-4.2) »-22. 32).
These observations suggest that gonococcal infec¬
tion or evposure to infection may be one of the factors
associated with the increased incidence of menin¬
gococcal disease among young adults.
Three hypotheses have :o be considered in evaluating
this information: (I) a deficiency in bacterial anti¬
body predisposes individuals to infection by both
V. meningitidis and .V. gonorrhoeae: (2) IgA antibodies
stimulated by gonococcal infection cross-react with
determinants on serogroupable meningococci to
which the natural bactericidal antibodies are directed,
so inhibiting bacteriolysis: (3) infection with .V, gonor¬
rhoeae may reduce titres of protective cross-reactive
antibodies, and in doing so, compromise host defences
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to -V. meningitidis. In contrast to the congenital
complement deficiencies, hypotheses 2 and 3 suggest
a transient, acquired susceptibility to infection.
There is evidence from two sources to cast doubt
on the first hypothesis In our studies, the patients
with gonorrhoea had normal litres of antibody
against non-serogroupable meningococci (31) and
against serum-sensitive strains of gonococci (3). It is
generally accepted that bactericidal antibodies play
an important role in the prevention of meningococcal
disease, but the role of these antibodies in prevention
of localized gonorrhoea is still debatable.
Griflfiss has suggested that blocking IgA antibodies
to meningococcal antigens may play a role in the
pathogenesis of the disease (12). If. as in the case of
.V. gonorrhoeae, bactericidal activity is due to « natu¬
ral antibodies » of the IgM class (28). then low litres
of IgA blocking antibodies in patients sera would
produce a prozone (13i. This was not observed in our
experiments; however. Kahty and colleagues (15)
observed the development of meningococcal disease
in the presence of high levels of serum antibody to
the meningococcal polysaccharide antigens. In their
study, over a quarter of the antibodies (28.3 °.) were
of the IgA class. The phenomenon appeared to
occur in conjunction with asymptomatic carriage
of .V. meningitidis or closely related bacteria; this
is also found during ano-genital gonococcal infec¬
tion (13).
The third hypothesis suggests that anti-meningo-
coccal antibodies may be absorbed by cross-reacting
antigens during gonococcal infections. Antigenic
similarities between gonococcal and meningococcal
lipopolysaccharides (LPS) have been observed (I)
and Seisseno species are known io reiease free LPS
and outer membrane vesicles during growth <5. 141.
These may act as absorbents of antibody, possibly
leading to the observed reduction <transient?) in
antibodies bactericidal for the serogroupable strains
tested. A similar phenomenon occurs during pneu¬
mococcal infection i6).
The presence of bactericidal an:ibody nas been
shown to reduce nasopharyngeal carriage of .V. menin¬
gitidis. and this reductior. appealed to De group-
specific (III. Young and colleagues observed that
women with gonorrhoea were more likely to be colo¬
nised by serogroupable meningococci than were
women without gonorrhoea. There were no significant
differences in colonisation of the two groups by non-
serogroupable strains of the organism <33i. These
findings are additional albeit, indirect evidence for
our suggestion that recent gonococcal infection may
be one of the many factors contributing to susceptibi¬
lity to meningococcal disease and could partially
account for the higher incidence of this infection
among young adults.
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INFECTION AND BRASHAMELLA CATAR¬
RHA US
by D. T. McLeod*, F. Ahmad** and M. A. Cal-
der**
(Chest Unit * and Department of Bacteriology **.
City Hospital. Edinburgh)
abstract
Of the Gram-negative cocci found in the nasopharynx
to which any pathogenic status can be attributed.
Neisseria meningitidis and Neisseria > Branhamellat
catarrhaiis hace coined significant notoriety. Traditio¬
nally. B. catarrhaiis is regarded as a nasopharyngeal
commensal and thus there is. in general, considerable
reluctance to accept that B. catarrhaiis may be
a pathogen * hen it is seen. Hence, it is under-reported
or totally ignored though there is more awareness
regarding its pathogenic potential, particularly as an
increasingly high incidence of i lactamase producing
strains is being reported from many countries. The
importance ol this development concerns the choice
o' routine antibiotic therapy as ampicillin. to which
this organism was previously sensitive, may no longer
be effective.
ABREGl
Neisseria meningitidis et Neisse-.a i Branhamellai
catarrnalis sc sont acquises une notoriete significative
parmi les cocci gram negotifs du nas<ipharynx auquel
on pcut aitribucr un poucoir pathogene. Traditionnel-
iement B. catarrhaiis est considerec comme un cammcn-
" Gretnbani. Drive. EainNjrth EH!0 5SB Scotland
Reprints: D T McLeod
sal du nasopharynx et il e.xiste done une reticence
considerable cis-a-cis de son caractere pathogene.
Par consequent, sa presence est sous-et aluee ou ignoree
bien qu une prise de conscience se fasse ris-a-cts de sen
pouvoir pathogene en pornculier deputs /'augmentation
de frequence des touches pr.oducrrices de 3 lactamase
dans de nombreux pays. Certe evolution est d'impor-
tance pour le choix d'une antibiothvrupie dc routine
car TampiciUinc. a laquelle certe o'janisme etait
preaiablement sensible, pourrail ne plus etre active.
HISTORY
Micrococcus Branhamella; catarrhaiis was first
isolated in 1396 from the culture of alveolar material
of children with bronchopulmonary infection (II).
Subsequently, in J902 Ghon and PfeilTer (12) isolated
the same organism from the sputum of patients with
acute bronchitis who in addition had an influenza-
like illness and concluded that M. catarrhaiis should
be regarded a».a human pathogen. Three years later
Dunn and Gordon supported this opinion by reporting
an epidemic of influenza-iike illness in Hertford
when again this organism was isolated i9). Morpho¬
logical and biochemical differentiation of Gram-
negative cocci was achieved by Von Lingelsheim (17)
and Kutscher tl6i in 1906 and thereby identification
of the various species of micrococcus became possible.
Kutscher suspected that some Gram-negative cipio-
cocci found in the cerebrospinal fluid in cases of
meningitis in 1906 may well have been M. catarrhaiis.
These diagnostic difficulties in distinguishing .V. me¬
ningitidis from M. catarrhaiis were certainly appre¬
ciated and carefully studied by Elser and Huntoon
in 1909 < 101. Later. Holland in 1920 (2) included
U. catarrhaiis in the genus Seisseria. Thereafter.
Neisseria rotarrhahs surplanted ihe original r.ame of
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thyroid protection after a nuclear
reactor accident
Sou—Your ooce (May 24, p 1225) dairas that "widespread u*"
■a made of iodine tablets ifter she Chernobyl nuclear acodmt md
you report chat the World Health Organisation'! European region
would wctace infbcmaaoo on compticaooc* of tha treatment
The rrwri axnpticabon to be expected in large region* of central
Europe with insufficient iodine suppty, hyperthyroidism, was not
fryprCTwi Experts from East and West Europe met at the WHO
rJKrr m Copenhagen on May 6, and agreed that the environmental
axtoammaoca with radioiodine from Chernobyl did not necessitate
the distribution of sable iodine id the general public Only in
Poland were children in certain areas supplied with stable iodine
during the first days of the aeddent. The West German authorities
exptiady asked the public to avoid iodine tablets. In this country
with endemic goitre there is a further proportion of the population
who are euthyroid and have autonomic thyroid assue; thus, after
make of higher amounts of stable iodine there would be a risk of
hyperthyroidism, especially in older people Some of these cases
might even proceed to thyrtxorsc crisis, which may result in early
cfcath. This represents the mam factor to be taken into consideration
in the benefit/risk analysis of any mass distribution of stable iodine
in countries such as Germany.
Another poinr is that some people treated with iodine for goitre
prophylaxis might interrupt their medication because they do not
know that their "micro-iodine" ablets differ from the "macro-
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persistence of coxsackce b
virus-specific ifm
Sot,—Professor BanatvaJx and his colleagues (June 28, p 1491)
report persistent Coxsackie B virus-specific IgM (for at least 6 years
and for 20 months) in two patients with recurrent pencardins. They
apparently used an ELISA to measure virus-specific IgM.
We have obtained similar results using the conventional
neutralising antibody test after separation of Ig dasses by two-step
column chromatography. By rigorous controls false-positive IgM
tests are excluded.1 One patient (bom in 1915) presented with
hypertension snd coronary artery disease and became positive for
fVnrt»Hri>- B type 4 neutralising antibodies in September, I960,
with virus-specific IgM that persisted in high hoe to at least
November, 1985. Antibody tests for other Coxsackie B virus types
were negative. Another panent (bom 1919) with the clinical
diagnosis ofmyocarditis exhibited Cuxsadtie B2 IgM antibodies for
a least 15 months. A third (bom 1946, with cardiac neurasthenia
and palpitations) had IgM antibodies to Coxsadtie B virus types 2,
4, and 5 for at least 18 months.
HOMOTYPtC AND HETEROTYPIC NEUTRALISING ANTIBODY
RESPONSE TO COXSACXIE VIRUS B TYPES 1—6 IN PATIENT WTTH
ASEPTIC MENINGITIS DUB TO C0X5ACXIE B TYP8 2
Type __
Ncumiiimg antibody ritre a onK(rao):
0 1/2 1 2 6* 7 11
1 IgG 312 236 256 192 1024 768 1336
1 IgM 53 net 2Q 22 278 134 220
2 IgG °e» org j*t 96 768 192
2 IgM 183 116 33
3 IgG net ■*t «» oeg «8 "1
3 IgM neg *«
4 IgG «g «g org oeg «I «« «8
4 IgM
J IgG 48 96 64 64 384 312 64
3 IgM 17 *8 net 278 38 110
6 IgG «« o«* «s "g 64 24 24
« IgM •• •• 46 29 35
However, we hesitate to interpret the persistence of Coxsarkie B
IgM a resulting generally from prolonged antigenic mrqUarm by-
persisting infection (whole virus or some ofha compooena), though
Dr Bowles sad colleagues' report (May 17, p 1120) of Cmnarkie B
RNA sequences m the myocardium a compatible wsh dm view.
We have seen an apparently healthy 33-year-old man with
B type 1 IgM persisting for tt least 6 months (table). At
that time he foil ill with aseptic meningitis due to G.ava fcie 8 virus
type 2 (virus isolated). He developed not only Conadric B type 2
IgM but also seroconverted id Qnrsactic B type 6 (IgG and IgM)
and had a rise in IgM ofat least 10-fold to Caxsadoe B types 1 sod 5-
IgM against these four Comrkie B virus types persisted for at least
5 "vwiN without a significant decline of litre.
We cannot exclude persistence of Coxsacfcic B viruses in these
patients. But from a practical point of view we should flee ®
that Caxmckie B IgM may persist for long periods of
ame and that significanr heterotypic responses may be observed."
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non-secretion of abo antigens
predisposing to infection by neisseria
meningitidis and streptococcus
pneumoniae
Sot,—A 1985 Lancet editorial emphasised the need for tmatch
on vaccines for serogroup B Neisseria memngiadit.1 The ahsmrv of
serogioup-sped&c antibodies is an important factor predisposing
the boot ooc only to meningococcal infection* but also to those
caused by Streptococcus pneumoniae.1* Our work on other xifocnous
agents suggested that boon that might be aworiatni vrkh
susceptibility of the non-immune host should be examined. Among
patients with teem lent urinary infections" or superficial infeqiona
due to Conduct a&ncanf* we found a significant increase in the
prevalence ofnoo-seoebon ofABO blood grotqi antigens into body
Quids. Secretion of the water-soluble glycoprotein farmof the ABO
antigens is inherited in a rocnririiarwirminani partem. The
frequency ofnoo-secretors was especially high among pabena wsh
candid* infections m whom the specific immune responses migtsr be
considered to be immunocompromised, and in pregnant women
with vaginal infection and elderly patients of both sexes with oral
infections.7 Secretion ofblood group antigens appears to play a part
in the innate defences at the mucosal surfaces. Because they lacked
protective antibodies, we viewed noo-gnmune individuals sa
immunocompromised hosts at the time they were exposed to the.
pathogenic men tngococri or poeumococa. Ass result, we predicted
there would be s higher incidence of noo-seaemrs among pabeno
with these mfrcrrrn
Saliva specimens were boded within3 hofooQectioa and stored at
- 20*C. Sectetor state was determined by the haemaggkiscooon
inhibition assay* and the resula were compared with figures for
blood donna in the Edinburgh tree* sod for blood donors snd
hospital staff in Iceland.'
Non seoemr status wis rigmfirandy more frequent in the
Scottish pabena with pneumococcal disease sod with
meningococcal disease and in the Icelandic patients with
meningococcal infircTinos (table I).
Anderaaoa and oo-workers1* have reported sgnificandy
deacased utarhmmr of pneimocnca to epnhe&ai oefls when
bacteria were prancubatrd with gtyoocompouods found in pooiad
human tssiBc Since hutmn mik is a nth source of blood poop
»»«ywtmniriingi.-ai studies compleninu their in vino
0b8CTWD0fl8>
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TAU 1—IX3D«NCI OP NCTMBCMTOM AMONG PATIENTS WTTH
LNF6CTTCN3 DCT TO N MZMNGITIDtS AND STTlf? PNEUMONIAE
T.
Infacuca Source Nee Kmion P
r- u -i Scodred 18/26 /«»•/./ <<30005
Iceland 33/98 (54%) <005
SrpvwwMr Scodred 22/47 (47*/.) <(301
Cootrok Scodred* 89/334 <M4%)
Iceland* 9V228 (41-2%)
TAILS B-8LOOO GROUF GLYCOPROTEINS FWESENT IN SECRETO*
AND NON-JSCRETOR BODY FLUIDS.
A* B Ht Leww" Lews'
Starrer f/- ♦/- * ±1 *
NaHKRBt - - - + -
■ piuMci of A or > btocd pwpf
l ofWood pwp 0.
I ■ pmiM of Leva*.
Our work on candid* suggested two mechanisms by which the
giyaxcanpounds in the body fluids of scuetors and noo-secreton
(tabic 11) might inhibit or enhance binding of microorganisms to
epithelial cells. Boiled saliva from secretors of blood groups A, B,
tod O can inhibit binding of the yeast to buccal epithelial cells."
Saliva of ooo-secretory enhanced the binding." We have found
that the Lewis' antigen in the body fluids of noc-secretory is one of
the receptees for C aSbiaou.u Unlike ABO blood group antigens,
Lewis antigens are not structuralcomponents ofhost cells. They are
acquired as a coat from either plasma or secretions. If the
carbohydrate moiety of the Lewis antigen in secretions recognises
an acftsesin on the surface of a bacterium or yeast, it might bind
afterwards to the epithelial surface by anodier portion of the
cnolroile along with the attached microorganism
Investigations are underway to find out if similar boat-parasite'
interactions might account for the increased jruvVmoc of non-
secretnrs among patients with infections due to S mtmngiridu and
Strtp pnawnomat. Irtmnfvanoc of the receptor for these organisms
would facilitate isolaoac of idhesins involved in colonisation of the
mucosal surfaces and their isyssmmt as potential vaccine
candidates.
We thank the Edinburgh md Saudi East Scoctad Regional Blood
Traosftaaon Service far tbc reagents used in this study.
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EPICARDIAL MONOFHASIC ACTION POTENT
Sat,—We agree with Dr Taggart and colleagues (Ju
p 1462) that epicardial monophasic acrion potential recording
considerable promise. We have devised a similar technique1
studying 37 patients, have concentrated on the error
reproducibility of the method. Our experience shows the n<
caution in interpretation.
We have found the amplitude of monophasic action poter.
be of limited value. Amplitude is critically dependent
pressure and orientation of the electrode. Gross changes
observed, within a short time interval, independently
intervention. This is illustrated in the figure. Potentials (a), (
(c) were recorded from the same epicardial site over
Considerable variation in amplitude is obvious. Tag^r
observed potentials for 30 s before the induction of bchaemi.
attempt to ensure stability, but this is no guarantee a
subsequent deterioration in the signal. Demonstration of oor
recovery of the potentials in afl patients, on restoration of
would have strengthened their conclusions.
<ai
Variation in epicardial mooophaaic action potential.
We believe that the technique provides a valid measure of ac
potential duration, but again limitations should be recognised.
95% confidence limits for our replicate observations of dun
have varied between 24 and 40 ms in different patients.
compares with a mean difference of 25 ms between jyharnur
noo-tschaenhc periods reported by Taggart et aJ. Hence
reported ischaemic changes are of a magnitude which border or
resolution of the method. In addition, we have evidence
mooophasic potentials are jnflumrrri by temperature and by
institution of cardiopulmonary bypass.
It is important that the limitations of any new technique she
be recognised. We suggest that this is especially relevant in tela










the lancet, September 20,1986 637
PSP may be a senncve marker for pancreatic fofiammaccn,
reflectxg pemcreaac acnar ceil damage persunng after acute
peaaeaoca and in chronic pencrabna. T< are now ootTeiacng
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NON-SECRETION OF ABO BLOOD GROUP
ANTIGENS PREDISPOSING TO INFECTION BY
HAEMOPHILUS INFLUENZAE
Sot,—TPe have reported (Aug 2, p 2S4) a significant increase in
the incidence of rvoc-secmorj of ABO blood group anbgens among
pabents with infections due » Unaeria memrxpadii or Snrpaxocaa
pneumomat. We suggested that the ability to secrete blood group
antigens plays a part in the innate defences of the acc-immune host
against these infeoous agents. These two organisms and
Haemcp/nha influenzal are responsible for 75 V. of bacterial
meningitis in young children during the period in which maternal
antibodies have wined and the infant has not developed active
immunity.1 If secretion plays a similar protectve role in the
host-parasite interactions that lead idestablishment or prevention of
these infections, we predicted an increased incidence of non-
jecretors among children with haemophilus infections.
Saliva samples were obtained from 43 Icelandic children who had
invasive disease due to H aflutnzae (meningitis 30, sepsis/cellulitis
II, and epiglottitis 2). Secresor sate was assessed by the
haemagghibaaboa inhibition method.' The saliva specimens yerc
boiled within 2 h of collection and stored frozen until tested. The
secretor sates of the patients were compered by Teat (with Yates'
correction) with those reported .'or Icelandic blood donors and
hospital personnel.1
29/43 pabena (67V.) and 94/228 (41%) controls' were noc-
seciemrsfp <0-005). These findings connrmrd our predicnon that,
as we had found for pneumococcal and meningococcal infections,
the inability of an individual to secrete his ABO blood group
andgens is a factor that predisposes to in/ecbon with haemophilu*
Secretor sate is a staoie host factor that can be used in
invescgabons of the pathogenesis and development of methods for
prevention of these pacdiatric infections.
We dunk die Edinburgh led South East Scotland Blood Trmsftisaoo
Service for remgena used in this study.
Deperenmr et Baamntotr,
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MATERNAL SMOKING DURING PREGNANCY AND
THE RISK OF CHILDHOOD CANCER
Six,—We are responding 00 Arte of foe lessen in your Aug 30
issue (pp 519 and 320) commennrg an our June 14 paper. The
discrepancy between our finding. arvl fooae from foe Inter-
Regional Epidemiological Study of Oi.icOvwi Cancer (TRESCO
is attributed by Dr McKjnney and Dr Seller to differences in study
design la IRESCC roc children were age and sea matched for
every case but we are aoc convinced that individual mra-hing is t
safeguard against recall bias, especially if diseases with ooaHy
different outcomes are being compered. It il unlikely foar mothers
of children tdrmrrrrt with, ay, atridtnnl injury or far
tonsillectomy, will try to recall pest events as vigorously as will
mothers of children with a malignant or serious, chronic disease of
unknown origin. Furthermore, controls teteord from general
ptaebboner Ssa and hospital trimming for minor condioons may
be biased in respect of smoke exposure. There are several reports of
an association between maternal smoking and, for example,
upper-respiratory-ma disease, bronchia, pneumonia, asthma,
coughs, and adenoidfaomy/mruTVrnray in focr children. This
may pertly explain why foe IRESCC found as evidence of an
increased risk of cancer an foe children of mothers who smoked
during pregnancy.
Diabetic children are not represcaabve of foe general population
of children but that does acx necessarily mean that foe smoking
histories for their mothers are atypical. The smoking habits of the
mothers we studied axrespood fairly well wich those of women of
similar ages in the general populaooa in Sweden' (able I), and it is
dear that mothers ofchildren with leukaemia smoked more than the
average.
McKianey and SoBer also raise foe question of different ages at
diagnosis in cases and controls, and hence different intervals since
the pregnancy. Age-specific confounding was coo trolled for by
principles outlined by Mictncen" and by calculating the
confidence interval (CI) of foe nsk ratio.4 Indirect standardisation
was done with foe age-tpcafic strata 0-4, 5-9, and 10-16. In foe
acute lymphoblastic leukaemia (ALL) or diabetes setting this pre,
for the group exposed to 10 or more agamies per day, a standard
morbidity rabo (SMR) of 2-03; foe crude nsk raoo(CRR) was 2-07.
TABLE I—FREVALENCI OF DAILY CIGARETTE SMOKING AMONG
MOTHERS OF CASES AND CONTROLS AND OF WOMEN IN
CHILDBEARING AGES IN SWEDEN
Duly opretie smokers (%) among
momen bora ec
Group 1926-35 1936—43 1946-58
ALL* 200 60-7 62-7
Solid tumours* 300 424 46-3
Diabetes* (controls) 29-1 41 7 48 1
Twin study* 294 390 404
*Ow rduc » 5-ywr penod Safari napmay.
TABLE n—ACUTE LYMPHOBLASTIC LEUKAEMIA ACCORDING TO
MATERNAL SMOKING AND OCCUFATION DURING FRECNANCT
Occupation*
Eapoeed/unexposed in
out 95* aCasa Controls
Housewife 19/32 31/108 1-26 0-65-243
Admimsuabon, office 7/10 14/34 1 70 0-54-5-38
Nurse, nurse assistant 1/24 300 0-89-10-10
Teacher 4/7 1/16 914 1-07/78-30
tndujcnii, umsuueoon 1/2 5/10 i-oo 1-30/4928
Service 7/4 5/8 280 0-52-14-98
Commercial, sties, sales staff 3/5 Si« 0-72 0-11-485
Technical, sriennfir 0/4 1/8 0 0
Agncuiturv, forestry, Sahiag 0/1 2/2 0 0
Transport, communionnn (DO 1/2 — —
Student on 0/2 ' — —
ckm. inn.
J. Clin. Lab. Immunol. (I9H7). 22. 133-137
SECRETOR STATE AND IMMUNOGLOBULIN LEVELS
AMONG WOMEN WITH RECURRENT URINARY TRACT
INFECTIONS
C. C. Blackwell,1 S. J. May,1 R. P. Brettle,2 C. J. Maccallum1 and D. M. Weir1
1 Department of Bacteriology, University of Edinburgh, Medical School, Teviot Place and 2 Pyelonephritis
Unit and Division of Infectious Diseases, City Hospital, Greenbank Drive, Edinburgh, UK
(Received 29 July 1986)
SUMMARY In this study we tested the hypothesis that the
increased susceptibility of non-secretors of blood group anti¬
gens to recurrent urinary tract infections might be due, in part,
to lower levels of IgA reported for non-secretor Caucasian
women. Total serum IgA and IgG levels of 200 women in a
retrospective study group monitored by the local pyelo¬
nephritis unit for 20 yr was compared with those of 100 women
from a prospective group recently referred to the clinic.
Immunoglobulin levels of the retrospective group were
analyzed with reference to the secretor state of the patient,
improvement over the 20 yr and presence or absence of renal
scars. Total IgA and IgG levels were significantly higher in the
sera of non-secretors with or without renal scars and also
among patients who had clinically improved over the 20-yr
period. Most women appeared to improve regardless of age of
onset of infections or treatment prescribed. It was suggested
that improvement might be associated with a self-immunization
phenomenon. The significantly higher levels of IgA and IgG
found among the women in the retrospective study compared
with the levels found in the sera of age-matched women in the
prospective study is evidence for this hypothesis. The implica¬
tions of these findings for further investigations of the patho¬
genesis of urinary tract infections are discussed.
Key words: Urinary tract infections, secretor state, immuno¬
globulins, women
Introduction
Recurrent urinary tract infections (UTI) occur among
women despite the availability of antibacterial agents with
good in vitro efficacy. Up to 80% of these recurrent infections
have been found to be reinfections, suggesting that there
may be a failure of host defences in this population (1).
Non-secretion of ABO blood group antigens is a stable
host marker associated with susceptibility of non-immune
hosts to meningococcal and pneumococcal infections (2).
We have also found a higher incidence of non-secretors
in adult women with recurrent urinary tract infections
(3,4) and non-secretion appears to predispose the host to
kidney scarring associated with pyelonephritic infections
(Lomberg and Svanborg-Eden, personal communication;
May et al., manuscript in preparation).
Indirect evidence from early epidemiological observa¬
tions by groups working on problems unrelated to
urinary tract infections led us to examine the hypothesis
that the reported lower levels of serum IgA found among
Correspondence: Dr. C. C. Blackwell, Department of Bacteriology,
University of Edinburgh, Medical School, Teviot Place, Edinburgh,
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non-secretor women might play a role in host-parasite
interactions underlying their increased susceptibility to
recurrent UTI. In a randomly selected population,
Caucasian women who were non-secretors had lower
levels of serum IgA than secretors (5). A similar pattern
had also been reported for secretory IgA levels. Those of
non-secretors were lower than those of secretors (6).
Among women of child-bearing age, isolation of
Candida albicans has been associated with low levels of
specific anti-candida serum IgA but not anti-candida
serum IgG antibodies (7). If a similar set of interactions
occurs at the mucosal surfaces of the urinary tract, the
apparent increased susceptibility of non-secretors to
recurrent UTI might be due, in part, to low levels of
serum IgA specific for the infecting strain of Escherichia
coli. Secretory IgA levels have been found to be lower in
young girls with recurrent urinary tract infections com¬
pared with levels for age matched controls (8).
Because there is no one bacterial strain or common
antigen to which protective antibodies have been shown
to be produced (9-12), total serum IgA and IgG levels
were determined for 2 groups of patients: a retrospective
study group, women who had been monitored for 20 yr
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by the pyelonephritis clinic; and a prospective study
group, women recently referred to the clinic for investiga¬
tion of recurrent UTI. We predicted that if non-secretors
were not able to produce an effective IgA response to
mucosal pathogens their total serum IgA would be lower
than that of secretors. Analysis of our results in the
context of severity of the disease and clinical improve¬
ment over 20 yr provided insights into the roles of both
innate factors and specific immune responses in the host's
defences against these infections. The implications of
these findings for further investigations of the patho¬
genesis of UTI are discussed.
Patients and Methods
Patients in tbe study had been referred to the Pyelonephritis Clinic.
City Hospital, Edinburgh for specialist investigation of recurrent
urinary tract infection. There were 2 groups: a retrospective group
consisting of 202 women who had been monitored for 20 yr by the
clinic and 100 patients selected from a prospective study group of 516
women referred during or after 1982 to the Pyelonephritis Unit for
investigation of recurrent UTI. The 100 women from the prospective
study were selected by age to compare the immunoglobulin levels of
women who had recently developed recurrent urinary tract infections
with those found for women who had these infections for a number of
years.
The records of 200 patients in the retrospecuve study were assessed
to determine diagnosis and clinical progress over 2 decades. Of these. 54
had renal scars as defined by pathological examination of nephrectomy
specimens (19 patients) or radiological evidence (35 patients). The
remainder had a history of recurrent symptomatic infections but no
radiological evidence of scarring. The mean age of the women with
renal scars was 50-5yr (range 23-74) and of the women without scars
54 yr (range 17-84). The differences in ages were not statistically
significant (13).
Improvement was defined as fewer episodes of infection in the second
decade of the study compared with the number in the first decade. No
improvement was defined as the same number or more infections in the
second decade. For the group with renal scars the mean number of
documented infections for 42 patients dunng the first decade was 5
(range 1-20) and for the second decade 2 5 (range 0—10). For the group
without renal scars the mean number of documented infections for 96
patients for the first decade was 4-6 (range 0-23) and for the second
decade 2-8 (range 0—35). The differences between the episodes of
infection per decade were 2-4 for the patients with renal scars and 1-8 for
those without scars (p < 0001 for both groupsl (13).
Secretor state was determined by the method described by Mollison
(14) and total serum IgA and IgG levels determined with NOR-
Partigen immunodiffusion plates (behring diagnostics). Data from
those patients between the ages of 23 and 64 were used in the analyses of
improvement and diagnostic category because the age range for which
the plates were standardized is 16-64. The results were expressed as
international units per ml and analyzed by X2 or Student's t-test.
Results
Secretor State of Patients in the Study
Compared with local controls (26-6%), there was
a significant increase in the incidence of non-secretors
(34-8%, p < 0-01) among the 718 women referred to the
clinic. This increase in non-secretors was found in both
the prospective and retrospective groups.
Table 1 Incidence of non-secretors among women referred for in¬
vestigation of recurrent urinary tract infection
So in each category
non-secretors
Category Total no. (*/.) X2 P
Total 718 250 34-8 705 <001
prospective group 516 172 33-3 4-26 <005
retrospective group 202 78 386 7 856 <001
without renal scars 146 53 36-6 4094 <005
with renal scars 54 23 42-6 5-006 <005
improved 127 47 37 4 264 <005
not unproved 50 20 40 3-186 OS.
no change 22 10 45-5 2-760 tLS.
Controls 334 89 26-6
Among the 202 patients in the retrospective study, 78
(38-6%) were non-secretors. This significantly increased
incidence of non-secretors was observed among the
women with renal scarring and those with no evidence of
scars (42-6% and 36-6% respectively) and those who had
improved over the 20 yr (37%). The remaining groups
showed a similar pattern, but the numbers were too small
to provide statistically significant differences (table 1).
Total Serum Immunoglobulin Levels
Contrary to our predictions based on the report of
Grundbacher (5), there were significantly higher levels
Table 2 Comparison of geometric means of total serum IgA and IgG
levels from secretors and non-secTetors in the different diagnostic
categories
IgA IgC





non-secretor 70 125-4 139-7
without renal scars




non-secretor 49 127-4 138-7
with renal scars










non-secretor 44 133-1 1407
not improved




non-secretor 16 113-3 133-8
no change
total 20 110 129-4
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Table 3 Comparison of geometric means of serum immunoglobulin levels between patients in the
retrospective and prospective studies
Geometric means ofserum immunoglobulin levels
IgA IgG
Patient category no. IV ml P no. lU/ml P
Total
retrospective 182 111-9 <0001 182 126-2 <0001
prospective 100 824 100 105-7
secretors
retrospecuve 111 103 <001 111 118 OS.
prospective 65 82-2 65 108
noo-secretors
retrospective 71 127-1 <0001 71 146 <0001
prospective 35 89-7 35 104
of IgA and also IgG among the non-secretors in the
retrospective study. This increase was observed in each of
the categories in Table 1 in which there was a significant
increase in the incidence of non-secretors (table 2). The
levels of immunoglobulins found among patients in the
prospective study were significantly lower than those
found for age-matched women in the retrospective study.
In the prospective study there were no significant dif¬
ferences in the levels of IgA or IgG of secretors and
non-secretors (table 3). Comparison of IgA and IgG
levels between these 2 groups by decade of birth is shown
in Table 4.
When immunoglobulin levels for the patients in the
Table 4 Comparison of geometric means of total serum [gA and IgG
of patients in retrospective study with those from women in the
prospective study matched by decade of birth
Retrospective Prospective
study study
Decade of IgA IgA
birth no. lU/ml no. IV ml P
1900-1910 7 133-3 4 131 ns.
1911-1920 30 107-9 11 108-1 n.s.
1921-1930 43 112-2 16 68 5 <00025
1931-1940 69 1107 23 811 <00125
1941-1950 17 109-6 23 75-7 <001
1951-1960 12 130-6 15 95-1 <001
1961-1970 3 87-1 9 69-7 DA
IgG IgG
IU/ml IU/ml P
1900-1910 7 103 4 1107 nj.
1911-1920 30 1205 11 113-5 nj.
1921-1930 43 127-1 16 101-4 <0025
1931-1940 70 125-9 23 105-7 <0025
1941-1950 17 137-4 23 107-4 <0005
1951-1960 11 132-1 15 102-1 <0025
1961-1970 3 158-1 9 109-9 HA.
retrospective study without renal scars were analyzed
with reference to improvement, there was a significant
difference between the IgA levels of secretors and non-
secretors who had improved; however, these differences
were not apparent for any of the other categories or for
IgG levels. The mean of the IgA levels for non-secretors
who had not improved (106 ILJ/ml) was lower than that
for non-secretors who had improved (136 IU/ml). When
analyzed by the Student's t-test, these differences were
just outside the 95% confidence limits (table 5).
Table 6 presents the means of the immunoglobulin
levels for patients with renal scars. For the non-secretors
who had improved, both IgA and IgG levels were signifi¬
cantly higher than those for secretors who had improved.
Among these patients who had not improved, the IgG
levels of secretors were significantly lower than those for
non-secretors. The IgA levels for secretors who had
improved (83-9 IU/ml) were lower than those for secre¬
tors who had not improved (128 9 IU/ml), but these
differences were just outside the 95% confidence limits.
Table 5 Comparison of geometric means of toial serum IgA and
IgG levels from secretors and non-secretors without renal scars with
reference to improvement over 20 vr
IgA IgG
Category So. lU/ml P lU/ml P





non-secretor 31 136 OO
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Table 6 Comparison of geometric means of total serum IgA and IgG
levels of secretors and non-secretors with renal scan with reference to
improvement over 20 yr
IgA IgG
Category No. IV, ml P lUml
improved 36 96-7 123-2
secreior 24 83 9
<001
109-1
non-secretor 12 128 5 156-9
not improved 8 136-3 104-3
secretor 5 128 9
na.
84 I
non-secretor 3 149-5 149-4
no change 4 88 8 130-8
secretor 0 — —
non-secretor 4 88 8 130-8




The differences between IgG values for secretors who had
improved and those who had not were not significant.
Discussion
The results refute our original hypothesis that the in¬
creased incidence of non-secretors among women with
recurrent UTI might be associated with an inability to
produce an IgA response as effectively as secretors. The
total serum IgA levels of the non-secretors in the retro¬
spective study were significantly higher than those for
secretors as were their IgG levels. These higher levels
of immunoglobulins were found for non-secretors regard¬
less of the presence or absence of renal scars. The raised
levels of these antibodies among non-secretor patients
who had improved suggests that non-secretors are more
dependent on their specific immune responses for pro¬
tection against these infections.
The IgA and IgG levels of women recently referred to
the clinic were significantly lower than those of patients
of similar ages in the retrospective group (table 3). There
were no significant differences in either IgA or IgG levels
of the secretors and non-secretors in the prospective
study group. If initial IgA levels of non-secretors were
lower than secretors as suggested by Grundbacher (5),
these results might be due to responses to the antigenic
stimuli of their infecting strains. Any initial differences in
immunoglobulin levels are not found by the time these
women have suffered enough episodes of UTI to be
referred for specialist investigation.
Regardless of age of onset or therapy prescribed, the
majority of the women followed for 20 yr by the clinic
had fewer episodes of infection during the second decade.
This occurred in women who had begun to have symp¬
toms at a very early age as well as those whose problems
began with the onset of sexual activity. The decrease in
the numbers of infectious episodes was not associated
solely with a decrease in frequency of intercourse. This
suggested a self-immunization phenomenon. Comparison
of the total serum IgA and IgG levels of the women in the
retrospective study with those found for women of the
same ages recently referred to the clinic supported this
hypothesis (tables 3,4). The significantly higher levels of
total serum IgA and IgG among the retrospective group
suggests that antibody response might play a part in
controlling recurrent infections. A significant correlation
between the levels of anti-candida IgA and IgG in serum
and cervico-vaginal secretions has been reported (15). If
similar responses to infecting strains of £. coli are
elicited, the increased levels of serum IgA and IgG might
reflect increased levels of these antibodies in body fluids
and secretions.
When the immunoglobulin levels were examined with
reference to improvement, the pattern for patients with¬
out renal scars differed from that observed for those
with scarring. Among patients without scars, the only
significant difference found between secretors and non-
secretors was an increase in the total serum IgA levels of
non-secretors who had improved. These findings appear
to parallel those of the association between the decreased
incidence of carnage of C. albicans with high levels
of specific anti-candida serum IgA. Our next step in
elucidation of protective immune response to UTI is
identification of the antigen(s) that have elicited these IgA
antibodies in the sera of women who have improved.
Among women with scars who had improved, there
was a similar significant difference in total IgA in the sera
of non-secretors compared with secretors. Non-secretors
in this category also had higher levels of IgG. Among
the patients with scars who had not improved, there was
an intriguing difference in the levels of IgG found for
secretors and non-secretors. Although the numbers of
patients were small, the IgG levels of 4 of the 5 secretors
were significantly lower than those for the non-secretors
in the study and unusually low compared with the
reported mean for central Europeans (16), 144IU/ml:
74-8, 70-5, 63-8 and 80-5 IU/ml.
A recent report described lung injury mediated by
reactive oxygen radicals produced by tissue macrophages
that had bound immune complexes containing IgA (17).
There is a significant increase in the incidence of non-
secretors among children who develop renal scarring as a
result of recurrent urinary tract infections. If the immune
responses in children parallel those we have observed in
adults, the following scheme might partly explain the
association between non-secretion and formation of renal
scars in children.
The uroepithelial cells of non-secretors have been
shown to bind significantly higher numbers of uropatho-
genic bacteria than secretors (18). If this increases the
probability of colonization the following interactions
might occur. In the non-immune non-secretor the in¬
fection would be countered only by the inflammatory
136 blackwell et al.
'
.esponse. This might result in tissue damage if the
organism reached the kidney. There is evidence that IgA
is produced locally in the lower urinary tract in response
to infecting bacteria. Secretory IgA appeared in the urine
of some children with pyelonephritis and most of the
patients with cystitis before antibodies were detected in
the serum (19). If complexes of bacteria and IgA were to
be formed in the kidney, these might induce tissue
damage by mechanisms analogous to those reported in
the lung (17). High levels of IgG antibodies are also found
in the urine and a similar mechanism for tissue damage
mediated by IgG immune complexes and polymorpho¬
nuclear leukocytes has been reported (20).
In conclusion, our results indicate that the increased
incidence of non-secretors among patients with recurrent
UTI is not associated with an inability to produce an
effective humoral response. Non-secretors appear to be
more dependent than secretors on their specific immune
responses for defence against recurrent UTI because the
non-specific protection associated with the secretor gene
is absent. The results also suggest an approach to defining
the antigens that elicit a protective response in women
with recurrent infections and an approach to investiga¬
tion of the pathogenesis of kidney scarring.
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Abstract
Gram negative bacteria precipitate reactive arthritis and may be
concerned in the pathogenesis of ankylosing spondylitis and
other spondyloarthropathies. Susceptibility to many infections
agents is associated with ABO blood group or secretor state, or
both. The distribution of the ABO blood group or secretor state,
or both, was therefore determined in 87 patients with ankylosing
spondylitis and 32 with other forms of spondyloarthropathy.
The prevalence of non-secretors was significantly increased in
the total patient group (54/114; 47%) and in the subgroup with
ankylosing spondylitis (41/84; 49%) compared with local controls
(89/334; 27%) (p<0-00l). Other subgroups of patients showed a
similarly increased prevalence of non-secretion (33-47%). The
distribution of ABO blood groups did not differ between patients
and controls.
The association between non-secretor state and ankylosing
spondylitis strengthens the hypothesis that ankylosing spondy¬
litis is a form of reactive arthritis. It also suggests several
pathogenic mechanisms which may be relevant to the initial host-
parasite interaction in ankylosing spondylitis.
Introduction
An infectious aetiology for ankylosing spondylitis has been
postulated on several occasions, and many workers consider this
disease to be a form of reactive arthricis. : The hypothesis chat the
aetiology of ankylosing spondylitis is related to the gut is based on
the abnormalities of the bowel that occur in other spondyloarthro¬
pathies' and on inaiogy with the reacuve arthritis that may occur
after gascrointesunai infection.' These associations suggest
that Gram negative bacteria actiag at the gut mucosal surface
may be important in the pathogenesis of ankylosing spondylitis.
Investigators have examined the role of faecal klebsieila1"" and the
interaction of these and similar organisms with HLA-827,'* but no
clear relation among enterobacteria, HLA-B27, and ankylosing
spondylitis has emerged. It may therefore be pertinent to consider
aspects of the host-parasite relation other than HLA-B27, and in
particular those host factors associated with infection by Gram
aegacive bacteria.
Blood group specificities of the ABO system are genetically
determined, stable host characteristics which have been associated
with susceptibility to some infectious diseases. The prevalence
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of blood group 0 is increased in patients with typhoid," para¬
typhoid," and cholen'1; group B is increased in pacieats with
gonorrhoea,'1 chlamydial infections (unpublished observations),
urinary tract infection caused by Escherichia coii,'' and in children
with Gram aegacive enteric infections"; and there are reports
of an increased prevalence of group A among patients with
meningococcal meningitis." By contrast, a normal distribution of
blood groups is found among patients with diphtheria, brucellar
infections, and whooping cough. * At least two infections associated
with an increased prevalence of the B blood group, gonorrhoea and
chlamydia, may precipitate reactive arthritis.4
A second genetically controlled host characteristic which has
been associated with suscepcibility to infection is the inability to
secrete the water soluble glycoprotein forms of the ABO blood
group antigens. The prevalence of aon-secretors is increased among
patients with cholera," urinary tract infection caused by E coii, '
candidiasis," meningococcal meningitis," and pneumococcal
infections," but not among those with tuberculosis," leprosy, * or
gonorrhoea." Though only a few studies have been reported, a
pattern is emerging of an association berween oon-secretion ofblood
group antigens and susceptibility to infections of the mucosal
surfaces.
These observations led us to examine che hypothesis that there
would be an increased prevalence of blood group B or non-secretor
state, or both, among patients with ankylosing spondylitis and other
spondyloarthropathies. As concentrations of IgA (the immuno-
globalin associated with protection ofmucosal surfaces) are raised in
ankylosing spondylitis,"' and reportedly influenced by secretor
state,"" we have also determined IgA concentrations in the serum
and saliva of our patients.
Patients and methods
We studied 119 patients with clinically well denned spondylarthrites
selected at random from die populauoa attending outpauent clinics at the
rheumatic diseases unit of the Northern General Hospital over two years.
Patients were classified into four categories according to their medical
history: ankylosing spondylitis (87 patients), reacuve arthritis (22),
and radiological sacroiiiids (with or without ankylosing spondylitis)
(a) associated with inflammatory bowel disease (three pacients) or
(4) associated with psoriasis (seven patients). Patients with ankylosing
spondylitis fulfilled the New York criteria," and those with reacuve arthritis
fulfilled criteria for definite Reiter's disease" (14 patients) or posunfective
reacuve arthritis14 (eight patients).
When possible pauents' records were analysed for HLA state (55 patients)
and for a history of ocular inflammation (101) or inflammatory arthritis of
peripheral joints (100). A single sample of venous blood and saliva was
collected from each of 113 pauents. A further five patients provided blood
but no saliva, and one provided saliva only.
ABO Blood group was determined in 118 paoents by agglutination of red
cells with appropriate an users. Secretor sate wis determined in 114 patients
by the haemagglutinatioo inhibition assay using saliva, as described.°
Controls were 334 randomly selected normal people attending the Edin¬
burgh blood donor centre during 1981." IgA Concentrations in samples of
scrum (98 patients) and saliva (97) which had been stored at -20*C were
determined by single radial immunodiffusion with commercially prepared
plates (Behring Diagnostic, Hounsiow).
Statistical analyses were by j* test, using Yates's correction for continuity
in fourfold tables. Relative risk (odds raoo) was calculated by simple
proportion. Ninety five per cent confidence limits for relative risk were
calculated using natural logarithm-conversion.
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Results
Tibles I and II show the distribution of ABO blood group and secretor
state tn the patients and controls. There was a significant increase (p<0 001)
in die proportion of non-secretors in the total patient group (54/114; 47%)
compared with the local control population (89/3 J-*; 27%). The relative risk
for spondyloarthropathy in aon-secretors wis 2 5 (95% confidence internl
1-6-3 8). The increase in non-secretors was evident in all subgroups of
patients and achieved statistical significance (p<Q'00l) in both the total
groap with sacrotliitis (4697; 47%>— that is, ail patients with radiological
sacroileitis irrespective of disease category—and the group with ankylosing
spondylitis (41/84; 49%). Nine out of 20 patients with reactive arthritis
Discussion
Secrecioa ol blood group antigens into body fluids is a dominant,
genetically determined characteristic. Roughly 25% of people
throughout the world are recessive for the secretor (St) gene,
genotype sr.se, chough the proportion varies in some populations.*
Our control group shows that the local populatioa had a proportion
of non-secretors similar to but slightly higher than the expected
frequency, as is usual among populations of Celtic origin.
This study found a significantly increased prevalence of noo-
secretors of blood group antigens among pacients with spondylo-
tajliI—Ous-iBunen ofABO blood /roup amonf patients auk spandyloartkrapaikia
So(%) with Mood group
NO
toted 0 A 1 A3 ri ? octroi 9
Control population 134 171(52) 104(31) 42(13) 13 (4)
Tool peoent froup III 49(42) 47(40) 17(14) 5 (4) 143 >0-10
Tool froup with sacrotlijaa* 49 41(41) 39(34) 14(14) 5 (5) 1 44 >0-10
AAkykssuf ipoodvlicis 14 15(41) 14 f 40) 13(15) 4 (5) 3 51 >0-10
Reactive arthntii 22 10(45) 1(14) 4(11) 0 StA
SdcroUiiOj iiK.Jiri -nth utAaiiunatory bowel disease 1 1(11) 2(47) 0 0 StA
Sacrotliios associated with psoriasis 7 1(45) 1(41) 0 1(14) StA
X/A» Sot applicable.
*.AU pencasts with radioiofieaJ sacrotliini irrespective of disease eatefory
TAILS 1I—Secretor uau ofpatuna unth tpondyloartkropatkies
So So (%) of Relative nik
tested ■aon-seitretors j- s cootrol 9 (95% cwisdeoce interval)
Cootrol population 134 19 127)
Tsui pauent (roup 114 54(47) 15 15 <0-001 2-5(1-61-1)
Total froup with ncrotliios* 97 •4(47) 14-11 <0-001 21(15-4-2)
Aokytosmf spondylitis 14 41 (49) 14)7 <0-00! 2-4(1 5-a«)
Reaca*e arthnui 20 9(45) 2-12 X3-10 2-3(0-7.70)
Sacrodsius associated with LoAam.rulory bowel disease 1 1(31) StA
Sacrouiius associated with psoriasis 7 1(41) StA
NtA - Not applicable.
'All palxncs with radjolopcal sacrotliius irrespective of disease category
"(45%) and three out of seven with sacroiliius associated with psoriasis (43%)
were non-secrecors, proportions similar to that in the group with ankylosing
spondylitis.
There was no evidence that the distribution of ABO blood group among
the patrencs was different from that among local controls (p>0-10), and in
parucuLar no evidence of an increased prevalence of blood group B. The
blood group distribution was similar in each disease category.
Analysis of IgA concentrations and clinical features in the total patient
group showed few differences between set re ion and non-secretors. There
was no evidence of differences in serum or salivary IgA concentrations
between the two groups (table LII); eye lesions were more common among
tajli [ii—Secrttor uau and ftometrv mean IfA concentrations (SD ui parentheses)
oi patients uruk spondyloarthropathies. Values art IV!ml
Scrum IfA Salivary IfA
Sccrvtor-i (o — 51 serum. 50 salivary) 174 1(1-5) 4-3(11)
Noo-secreeoo (a-l7 serum, 47 salivary) 172-4(19) 4-1(1-7)
ooo-secretocs(17/4g; 35%) than secretors(l 1/53; 21%), but not significantly
so; peripheral joint disease was less common among noo-secretors
(24/47; 51%) than secretors (35/53; 66%), but again the difference was not
tigmfiranr
Data oc HLA typing were available for 55 patients; 50 were B27 posiave
and five B27 negative. Three of the B27 negative patients were aoo-secretors
and two were secretors.
arthropathies. There are several possible explanations. The gene for
secretion may be linked to another which affects susceptibility to
disease or immune respoosiveness; the product of the St gene may
modify antigens on cells of host or parasite; or blood group antigens
may themselves be important in determining susceptibility to these
diseases.
Family studies of ankylosing spondylitis and reactive arthritis
show chat genetic determinants additional to HLA-B27 are neces¬
sary for the development of these diseases.3 " It has been suggested
that such additional genes are concerned with the functioning of the
immune system, and it is therefore tempting to speculate that there
is a genetic link between secretor state and immune responsiveness.
There is evidence that the St gene forms pan of a linkage group on
chromosome 19 with complement component C3, but this is the
only known immunological function coded for nearby; genes coding
for HLA and most other immune determinants are on chromo¬
some 6.3 A single report that salivary IgA concentrations are
reduced in noa-secretor adults'1 suggests that IgA deficiency may be
responsible for increased susceptibility to infection in aon-
secretors, which irr turn might predispose to reactive arthritis and
spondylarthritis. Our data do not support such, a hypothesis. Our
studies suggest that oon-secretion increases the relative risk for
ankylosing spondylitis and reactive arthritis, albeit only twofold to
threefold. Hence the gene determining secretor state is possibly in
icself a subsidiary determinant for these diseases. Family studies
will be required to assess the combined relative risk of being
HLA-827 positive and the oon-secretor genotype st^st.
The biological role of the St gene is not clear, but there is
biochemical evidence chat Se is a structural gene encoding a specific
fucosy!transferase. At least r*o such enzymes are concerned with
che synthesis of blood group specificities, adding fucose residues to
one of several types of precursor chain. Evidence suggests that the
5« gene product preferentially uses the type I chain as substrate."
Possibly this enzyme glycosylates other structures such as HLA or
other cell surface antigens, or even antigens on invading micro¬
organisms. Any such modification of antigens on host tissue or
infecting agent might affect the balance of the inioai host-parasite
interaction.
The differences between secreton and ooo-secretors are
related to the antigens present in their body fluids. With the
exception of the extremely rare Bombay phenocype, all secreton
have the water soluble form of the H antigen (the antigen of blood
group 0), and the 94% who possess the Lewis blood group gene
have Le' antigen. People of the appropriate blood groups will also
secrete water soluble forms of the A and B antigens. Noo-secreton
do not have A, B, H, or Le' anrigeas in their body fluids, but the
94% with the Lewis gene have a different form of the Lewis antigen,
Le*. ABH antigens occur in two forms, a glycolipid which forms
part of che structure of a ceil and a glycoprotein which is found in
body fluids. Lewis antigens occur as glycolipids in the plasma and as
glycoproteins in secretions; they do not form pan of the structure of
cells but are passively adsorbed to cell surfaces.
Much epidemiological evidence suggests that ankylosing
spondylitis and reactive arthritis occur in genetically predisposed
subjects after exposure to micro-organisms. Finding an associauon
between secretor state and spondyloarthropathies suggests a
possible role for blood group antigens in these diseases. Non-
secrecion appears to be a marker associated with infections of the
mucosal surfaces""" and may be important in the colonisation
stages of an infectious process. We suggest two models to explain
the increased suscepcbilicv of noa-secretors to initial infection; Le"
in the body fluids of non-secretors may act as a receptor for infecting
micro-organisms; or H or Le*, or both, in the body fluids of
secretors may inhibit the attachment of organisms. These two
mechanisms are not mutually exclusive. It is unlikely that water
soluble forms of the A and B antigens play a part in the
spondyloarthropathies, as our studies showed no association
between these blood groups and ankylosing spondylitis or reactive
arthritis.
There is at present little direct evidence that the ABO or Lewis
blood groups act as receptors for micro-organisms. Nevertheless,
antigens of other blood group systems do act in this way," a and
recent work from our laboratory has identified the Le" antigen as a
receptor for certain strains of Candida." Indirect evidence for a
receptor role for these antigens comes from finding that £ coli binds
in greater numbers to non-secretor than secretor cells," and from
studies showing that attachment of micro-organisms may be
inhibited by glycocompounds in body secretioos."" Experiments
are under way in our laboratory to see whether any of these
mechanisms are operative in the interaction of arthritogenic Gram
negative bacteria with secretor and aon-secretor cells of patients
with ankylosing spondylitis and controls.
Finding chat non-secrecion is associated with ankylosing
spondylitis and reactive arthritis, together with the accumulating
evidence of an association between non-secretion and mucosal
surface infections, strengthens the hypothesis that ankylosing
spondylitis is a form of reactive arthritis.
Though the increased relative risk for spondylarthritis associated
with non-secretion is less than that associated with HLA-B27,
noa-secretkm is nevertheless a host susceptibility factor for these
diseases. Moreover, it may be particularly important in poinaog the
way to our understanding of the pathogenetic mechanisms in the
initiation of disease in susceptible people.
This work wis supported by « proiec: |rant from the Arthr.us and
Rheumatism Council. We thank che Edinburgh and South East Scotland
Bleed Transfusion Service for esse.iual reagents and Dr R Prescott, of the
University of Edinburgh, for sutisricai ad vice We also thank .Hn M Cole
for help in preparing the manuscript.
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LIPOPOLYSACCHARIDE STRUCTURE AND SERUM
SENSITIVITY OF NON-SEROGROUPABLE NEISSERIA
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SUMMARY Bactericidal activities of normal human serum
for non-serogroupable strains of Neisseria meningitidis were
determined. In similar experiments with isolates of Neisseria
gonorrhoeae from localized infections, strains with group I
lipopolysaccharide (LPS) were uniformly serum resistant and
those with group II were serum sensitive. We found no similar
association between serum sensitivity of the meningococcal
strains and their lipopolysaccharide groups determined by the
same pyocin typing system used to classify the gonococcal
isolates.
Immune mouse sera raised against non-serogroupable
meningococci of either LPS group I or II were bactericidal for
non-serogroupable strains of the same LPS group and also
cross-reactive for strains of the opposite group. They were not
bactericidal for the majority (13/17) of the serogroupable strains
tested.
These findings suggest there are antigens, in addition to the
LPS and capsules, that elicit some of the "natural" bactericidal
antibodies to pathogenic meningococci
Key words: Serum sensitivity, meningococci, lipopolysaccharide,
natural antibodies
Introduction
In studies on host-parasite interactions influencing
gonococcal infection, killing of N. gonorrhoeae by normal
human serum depended on the lipopolysaccharide (LPS)
structure of the bacteria. A pyocin typing scheme divided
strains into 2 major groups. Group I strains, those with a
"simple" LPS, were inhibited only by pyocins of the R5
class as defined by Kageyama (1); group II strains, those
with a "complex" LPS, were inhibited by pyocins of the
R5 class and by pyocins of the R1 class. The group I
strains were uniformly resistant to the bactericidal
activity of normal human serum while those of group II
were serum-sensitive. Immune mouse sera raised against
either group I or group II organisms were bactericidal for
other strains of the same group and also cross-reactive for
strains of the opposite group (2).
LPS is the target antigen for "natural" bactericidal
antibodies against gonococci in normal human serum
(NHS) and a correlation between the presence of
bactericidal antibodies and immunity to meningococcal
disease has long been established (3). Development of
Correspondence: Dr. C. C. Blackwell, Department of Bacteriology,
University of Edinburgh, Medical School, Teviot Place, Edinburgh
EH8 9AG, UK-
antibodies to pathogenic strains of meningococci has
been associated with carriage of the usually non¬
pathogenic, non-serogroupable strains of the organism
(4,5). Previously we divided non-serogroupable strains of
N. meningitidis into the same 2 groups as the gonococci
with the pyocin typing system (6). In this study sera from
the same population tested for bactericidal activity to
gonococci were screened to determine if there was a
similar correlation between LPS structure and suscepti¬
bility to "natural" antibodies for non-serogroupable
meningococci.
The bactericidal activity of antisera produced by mice
inoculated with non-serogroupable meningococci of
group I or group II was examined to test the hypothesis
that these might be responsible for induction of
bactericidal antibodies to serogroupable strains.
Materials and Methods
Bacterial Strains
Non-serogroupable strains of N. meningitidis were obtained from Dr.
J. Etienne and Professor J.-P. Albert, Centre Collabrateur, OMS de
Reference et de Recherche pour les Meningococques, Marseille-Armees,
France and Dr. R. J. Fallon, Ruchill Hospital, Glasgow; 5 group I
strains, 6 group II strains and 6 strains resistant to all the pyocins in the
typing scheme. Those strains with PA before the number were polyag-
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following serogroaps were also included: (number in brackets is the
number of strains tested); A (1), B (6\ C (3), D (1), W135 (4), Y (1), Z (2).
Each conformed to the morphological and biochemical characteristics
of N. meningitidis.
Culture
Strains were cultured on Modified New York City (MNYC) medium
(7) at 37*C in a humidified atmosphere enriched with 10% CO,.
Pyocin Typing
Strains of non-serogroupable meningococci were divided into group
I, group II or pyocin resistant categories by the pyocin typing method
described previously (6,8).
Preparation of Immunizing Antigens and Immunization Schedule
Immune mouse sera to isolates of group I (42619-4) or group II (1419)
were produced as described for gonococcal strains (2).
Complement
Human serum from a blood group AB donor with no history of
gonococcal infection was absorbed at 4"C with a live suspension of a
"cocktail" of the serogroupable strains and the non-serogroupable
strains of group I or group II used to immunize the mice. After 4 hours
the bacteria were removed by centrifugation and the serum was
absorbed a second time overnight. The absorbed serum was distributed
in 1ml aliquots and stored at — 20*C before use. It contained no
bactericidal activity for the strains tested and the minimum haemolytic
titre of the serum was 32-64.
Normal Human Serum from Women ofBlood Croups A and B
These were obtained from women attending post-natal clinics and
kindly supplied by Dr. S. Urbaniak and Dr. P. L. Yap of the Blood
Transfusion Service, Royal Infirmary, Edinburgh (RIE). They were
heated to 56"C for 30 min and stored at — 20'C.
Table 1 Frequency distribution of titres of normal human serum bactericidal activity against strains of N.
meningitidis
No. sera with bactericidal activity
(log titre)
No. sera <0-6 0-6 0-9 1-2 i-5 1-8 21 2-6
Non-serogroupable strains
LPS group I
PA 1190 36 5 7 1 1 7 4 6 5
NA 935113 31 2 15 0 0 2 4 4 4
42619-4 16 0 5 0 1 0 3 1 6
PA 477 33 4 19 1 1 1 2 3 2
LPS group II
1419 32 3 5 1 0 4 3 10 6
PA 469 30 5 5 0 0 0 1 9 10
0452 25 0 0 0 1 0 0 18 6
14795 30 . 4 2 4 11 5 3 1 0
Pyocin resistant
PA 846 32 9 3 4 3 4 9 0 0
PA 520 31 0 9 0 1 0 0 0 21
Serogroupable strains
ref A 29 8 1 3 1 8 4 3 1
refY 32 32 0 0 0 0 0 0 0
W 135 16 6 1 4 3 2 0 0 0
1 UVJV —- — —^ pi'-» IUUOIJ I —1 IIV. Ill ^ 11V.JI,
serum dilution to give a reduction in viable count > 80% compared with
the controls was taken as the bactericidal titre of the serum. The small
quantities of human sera available allowed only one titration to be
made against each strain. Control positive sera were included for each
test to ensure the experimental system was functioning correctly. The
mouse sera were tested 3 times.
Bactericidal Assay with Immune Mouse Serum
These were performed as described previously with heat inactivated
immune mouse serum and freshly-thawed, absorbed human AB serum
as the complement source (2). A reduction in viable count > 80%




"Normal human sera" from 48 women of blood groups
A and B attending a postnatal clinic were screened for
bactericidal activity against meningococci. This popu¬
lation had a very low incidence of gonorrhoea and was
used in the previous study to determine the presence of
"natural" bactericidal antibodies to N. gonorrhoeae.
Results for non-serogroupable and serogroupable
isolates are shown in Table 1. There was no clear cut
pattern such as that observed for gonococci. Regardless
of LPS type, bactericidal activity was observed for each of
the non-serogroupable strains, serogroups A and W135,
but none was found against Y. The distributions of titres
for sera of blood groups A and B against each serum
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Table 2 Sensitivity of non-serogroupable isolates of N. meningitidis to
mouse antisera raised against non-serogroupable meningococci with
group I or group II LPS




NA 935113 + +





NA 0352 0 0




PA 846 + 0
PA 520 + +
NA 499 + +
NA 879 + +
76/15373 0 0
NA 1784 0 0
-I- = > 80% decrease in viable count of control.
0 = no significant bactericidal activity.
* strain used as immunogen.
sensitive strain were compared by the Mann-Whitney li¬
test. No significant differences were observed in a one-
tailed test at a probability level of 0-025.
Immune Mouse Antibodies
Mouse antisera raised against non-serogroupable
strains of either group I or II meningococci were
bactericidal for a number of non-groupable strains (Table
2). The majority of serogroupable strains (13/17) were not
killed by either mouse serum. Each of the strains of
serogroups A, B, C and D were resistant to both antisera.
Both 29E strains were sensitive to these antisera as were
2 of the 4 W135 strains.
Discussion
Schneider and co-workers (9) reported that resistance of
gonococci to NHS was due to the lack of an LPS
determinant that binds "natural" antibody. Our previous
study suggested that among isolates from localized'
infections this antigen is found on serum sensitive strains
with a "complex" LPS (group II) but not on those serum
resistant ones with a "simple" LPS (group I) (2). We also
found that induction of phenotypic serum resistance was
correlated with a change from group II to group I LPS
(10). This alteration in LPS structure has since been
confirmed (11). We did not observe this pattern of serum
sensitivity among non-serogroupable strains of
meningococci divided into group I and group II by the
same pyocin typing method used for gonococci.
Experiments with mouse antisera suggest that
bactericidal antibodies can be induced by non-
serogroupable strains of meningococci of LPS group I or
group II. As with the mouse antisera produced against
group I and group II gonococci (2), cross reactions
among strains from both LPS groups were found (Table
2). Since the LPS is one of the principal target antigens
for bactericidal antibody, it was predicted that specific
antibodies produced against non-serogroupable strains
might be effective against serogroupable capsulate ones.
The results obtained are evidence against this hypothesis;
there was no bactericidal activity against strains of sero¬
groups A, B, C or D. Both strains of group 29E were
sensitive to these sera. These results are similar to those
reported by Craven et al. (12), each of their four 29E
strains were serum sensitive. The sensitivity of the two W135
strains might be due to a decrease of capsular material
following subculture resulting in the underlying LPS
being more accessible to the antibodies. Pyocin typing
data suggests that the LPS of non-serogroupable strains
is more accessible; 66% of non-serogroupable strains
tested were sensitive to pyocins compared to only 11% of
serogroupable strains (6). In contrast, other workers (12)
were unable to correlate serum sensitivity with quantities
of extractable group B polysaccharide.
These findings suggest, as do those of Craven et al. (12)
that induction of "natural" bactericidal antibodies to
pathogenic meningococci is dependent on the host's
response to more than one group of antigens. Additional
evidence for this comes from one of our earlier studies. It
had been predicted that since the LPS of gonococci and
meningococci are structurally similar (13), gonococcal
infection might act as a stimulus for bactericidal anti¬
bodies against N. meningitidis. Sera from patients with
meningococcal infection have been found to have
increased levels of bactericidal antibodies to serum
sensitive gonococci (14). There were however decreases in
the titre of antibodies in the sera of patients with
gonorrhoea against serogroups A, B and C but not
against non-serogroupable strains (15).
These findings suggest the presence of antigens, in
addition to those of the LPS and capsules, common to
both gonococci and meningococci, that are responsible
for induction of some of the "natural" bactericidal anti¬
bodies that protect the host from meningococcal disease.
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Tili< study has shown that urucnpcyiine and several related
tricyclic aaadepressaacs have higher fatal toxicicy indices rhan the
monoamine oxidase inhibitors, which are in turn more toxic than
several newer antidepressants. Ail of the drugs introduced since
1973 have a favourable toxicicy pronle except maprociline. If the
newer drugs have as good a record of diniral effectiveness,
combined wich their apparent lower potential to cause fatal
poisoning when taken in overdose, serious consideration should be
given to preferentially prescribing the newer drugs, especially to
patients who are considered ic particular risk of nnade by ingestioa
of an overdose of their mediaDon.
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SHORT REPORTS
Secretor state of patients with insulin
dependent or non-insulin-dependent
diabetes mellitus
The inability to secrete the water soluble glycoprotein form of the ABO
stood group anagens is associated with increased susceptibility to several
ruecuoos, particularly among children in the vuineraole period between
osrng maternal anubodies and developing their own active immunity.' This
s a characcensoc that does aot alter with age or environmental influences.
The secretor (Si) gene is located oo chromosome 19; it is not linked »sex
<t to the histocompatibility locus antigen (HLA) markers. We have also
ound a considerable increase in the proportion of noa-secretors (u) among
aueats who have ankylosing spondylitis, a rheumatic condition that has a
lose association (about 95% of cases) with the HLA B27 marker aad for
rhich an mfecbous aetiology has been postulated.' As viral infections have
een suggested to contribute to the development of type I diabetes,' a recent
Patients, methods, aad results
During six weeks 205 diabebe pa beau were examined (102 insulin dependent
(5b men and *6 women); 103 aoo-insuiln-dependent (60 men and 63 women)).
The patients were recruited from those attending routine eiimcs; the first five to
12 patients ax each sessioa were asked to parucpatc. None of the paoenu was
aomiaed to hospital. Paocats who had type I disease were classified by insulin
dependence, their tiinral history, and family history of the disrate The paoenu
who had type 0 disrate were aot dependent on insuiin.
The ABO and Lewis Mood group* were determined by aggjutmaooo and the
secretor state by the haemaggiuanaooa inhibiooa method* from saliva. The
Lewis group was used to coofira the resulu ootained from the saliva sample. The
resulu wen compared with those found for local Mood donors by x* tost.
There was oo significant difference m the distribuuoo of the ABO Mood groups
between the insuiin dependent and ooo-insuiin-dependent diabetic paoenu
(ri"Q"59Il, df-3, p>0*50), and the resulu were similar to chose found for local
blood donors (type I: df»3, p>0-lO; type Q: r"l'7fi6, df-3,
pX)-50). Among the pataenu who had type Q disrav there was no significant
difference m the proporooo of aoo-secrctors (25%) compared with the concrou.
Among the paoeau who had type I disease the proportion of ooo-secreton was
ngnifirandy increased (40%) 223, p<0*02) (taMe).
Blood [roup ad ucrtur aau ofpatina auk typi I and typa II tiiobitrt mitBoa, AHfifms art inanhwi (ptrwuafa) ofparwm
ABO blood graup Soermr
ABO AB Soavtor (Si) Noe-wcmor (w) SgmVinnr
Ovsbcoc psococc
Type I (a-102) 33(34) 1101) 3«(5S) U(W> 41(60) p<»d2
Type Q (a-103) 37(36) 11(11) 53(31) 2(2) 77(73) 26(23) N5
Controls (a-134) 104(31) *2(13) 173(32) 13(4) 243(71) »C27)
icorui oa the genetics of dais disorder* prompted us to compare die
sretoc state ofpatients who have type I disease with chose *rfao have type II
wane. If (here were a panBd srith ankylosing spoodylicis we predkted chat
st would be l higher proportion of aoo-section among the patients who
1 type I diabetes.
Comma*
Among tbe patients studied there were probably Hiniral and genetic
heterogeneities within the insulin dependent and noo-snsniin-dependent
groups; secret* state, however, is an arUiriontl, easily determined genetic
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marker that can be used further to investigate differences in the two main
aetiological types of diabetes.
The parallel of our results for type I diabetes with those for ankylosing
spondylitis is striking. In both there are strong associations with particular
HLA markers and a significant increase in the proportion of non-sccretors.
This is further indirect evidence to support the suggestion that an infectious
agent is implicated in the initiation of type I diabetes in some genetically
predisposed patients. Determining the secretor state of patients who have
various viral infections would be a useful first step in investigating this
hypothesis. We suggest that the initial susceptibility to some viral infections
might be greater in the non-immune, non-secretor host. The specific
immune response to the putative infectious agent, controlled by the class II
HLA DR3/4 genes, might contribute to pathogenic sequelae leading to the
diabetic state.
We are grateful to Dr A E Mourant for helpful discussions and to the
Edinburgh and South East Scotland Blood Transfusion Service for reagents used
in the study.
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Quality of haemofiltration fluids:
a potential cause of severe electrolyte
imbalance
Haemofiltration, which requires the infusion of large amounts of electrolyte
replacement solutions, is finding increasing application in general hospitals.
These solutions do not have a product licence, so responsibility for their
quality, safety, and efficacy is taken by the prescriber. We report a case in
which the wide limits ofquality control of a solution had clinical implications
and discuss a survey of the limits of quality control of some commonly used
haemofiltration fluids.
Patient, method, and results
A 73 year old woman was admitted to hospital because of worsening
breathlessness and peripheral oedema. She had a history of two mitral valve
replacements nine years and two months previously. The clinical findings were
severe tricuspid regurgitation with competent aortic and mitral valves. She
progressively gained weight in hospital despite diuretics and infusion of
dopamine. We decided to perform further tricuspid valve surgery, and to
improve her clinical state haemofiltration was performed for 48 hours before
surgery.
She underwent venovenous haemofiltration with a BSM-22 (Hospal UK), with
vascular access through a right internal jugular haemofiltration catheter; a Biospal
SCU/CAVH filter was used. About 16 litres of haemofiltrate was obtained on
each day, with a negative balance of four litres. Fluid replacement through the
BSM-22 was with Hemofiltrasol-21, with 8 mmol potassium chloride added to
each three litre bag. In addition, she also received two units of human plasma
protein fraction for the first 24 hours, 20% mannitol 100 ml intravenously twice
and frusemide 80 mg intravenously once in the second 24 hours, and spirono¬
lactone 100 mg once daily.
Her clinical state improved. To our surprise her plasma sodium concentration
decreased progressively from 138 mmol/1 at the start of the procedure to 133
mmol/1 after 48 hours of haemofiltration. Forty eight hours after haemofiltration
had stopped her plasma sodium concentration remained at 134 mmol/1. Blood
glucose concentration rose from 5 2 mmol/1 (random level) before treatment to
8 4 mmoil during haemofiltration. The plasma potassium concentration,
supplemented as described above, remained at 3 8 mmol/1. The serum calcium
concentration rose from 2 37 mmol/1 to 2 60 mmol/1. "There was no appreciable
change in the magnesium concentration.
VCe were surprised by the progressive decrease in plasma sodium concentration
during haemofiltration. The Hemofiltrasol-21 bag quoted the sodium concentra¬
tion as being 140 mmol/1. When a sample of this was analysed on the same flame
photometer as the plasma it was found to contain 133 mmol sodium/1. This
was confirmed in two other bags of the same batch.
The sodium concentration of 133 mmol/1 is within the limits of quality control
of Hemofiltrasol-21. We therefore investigated the limits of quality control fluids
from four suppliers in this country. The limits varied widely between manu¬
facturers—for example, the limits of quality control for sodium with one
manufacturer were +3% to -3%, while with another they were +5% to -7%.
Those of magnesium were +5% to -5% with one manufacturer and +13% to
-13% with another. The table shows the stated concentration and the limits of
some ions.
Concentration (rrtmoll) of some common ions in haemofiltration fluids (figures in
parentheses are limits ofquality control)
Supplier Sodium Calcium Magnesium Chloride
1 142 (138-146) 2 00(1 90-2 10) 0-75 (0-71-0-79) 103 0 (98 0-108 0)
2 140(130-147) 1 60(1 40-1 80) 0-75 (0-68-0-83) 100 0(900-1100)
3 135(128-142) 1 88 (1-79-1-97) 0-75 (0-71-0-79) 106 5 (101 2-111 8)
4 135(128-142) 1 20(1-10-1-30) 0-75(0-65-0-85) 103 0 (98 0-108 0)
Comment
The development of hyponatraemia in heart failure is associated with poor
prognosis.' The wide limits of quality control applied to some ion
concentrations make control of electrolyte balance during haemofiltration
unpredictable and potentially hazardous, especially when large volumes are
infused. Fluids from suppliers 3 and 4 are within 2% of their intended ion
concentrations at the time of manufacture, though they apply wider limits of
quality control at the end of the shelf life owing to the evaporation of water
from polyvinylchloride bags.
Doctors must remain alert to electrolyte imbalance caused by variations in
fluid constituents during large intravenous infusions. Medicinal products
without a product licence are prepared as "specials," made to the clinician's
specification. Until a manufacturer obtains a product licence doctors
who require haemofiltration fluids should specify not only the required
concentration of ions but also the acceptable limits of quality control.
1 Lre WH, Packer M. Prognostic importance ofscrum sodium coocratracioo and its roodiBcabom by
converting enzyme inhibition in patients with severe chronic heart failure. Circulation
1986;73:257-67.
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Increased cough reflex associated with
angiotensin converting enzyme inhibitor
cough
Angiotensin converting enzyme inhibitors are being used increasingly to
treat hypertension and congestive cardiac failure as they are one of the few
treatments that improve life expectancy in these conditions.1 In general,
these drugs are well tolerated, but recently unexpected and troublesome
cough, without obvious pulmonary abnormality, has been reported in as
many as 5-10% of patients taking both captopril and enalapril.2 Until
recently cough has been difficult to assess, but we have developed a method
for measuring the sensitivity of the cough reflex to a standard inhaled
stimulus; capsaicin (red pepper).' Usingj modification of this method, we
assessed the sensitivity of the cough rifiex in five patients with cough
associated with treatment with angiotensin converting enzyme inhibitors.
t
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SUMMARY
In November 1986 a large-scale survey was undertaken in the Gloucestershire
town of Stonehouse during an outbreak of meningococcal disease due to group B
type 15 subtype Pi. 16 sulphonamide-resistant strains. There were 15 cases in
Stonehouse residents during the 4 years from April 1983. an annual attack rate of
56 5 per 100000. Four secondary cases occurred despite rifampicin prophylaxis.
The objectives of this community survey were to investigate patterns of
meningococcal carriage, transmission and immunity and to determine the
proportion of non-secretors of blood group antigens in the Stonchouse population
and amongst meningococcal carriers. A total of 6237 subjects participated
including 75% of the 6635 Stonehouse residents. Over 97% of the participants
provided all three of the requested specimens - nasopharyngeal swabs, saliva and
blood samples.
The co-operation between the many organizations involved in the detailed
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preliminary planning was instrumental in the success of the survey; in particular
the value of effective collaboration between Departments of Community Medicine
and Microbiology and of the Public Health Laboratory Service network of
laboratories in undertaking investigations of this size and type was clearly
demonstrated.
introduction*
Since 1974 meningococcal disease due to group B type 15 pi. 16 sulphonamide-
resistant (Bio. 16R) strains has been encountered increasingly in several European
countries including Britain (Poolman et al. 1986). It has been characterized by
prolonged outbreaks with high attack rates in teenagers and young adults and a
low carriage rate in community contacts (Cartwright. Stuart Jc Xoah. 1986). These
unusual features of meningococcal disease suggest that B15.16R strains have a
greater virulence, longer duration of carriage and lower transmissibility than most
other strains of meningococci and that they may not have circulated in the
affected communities for 2U years or more.
The factors infiueiuimj >u>ceptibility of the nou-immunc individual to men¬
ingococcal disease are not fully understood though recent studies have shown that
a genetically determined inability to secrete ABO blood group antigens in saliva
and other body fluids (non-secretion) is one such predis|>osing factor (Blackwcll
et al. 1986).
In south-west England both Gloucester and Plymouth Health Districts have
experienced prolonged outbreaks of meningococcal disease due to Bio. 16R
strains since 1981 (Cartwright. Stuart & Xoah. 1986. Dawson. Rickard 3:
Wilkinson. 1986). In Gloucester Health District (population 308500) 94 cases
occurred between 1 October 1981 and 31 March 1987. an average annual attack
rate of 5-5 per 100 000. Of these cases 15 occurred in the parish of .Stonehouse
(population 6635). a town in Stroud Local Authority District. Eleven of the 15
cases lived on one estate, which housed 36% of the town's population.
This report describes the outbreak in Stonehouse and the planning and
execution of a large scale study which had the following principal objectives:
1. To measure the prevalence of nasopharyngeal carriage of. and immunity to.
B15.16R and other strains of meningococci in the Stonehouse population by age.
sex. school and area of residence during an outbreak of meningococcal disease
caused by Bl5.16R strains.
2. To examine the hypothesis that B15.16R meningococci have a relatively low
transmissibility and long duration of carriage.
3. To determine the proportion of non-secretors in the Stonehouse population
and amongst meningococcal carriers.
The bacteriological findings are described in the companion article (Cartwright




Planning meetings were held during the summer and autumn of 1986. Six of the
authors (J.S., K.C., D. J., N.N., R. W., C. B.) constituted the core planning team.
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The local planning team was made up of one nursing, one administrative and one
finance officer, a general practitioner, a computer programmer, two head medical
laboratory scientific officers (MLSOs), a county education officer, a community
physician and three Public Health Laboratory (PHL) directors. The laboratory
planning team consisted of the Directors and Head MLSOs of Gloucester.
Manchester, Bristol and Hereford PHLs
Timing
The duration of the survey needed to be as short as practicable so that an
estimate of point prevalence of meningococcal carriage and immunity could be
obtained. It was also considered important to complete the survey before the end
of 1986 in order to study the community during a period of high disease activity.
The two weeks beginning 3 November 1986 were chosen: sampling sessions were
planned on weekday evenings and Saturdays at Stonehouse Health Clinic and at
Stonehouse schools during the week days.
Sample size
A low carriage rate of Blo.lOR organisms (1% or less) was anticipated. The
uneven distribution of the cases made it important to compare the prevalence of
immunity, carriage rates and secretor state in different areas of the town. With the
exception of infants who were excluded for practical reasons, all residents of
.Stonehouse Parish were invited to participate. All children and staff at rjtonchouse
schools, whether or not .Stonehouse residents, were included so that comparisons
could be made between schools. The total sample size was estimated as 1100 from
Gloucestershire Family Practitioner Committee (FPC) records and school lists.
Specimens
Postnasal swabs were needed to determine rates of nasopharyngeal carriage of
meningococci, saliva samples to determine secretor status, and blood samples to
validate the secretor results and to detect specific IgM and IgG antibodies against
B15.16R and other meningococci by ELISA tests
Staff and equipment
A dummy run' was held at the Health Clinic. Estimates were made of the time
to complete sampling, the staff and equipment needed, and costs. Calculations
were based on a 90% attendance rate with a maximum throughput of 90 people
per hour in each evening session and 60 per hour in each school session. Medical,
nursing, laboratory, administrative and clerical staff were recruited and
equipment was ordered pending approval of funding.
Ethical issues
Approval for the study was obtained from the District Ethical Committee and
medico-legal advice was sought on wording of consent forms.
Publicity
Plans of the survey giving details of the reasons for its undertaking, the dates,
and further general information were made widely available through the local
media.
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Representatives of the national press and television were invited to a press
conference on the first morning of the survey. This increased local awareness and
allowed the survey to proceed thereafter without disruption from the media. The
Press Office of the South Western Region Health Authority handled enquiries
during the survey.
Implementation
The Meningitis Trust, a locally based charity, arranged for the separate delivery
of two explanatory letters, the second with four registration cards, to each
household in Stonehouse Parish. The registration cards included details of
surname, forename, date of birth, sex. address, postcode, general practitioner,
school and class (where relevant) and signed consent.
The 1985 electoral register was used to divide the town into 10 localities with
approximately equal adult populations. Householders were asked if possible to
attend Stonehouse Health Clinic with their completed cards on one of the 10
designated weekday evenings between 4 p.m. and 9 p.m. Children of preschool age
or at school outside Stonehou>e were also invited to these evening sessions.
Residents who were unable to attend during a weekday evening were asked to
come between 9 a.m. and 0 p.m. on one of the two Saturdays.
The head teachers of the Stonehouse schools issued a letter to parents and a
registration card to each pupil prior to the start of the survey. Pupils were asked
to take the letter and card home, complete the card, obtain signed parental
consent (if aged less than 16) and return the completed card to form teachers.
Day3 and times for sampling at schools were agreed with head teachers.
Three teams, each consisting of one clerical assistant, three nurses, one MLSO
and one phlebotomist. collected the specimens at each evening session: there were
two teams at the schools. In addition there was an administrator assisted by
volunteers to control flow of subjects to the teams, a medical officer to deal with
emergencies and to assist in taking blood samples, the two co-ordinators (K. C. and
J.S.) to supervise and to assist in specimen collection, a volunteer from the Red
Cross to administer first aid. a clerical officer to enter registration data on to a
computer and a driver to transport specimens. Each team had the use of three
rooms - the first for checking data registration and for saliva collection, the
second for throat swabbing and plating and the third for blood sampling.
Room One: A clerical officer helped to complete registration cards where
necessary and checked that data entry was complete and legible. Postcodes were
cross-checked against addresses on a Post Office list. Six adhesive labels bearing
an identical number were used to identify the registration card and all the
specimens from one subject. Xo other specimen identification system was used.
Saliva specimens (2 ml) were collected by a nurse. Subjects expectorated into
20ml sterile Universal containers; plastic disposable pipettes were used when
necessary in young children. A flow of saliva was stimulated by smelling fresh cut
lemons. Samples were frozen to —20 °C within 3 h of collection and subsequently
transferred to Edinburgh in insulated containers.
Room Two: A nurse swept the posterior pharyngeal wall behind the uvula with
a fluffy charcoal swab. Pernasal swabs were used if necessary in small children.
Plates were inoculated directly by an MLSO and taken by van in alternate 3 h
batches to Gloucester and Bristol PHLs.
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Little Australia
Xuinliers of cases of meningococcal disease are shown in parentheses. Boundaries
hetaffn areas.
Table 1. Men in•gococcal di*ea*e in Stoneho if.se resident* , case details
Case Disease onset Aire at Area of Organism
number (month/year) nii*et Sex residence School isolated
1 5/83 40 M PE
— Bl5 Pi.I6R
2 3/84 in M PF. State junior B15 Pi.I6R
.1 9/84 12 F PE State secondary B2bR
4 I2/S-5 11 F PE Outside Stonehouse CSF film positivi
5 12/85* 0 M PE State infant BloPl.16R
6 1/86* 11 F PE Special B15R
7 3/S6** 5 M PE •State infant Bio.Pi. 16R
8 6/86** 9 F PE State junior Bio: Pi. 16R
9 7/86* 32 M PE
— Bl5: Pi.16R
10 7/86*** 4 .M VF
— Clinical diagnosi:
11 7/86 (Died) 1 M PE State infant Clinical diagnosi:
12 7/86 6 M \"F State infant Clinical diagnosi:
Survev November 1986
13 ' 12/86 (Died) 1 M PE State junior Bl5:Pi. 16R
14 12/86*** •) M \T
— B15P1.16R
15 3/87 9 F R State junior Bio:Pi.16R
*. **. *•* indicate cases in same households.
PE. Park Estate: VP. Verney Fields: R. Rosedale.
estimated 207% in Stroud District: the proportions in Park Estate and Verney
Fields were close to the mean for Stonehouse (Table 2). The proportion of people
aged 65 and over was 17-6% in Stonehouse compared with an estimated 160% in
Stroud District: of the five Stonehouse areas Park Estate had the highest figure
at 206%.
Table 2. Population and age distribution in Stonehouse
Park Vemey Little
Population Estate Fields Australia Rosedale Bridgend Total
Total 1729 1836 869 1423 778 6635
< 16 years (%) 263 27 9 318 26-8 24-9 27-4
> 64 years (%) 20-6 20-1 8-8 15 9 181 17 6
Sources: Glos F.P.C.: Stroud District Council.
Table 3. Housing, population density and occupation in Stonehouse
Park Vemey Little
Estate Fields Australia Rosedale Bridgend Total
No. of houses 641 760 370 5-41 289 2610
Council-owned (%) 56 5 57 2 0 5-2 17 5 336
Mean no. people per 2 7 24 2-4 2-0 2-6 2-5
house
Mean no. people per acre 26-6 246 28 8 14-6 12-1 2<H>
Household heads with 77-5 74-1 51-7 40-3 lvH> 63-7
manual occupation (%)
Sources (.Ins. F.P.C : Stroud District Council: IUS 1 Census.
Boundaries of enumeration districts did not coincide with the boundaries of the
designated areas. An analysis of the 1 OS 1 Office of Population Census and Surveys
Small Area Statistics showed that in those enumeration districts most closely
corresponding to Park Estate and Verney Fields there was a higher incidence of
employed household heads in Social Classes HIM. IV and V compared with the
rest of Stonehouse (Table 3). Another socio-economic indicator, the proportion of
council-owned housing, was 336% in Stonehouse at the time of the survey
compared with 17-8% in Stroud District. Park Estate and Verney Fields
contained 91 % of council-owned housing in Stonehouse. There was little variation
in the average number of people per house though Park Estate had the highest
figure; estimates of population density within the residential parts of each area
averaged 20 people per acre, the highest densitv being in Little Australia (Table
3).
During the fortnight of the survey 6237 persons attended for screening: 5006
were Stonehouse residents and the remaining 1231 were non-resident pupils and
staff of Stonehouse schools. This represented a 75% attendance by the residents
of Stonehouse and included 87% of the 1-19-year-olds (Table 4). The under 1-
year-olds had not been invited but 16 (15%) were tested on request by their
I" rents.
The lowest attendance from the five areas was 66% from Verney Fields (Table
All the schools had very high attendance figures including those pupils not
living in Stonehouse. The overall percentage of school-children tested was 96%
(Table 6). Technical failures in testing or refused consent w ere uncommon - 99 8%
of the 6237 attenders provided a nasopharyngeal swab, a saliva sample was
collected from 98 9% and a blood sample from 97-5% (Table 7). Even in the 1-4-
vear age group venepuncture was successful in 87%.
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Table 4. Attendance of Stonehouse residents by age and sear
Males Females
Tested Tested
Age in r— 1 r
(*/.)years Population No (•/.) Population Xo
< 1 59 6 (10-2) 46 10 (217)
1-4 214 179 (83 6) 169 133 (78 7)
5-9 237 226 (95 4) 198 195 (96-5)
10-14 182 181 (99-5) 193 1S6 (96-4)
15-19 261 187 (71-6) 256 201 (76 5)
20-24 257 177 (66 9) 257 209 (81-3)
25-34 492 388 (7S9) 533 424 (79-5)
35—44 421 324 (77-0) 418 354 (84-7)
45-54 298 216 (72-51 295 226 (76-6)
55-64 300 214 (71-3) 381 296 (77 7)
65 —■ 475 268 <56 4) 693 406 (56-6)
Total 3196 2366 (74-0) 3439 2640 (76-6)




Park Estate 1729 1273 (73-6)
Vernev Fields 1836 1216 (662)
Little Australia 869 7.50 (86-3)
Rosedale 1423 1226 (86-2)
Bridgend 778 541 (69-5)
Total 6635 5006 (75-4)





School* Total Xo. (%) Xo. <%)
State infant/junior 443 428 (96-6) 441 (99-1)
Private junior (a) 49 4 (8-2) 49 (100-0)
Private junior (b) 194 19 (9-8) 180 (92-8)
State secondary 781 280 (35-9) 736 (94-2)
Private senior 337 14 (4-2) 331 (98-2)
Special 58 5 (8-6) 51 (87-9)
Total 1862 750 (40-3) 1788 (96-0)
• See Fig. t.
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No (%) No <%) No (%)
324 (1000) 296 (91-4) 282 (87-0)
535 (99-3) 531 (98 9) 515 (959)
5375 (100-0) 5340 (99-3) 5285 (98 3)
6234 (99-9) 6167 (98-9) 6082 (97-5)
Throughput sometimes reached the planned maximum of 90 subjects per hour
but waiting rarely exceeded 15 min at any time. The school testing also kept to
schedule.
One brief grand mal seizure was recorded in a boy with no history of fits: there
were no other serious adverse events.
DISrl'ssiON
Interesting features of the Stonehouse outbreak include the localization of the
disease within the town, the high attack rate in 5- to 9-year-old children and the
high secondary attack rates.
It is difficult to obtain an accurate age-sex structure of any defined population
between each 10-year census. Elec toral registers are updated annually but provide
only a list of residents eligible to vote. Consequently it was considered that the
computerized FPC' registration list, despite inaccuracies due to logistic delays,
would provide the most accurate estimate of the Stonehouse population without
conducting a separate household census. Although Stonehouse had a 7% higher
proportion of under-16-year-olds than the mean for the Stroud District, the
proportions of under-16-year-olds (and of 5- to 9-year-olds) in Park Estate and
Verney Fields were close to the mean for Stonehouse so that the higher disease
rates in these areas could not be explained by a predominance of the more
susceptible age groups. The mean number of people per house was marginally
higher in Park Estate but the population density was higher in Little Australia.
The main associations found in this analysis were that the two areas in which all
but one of the cases lived had considerably higher proportions of council-owned
housing and of correspondingly lower social class in household heads than the rest
of the town. Previous research has also shown an association between lower socio¬
economic indicators and meningococcal disease (Farries et al. 1975).
Rifampicin prophylaxis for household contacts of a case of meningococcal
<li>«-ase is recommended in Britain and North America in order to reduce
-•«.ni«lary attack rates (PHLS. 1986: Centers for Disease Control, 1981).
1 "ii!|>liancc is likely to be good in the family members of a child with
meningococcal disease. The high secondary attack rate reported here is
*li>af ijNiinting and raises doubts about the effectiveness of rifampicin in preventing
v-euiulary cases. The long delay between index and secondary cases could be
explained by the time taken for the virulent strain to be reintroduced into the
family and thence to reach another susceptible family member; rifampicin may do
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Table 4. Attendance of Stonehouse residents by age and sei
Miles Females
r K > f A
Tested Tested
Age in r~ - ■
years Population No. (%> Population No. (%>
< 1 59 6 (10-2) 46 10 (217)
1-4 214 179 (83 6) 169 133 (78-7)
5-9 237 226 (934) 198 195 (98-5)
10-14 182 181 (99-5) 193 186 (96-4)
15-19 261 187 (716) 256 201 (78 5)
20-24 257 177 (68 9) 257 209 (813)
25-34 492 388 (78-9) 533 424 (79-5)
35—44 421 324 (77-0) 418 354 (8-4 7)
43-54 298 216 (725i 295 226 (76-6)
55-64 300 214 (713) 381 296 (77 7)
65-r 475 268 (564) 693 406 (58-6)
Total 3196 2366 (740) 3439 2640 (768)
Table 5. Attendance of Stonehouse residents by area
Tested
Population No <%)
Park Estate 1729 1273 (73-6)
Verney Fields 1836 1216 (662)
Little Australia 869 7.50 (86 3)
Rosedale 1423 1226 (86-2)
Bridgend 778 541 (69-5)
Total 6635 5006 (75 4)







School* Total No. (%) No. (%)
State infant/junior 443 428 (96-6) 441 (99-1)
Private junior (a) 49 4 (8-2) 49 (100-0)
Private junior (b) 194 19 (9-8) 180 (92-8)
State secondary- 781 280 (35-9) 736 (94 2)
Private senior 337 14 (4-2) 331 (98-2)
Special 58 5 (8-6) 51 (87-9)
Total 1862 750 (403) 1788 (96-0)
* See Fig. 1.
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no more than defer the onset of disease in close contacts of cases The long interval
between primary and secondary cases adds further weight to the hvpothesis that
B15.16R organisms are less transmissible than other strains of pathogenic
meningococci.
Although there have been extensive studies of meningococci in military-
populations. particularly in the USA (Goldschneider. Gotschlich 4 Artenstein.
1969). no study on this scale has been previously undertaken to investigate
meningococcal carriage and immunity in a civilian population. The relationship
between non-secretion and meningococcal carriage has not been examined
previously.
There was a very high overall attendance and nearly all who came to a sampling
session provided all three requested samples. Several factors may have contributed
to the high attendance. First, meningococcal disease can be frightening in its
severity. It often begins suddenly in previously healthy individuals and may cause
death within a few hours. A case in a school causes intense anxiety in pupils,
parents and teachers, whereas cases occurring in infants generally receive less
publicity. As several cases had occurred recently in school-children living in
Stonchouse. parents and school-children were all well aware of the problem.
Second, enlisting the support of the local and national media ensured that interest
was maintained at a high level. Third, individual explanatory letters to each
household accompanied by registration cards ensured that all individuals were
aware that their active participation was being sought. Fourth, the provision of
an adequate number of sampling sessions ensured that processing of subjects was
rapid and that delays were minimal. The co-operation of the school authorities in
this respect was invaluable in providing facilities for sampling at the individual
schools and in releasing children class by class to attend.
The high compliance in providing all three specimens was primarily a reflection
of the willingness of nearly all the subjects to help. An additional factor was the
use of a single signed consent for all three tests. Separate rooms for the sampling
procedures assisted in reducing anxiety and in improving compliance in blood
testing. Only a few individuals declined to provide the full set of specimens. The
main reason for not achieving even higher compliance for blood collection was
occasional technical failure, particularly in very young children. Nevertheless it is
possible, with the co-operation of parents, to collect blood samples from the
majority of children as young as 1 year of age.
The survey was completed within the planned 2-week period, and continuing
disease activity was confirmed by the occurrence of the three further cases.
Early recruitment of nurses, phlebotomists. technical, clerical and medical staff
and their subsequent briefing meant that all the teams were well informed about
the methods and objectives of the survey. Sharing of data in the collaborating
centres was made possible by the use of compatible computer hardware and by the
early involvement of PHLS Computer Services in the design of programs. The
division of the laboratory- work between four Public Health Laboratories proved
essential in managing the large workload additional to the routine services. The
high attendance and high compliance for all three sampling procedures emphasized
the importance of detailed preliminary planning. Effective collaboration between
the Departments of Community Medicine and Microbiology and within the
network of PHLS laboratories was vital to the success of this survey.
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Non-secretion of blood group antigens. A genetic factor
predisposing to infection by \eisseria meningitidis
C.C. BLACKWELL. K. JONSDOTTIR1, I. MOHAMMED2 &
D. M. WEIR
Dept. of Bacteriology. University of Edinburgh. Scotland. UK: ' Dept. of Bacteriology. University
ofIceland. Iceland: '-Dept. oj Medicine. University ofMaiduguri, Sigeria
Abstract. We have identified a genetic factor associated with susceptibility to bacterial meningitis.
This is the inability of an individual to secrete the water-soluble glycoprotein form of the ABO
blood group antigen. Compared with local controls, a significant increase in the proportion of non-
secretors was observed among patients with infection due to Seissereria meningitidis in Scotland.
Iceland and northern Nigeria.
Investigation of the host-parasite interactions responsible for these epidemiological observations
might provide valuable insights into the pathogenesis of these infections.
Introduction
Efforts to produce vaccines against Neisseria meningitidis have focused on viru¬
lence factors of the microorganism. Our knowledge of stable host factors that
predispose the non-immune individual to these infections is much more limited.
Distribution of the ABO blood groups and alterations in the predicted frequen¬
cies of secretors and non-secretors of blood group antigens in various popula¬
tions suggested that these factors might influence susceptibility or resistance to
infectious agents (Mourant 1982. 1983). There is an increased incidence of non-
secretors among patients with cholera (Chaudhuri & DasAdhikary 1978). recur¬
rent urinary tract infections (Blackwell et al. 1986b) superficial Candida infec¬
tions (Black well et al. 1986c). invasive pneumococcal disease and meningococcal
infection (Blackwell at al. 1986a).
The ability of an individual to secrete the water-soluble glycoprotein form
of his ABO blood group antigens into body fluids is a stable character inherited
in a Mendelian-dominant pattern. The recessive non-secretor phenotype is pre¬
dicted for about 25% of any population. Because this figure can vary in different
ethnic groups (Thordarson et al. 1972; Chown & Lewis 1955). local controls
J T Poolman et al. (Eds) Gonococci and Meningococci. ISBN 90-247-3607-2
C 1988. Kluwer Academic Publishers. Dordrecht - Printed in the Netherlands
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are very important. Secretor state does not alter with age or environmental in¬
fluences, so retrospective studies can be carried out.
Materials and methods
Secretor state was determined by the method described by Mollison (1979). Lo¬
cal controls were blood donors from the Edinburgh area, blood donors and
hospital personnel in Iceland, women attending antenatal clinics at Maiduguri,
Nigeria. Specimens were obtained from household contacts of the Icelandic pa¬
tients. The blood groups of the Nigerian populations were also supplied.
Results
In each of the 3 different populations studied there was a significant increase
in the incidence of non-secretors among the individuals with meningococcal in¬
fections compared with local controls (Table 1).
Because the meningitis belt of Africa can be superimposed on the area in which
there is the highest incidence of the B gene (Winstanley et al. 1985). we have
predicted there might also be an increase in the incidence of B and. or AB indivi¬
duals with meningitis. There was no significant differences between patient and
control groups (Table 2).
Among the 26 contacts of Icelandic patients tested. 11 were secretors and
15 non-secretors. Because older children might have developed protective anti¬
bodies. we analyzed the contacts by age and secretor state. When the ages of
the contacts younger that the patient were compared, the mean age of the secre-





Controls 334 89 (26.6) < .005
Patients 26 18 (69)
Iceland
Controls 228 94 (41.2) <0 05
Patients 98 53 (54)
Niaena
Controls 186 92 (49.5) <0.01
Patients 42 31 (73.8)
Host susceptibility factorfor meningococcal meningitis 635
Table 2 Distribution of ABO blood groups for Nigerian controls and patients.
ABO blood group















* Mean age of younger patients 1.3 3.2
*0.1 }p >0.05
tors was 1.3 years and that of the non-secretors 3.2 years (0.1 > p < 0.05). The
numbers are small, but the t value was just outside the 95° o confidence limits
(Table 3).
Discussion
In comparison with local controls, there was a significant increase in the inci¬
dence of non-secretors among patients with meningococcal infections, even in
Iceland and the area around Maiduguri where the incidence of this recessive
character is unusually high. These results suggest that the ability to secrete blood
group antigens is part of the host's innate defences, and this protective effect
is observed particularly in non-immune (Blackwell et al. 1986a) or immunocom¬
promised persons (Blackwell et al. 1986c). Among the contacts of Icelandic pa¬
tients, differences in the ages of the secretors and non-secretors suggest that
secretion might help protect very young children during the critical period be¬
tween decline of maternal antibodies and development of child's own active im¬
munity to these pathogens.
We have suggested 2 hypothesis to explain the host-parasite interactions un¬
derlying these epidemiological observations:
1. There are glycocompounds in the body fluids of secretors that can inhibit
binding of lectin-like adhesins on the surface of microorganisms thus reduc¬
ing the probability of colonization.
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2. The Lewis'1 antigen found on the cells of non-secretors is one of the receptors
for adhesins on the microorganisms.
There is evidence for the first hypothesis from our work on Candida (Blackwell
et al. 1986c). We were able to demonstrate inhibition of binding by preincuba¬
tion of the yeast with boiled saliva from secretors but not non-secretors.
Evidence for the second hypothesis comes again from our studies of Candida.
Binding of the yeast was inhibited if non-secretor epithelial cells were pretreated
with anti-LewisJ antisera, but no inhibition was observed following treatment
of secretor cells with anti-Lewisb antisera (May et al. 1986).
By identifying host receptors we plan to exploit this information to isolate
adhesins from these microorganisms and to examine their immunogenicity to
evaluate their potential as vaccine candidates.
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pedsI cyclists. 93 . i9*-S: had mild concussion, 13 (3%) had severe head imunes,
ar.d 53 (11%) had cuts and jrices
The Oxford ring road encloses 227 1cm of road and only 23 lem of cycle lane, of
which 3 icm are part of the road and 15 km are separaie. The number of imuries
per kilometre was 0-9 on the road, O'-t on the road cycle lane, and 0 3 on the
separate cycie track. Another vehicle caused or was involved us 1012 (55%) of the
accidents.
Commeal
In accidents motorcyclists have been shown to sustain more severe injuries
to the body and pedal cyclists more severe head injuries,' a finding confirmed
by our study. .Although the two groups are not strictly comparable, we
suggest chat ifcyciists wore heimecs the number of head iniuries in this group
would be reduced. The incidence of head injuries sustained by pedal cyclists
is similar whatever their age.' Though children form the largest group of
cyclists with head injuries, it would be desirable for all cyclists to wear
helmets.
Our study suggests that cycle lanes are safer than ordinary roads for
cyclists. After the introduction of cycle lanes on certain routes in Oxford the
number of accidents remained che same despite double the number of road
users (unpublished report of city engineer). It has been suggested that cycle
lanes relocate bicycle accidents to the place where the lanes end'; thus special
cycle routes using quieter parts of the existing road system should perhaps be
developed. All che deaths in our study and 87% of chose in the study by
Nixon tt aC occurred after an accident with a motor vehicle and could have
been averted by complete segregation of cyclists. Although this aim is
currendy impracticable because of the dominance of cars, cycle lanes and
especially separate cycle tracks are a worthwhile addition to cicy centres.
Patients, methods, and results
Te studied 77 patients with Graves' disease, 33 with spontaneous primar.
atrophic hypothyroidism, and 26 with Hashimoto's thyroiditis. ABO and Lewi,
blood groups were determined by agglutination and the secretor state from salivi
by the haemagglutinatioo inhibition method." Secretor state was confirmed by the
Lewis blood group. The results were compared with those from local blood
donors with the jf test. The table shows that the proportion of ooo-secre-ors with
Graves' disease was significantly increased compared with that in the coacrol
population (p<0 005). Tlus was not true for pacients with primary atrophic
Blood protp tod secrrtor not* of pahena aoik tutosmmune Jtyroid disease tod
controls. Valius trt .sjothers (percenia/a) of TubJtea
ABO blood group Secretor sure
Noo-
A 5 O AS Secretor Kcrctor
Gravel' iimyr (a— 77) a (30 4(f) 40(52) 3W 43(54) 34(44)
Spoooocoui pessary icropluc
hypothyroidism (a»33) 11(33) 3(9) 11(55) 1(3) 23(70) 10(30)
Hashimoto's thyroadios (a* 24) 5(19) 1(4) 19(73) 1(4) 19(73) 7(27)
Coocrols(a»334) 104(31) 42(13) 173(52) 15(4) 245(73) 19(27)
hypothyroidism or Hashimoto's thyroiditis. There was no significant difference
in the distnbuuoo of ABO blood groups between any of the categories of thyroid
disease and the control population.
1 N'ixoc J, Gscher R. Pais J, Cotcoeia A. Bicycle acodeoa in childhood. Br MUJ 19I7-.244:
1247-9.
2 McDenwxt FT. XJujGL- Hewd injury predominance: polaSeyciistl *5 asoax-cydisu. MtdJ Akm
3 Aoooymoui. Moaxeyck sod bkyde acodcfla. Br Mad7 i979u iV-41.
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Increased prevalence of non-secretors in
patients with Graves' disease: evidence
for an infective aetiology?
Graves' disease is associated with HLA-38 and HLA-DRJ on chromosome
6. The abnormalities of humoral immunity causing the production of
antibodies that scimulate thyroid stimuiadng hormone receptors, and the
role of cell mediated immunity, are well known, but the trigger that allows
predisposed people to develop the disease is not. Environmental influences
such as stress and infection have been proposed.' An inability to secrete the
water soluble glycoprotein form of the ABO blood group andgens is
associated with increased susceptibility to several infecdons, particularly in
children in che time between their losing maternal andbodies and developing
their own acdve immunity. This characteristic does not alter with age or
environment. The secretor gene is on chromosome 19 and is not linked to
sex or che HLA markers. There is a significandy higher proportion of
noa-secrecors in pauencs with insulin dependent diabetes mellitur and
ankylosing spondylitis' than in the general population. These conditions are
closely associated with HLA markers, and an infective aetiology has been
suggested for each. Te examined the secretor state of patients with organ
specific autoimmune thyroid disease. This group of diseases is not
uncommon in patients with insulin dependent diabetes meilitus and their
first degree relatives.
Comment
Our results show that the inherited susceptibility to Graves' disease
is associated with genetic markers on chromosome 19 as well as on
chromosome 6. As some patients with Graves' disease eventually develop
hypothyroidism it might have been expected chat patiencs with primary
atrophic hypothyroidism would show the same increased proportion of non-
secrerors. This was not so, but che number studied was small.
The increased susceptibility of aon-secretors to infection raises the
possibility chat an infective agent may play a part in the development of
Graves' disease. A sinking issociacica has been shown between tile
prevalence of antibodies against the enteric pathogen Yersinia enierocolinca
and autoimmune thyroid disease, particularly in Scandinavia.' Thus
organism, in addition to Escherichia coii and ocher Gram negative bacteria,
has been shown to contain a binding site for thyroid stimulating hormone,
and this is recognised by immunoglobulins from patiencs with Graves'
disease.' Possibly the increased susceptibilicy of non-secretors to bacrenai
infection might result in the production of antibodies to microbial antigens
that then cross react with the receptor for thyroid stimulating hormone and
trigger the onset of hyperthyroidism.
1 Heym* P. Harrison LC. Roetna-Browrx R. Thyrooupllin (TSH) bindiaj otcs on Yenuia
encerocouoa recognised !>▼ rr.m unoyoouiins from buznuu with Gnves' Co* Ezp
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SECRETOR STATE AND COMPLEMENT LEVELS (C3 AND C4)
IN INSULIN DEPENDENT DIABETES MELLITUS
C. C. Blackwell.1 D. M. Weir.1 A. W. Patrick.2 A. Collier2 and B. F. Clarke2
i Department of Bacteriology. University of Edinburgh. The Medical School. Teviot Place, and JDiabetic and Dietetic
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(Received 23 April 1988)
SUMMARY Lower levels of C3 and C4 components of the
complement system have been reported for patients with insulin
dependent diabetes mellitus fIDDM) but not among those with
non-insulin dependent diabetes (NIDDMi. We have found a
significantly higher proportion of patients who are non-secretors
of the A30 blood group antigens among patients with IDDM
but not among those with NIDDM. As the gene that controls
secretion of these antigens is in the same linkage group as that
for the C3 complement component we compared the levels of
C3 and C4 of patients with IDDM by secretor state. The mean
level of C3c for 45 non-secretors (75-2 IU/ml) was significantly
lower than that found for 59 secretors f86-4 IU/mJ) (p < 0025).
The level of C4 among non-secretors (77-1 IU/ml) was also
significantly lower than that of secretors (96-3 IU/ml) (p < 0-025).
The significance of these observations is discussed.
Key words: Secretor state, complement C3. C4. insulin de
pendent diapeies mellitus
Introduction
The C3 and C4 complement components play a central
role in dealing with infectious agents and clearance of
immune complexes. Lower levels of C3 and C4 have been
found among patients with insulin dependent diabetes
mellitus (IDDM) (1.2). but normal levels of these
components are reported among patients with non-
insulin dependent diabetes mellitus (NIDDM) (3). The
gene for C3 is in the same linkage group as the gene that
controls secretor status. In a previous study we found no
significant differences in the mean levels of C3 for 109
secretors (126IU/ml) and 110 non-secretors (120IU ml).
There were, however, eight individuals with C3 levels
below the lower limits of the normal range: seven of the
eight were non-secretors (4). None of these eight donors
was a diabetic.
Our recent survey found a significantly higher
proportion of non-secretors among patients with IDDM
(40-2%) but not among those with NIDDM (25-2%)
compared with local controls (26-6%) (5). From this we
Correspondence: Prof. D M. Weir, Department of Bacteriology,
Universitv of Edinburgh. The Medical SchooL Teviot Place. Edinburgh
EH8 9AG, UK
predicted that the lower levels of C3 reported for patients
with IDDM might be due to the increase in the
proportion of non-secretors. To test this hypothesis we
determined the C3 and C4 levels of patients with IDDM
and compared these values by secretor status.
Subjects and Methods
The study population consisted of patients attending routine diabetic
ciimcs. They ranged in age from 18-65: there were 59 secrerors and 45
non-secretors. None of the patients showed any signs of infection at the
ume of venepuncture.
Secretor state was determined from saliva by the haemaggiunnation
inhibition method (6) and confirmed by Lewis blood group determined
with polyclonal antisera fBehnng). C3c and C4 levels were determined
with Behrmg NOR-Partigen immunodiffusion plates. The results were
recorded as mternauonai units (IU)/ml and the results compared by
Student's t-test after conversion of the data to logarithms.
Results
The table shows a significantly lower level of C3c among
the non-secretors with IDDM (75-2 IU/ml) compared
with the values for secretors (86-4 IU/ml) (p < 0-025). The
same pattern was observed for C4 values: the non-
secretors (77-1 IU/ml) had significantly lower levels than
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Table 1 Comparison of the geometric means ofCJcanc C» lev eis of
secretors and non-secretors with lDDM
secretary (59) non-secretors (-<51





75-2 2-03169 102 <0-025
77-1 2-10037 102 < 0-025
the secretors (96-3 IU/ml) (p < 0-025). The mean values
for healthy adults given in the Table of Calibration
Values for the NOR-partigen plates are 105 IU ml for
C3c and 96 IU ml for C4. While the C3 value for secretors
with IDDM is lower than the mean for the normal range,
their C4 value for secretors is verv close to the mean.
Discussion
The mean levels of C3 for both secretors 186-4 IUml) and
non-secretor (75-2IU/ml) patients in the present study
were lower than those reported for central Europeans
(105 IU/ml) and for secretors and non-secretors in our
previous study. 126 IU/ml and 120 IU/ml respectively (4).
Although immune complexes are found in a high
proportion of patients with IDDM (7), the lower levels of
C3 and C4 previously reported did not correlate with
leveis of complexes detected by CI binding assays.
Binding of these components to immune complexes was
not excluded: but turnover studies suggested a major
influence was reduction in synthesis of C3 and C4 {1).
The association between non-secretion of ABO
antigens and reduced levels of C3 in IDDM remains
unciear. It may be significant that the C3 gene is in the
same linkage group as the secretor gene (8) which codes
for fucosyl transferase. Prior to secretion complement
components undergo post translational modifications
that include glycosyiation that influence intracellular
catabolism of the products (9i. Modification of normal
glvcosvlation of complement components in IDDM may
need to be considered.
The C4 gene, in contrast, is associated with the HLA
region of chromosome 6 (10). The unexpected reduction
in C4 leveis in non-secretors suggests that reported effects
of genes outside the MHC may be responsible. Deficiency
in C4 production has been found in a patient with SLE
and 6 healthy family members that was not linked to
HLA. Bf or C4 structural loci (11). In studies in mice non-
MHC genetic factors appear to be responsible for the
post-translational modification of pro-C4 (12). Vergami
ei al. (13) suggested the lower levels of C4 in chronic
active hepatitis patients and their relatives, may be due to
non-MHC genetic influences such as post-translational
modification.
In our earlier studies we have found significantly
higher proportions of non-secretors among patients with
recurrent unnarv tract infections (13-15) and superficial
cuncida infections (16.17;. two common infection
problems encountered among diabetics. A highe
proportion of non-secretors has been found amon.
"normal" individuals colonized by Candida species (IS
and uropathogenic Escherichia cob. strains bind in greater
numbers to ceils of non-secretors (19).
An infectious trigger has been postulated for IDDM
(20). We have suggested that the non-immune non-
secretor host might be more susceptible to the original
colonization by infectious agents (4). The specific immune
responses to the agent controlled by the class II HLa
DR3 4 genes and the lower levels of C3 and C4 migh:
contribute to the pathogenic sequelae that result in the
diabetic state.
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Leading Article
GENETIC SUSCEPTIBILITY TO INFECTIOUS AGENTS
C. Caroline Black-well, Department of Bacteriology, University Medical School,
Edinburgh
'Much more attention should be given to the combined effects of blood group and
secretor status on susceptibility to bacterial infection.' A E. Mourant, FRS.1
It is appropriate that this article is published in the April issue of the Proceedings as
Dr Arthur Mourant will be 85 on the 11th of the month. As he pointed out in
his introductory chapter to Blood Groups and Diseases, associations between these
genetic markers and human diseases had long been of interest. It was, however,
only in 1953 that the first convincing evidence was found, an association between
group A and carcinoma of the stomach.2 The group led by C.A. Clarke and
R.B. McConnell at Liverpool found additional associations of other forms of
cancer and ulcers with ABO blood groups and with the ABH secretor system.3
The ABH secretor system has been of interest mainly to two very different
groups: physical anthropologists who used blood groups and secretor status to
examine genetic markers of different races; and blood transfusion services because
it affects expression of the Lewis blood group antigens (Table 1). The ability to
secrete the ABO blood group antigens into body fluids is controlled by a single
gene on chromosome 19. As it is inherited in a dominant pattern the predicted
proportion of secretors within a population is 75 per cent and that for the
recessive non-secretor phenotype 25 per cent. This ratio can vary widely in
different ethnic groups and some geographically isolated populations.3,4 When
Blood Groups and Diseases was published in 1978, nearly 25 pages were devoted to
the reported studies of associations of ABO blood groups with infectious diseases.
Less than one page summarized the studies on secretor status and infection.
EPIDEMIOLOGICAL STUDIES
Infectious diseases
Since the early 1980s work in the Department of Bacteriology at Edinburgh
Table 1
Blood group antigens found in the body fluids of
secretors and non-secretors.
Blood group antigens in body fluids
H* B Lewis' Lewis'
Secretors + + ;0 + /0 (±) +
Non-secretors 0 0 0 + 0
*H is the antigen of blood group O
{Depending on the presence of the A and/or B gene
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University has expanded the studies on secretor status and susceptibility to
infectious diseases (Table 2). These surveys were made possible through the
cooperative efforts of colleagues from a variety of clinical disciplines in Britain,
Iceland and Nigeria.
Studies of secretor status among patients with meningococcal disease and their
local controls (Table 3) suggested that in areas of the world where there were
prolonged outbreaks or epidemics (Iceland and Nigeria), there was an unusually
high proportion of non-secretors in the indigenous population. During the
prolonged outbreak of meningococcal disease that occurred in Gloucestershire
from 1984-1987, the town of Stonehouse had an attack rate at least 10 times
greater than other parts of the county. In November 1986 our research team
participated in the Stonehouse Study, a project in which over 6,000 residents and
children attending school in Stonehouse were screened for carriage of the
outbreak strain, antibody to the outbreak strain and secretor status.23
As we predicted, there was a significantly higher proportion of non-secretors
in Stonehouse, 33 per cent compared with 23 per cent for the blood donors in
the Southwestern Region (P< 0-005). This cannot account in itself for the
outbreak, but it indicates there is a significantly larger proportion of individuals
genetically susceptible to infection in the town.2*
Autoimmune diseases
Associations between genes of the major histocompatibility complex (MHC) and
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Table 3
Sccretor status of patients with meningococcal infection
Son-seiretors
Total So. Per cent
Scotland
Controls' 334 89 26 6
Patients'4 26 18 69
Slonehouse, England
Controls24 4906 1352 27 6
Patients24 13 7 54
Iceland
Controls21 228 92 412
Patients'4 98 53 54
Sigma
Controls22 186 92 49 5





Association between secretor status and susceptibility to autoimmune
diseases.
Increased proportion
Disease of non-secretors Reference
rheumatic diseases
Rheumatic fever Yes 13
Ankylosing spondylitis Yes 26
Rheumatoid arthntis No 27
Psoriasis No 27
Psoriatic arthropathy Yes 27
endocrine diseases
Diabetes mellitus, unclassified Yes 30
insulin dependent Yes 28
non-insulin dependent No 28
Hashimoto's thyroiditis No 29
Primary atrophic hypothyroidism No 29
Graves' disease Yes 29
several autoimmune diseases have been established,25 but the existence of
additional genetic susceptibility factors outside the MHC cluster on chromo¬
some 6 was predicted. Our studies on infectious diseases suggested there might be
an association between non-secretion and some autoimmune diseases for which
infectious aetiologies have been proposed; and this is the pattern wc found among
patients with several rheumatic diseases, insulin dependent diabetes (1DDM) and
Craves' disease.26"29 (Table 4).
A review of available data on HLA markers associated with 1DDM and
secretor status of ethnic groups in which the disease is rare was striking. 1DDM is
rarely found among American Indians and Eskimos.31 They do not lack the HLA
1)2 <_ C AROLINE BLACK)* ELL
T sule 3
Frequency of HLA B8. DR3 and DR4 2nd proportion of
non-see rctors in Caucasian 2nd Indi2n populations25 32.
Frequencies of
Ethnic Per cent
group B# DR1 DR4 non-secretors
American Caucasians IT 1 22 2 27 3 2D-25
American Indians 2 9 6 47 8 0-2
Table 6
Proportion of HLA B27 2nd non-
sccretors in different ethnic
groups32,33,JS.
Per cent Per cent





antigens associated with IDDM.2S but, compared with Caucasians, non-secretors
are very much a minority (0-2%) (Table 5).32
The Haida Indians of British Columbia have ah unusually high prevalence of
ankylosing spondylitis (10% among adult males) and the associated HLA B27
marker (50%).33 In addition, the proportion of non-secretors (25%) among the
Haidas is similar to that of Caucasians, at least ten-fold greater than that reported
for other Canadian Indians.32 Although 20-30% of American Indians, Eskimos
and Lapps are B27 positive, the proportion of non-secretors in each of these
groups is very low, and the prevalence of ankylosing spondylitis is lower among
these groups than among the Haida (Table 6).33
Susceptibility of non-secretors to infectious agents
Although the ABO blood groups and secretor status are stable, easily and
inexpensively determined genetic markers, investigation of these early epidemio¬
logical observations was not actively pursued for many years. There are probably
a number of reasons for this. Different research groups obtained different ABO
blood group associations for the same diseases (Table 7). These discrepancies
might be due to variation in the strains causing the outbreaks studied,44-46 or
there might be differences in populations or patient categories exa¬
mined." 12 41 42 With the advent of tissue and organ transplantation, advances in
definition of the MHC overshadowed studies of blood group antigens with
reference to immunity and infection. In my opinion however, the main reason
these observations were not pursued is that only one hypothesis was suggested to
Table 7
Associations between ABO blood groups and susceptibility to infection.
Injections agent disease Blood group as<ocianon Reference
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explain these associations. Many microorganisms possess antigens crossreactive
with the ABO antigens42'50 51 or incorporate blood group antigens into their cell
envelopes.43 Anti-A and anti-B isohaemagglutinins might act as 'natural anti¬
bodies' against strains with these surface components in a non-immune host.
Since the mid-1970s it has become increasingly apparent that protein-
carbohydrate interactions play an important role in the phagocytosis of
microorganisms in the non-immune host,52-53 and many adhesins on
microorganisms bind preferentially to carbohydrate receptors on epithelial cells.54
Although there is no direct evidence for ABO or Lewis antigens acting as host
cell receptors, several pathogens bind to other blood group antigens (Table 8).
These findings have led to some new hypotheses outlined below.
Reduction of colonisation. If microbial adhesins bind to ABO or Lewis blood
groups on epithelial cells, the secreted forms of these antigens might interfere
with attachment of the microorganisms to the mucosa. Attachment of Strept.
salivarius to epithelial cells is inhibited by salivary glycoproteins with blood group
activity,62 and heat-treated saliva from secretors reduces binding of Candida to
epithelial cells.910 These interactions might contribute to the increased proporton
of non-secretors among carriers of group A Strept. pyogenes13 or C. albicans.17
Table 8
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Lewis* acts as a receptor for some strains of microorganisms. Uropathogenic strains of
Esch. coli bind in greater numbers to cells from non-secretors than to cells from
secretors.6,5 A major difference in the antigens on the mucosa of non-secretors is
the presence of Lewis*. Binding of one Candida strain was reduced if non-secretor
cells were prc-treated with anti-Lewis* antisera, but treatment of secretor cells
with anti-Lewisb did not reduce binding.60
Alteration of a receptor by the product of the secretor gene. The product of the
secretor gene is a fucosyl transferase. It has been suggested that this enzyme might
alter carbohydrate antigens on the cell surface, reducing access of the
microorganism to its receptor.63
Immune responses of non-secretors. Lower levels of both salivary and serum IgA
are reported for non-secretors;64,64 however, our studies found neither salivary
nor serum IgA responses of non-secretors to be impaired. In most patient groups,
the non-secretors had higher levels of total serum IgA. The differences in total
IgA levels for secretors and non-secretors observed in these groups require further
investigation for their possible roles in protection of mucosal surfaces, or
conversely as non-complement fixing/blocking antibodies in the pathogenesis of
infectious diseases and their sequelae.6,66
The complement system of non-secrelors. Most of the genes for the complement
system are on chromosome 6, but the structural gene for the third component of
the system (C3) is in the same linkage group as the secretor gene. Although C3
levels of 100 non-secretors in the Stonehouse survey were not significantly lower
than 100 age-matched secretors, 7 of the 8 individuals whose C3 levels were
below the lower limits of the normal range were non-secretors.67 Among
diabetic patients C3 and C4 levels are lower in those with IDDM than in those
with NIDDM or in non-diabetic individuals.64 Among patients with IDDM, we
found levels of C3 and C4 significantly lower among non-secretors compared
with secretors.69
Selective advantage of non-secretion. If non-secretors are more susceptible to
infectious agents, why does the phenotype persist? Mourant and others have
suggested that ABO incompatibility of the fetus with respect to the mother
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determines ABO haemolytic disease of the newborn and also early spontaneous
abortions. Among infants with ABO haemolytic disease there is a marked
deficiency of non-secretors. A considerable proportion of aborted fetuses are
anatomically normal, but show various degrees of necrosis. This has been
suggested to result from attack by the maternal antibodies on incompatible blood
group antigens in fetal tissues. There is a selective loss of group A and B fetuses
and neonates and this is partly controlled by the secrctor gene.70
CONCLUSIONS
The ability to secrete the ABO blood group antigens appears to play a role in
protecting individuals whose specific immune defences are compromised in some
way. The compromising factors range from absence of protective antibodies to
meningococci in young children to less well defined reduced T cell functions
observed during pregnancy. Future investigations should include examination of
the role of secretor status in development of opportunistic infections among
patients who are immunosuppressed following chemotherapy or organ
transplantation or those infected with the human immunodeficiency virus (HIV).
Identification of non-secretion as a susceptibility factor might be of predictive
value in the study of AIDS. Because HIV infection in male homosexuals and
intravenous drug users bypasses the defence of skin and mucosa, the proportion
of secretors and non-secretors in these two groups probably reflects that of the local
uninfected population. The role of secretor status in heterosexual transmission of
HIV and in development of opportunistic infections during the course of the
disease remains to be determined. If secretion plays a role in the innate host
defences, as the specific immune function declines, non-secretors might be
susceptible to organisms such as Candida earlier in the course of the disease than
secretors.
Identification of the associations of non-secretion with susceptibility to
particular infectious and autoimmune diseases provides an additional genetic
marker that can be used in epidemiological studies and in investigation of the
complex interactions that lead to these disease states. It also suggests that in light
of recent studies on the role of Campylobacter pylori in the aetiology of peptic
ulcers, the old associations of non-secretion with ulcers and with some
malignancies might be reviewed with reference to infectious aetiologies.
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FURTHER READING
In 1989 a special issue of FEMS Microbiology Immunology has been devoted to the association of
blood groups and secretor status with diseases to celebrate Dr Mourant's 85th birthday and to
recognize his contribution to initiation of these studies.
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SUMMARY
The genetically determined inability to secrete the water-soluble glycoprotein
form of the ABO blood group antigens into saliva and other body fluids is a
recognized risk factor for meningococcal disease. During a community-wide
investigation of a prolonged outbreak ofdisease due to a Bio: Pi. 16 sulphonamide-
resistant strain of Neisseria meningitidis in Stonehouse, Gloucestershire (the
Stonehouse survey), the ABO blood group and secretor status of almost 5000
residents was determined.
The proportion of non-secretors in the Stonehouse population was significantly
higher than the proportion of non-secretors among blood donors in the South West
Region and in England generally. Seven of 13 Stonehouse residents with
meningococcal disease who were tested were found to be non-secretors. a high
proportion. The outbreak in Stonehouse cannot be explained solely in terms of the
increased proportion of non-secretors. There was no clear correlation between the
proportions of non-secretors in different areas within the town and the incidence
of cases of meningococcal disease.
Carriers of meningococci, whether outbreak or other strains, were not more
likely to be non-secretors. The reasons why non-secretors are more susceptible to
meningococcal disease remain to be determined, but they do not appear to be
related to carriage of meningococci.
INTRODUCTION*
The large-scale survey undertaken in Stonehouse. Gloucestershire provided an
opportunity to examine factors that might explain the prolonged local outbreak
of disease due to serogroup B, serotype 15 Pi.16, sulphonamide-resistant (B15
P1.16R) Neisseria meningitidis (Stuart et al. 1987). The results of the bacterial
screening established that there was a low carriage rate of the B15 P1.16R strain
in a defined community at a time of high disease activity. An outbreak continuing
for several years implies that a virulent strain is moving slowly through a
susceptible community. The factors responsible for the apparent virulence of the
outbreak strain remain to be elucidated (Cartwright et al. 1987).
Environmental influences contributing to susceptibility of the host to these
infections include severe overcrowding (Kaiser et al. 1974) and passive smoking
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(Haneberg et al. 1983, Stuart et al. 1988). The former does not appear to play a
significant role in the Stonehouse outbreak. Cigarette consumption is higher
among men and women in unskilled jobs compared with those in professional
employment (Wald et al. 1988), and there was a higher proportion of household
heads with manual occupations in the two areas of the town with 14 of the 15 cases
(Stuart et al. 1987).
We have identified a genetic character that is found in a significant proportion
of patients with bacterial meningitis compared with individuals within their
respective local control populations. This is the inability of an individual to secrete
the water-soluble glycoprotein form of ABO blood group antigens (Blackwell
et al. 1986a, b). The secretor gene is inherited in a Mendelian-dominant pattern; in
most west European populations 20-25% express the recessive non-secretor
phenotype associated with increased susceptibility to meningococcal infections
(Eriksson et al. 1986; Race & Sanger, 1975). In areas of the world in which there
have been prolonged outbreaks or epidemics of meningococcal disease such as
Iceland and northern Nigeria and secretor status has been investigated, the
proportions of non-secretors in these populations are higher. In Iceland non-
secretors make up about 40% of the population (Thordarson et al. 1972), and near
Maiduguri, Nigeria almost 50% (Blackwell et al. 1988). One objective of the
survey was. therefore, to determine the proportion of non-secretors in Stonehouse.
There is a significantly higher proportion of non-secretors among patients with
rheumatic fever and also a higher proportion of non-secretors among carriers of
group A Streptococcus pyogenes (Haverkom 4. Gosling, 1969). The increased
susceptibility of non-secretors to meningococcal disease might be due to an
increased tendency to acquire the outbreak strain compared with secretors. The
second objective was to establish the proportion of non-secretors amongst carriers
of meningococci, especially those carrying the outbreak strain.
subjects and methods
The population examined has been described in detail (Stuart et al. 1987). ABO
blood groups were determined for Stonehouse residents who participated in the
study and from whom a blood sample (EDTA anti-coagulant tube) was collected.
Because contamination of saliva with blood can result in a false positive secretor
result when tested by the haemagglutination inhibition method, every eighth
specimen was tested for Lewis blood group. Secretors express Lewis6 on their
erythrocytes and non-secretors Lewis*. Generally, 3—4% of individuals express
neither Lewis* nor Lewis6 on their erythrocytes; the majority of these are
secretors by the saliva test. ABO group was determined by slide agglutination
with monoclonal anti-A and anti-B antibodies supplied by the Edinburgh and
South East Scotland Blood Transfusion Service. Lewis groups were tested by tube
agglutination with polyclonal anti-Lewis* and anti-Lewis6 antisera (Dade). All
blood specimens were processed within 24 h of collection.
Saliva specimens were frozen within 3 h of collection and transported to
Edinburgh for determination of secretor status by the haemagglutination
inhibition method (Mollison, 1979) with monoclonal anti-A and anti-B antibodies
and Ulex europaeus lectin (Sigma) for detection of H antigen (the antigen of blood
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group O). Isolation and identification of the Neisseria species from the Stonehouse
residents has been reported (Cartwright el at. 1987).
The results were analysed by the data processing system described previously
(Stuart el cd. 1987).
The Lewis blood groups of 672 randomly selected donors from the area served
by the South Western Region Blood Transfusion Service were determined by Dr
I. D. Fraser and colleagues (South Western Region Blood Transfusion Service).
RESULTS
ABO blood groups of Stonehouse residents
The distribution of the ABO blood groups among 4899 Stonehouse residents
tested is similar to that reported for England (Mourant el at. 1976): 2201 group A
(44-9%); 411 group B (8'4%); 2147 group 0 (43 8%); 140 group AB (2 9%).
Secretor status and Lewis blood groups of Stonehouse residents
Saliva specimens were obtained from 4906 (98%) of Stonehouse residents who
participated in the study (Table 1). Both the saliva tests and the Lewis blood
groups indicate there is a higher proportion of non-secretors in Stonehouse than
the predicted 20-25%. By the saliva test. 3554 ( 72*4 %) were secretors and 1352
(27-6 %) were non-secretors (Table 2). Of the 15 Stonehouse residents who had had
meningococcal infection we examined saliva specimens from 13; 7 of the 13 (54%)
were non-secretors.
Of the 672 blood donors from the South Western Regions, 40 (5-9%) were Lewis
negative and 632 were Lewis positive; of the remainder 484 (765%) were
Lewis" and 148 (23 4%) were Lewis1. Among the 598 blood specimens from the
Stonehouse study tested. 32 (5*3%) were Lewis negative; 7 (22%) were non-
secretors and 25 (78%) were secretors by the saliva test. There was no saliva
specimens from the blood donors for comparison with those from the study group;
therefore, the Lewis negative individuals of both groups were not included in the
analysis.
The difference between the distribution of Lewis groups among Stonehouse
residents, 276 Lewis" (67 3%) and 134 Lewis1 (32-7%), and the population in the
South Western Region is highly significant (x1 = 10-2, d.f. = 1, P < 0-005). The
difference between the distribution of Lewis groups among non-Stonehouse
residents in the study (e.g. children attending school in Stonehouse), 112 Lewis"
(72%) and 44 Lewis1 (28%), and the South Western Region was not statistically
significant x* ~ 1'3, d.f. = 1, P > 0-05) (Table 3).
Saliva from Lewis1 individuals (non-secretors) may give false positive secretor
results if it is contaminated with small amounts of blood as a result of poor oral
hygiene or, conversely, over-vigorous brushing of teeth. There was, however, close
agreement between the results of the saliva tests and the Lewis blood groups.
Among both residents and non-residents tested 389 were Lewis" and 371 (954 %)
were secretors. The discrepancy might be due to weak expression of the secretor
gene or to dilution of very small saliva specimens. Of the 178 Lewis1 individuals,
165 (92-7%) were non-secretors by the saliva test.
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Table 1. Specimens tested from participants in Stonehouse survey for secretor state
and Leu-is blood groups by area of residence
Participants Saliva Lewis*
Pop¬ r A A , ▲ \ blood Partici¬
ulation So. (%) No (%) specimens pants (%)
Park Estate 1729 1273 (73-6) 1264 (99-3) 119 (9-4)
Verney Fields 1836 1216 (66-2) 1184 (97-4) 103 (8-7)
Little Australia 869 750 (86-3) 738 (98-4) 61 (8 3)
Rosedale 1423 1226 (86 2) 1188 (96-9) 102 (86)
Bndgend 778 541 (69-5) 532 (98 3) 25 (4 6)
Total 6635 5006 (75-4) 4906 (98) 410 (8 4)
Secretor status and Leu-is blood group distribution by area of residence in
Stonehouse
The numbers of specimens tested for secretor status and Lewis group for the five
areas of Stonehouse are shown in Table 1. Table 2 compares the secretor status and
Lewis blood group distributions by area of residence in Stonehouse. While there
is close agreement between the saliva tests and Lewis groups for Rosedale and
Bridgend areas, the results suggest that the proportion of non-secretors in Park
Estate. Little Australia and Verney Fields is underestimated by the saliva test.
Except for Rosedale, the proportion of Lewis* individuals was over 30%; Park
Estate-33%, Verney Fields-36%, Little Australia-38% and Bridgend-33%.
There was no significant difference in the proportion of Lewis* individuals.
When secretor status was analysed by age bands, the highest proportion of non-
secretors was found in the 0-4 and 5-9 age groups (Table 4).
Distribution of secretors and non-secretors in Stonehouse schools
By the saliva test there were no significant differences in the proportions of
secretors and non-secretors attending state or private schools in Stonehouse.
although most children attending private schools were not Stonehouse residents.
The number of pupils for whom Lewis blood group was determined was small, but
the results suggest that the numbers of non-secretors were underestimated,
particularly among those at the state schools.
Among the schoolchildren tested for Lewis group the proportion of Lewis*
individuals among the 122 from state junior and 3tate secondary schools was 37%
compared with 28% among 75 pupils from the corresponding private schools; but
the difference was not statistically significant.
Carriage of Neisseria species and secretor status
Among the 69 Stonehouse residents who were carriers of the outbreak strain we
examined saliva specimens from 67; there were 47 secretors (70%) and 20 non-
secretors (30%). Among the carriers of the non-outbreak strains. 327 (71 %) were
secretors and 132 (29%) were non-secretors (Table 5).
Tables 6 and 7 include data for carriers resident in Stonehouse as well as non¬
residents. There were no significant differences in the proportion of non-secretors
among the carriers analysed by serogroup (Table 6). There were no differences in
the proportion of non-secretors carrying serotypable strains (31 %) compared with
those carrying non-serotypable strains (31%) (Table 7).
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Table 3. Secretor state of Stonehouse residents compared with UK as a whole
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Table 4. Secretor state and number of cases in Stonehouse by aye group
Secretors Non-secretors
-A A No.r r ■ s
-4g« Number No. (%) No. (•/.) cases
0—4 296 199 (67-2) 97 (32-8) 2
5-9 434 299 (68-9) 135 (31-1) 7
10-14 362 275 (76) 87 (24) 4
15-19 384 276 (719) 108 (28 1) 0
20-24 308 278 (73-2) 102 (26-8) 0
25-34 807 568 (704) 239 (29-6) 1
35-44 674 487 (72-3) 187 (27-7) 0
45-54 439 325 (74) 114 (26) 1
55-64 507 366 (72-2) 141 (27 8) 0
65 + 647 462 (71-4) 185 (28 6) 0
Total 4930 3535 (71-7) 1395 (28-3) 15















Carriage of Neisseria lactamica among Stonehouse residents was analysed with
regard to age and secretor status (Table 8). The proportion of non-secretors among
the carriers was similar to the proportion of non-secretors in the age band.
DISCUSSION
There is a significantly higher proportion of individuals with Lewis* blood group
in Stonehouse compared with blood donor controls from the South Western
Region and other English populations studied (Table 3). Although the saliva test
underestimates the numbers of non-secretors, comparison of the results with data
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Table 6. Distribution of secretors and non-secretors among carriers of serogroupable




No. (%) No. (%)
Serogroupable 262 (72) 104 (28)
A 3 3 —
B 211 151 (72) 60 (28)
C 32 23 (72) 9 (28)
W135 22 15 m 7 (32)
X 4 4 0
Y 53 35 (66) 18 (34)
Z 29 22 (76) 7 (24)
Z/29E 19 13 (68) 6 (32)
29E 12 9 (75) 3 (25)
Non-serogroupable 309 209 (68) 100 (32)
Table 7. Distribution of secrelors and non-secretors among carriers analysed by
serotype of X. meningitidis
Secretors Non-secretors
Total No. (%) No. (%)





Pi.16 25 13 (52) 12 (48)
Pi.2 77 52 (68) 25 (32)
PI .3 33 27 (82) 6 (18)
15 67 41 (61) 26 (39)
15 Pi 16 74 55 (74) 19 (26)
Non-typable 260 180 (69) 80 (31)
from 10 pooled studies of English populations in which saliva was tested for ABH
secretion (Mourant et at. 1976) shows a higher proportion of non-secretors in
Stonehouse.
The relative risk of non-secretors developing meningococcal disease in
Stonehouse was 24 (95% confidence interval 1-3 to 4 3). This is similar to the
relative risk calculated from previous studies in Iceland (1-7), Nigeria (2 9) and
Scotland (6 2) (Blackwell el al. 1988). If there had been 23% (the South Western
Region percentage) instead of 33% non-secretors in Stonehouse with the same
attack rate and the same relative risk (2-4), the number of cases would have been
136 instead of the 15 observed.
Non-secretors appeared to be more likely to be cases within Park Estate than
secretors. In Park Estate 33 % of the residents tested were Lewis* compared with
5 of the 8 cases (62 5%) tested. In Verney Fields 36% of the residents were
Lewis* compared with 2 of the 5 cases (40%). These figures indicate a trend, but
are too small for statistical analysis.
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Table 8. Secretor state and age of X. lactamica carriers in Stonehouse
Secretors Non •secretors
No. r A A i , Non-secretors in
Age isolates No. (V.) No. (%) Stonehouse (%)
0-4 46 ■26 (62) 16 (38) 32-8
5-9 20 14 (70) 6 (30) 31 1
10-U 11 6 (53) 5 (45) 24
15-19 11 7 (64) 4 (36) •28 1
20-24 10 7 (70) 3 (30) 268
25-34 27 19 (73) i (27) 29-6
35—44 1 7 0 27-7
45-54 6 6 0 26
55-64 5 4 1 27-8
65 + 4 2 2 286
Total 147 98 (69) 44 (31)
These results suggest that while the proportion of non-secretors who are more
susceptible to bacterial meningitis is significantly higher in Stonehouse, it is not
sufficient of itself to explain the outbreak.
Our suggestion that blood contamination might account for differences between
the saliva tests and Lewis blood groups is supported by detection of Lewis*
antigen in the saliva of a number of 'secretors' by a recently developed ELISA
with monoclonal antibodies (unpublished observations). The higher proportion of
non-secretors in the under-10 age group might reflect less periodontal disease. In
developed countries, periodontal disease is uncommon before puberty, but the
frequencv of disease begins to rise in the circumpubertal period (11-14 vears)
(Murray* 1983).
Blood contamination of the saliva could be due to inadequate oral hygiene
which is often associated with poor economic background (Waerbaug, 1971:
Murray, 1983). There were 21 pairs of blood and saliva specimens from Stonehouse
residents in which there was disagreement between the results of the saliva test
and the Lewis group. Of the 8 Lewis1/secretor pairs (false secretors), 7 were from
residents of Verney Fields and Park Estate where 14 of the 15 cases of meningitis
occurred. The other was from a resident of Little Australia. Of the 13 Lewis"/non-
secretor specimens, 4 were from residents of Park Estate and Verney Fields and
9 from the other three areas.
Agreement between the saliva test and Lewis blood groups was better in areas
where socioeconomic levels were higher - Rosedale and Bridgend (Table 3). In
Park Estate and Verney Fields where most of the cases of meningococcal disease
occurred, the proportion of non-secretors found by the saliva test is lower than
that indicated by the proportion of Lewis1 individuals, and there was a higher
proportion of household heads in semi-skilled/unskilled occupations. There were
no cases of meningococcal disease in Little Australia which had the highest
proportion of Lewis1 individuals (38%) but the lowest proportion of non-secretors
by the saliva test (24-7 %). In this area there was a higher proportion of household
heads with skilled jobs than in Park Estate and Verney Fields. The sampling in
Little Australia was not as random as in other areas of the town; over half
(13/23) of the Lewis1 specimens were from residents in 3 of the 12 postcode areas.
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Of the 61 blood specimens tested from Little Australia for Lew-is group, there were
only 3 in which the saliva test did not agTee with the Lewis group; 1 was
Lewis*/secretor and 2 LewisVnon-secretor. The number of individuals in Little
Australia tested for Lewis group was smaller, which might account for the
differences observed for the two tests.
Factors associated with poorer socioeconomic background contribute to
susceptibility to infectious diseases. Smoking which might be important in the
transfer of meningococci from one individual to another is more prevalent among
manual and unskilled workers (Wald et at. 1988).
The increased susceptibility of non-secretors to meningococcal infection is not
associated with an increased carriage rate of the Bio Pi. 16 strain. As previous
studies (Blackwell et at. 1988) have shown a higher proportion of non-secretors
among patients with infection due to the three major serogroups of meningococci
(serogroups B and C were predominantly isolated from the Icelandic and Scottish
patients, serogroups other than B from the Nigerian patients), we did not expect
to find an association between secretor status and carriage of any particular
serogroups (Table 6). If the protein serotype antigens participate in lectin
mediated attachment to carbohydrates on epithelial cells, the carbohydrate
moieties of ABO or Lewis" antigens present in the body fluids of secretors might
bind to the bacteria reducing attachment of meningococci to epithelial cells. No
consistent patterns was observed; the proportion of non-secretors was the same
among carriers of either serotypable or non-serotypable strains.
The prolonged outbreak of disease due to the Bio Pi.16 meningococcus in
Stonehouse can be partly explained by the significantly higher proportion of non-
secretors compared with the South Western Region in general. Our results do not
parallel the model suggested for rheumatic fever in which a higher proportion of
non-secretors was found among the carriers of group A streptococci (Haverkom k
Gosling. 1969). The increased susceptibility of non-secretors has yet to be
explained but it does not appear to be due to increased carriage of these
organisms.
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with infectious diseases (Tables 1 and 2) and
recently we have found higher proportions of
non-secretors among patients with autoimmune
conditions such as ankylosing spondylitis, insulin
dependent diabetes mellitus and Graves' disease
for which infectious aetiologies have been sug¬
gested (Table 3).
Among patients with autoimmune diseases for
which infectious aetiologies have been postulated,
there has been no striking association with ABO
groups, but non-secretors are found in signifi¬
cantly higher proportions in a number of these
patient categories (Table 3). Particular HLA
markers or combinations of markers have been
found to be over represented in several of these
groups, but the existence of additional genetic
susceptibility factors outside the HLA cluster on
chromosome 6 has been predicted. The association
with non-secretion is the first, albeit indirect, evi¬
dence for involvement of infectious agents. Non-
secretion might predispose individuals of the sus¬
ceptible HLA type to the infectious agents that
trigger the disease process.
A review of the data on secretor status of
different ethnic groups in the context of epidemio¬
logical data for some of these autoimmune dis¬
eases presents some striking findings. Insulin de¬
pendent diabetes is rare among American Indians
and Eskimos and compared with Caucasians,
1. SUMMARY
Epidemiological studies on the associations be¬
tween ABO blood group antigens, secretor status
and susceptibility to infectious agents are sum¬
marized. Evidence for association of non-secretion
with some autoimmune diseases for which infec¬
tious aetiologies have been proposed is also given.
Several hypotheses are proposed to explain the
host-parasite interactions underlying the epide¬
miological observations, and evidence to support
or refute them is presented.
2. INTRODUCTION
'Much more attention should be given to the
combined effects of blood group and secretor
state on susceptibility to bacterial infections' [1],
The following papers represent current thinking
on this previously neglected topic, illustrating the
accumulating evidence of its real significance.
In the first article, Dr. Arthur Mourant outlines
the epidemiological evidence for associations be¬
tween ABO blood groups and secretor status with
susceptibility not only to infectious diseases but
also to other conditions such as carcinoma and
ulcers [2], There is now a relatively large body of
evidence for the association of these characters
0920-8534/89/S03.50 © 1989 Federation of European Microbiological Societies
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Table 1 Table 2
Associations between ABO blood groups and susceptibility to
infection




































Group A not O 34
Streptococcus
pneumoniae not B 9
Influenza A2 O 56












non-secretors are very much the minority (0-2%)
in these populations. The Haida Indians of British
Columbia have an unusually high incidence of
ankylosing spondylitis, and they are exceptional in
that the proportion of non-secretors among them
is similar to that of Caucasians (25%) [3]. These
observations parallel those of Eriksson et al. [4]
that autoimmune diseases and autoantibodies are
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Distribution of blood-group activity among Gram-negative bacteria [7,11]
Genus Strains A B H(O) A BH(O) A B AH(O) BH(O) Inactive
tested
Escherichia 135 8 18 22 6 3 3 4 71
Salmonella 19 1 2 9 0 0 I 0 6
Arizona 3 0 I 1 0 0 0 1 0
Klebsiella 42 2 6 4 3 1 1 5 20
Curobacter 24 2 2 2 0 2 2 3 11
Pasteurella 8 0 1 0 0 0 0 2 5
Proteus 20 0 6 2 0 0 0 1 11
Pseudomonas 15 1 1 2 0 0 1 0 10
Serratia 2 0 0 2 0 0 0 0 0
A lealIrenes 8 0 0 0 0 0 1 1 6
Shigella 5 0 0 0 0 0 0 0 5
Herrela 1 0 0 0 0 0 0 0 1
.V. gonorrhoea 6 6 6 - - 6 - - 0
Lapp populations in the same geographic regions,
they have lower proportions of non-secretors
(2-5%) [5],
Although both blood group and secretor status
are stable, easily determined host characters, the
host-parasite interactions underlying these epide¬
miological observations have not previously been
actively pursued, probably for several reasons.
First, there have been conflicting reports by differ¬
ent groups of researchers. Different blood group
associations have been found for the same infec¬
tion. One explanation is that different strains of
microorganisms were present in the populations
examined in each study. Foster and Labrum [6]
found a higher incidence of the blood group B
gene among women attending an antenatal clinic.
These were predominantly American black wo¬
men. A similar increase in the incidence of blood
group B individuals among patients with gonor¬
rhoea was reported for British Caucasians, but not
British blacks [7], Although there is a higher pro¬
portion of individuals of blood group B in the
Scottish population we examined, there was a
significant increase in the proportion of B individ¬
uals among patients with gonorrhoea [8]. In con¬
trast, no unusual distribution of any of the ABO
groups was found among male patients with
symptomatic gonococcal infections [9]. Different
associations with ABO blood groups reported for
susceptibility to natural or experimental viral in¬
fections might depend on the particular strain
examined in the study (Table 1).
The main reason why these studies did not
progress much beyond the descriptive epide¬
miology stage is that there was only one hypothe¬
sis suggested to explain the observations. A num¬
ber of microorganisms have been shown to possess
surface antigens that cross react with the A, B and
H antigens [7,10,11] (Table 4), and some have
been shown to incorporate blood group antigens
into their cell envelopes [12]. It was suggested that
the anti-A and anti-B isohaemagglutinins might
act as 'natural antibodies' for strains with these
surface antigens.
Advances in research on protein-carbohydrate
interactions involved in pathogenesis of infectious
diseases have suggested new approaches for ex¬
amining the epidemiological findings. Microbial
adhesins can bind to peptides, but it appears that
carbohydrates are preferentially selected, probably
due to the abundance of carbohydrate containing
compounds on animal cell surfaces [13]. Since the
ABO and Lewis antigens (the expression of the
latter is regulated by the secretor gene) are some
of the most extensively characterized carbohy¬
drates in man, they are prime candidates for these
investigations. A brief review of the genetics,
structure and biosynthesis of the blood group
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antigens is presented in this volume [14] as well as
a review of carbohydrate-protein interactions in
pathogenesis of infections [15].
Our recent studies on secretor status and sus¬
ceptibility to a number of infectious agents sug¬
gest that the ability to secrete might be one of the
host factors contributing to innate defences, re¬
gardless of ABO blood group. The protective ef¬
fect of the secretor gene is observed particularly
among groups of individuals who are immuno¬
compromised in some way. The clearest example
is bacterial meningitis. There is a significantly
higher proportion of non-secretors among patients
with invasive disease due to Neisseria meningitidis,
Haemophilus influenzae and Streptococcus pneumo¬
niae, the three pathogens responsible for 75% of
bacterial meningitis [16,17], These are infections
that occur predominantly during the period in
which maternal antibodies have waned and the
child has not yet developed his own active immun¬
ity (about 6 months to 4.5 years of age) [18]. A
higher proportion of non-secretors was also ob¬
served among patients with infections caused by
Candida species, but this association was noted
among those groups who are thought to be im¬
munocompromised in some way, e.g. pregnant
women and patients of both sexes with histories of
recurrent oral candidiasis [19].
The hypotheses proposed below are not mutu¬
ally exclusive; these various host-parasite interac¬
tions might often overlap in vivo. Details of evi¬
dence obtained to support or refute these models
are given in papers in this collection. A brief
overview of these hypotheses is provided here.
3. ANTI-A AND ANTI-B ISOHAEMAG-
GLUTININS ARE 'NATURAL' BACTERI¬
CIDAL OR OPSONIC ANTIBODIES FOR
SOME STRAINS OF MICROORGANISMS
Evidence for this mechanism comes from the
work of Reed et al. [12,19] on host susceptibility
to infections caused by Streptococcus pneumoniae
(see [20] for details) and the demonstration of
bactericidal and opsonic activity of anti-B for
Escherichia coli 086 [21,22], Although there ap¬
pears to be a synergistic effect between the B gene
and non-secretion on susceptibility to recurrent
urinary tract infections [23], we were unable to
demonstrate any role for isohaemagglutinins as
natural antibodies for the 8 serotypes of E. coli
most commonly isolated from women with urinary
tract infections [24],
Our investigation of the possible role of iso¬
haemagglutinins in the association between B
blood group and gonorrhoea found that the 'natu¬
ral' bactericidal activity of human serum for
gonococci was not associated with isohaemag¬
glutinins [25]. The anti-A and anti-B antibodies
did, however, enhance binding of the bacteria by
human monocytes, and those of group B bound
greater numbers of the strain tested than
monocytes of the other ABO blood groups [26], In
the context of the hypothesis that gonorrhoea is a
disease of the human macrophage [27], the en¬
hanced binding/uptake of gonococci by group B
monocytes might contribute to the increased sus¬
ceptibility of B individuals to this disease [26,28],
The greater numbers of bacteria ingested by their
monocytes are able to survive the actions of both
humoral and cellular defences and form more of
the 'infectious units' of bacteria and cellular de¬
bris observed in the electron microscopy studies of
pus [27],
A similar set of interactions might explain the
increased incidence of group B patients with dis¬
seminated coccidioidal infections [29] as the yeast
expresses a surface antigen that cross reacts with
blood group A antigen [30], The anti-A iso-
haemagglutinin of B individuals would act as a
'natural opsonin' for the yeasts expressing the
A-like antigen on their surfaces.
4. THE ABO OR LEWIS ANTIGENS ARE RE¬
CEPTORS FOR ADHESINS ON SOME
STRAINS OF MICROORGANISMS
Although there is no direct evidence that the
carbohydrate moieties of these antigens are recep¬
tors for bacterial adhesins, the P blood group is a
receptor for fimbrial adhesins expressed on strains
often isolated from patients with pyelonephritis
[31] and the Duffy blood group antigen is a recep¬
tor for the malaria parasite, Plasmodium knowlesi
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[32]. We have observed greater binding of N.
gonorrhoeae to uroepithelial cells from young wo¬
men of blood group B compared with cells from
those of group A [28]. There is also evidence that
the Anton antigen is one of the receptors for H
influenzae [33.34], and Lewis a appears to be one
of the receptors for some Candida isolates [35.36].
5. THE ABH OR LEWIS b ANTIGENS IN THE
BODY FLUIDS OF SECRETORS CAN BIND
TO LECTIN-LIKE ADHESINS ON THE
SURFACE OF MICROORGANISMS AND IN¬
TERFERE WITH THEIR ATTACHMENT TO
TARGET CELLS
This might affect carriage or degree of coloni¬
zation of the mucosa by potentially pathogenic
microorganisms. There is a higher proportion of
non-secretors among patients with rheumatic fever
and also a higher proportion of non-secretors
among carriers of group A Streptococcus pyogenes
[37], A significant increase in the proportion of
individuals of group O and of non-secretors of all
ABO blood groups was found among carriers of
Candida albicans in a healthy population [38].
One of the properties of lectin adhesins is their
inhibition by the specific sugars involved in their
protein-carbohydrate interactions. If the ABH or
Lewis b antigens are host receptors for some of
the adhesins involved in colonization, the glyco¬
protein forms of these substances in the body-
fluids of secretors might inhibit the ability of the
microorganism to bind to the host's mucosa. As
early as 1975. inhibition of attachment of
Streptococcus saliuarius to epithelial cells by-
salivary glycoproteins with blood group activity-
had been reported [39], and we have found
heat-treated saliva from secretors to inhibit bind¬
ing of Candida to epithelial cells [19],
6. THE LEWIS a ANTIGEN FOUND PRE¬
DOMINANTLY ON THE CELLS OF NON-
SECRETORS IS ONE OF THE RECEPTORS
FOR LECTIN-LIKE ADHESINS OF SOME
MICROORGANISMS
Lomberg et al. [40] found that binding of
uropathogenic strains of E. coli to target cells was
not associated with the density of the P antigens.
They observed that higher numbers of these
bacteria bound to cells obtained from non-secre¬
tors. Since one of the major antigenic differences
between secretors and non-secretors is the pre¬
dominance of Lewis * in non-secretors, we ex¬
amined the hypothesis that blocking the Lewis J
antigen might reduce binding of some strains of
microorganisms to non-secretor cells. Our evi¬
dence suggests Lewis J might be one of the recep¬
tors for some strains of Candida [35,36].
7. A PRODUCT OF THE SECRETOR GENE
ALTERS THE RECEPTOR FOR SOME MI¬
CROBIAL ADHESINS OR MOLECULES
NEAR THESE RECEPTORS REDUCING THE
NUMBERS OF MICROORGANISMS BOUND
There is as yet no published evidence for this
hypothesis but it was suggested by Lomberg and
coworkers to explain the higher numbers of
bacteria bound to cells of non-secretors [40].
8. THE LOWER LEVELS OF SERUM [41] AND
SALIVARY IgA [42] REPORTED FOR NON-
SECRETORS CONTRIBUTES TO A COM¬
PROMISED STATE AT THEIR MUCOSAL
SURFACES
The mass screening of the residents of
Stonehouse for carriage of meningococci [43] pro¬
vided an opportunity to examine the levels of
serum and salivary antibodies among carriers and
non-carriers matched for age. sex and secretor
status. We were unable to confirm the report of
lower levels of IgA in the saliva of non-secretors
for whom no neisseriae were isolated. The levels of
IgA in the saliva of both secretor and non-secretor
carriers of N. meningitidis were however signifi¬
cantly higher than those of non-carriers [44]. The
levels of salivary IgA among secretors or non-
secretors carrying the non-pathogenic Neisseria
lactamica did not differ from those of the non-car¬
riers [20].
We were able to confirm the reported lower
serum IgA levels among non-secretors from whom
no neisseriae were isolated. The non-secretors from
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whom serogroupable strains were isolated had sig¬
nificantly increased levels of IgA than the non-
secretors who did not carry meningococci [20],
The possible role of serum IgA acting as blocking
antibodies is discussed in the article in this volume
on bacterial meningitis [20].
In contrast to our predictions that non-secre-
tors might have impaired IgA responses, non-
secretor women with recurrent urinary tract infec¬
tions had significantly higher levels of total serum
IgA than the secretors. The levels of total serum
IgA among non-secretors who had improved over
the 20 year period were higher than those found
for secretors who had improved. No differences
were found between these immunoglobulin levels
for secretors and non-secretors who had not im¬
proved or in whom there was no change in the
number of infections [45]. The results of both
studies suggested that there is a difference in the
IgA responses of secretors and non-secretors to
colonization/infection and that non-secretors
might be more dependent on their specific im¬
mune responses than secretors to deal with these
infections.
These apparent differences in the specific im¬
mune responses of secretors and non-secretors
require further investigation for their possible con¬
tributions to prevention of infections and also to
their possible contributions to pathogenesis of
some infections [20.46].
9. AS THE SECRETOR GENE AND THE
STRUCTURAL GENE FOR THE THIRD
COMPONENT OF COMPLEMENT (C3) ARE
IN THE SAME LINKAGE GROUP. THERE
MIGHT BE DIFFERENCES IN THE LEVELS
OF C3 FOUND IN SECRETORS AND NON-
SECRETORS
Among the group from whom no neisseriae
were isolated in the Stonehouse study, the levels of
C3 found for non-secretors were slightly lower
than those of the secretors. In this group there
were 8 individuals in whom C3 levels were below
the 'normal' range; 7 of these were non-secretors
[44], The donors with these low levels of C3 were
not the very- young children in the survey (Fig. 1).
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Fig. 1. C3c levels of secretors and non-secretors.
Lower levels of C3 and C4 complement compo¬
nents have been found among patients with in¬
sulin dependent diabetes [47] but not among those
with non-insulin dependent diabetes [48]. Our
finding of a significant increase in the proportion
of non-secretors among insulin dependent diabet¬
ics [49] prompted us to determine their C3 and C4
levels. Both these complement components were
significantly lower in the non-secretors [50]. Any
functional differences in the activities of C3 and
C4 between secretors and non-secretors in the
patient and control groups remain to be de¬
termined.
10. CONCLUSIONS
The main value of these studies is that they
provide stable host markers that can be used in
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investigation of host-parasite interactions involved
in a number of infectious diseases as well as
intriguing observations such as the one alluded to
by Dr. Mourant — the association between the
old observation of an increase in the proportion of
non-secretors among patient with ulcers and the
newer association of ulcers with the presence of
Campylobacter pylori [1], Isolation of adhesins on
microorganisms that recognize blood group anti¬
gens and assessment of their immunogenicity
might provide new approaches to prevention of
colonization and subsequent infections. Examina¬
tion of the differences in levels and functional
activity of C3 and C4 complement components of
secretors and non-secretors will be of value in
studies of the susceptibility to infection, particu¬
larly among patients with diabetes. The dif¬
ferences between the immune responses of secre¬
tors and non-secretors following natural infections
or immunization might provide new insights into
(1) the role of different isotypes in relation to
pathogenesis and prevention of infections, (2) the
role of different isotypes in development and
clearance of immune complexes in the pathogenic
sequelae of infections (3) the role of infectious
agents as triggers for some autoimmune diseases.
Future work in this area should include ex¬
amination of patients who are immunosuppressed
to determine if secretion of blood group antigens
plays a role in prevention of opportunistic infec¬
tions. These would include individuals receiving
chemotherapy or radiotherapy or those undergo¬
ing organ or bone marrow transplants. Of particu¬
lar interest would be individuals with HIV infec¬
tions. Because the route of infection in in¬
travenous drug users bypasses the defences of the
mucosa, one would predict the proportion of
secretors and non-secretors with antibodies to the
virus in this group would reflect those of the local
population. Non-secretors whose immunity to a
specific pathogen is absent or reduced (e.g.. preg¬
nancy) appear to be more susceptible to infection.
Non-secretors with HIV infections might be those
who have problems with opportunistic pathogens
earlier in the course of the disease as their immune
responses become compromised.
No work has been published on secretor status
and viral infections. Such studies might be of
considerable value not only in elucidating host
factors influencing susceptibility to viral infection
but also in examining the role of viruses in the
development of invasive bacterial diseases such as
pneumonia and meningitis, autoimmune diseases
such as insulin dependent diabetes and malignant
disorders for which there is an association with
non-secretion.
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A.E. Mourant: a biographical note in celebration
of his 85th birthday
Arthur Ernest Mourant was born in Jersey 11
April 1904 and was educated there at Victoria
College. In 1922 he went up to Exeter College.
Oxford with a King Charles 1 scholarship where
he obtained a first class honours degree in Chem¬
istry in 1926. He was awarded the Burdett-Coutts
Scholarship for geological research and received
his D. Phil in Geology from Oxford in 1931.
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For two years he was a probationer geologist
with the Geological Survey of Great Britain. For¬
tunately for the field of blood groups and serol¬
ogy, he failed to be awarded a Commonwealth
Fellowship for a research project to seek evidence
in the Eastern United States for the theory of
continental drift!
At the age of 34 he became a medical student
at St. Bartholomew's Hospital and received his
MBChB degree from Oxford in 1943 followed by
his M.D. in 1948. The problems generated by the
increased demand for blood transfusion during
World War II largely involved the new field of
serology. Arthur Mourant was a pioneer in this
area as a medical officer in the National Blood
Transfusion Service, during which time he dis¬
covered two new blood groups. There followed a
period of research at Cambridge with R.R. Race
and R.R.A. Coombs, when the Coombs anti¬
globulin test was developed and should perhaps be
more correctly known as the Coombs-Mourant-
Race test, as all three were involved in the work.
This test was central to the methods used for the
discovery by Race, Mourant and others of many
of the blood groups now known.
In 1946, Arthur Mourant became the founder
director of the Blood Group Reference Labora¬
tory, later recognised by the World Health
Organization as the International Blood Group
Reference Laboratory. His interest in the distribu¬
tion of the blood group polymorphisms continued
and he compiled the published and unpublished
studies in several books that have been of compel¬
ling interest to physical anthropologists as well as
to biomedical scientists and clinicians. One re¬
markable fact is that the following texts were all
prepared before the availability of computerized
databases: The Distribution of Human Blood
Groups (1954); The ABO Blood Groups, Compre¬
hensive Tables and Maps of World distribution
(1958); The Distribution of the Human Blood
Groups and Other Biochemical Polymorphisms
(1976); Blood Groups and Diseases (1978) and
The Genetics of the Jews (1978).
The honours he has received reflect the wide
range of his contributions: Oliver Memorial Award
for services to Blood Transfusion (1952); Presi¬
dent, Section H (Anthropology). British Associa¬
tion for the Advancement of Science (1956); Hux¬
ley Memorial Medal, Royal Anthropological In¬
stitute, London (1961); Fellow of the Royal Society
of London (1966); Landsteiner Memorial Award.
American Association of Blood Banks (1973);
Marett Memorial Lecture, Exeter College, Oxford
(1978); Worth Award, Geological Society of
London (1982); Osier Memorial Medal, Univer¬
sity of Oxford (1980); Honorary Citizen of Tou¬
louse (1985). He is an honorary member of
Sociedad Peruana de Patologia, Societe Jersiaise,
International Society of Blood Transfusion, British
Society for Haematology, Society for the Study of
Human Biology, and the first and only honorary
member of the Human Biology Council. He has
been or still is a member of the editorial board of
7 scientific journals.
In 1976 Arthur Mourant officially retired as
Director of the Serological Population Genetics
Laboratory in London, but he has continued to
follow his various interests from his 'retirement'
home in Jersey. In 1982 I joined the worldwide
network of his correspondents and have often
wondered how he finds time for retirement activi¬
ties such as photography and the local historical,
archaeological and geological societies.
I, and I am sure many others, have benefited
from his advice and encyclopaedic memory for
early references. This special issue is an attempt to
.bring together the recent advances on the associa¬
tion of blood groups and secretor status with
infectious diseases which he suggested many years
ago would be a fruitful area of investigation. With
its publication go all good wishes for a happy 85th
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1. SUMMARY
In a study of 718 women referred for specialist
investigation for recurrent urinary tract infections,
250 (34.8%, P < 0.01) were non-secretors. The
proportion of non-secretors among the women
with renal scars (42.6%) was higher than that
found for women with no evidence of renal scars
(36.6%). Among 29 patients in whom symptoms
began in childhood or adolescence, 51.7% were
non-secretors. The proportion of non-secretors
among individuals with renal scars in this study
(42.6%) and that reported in the accompanying
paper for Swedish children (40%) suggests that
non-secretion might influence the pathogenic
sequelae of these infections. Possible host-para¬
site interactions underlying the increased propor¬
tion of non-secretors among women with recur¬
rent urinary tract infections and those leading to
development of renal scars are discussed.
Correspondence to: C.C. Blackwell. Department of Bacteriol¬
ogy, The Medical School, University of Edinburgh. Edinburgh,
U.K.
2. INTRODUCTION
Recurrent urinary tract infections are common
problems among women and girls. It has been
estimated that approximately 50% of women will
have at least one urinary tract infection during
their lives [1], Despite the availability of anti¬
bacterial agents with good in vitro activity, recur¬
rent infections occur in a number of women. Some
failure in the host defences has been suggested to
-underly this problem [2].
Although uncomplicated lower urinary tract in¬
fections rarely lead to renal damage [1], infections
of the upper urinary tract can result in renal
scarring. Scarring following urinary tract infec¬
tions occurs in young children, most of whom are
under the age of 5 [3]. This is the age range in
which maternal antibody has waned and the child's
immune system is not fully developed. It is also
the same age range in which bacterial meningitis is
most prevalent [4], The increased proportion of
non-secretors among patients with bacterial
meningitis suggested secretion of blood group an¬
tigens might play a role in the host's innate de¬
fences against infection during this vulnerable
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Table 1
Secretor state of patients with urinary tract infections
Reference Total No. % P
no. non-secretor non-secretor
Adults
Edinburgh study 161 718 250 34.8 < 0.01
20 year study group 202 78 38.6 <0.01
without renal scars 146 53 36.6 <0.05
with renal scars 54 23 42.6 <0.01
juvenile onset 29 15 51.7 <0.01
controls [81 334 89 26.6
Children
Swedish study [7]
patients with UTI 77 23 29 NS
without renal scars 42 9 21 NS
with renal scars 35 14 40 <0.05
controls [271 954 208 21.3
NS. not significant.
period. There was, indeed, a significantly higher
proportion of non-secretors among the women in
our study with juvenile onset of symptoms (51.7%)
and among those with renal scars (42.6%) [5,6].
The proportion of non-secretors among our
patients with renal scars is similar to those re¬
ported in the accompanying study of 77 Swedish
children (40%) [7] (Table 1). Here we wish to
consider possible host-parasite interactions re¬
sponsible for the increased susceptibility of non-
secretors to recurrent infections and those that
might result in development of renal scars follow¬
ing urinary tract infection.
3. EPIDEMIOLOGY
3.1. Host factors
In comparison with local controls (26.6%) [8],
there was a significant increase in the proportion
of non-secretors (34.8%, P<0.01) among women
referred to the Pyelonephritis Clinic for investiga¬
tion of recurrent urinary tract infections. Among
Swedish children followed from their first known
episode of pyelonephritis, there was an increase in
the proportion of non-secretors (29%), but this
increase was not statistically significant [7], De¬
termination of secretor status of a larger number
of children with urinary tract infections might
provide results similar to those for adults.
Among patients in both groups with renal scars,
the proportion of non-secretors was significantly
increased, 42.6% for the Scottish women and 40%
for the Swedish girls. As renal scarring usually
occurs before the age of 5, scarring found among
adults probably reflects damage during childhood.
None of the women in the study developed scars
during the 20 years they were followed [9].
The results of these two studies support the
concept that there are common host factors in the
subset of individuals who develop scars. Host
factors such as vesicoureteral reflux [10] and age
[3] have been identified. Both indicate that non-
secretion is another factor found among a sub¬
stantial proportion of individuals who sustain this
type of kidney damage.
3.2. The bacteria
In both the Scottish [6,11] and Swedish studies
[7], the numbers of infectious episodes among the
patients with scars did not differ from those
without scars. Although we had predicted the more
virulent strains would be isolated from the more
susceptible non-secretors, our study characterizing
E. coli strains from secretors or non-secretors
found that fewer of the strains from non-secretors
expressed mannose-resistant haemagglutinins
and/or haemolysin. Similar observations have
been made for isolates from the Swedish children.
The strains obtained from children who developed
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renal scars were not those with the virulence asso¬
ciated mannose-resistant fimbriae that attach to
the P blood group antigen. [Lomberg et al„
manuscript in preparation]. These studies have led
both our group and the Goteborg group to con¬
sider that the host's response to the invading
strain might play a significant role in the patho¬
genesis of kidney scarring.
3.3. The immune responses of secretors and non-
secretors to urinary pathogens
It has been suggested that the ability to secrete
the ABO antigens might play a role in the host's
innate defences influencing attachment/coloniza¬
tion of the urinary tract mucosa by pathogenic
bacteria [11-13]. Evidence is accumulating to sug¬
gest that secretor status might also influence both
the inflammatory responses and the specific im¬
mune response to uropathogenic strains of E. coli
[6],
The C3 gene is located in the same linkage
group as the secretor gene. We found lower levels
of C3 among non-secretors, but the differences
were not significant. Among the 8 individuals in
whom C3 was below the normal range, 7 were
non-secretors [13,14]. As C3 plays a role in de¬
fending the host from infection by both the classi¬
cal and the alternative complement pathways, this
might be a useful area to explore.
Lower levels of both serum [15] and secretory
[16] IgA have been reported for non-secretors. We
tested the hypothesis that if non-secretors re¬
sponded less effectively to colonization/infection
of their mucosal surfaces, this might contribute to
their susceptibility to recurrent urinary tract infec¬
tions. Secretory IgA levels among young girls with
recurrent urinary tract infections were reported to
be lower than those of age matched controls [17],
The results of the study refuted this hypothesis.
Among the women followed for 20 years by the
local pyelonephritis clinic, non-secretors had
higher levels of both IgA and IgG. This suggested
that they were more dependent than secretors on
their specific immune responses. Regardless of the
age at which symptoms of infection began or the
therapy prescribed for these patients, the majority
(127/202) improved over the 20 years. They had
fewer episodes of infection during the second de¬
cade compared with the number during the first
decade. Among those who improved, non-secre¬
tors had significantly higher levels of IgA and IgG
compared with those found for secretors. Among
those who had not improved, there was no dif¬
ference in levels of IgA and IgG of secretors and
non-secretors [6].
A review of the literature found that serum
antibodies specific for some pathogens appear to
influence their carriage. Reduction in carriage of
serogroup C meningococci, but not other sero-
groups, followed immunization of recruits with
group C polysaccharide [18]. The probability of
becoming a carrier of serogroup B meningococci
was greater in recruits who lacked antibodies to
serogroup B at induction [19], Candida was iso¬
lated more frequently from women with low levels
of anti-candida IgA. The levels of anti-candida
IgG were not associated with isolation of the yeast
[20]. A significant correlation between anti-candida
IgA antibodies in serum and secretions has been
reported [21]. Investigation of the E. coli antigens
to which the increased levels of IgA in non-secre¬
tors are directed might identify those that induce
protection from reinfection.
Two hypotheses arise from these observations.
First, in the non-immune secretor, glycoproteins
in the urine might limit the numbers of bacteria at
the attachment/colonization step of the patho¬
genic process. Small numbers of microorganisms
might elicit a modest inflammatory response and
induce antibodies specific for the particular strain.
Second, in the non-immune non-secretor, coloni¬
zation might not be inhibited but enhanced by
interactions with Lewis a antigens as suggested by
studies with Candida [22,23] and by increased at¬
tachment of uropathogenic strains to cells of non-
secretors [12], The larger population of bacteria
might multiply in the absence of specific immune
protection and induce a strong inflammatory re¬
sponse. If this happened in the kidney, the in¬
flammation might result in scar formation.
A role for antibodies in pathogenesis as well as
protection can be postulated for urinary tract in¬
fections. In a rat lung model, binding of IgA-con-
taining immune complexes to alveolar macro¬
phages elicited production of reactive oxygen radi¬
cals resulting in significant damage to surrounding
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tissues [24], Similar reactions might occur in the
bladder, contributing to the tissue damage and
symptoms associated with these infections. If the
immune responses in children parallel those we
have observed in adults, we suggest that the in¬
creased levels of IgA in particular might contrib¬
ute to renal scarring by mechanisms similar to
that described for the rat lung model [6], There are
reports of local production of IgA in the urinary
tract and significant levels of both IgA and IgG in
the urine of children with pyelonephritis (25). In
the presence of complement, IgG containing com¬
plexes can elicit tissue damage via a similar mech¬
anism via neutrophils [26],
Host-parasite interactions leading to establish¬
ment of urinary tract infections are multifactorial.
Secretor status is a stable host marker that can be
used to investigate the interactions between the
host's innate and specific immune responses in
both pathogenic and protective responses to in¬
fecting organisms.
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1. SUMMARY
Strains of Escherichia coli isolated from urine
of secretors (242) and non-secretors (121) were
compared for their serotype and their ability to
express mannose-sensitive (MS) haemagglutinins
and mannose-resistant (MR) haemagglutinins and
to produce haemolysin. The results of the survey
refuted our hypothesis that strains with character¬
istics associated with virulence, those with MR
haemagglutinins and/or haemolysins, would be
isolated more frequently from non-secretors. MR
haemagglutinins were detected among 36.4% of
isolates from secretors and 27.3% of isolates from
non-secretors. Haemolysin production was de¬
tected among 19.8% of isolates from secretors and
12.5% of isolates from non-secretors. Both MR
haemagglutinins and haemolysin were detected
only on 12.4% of strains from secretors and 6.7%
of strains from non-secretors.
Correspondence to: C.C. Blackwell, Department of Bacteriol¬
ogy, The Medical School, University of Edinburgh. Edinburgh,
U.K.
2. INTRODUCTION
The observations of increased proportions of
non-secretors among women with recurrent
urinary tract infections [1,2] and among young
girls who developed kidney scars following urinary
tract infection [3] has provided a stable host factor
for investigation of the interactions between
bacterial strains and epithelial cells that lead to
colonization/infection. Mannose-resistant (MR)
haemagglutinins are reported to be present on a
high proportion of strains of Escherichia coli iso¬
lated from extraintestinal sites [4-6]. The report
that strains with MR haemagglutinins bound in
greater numbers to uroepithelial cells from
non-secretors compared with uroepithelial cells
from secretors [7] prompted us to compare expres¬
sion of haemagglutinins among strains isolated
from secretors and non-secretors. In this study we
wished to examine 'disease markers' for both host
and parasite to test the hypothesis that the more
susceptible non-secretor hosts would be infected
with the more virulent strains.
In vitro studies of haemagglutination inhibition
of several adhesins associated with enteric patho-
0920-8534/89/S03.50 © 1989 Federation of European Microbiological Societies
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gens suggested that oligosacchandes with blood
group activity might be involved in blocking at¬
tachment of these bacteria to receptors on
erythrocytes- Haemagglutination by CFA I. CFA
II. and K88. fimbrial adhesins associated with
enteropathogenic strains of £. coli is inhibited by
oligosaccharides in pooled human milk, a rich
source of secreted blood group antigens. This ag¬
glutination is not inhibited by mannose. Haemag¬
glutination by type I fimbriae is inhibited by
mannose (mannose-sensitive. MS), but not by these
oligosaccharides from milk [8],
If secreted blood group antigens interact in a
similar manner with the MR adhesins found on
uropathogenic strains of E. coli. strains with these
adhesins might more readily colonize non-secre-
tors. In this study we characterized strains of E.
coli from secretors and non-secretors for expres¬
sion of MR and MS haemagglutinins, production
of haemolysin and the serotype. A higher propor¬
tion of strains with MR haemagglutinins was pre¬
dicted among the strains isolated from non-secre-
tors but no difference in the proportion of strains
with MS haemagglutinins was predicted.
3. SUBJECTS AND METHODS
£. coli strains were obtained from urine cul¬
tures examined by the diagnostic laboratory at the
City Hospital. Edinburgh. They were subcultured
to egg storage agar slopes and kept at room tem¬
perature until examined. MS haemagglutination
was detected with guinea pig erythrocytes follow¬
ing culture in brain heart infusion (BHI) [9] and
MR haemagglutination with human group A
erythrocytes following incubation on CFA agar
[10]. Haemolysin production was detected with
horse blood agar and serotype by agglutination
with commercially available antisera (Difco). An-
tisera to serotypes reported to be isolated com¬
monly from urinary tract infections [11] were in¬
cluded in the set used: 01 A, 01B, 02A, 02B. 04, 05.
06. 07. 08, 011. 012. 017, 018ab, 018ac, 020, 021,
022. 024, 025. 026, 045, 062, 068, 075, 086, 0111,
0140.
The 363 isolates were obtained from women
attending outpatient clinics of the Infectious Dis¬
eases Unit. City Hospital, Edinburgh. ABO blood
group of each patient was determined from a
heparinized blood specimen by slide agglutination
and secretor state from saliva by the haemag¬
glutination inhibition assay [12].
The results were compared by the chi square
test.
4. RESULTS
The results in Table 1 refute our prediction that
strains expressing MR haemagglutinins would be
isolated more frequently from infected urine of
non-secretors. Although the proportion of strains
with MR haemagglutinins is lower for non-secre¬
tors, the difference is not statistically significant.
No difference in the proportion of strains with
MS haemagglutinins was predicted; although the
proportion of strains with MS haemagglutinins
was lower among the isolates from non-secretors,
the difference was not statistically significant (Ta¬
ble 2).
Haemolysin production was detected in 48 of
the 242 strains (19.8%) isolated from secretors and
in 15 of the 121 strains from non-secretors (12.5%).
Among the strains isolated from secretors, 30
(12.4%) expressed both MR haemagglutinins and
haemolysin. Among those isolated from non-secre¬
tors. 8 (6.7%) had both these characters. Although
the proportions of strains with both these char¬
acteristics were lower among those isolated from
non-secretors. the difference was not statistically
significant.
The majority of strains obtained from these
patients were either autoagglutinable or were not
Table 1
Proportion of strains obtained from secretors and non-secre¬






no. (%) no. (S) no. <%)
Secretors
(242) 6 (2.5) 88 (36.4) 148 (61.1)
Non-secretors
(121) 4 (3.3) 33 (27.3) 84 (69.4)
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Table 2
Proportion of strains obtained from secretors and non-secre-





no. (*> no. (*) no. <%)
Secretors
(242) 102 (42.1) 15 (6.2) 125 (51.7)
Non-secretors
(119) 43 (36.1) 3 (2.5) 73 (61.3)
agglutinated by any of the 28 antisera used in the
study. Table 3 lists the numbers of strains ag¬
glutinated by the individual typing sera tested. A
number of strains were polyagglutinable: 39 of the
Table 3
Agglutination of strains obtained from secretors and non-
secretors





no. % no. %
autoagglutinable 68 (28) 20 (16.7)
not agglutinable 61 (25) 44 (36.7)
1 14 (5.8) 6 (5)
2 4 (1.7) 1 (0.8)
4 5 (2.1) 1 (0.8)
5 3 (1.2) 1 (0.8)
6 9 (3.7) 0
7 16 (6.6) 7 (5.8)
8 3 (1.2) 0
11 3 (1.2) 1 (0.8)
12 3 (1.2) 1 (0.8)
17 14 (5.8) (5)
18 7 (2.9) 2 (1.7)
21 2 (0.8) 2 (1.7)
22 9 (3.7) 4 (3.3)
24 12 (5) (6.7)
25 7 (2.9) 7 (5.8)
26 9 (3.7) 2 (1-9)
45 16 (6.6) 5 (4.2)
62 2 (0.8) 0
68 2 (0.8) 1 (0.8)
75 7 (2.9) (6.7)
78 3 (1.2) 1 (0.8)
86 0 0 1 (0.8)
111 1 (0.4) 0 0
140 3 (1.2) 4 (3.3)
Table 4






















































242 strains from secretors (16%), and 18 of the 120
from non-secretors (15%) (Table 4).
There were 72 women from whom 2 or more
isolates were obtained during the 5 years of the
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study. Of these 47 (28.81) were secretors and 25
(28.71) were non-secretors. Based on the proper¬
ties used to characterize the isolates in the study,
there were only 14 in which strains with identical
properties were obtained on 2 or more occasions
from the same patient. Of these, 9 patients were
secretors and 5 non-secretors. MR hemag¬
glutinins were detected on 3 of the strains from
secretors but none of the strains from non-secre¬
tors expressed these adhesins. MS haemag-
glutinins were detected on 4 strains from secretors
but only on 1 strain obtained from the non-secre¬
tors.
5. DISCUSSION
The results of this study did not substantiate
our original hypothesis that we would find the
strains with more virulence markers among the
more susceptible non-secretors. The proportion of
strains expressing either MR or MS haemagg-
lutinins were lower among those isolated from
non-secretors compared with those isolated from
secretors. Haemolysin is an aggressin reported to
be associated with pathogenic strains of E. coli,
but, again, there were fewer strains from non-
secretors producing this enzyme compared with
strains from secretors.
These results suggest that there are adhesins or
other virulence markers not yet identified that
contribute to the pathogenesis of urinary tract
infections. One hypothesis proposed to explain the
increased proportion of non-secretors among pa¬
tients with recurrent urinary tract infections is
that the blood group antigens in body fluids of
secretors can bind to adhesins on the surface of
microorganisms, interfering with their coloniza¬
tion of epithelial cells [13], Strains of E. coli were
examined for their ability to adsorb A. B. and H
antigens from body fluids by the haemagglutina-
tion method. Several of the clinical isolates ad¬
sorbed these antigens, principally H (Blackwell
and Rahat, unpublished observations). The ability
to adsorb H antigens was not dependent on the
presence of MR or MS haemagglutinins or sero¬
type.
Binding of Streptococcus salivarius to epithelial
cells is inhibited by salivary glycoproteins with
blood group activity [14J. and binding of Candida
blastospores to epithelial cells is inhibited by pre¬
incubation of blastospores with boiled saliva of
secretors but not that of non-secretors [15]. Stud¬
ies are underway to determine if secreted blood
group antigens might inhibit binding of uropatho-
genic strains to epithelial cells and to determine
the nature of the components that adsorb the
blood group antigens.
ACKNOWLEDGEMENTS
We are grateful to Dr. J.A. Gray and Dr. P.D.
Wellsby for access to their patients and for their
support for this study, to Dr. B. Watt, Dr. M.
Calder and the staff of the diagnostic laboratory.
City Hospital, Edinburgh for their cooperation.
This work was supported by a grant from the
Scottish Home and Health Department (K/MR-
S/C449) and by travel funds from the Wellcome
Trust.
REFERENCES
[1] Kinane, D.F., Blackwell. C.C.. Brettle. R.P., Weir, D M.,
Winstanley. F.P. and Elton, R.A. (1982) ABO blood group,
secretor stale and susceptibility to recurrent urinary tract
infections in women. Br. Med J. 285. 7-9.
[2] Blackwell. C.C., May. S.J., Brettle. R.P.. MacCallum. C.J.
and Weir. D M. (1987) Secretor state and immunoglobulin
levels among women with recurrent urinary tract infec¬
tions. J. Clin. Lab. Immunol. 22, 133-137.
[3] Lomberg, H„ Hellstrom. M„ Jordal, U. and Svanborg-
Eden, C. (1989) Secretor state and renal scarring in girls
with recurrent pyelonephritis. FEMS Microbiol. Immunol.
47, 371-376.
[4] Minshew, B.H., Jorgensen, J.. Counts, G.W. and Falkow.
S. (1978) Association of hemolysin production, haemagg-
lutination of human erythrocytes, and virulence for chicken
embryos of extra-intestinal Escherichia coh isolates. In¬
fect. Immun. 20. 50-54.
[5] Evans. D.J.. Evans. D.G., Young, L.S. and Pitt, J. (1980)
Haemagglutination typing of Escherichia coli: Definition
of seven hemagglutination types. J. Clin. Microbiol. 12,
235-242.
[6] Hagberg. L.. Jodal. U., Korhonen, T.K., Lindin-Janson,
G., Lindberg, U. and Svanborg-Eden, C. (1981) Adhesion,
381
haemagglutination and virulence of Escherichia coli caus¬
ing urinary tract infections. Infect. Immun 31. 564-570.
[7] Lomberg. H.. Cedergren. B.. Leffler. H.. Nilsson. B .
Carlstrom. A.-S. and Svanborg-Eden. C. (1986) Influence
of blood group and availability of receptor for attachment
of uropathogenic Escherichia coli. Infect. Immun. 51.
919-926.
[8] Holmgren, J . Svennerholm. A-M and Ahren. C. (1981)
Nonimmunoglobulin fraction of human milk inhibits
bacterial adhesion (hemagglutination) and enterotoxin
binding of Escherichia coli and Vibrio choierae Infect.
Immun. 33. 135-141.
[9] Svanborg-Eden. C. and Hanson. L A. (1978) Escherichia
coli pili as possible mediators of attachment to human
urinary tract epithelial cells. Infect. Immun. 21, 229-237.
[10] Evans, D.G., Evans. D.J. and Tjoa. W. (1978) Haemagg-
lutination of human group A erythrocytes of enterotoxi¬
genic Escherichia coli isolated from adults with diarrhea:
correlation with colonization factor. Infect. Immun. 18.
330-337.
[11] Orskov, I.. Orskov. F. Birch-Anderson. A.. Kanamoti. VI.
and Svanborg-Eden. C (1982) O. K. H and fimbrial
antigens in Escherichia colt serotypes associated with
pyelonephritis and cystitis. Scand. J Infect. Dis. (suppl)
33. 18-25.
[12] Mollison. P L. (1979) Blood Transfusion in Clinical
Medicine (6th edition) pp. 414-482. Blackwell Scientific
Publications. Oxford.
[13] Blackwell. C.C. (1989) The role of ABO blood groups and
secretor status in host defences. FEMS Microbiol. Im¬
munol. 47. 341-350.
[14] Williams. R.C. and Gibbons. R.J. (1975) Inhibition of
streptococcal attachment to receptors on human buccal
epithelial cells by anligenically similar salivary glycopro¬
teins. Infect. Immun. 11. 711-718.
34
FEMS Microbiology Immunology 47 (1989) 401-406 401
Published by Elsevier
FIM 00066
Non-secretion of blood group antigens and susceptibility
to infection by Candida species
S.M. Thorn \ C.C. Blackwell C.J. MacCallum \ D.M. Weir 2, R.P. Brettle D.F. Kinane 3
and D. Wray 1
'
Department of Bacteriology and Department of Oral Medicine and Pathology . University of Edinburgh. - Division of Infectious Diseases,
City Hospital, Edinburgh, and 3 Department of Periodontology. The Dental School, University of Dundee. Dundee, U.K.
Received 1 September 1988
Accepted 12 January 1989
Key words: Blood group antigens; Secretor status: Candida infection
1. SUMMARY
One of the innate defences against superficial
infections by Candida species appears to be the
ability of an individual to secrete the water-solu¬
ble form of his ABO blood group antigens into
body fluids. There was a significantly higher num¬
ber of non-secretors (48.9%) among 174 patients
with either oral or vaginal Candida infections com¬
pared with the proportion of non-secretors in the
local population (26.6%).
The protective effect afforded by the secretor
gene might be due to the ability of glycocom-
pounds in the body fluids of secretors to inhibit
adhesins on the surface of the yeast. In attach¬
ment studies, preincubation of blastospores with
boiled secretor saliva significantly reduced their
ability to bind to epithelial cells. Non-secretor
saliva did not reduce the binding and often en¬
hanced the numbers of attached yeasts.
Possible host-parasite interactions underlying
the susceptibility of non-secretors to Candida and
other infections are discussed.
Correspondence to: S.M. Thorn, Department of Bacteriology,
University of Edinburgh, Edinburgh, U.K.
2. INTRODUCTION
A 1980 review of the immune response to
Candida albicans stressed the need to obtain more
basic information on innate host defence mecha¬
nisms that control diseases caused by this oppor¬
tunistic pathogen [1], There were a number of
observations that suggested non-secretion of blood
group antigens might be associated with suscept¬
ibility to infection by the Candida species. Wil¬
liams and Gibbons [2] reported that salivary gly¬
coproteins with blood group antigen activity were
able to inhibit and even reverse binding of
Streptococcus salivartus to buccal cells. If particu¬
lar strains of Candida have adhesins that recognize
blood group antigens on host cells, we predicted
interactions similar to those described for the
streptococci might place on mucosal surfaces of
secretors but not on those of non-secretors.
Fucose has been found to inhibit binding of the
yeast to human epithelial cells [3], Fucose is also
the immunodominant sugar of the H antigen of
blood group O and a terminal component of the
Lewis antigens. Except for individuals of the ex¬
tremely rare Bombay phenotype. the H antigen is
present in body fluids of secretors of all four ABO
blood groups; and, in 94% of secretors. there will
0920-8534/89/S03.50 © 1989 Federation of European Microbiological Societies
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also be Lewis J antigen but predominantly Lewis h
antigen [4],
This led to our hypothesis that the inhibition of
binding of Candida to epithelial cells by fucose
might be due to inhibition of a lectin-like adhesin
on the surface of the yeast. Glycoproteins on the
surface of Candida involved in binding have been
isolated and characterized and one of these ad-
hesins can be inhibited by fucose [5]. If these
glycoproteins are involved in colonization, the H
or Lewis b antigens of secretors might bind to the
adhesin and decrease the probability of the yeast
attaching to the host's mucosal surfaces.
The following questions arose from these pro¬
posals:
1. Is there an increase in the incidence of non-
secretors among patients with Candida infections?
2. Are there differences in binding of the yeast to
epithelial cells if the blastospores are pre-incubated
with saliva from secretors or non-secretors?
3. MATERIALS AND METHODS
Candida strains 3091 and 3118C originally iso¬
lated from oral infections were kindly provided by
Dr. M.V. Martin, Department of Dental Sciences,
The University of Liverpool. They were cultured
on Sabouraud agar.
Saliva specimens were obtained from women
attending outpatient clinics of the Infectious Dis¬
eases Unit (City Hospital, Edinburgh), from wo¬
men attending ante-natal clinics (Royal Infirmary.
Edinburgh), and from both men and women at¬
tending dental outpatient clinics for investigation
of oral Candida infections (the dental schools Uni¬
versity of Edinburgh and University of Dundee).
Secretor state was determined by the haemag-
glutination inhibition method described by Molli-
son [6] and the results compared with those for
local blood donors [7],
Attachment of the yeasts to buccal epithelial
cells was determined microscopically. In order to
eliminate the possibility of contamination by
secreted blood group antigens, buccal cells were
obtained from non-secretor donors of blood groups
A, B, and O. Two donors of each group were used.
Saliva samples obtained from secretors and non-
secretors of blood groups A, B and O were boiled
for 30 min in glass universal containers to in¬
activate enzymes that destroy secreted blood group
antigen and any antibodies present. They were
centrifuged to remove particulate matter and
stored at — 20 °C. The yeasts were incubated with
saliva samples or Dulbecco's phosphate buffered
saline containing supplement B composed of Ca:*
and Mg:+ (0.9 mM and 0.5 mM respectively)
(DPBS + B). Mixtures of yeasts and buccal epi¬
thelial cells from a non-secretor of the correspond¬
ing ABO blood group (10 yeasts per buccal cell)
were incubated for 1 h at 37 °C. Mixtures were
centrifuged and washed 3 times to remove non-ad¬
herent blastospores and slides prepared in a cyto-
spin. The slides were Gram-stained and 60 cells
per slide observed for numbers of attached yeasts.
The results were analyzed by Wilcoxon's rank
sums test as described by Swinscow [8], The analy¬
sis of Rosenstein et al. [9] suggested results of
attachment studies have a non-parametric distri¬
bution and that transformation of the data for
application of more exact tests was not valid.
They recommended using the medians rather than
the means for calculation of the P values. In these
studies we found no difference between the P
values when either the means or the medians were
analyzed by this test.
4. RESULTS
4.1. Epidemiological studies
The numbers of non-secretors for the different
patient groups are compared with figures for local
blood donors, 26.6% [7], Of the 174 patients, 48.9%
(X2 = 24.069. P < 0.0005) were non-secretors.
The proportion of non-secretors among 101
women with a history of recurrent Candida infec¬
tions was 40.6% (xz = 6.549, P < 0.025). There
were also 30 pregnant women with symptoms of
infection and from whom Candida was isolated;
among these 17 (56.7%; x2 = 10.608, P < 0.005)
were non-secretors.
Of the 43 patients, both male and female, re¬
ferred to the dental hospitals for treatment of
recurrent oral Candida infections, 27 (62.8%) were
non-secretors (x: = 21.697, P < 0.0005).
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4.2. Attachment of blastospores to buccal epithelial
cells
To test our hypothesis that binding of blasto¬
spores might be inhibited by heat-stable glyco-
compounds in the body fluids of secretors, we
) compared attachment of blastospores of the two
Candida strains following preincubation of the
yeasts in either DPBS + B or boiled saliva from
secretor donors. If a lectin-like interaction is in¬
volved in attachment, the supplement B of the
DPBS supplied the divalent cations needed. The
general pattern observed was that, in comparison
with the controls incubated with DPBS + B, in¬
cubation of the blastospores of either strain with
secretor saliva resulted in reduction of the num¬
bers of yeasts attached to the buccal cells. This
pattern was observed with cells and saliva from
donors of blood groups A, B, and O and with both
strains of Candida. Analysis by Wilcoxon rank
sum test of 10 experiments with 3091 and 13
experiments with 3118C found preincubation of
the blastospores with secretor saliva significantly
reduced their ability to bind to epithelial cells
(P < 0.05).
Saliva from non-secretors did not have a simi¬
lar effect and often increased the attachment of
yeasts to the buccal cells. Analysis by Wilcoxon
rank sum test of 8 experiments comparing binding
of blastospores preincubated in DPBS + B with
that of blastospores preincubated in non-secretor
saliva found a significant increase in binding in
the presence of non-secretor saliva (P < 0.01).
Dilution of the secretor saliva reduced its ability
to inhibit binding of Candida to the epithelial
cells. The inhibitory effect was not present at
dilutions in which there was no detectable blood
group antigen and was usually lost by dilutions of
1 in 10.
5. DISCUSSION
As predicted, we found a significantly higher
proportion (54.4%) of non-secretors among pa-
t tients with symptomatic Candida infections or in¬
dividuals who had a history of recurrent Candida
infections compared with that found for the local
population (26.6%) [7]. When the patient groups
were analyzed, the significant increases in the
numbers of non-secretors were found among those
who were immunocompromised by pregnancy or
those who had a history of recurrent infections.
Our recent studies of patients with infections
due to Neisseria meningitidis. Streptococcus pneu¬
moniae and Haemophilus influenzae revealed sig¬
nificant increases in the proportions of non-secre¬
tors among these individuals [10,11]. The com¬
promising factor among these patients is known.
At the time of exposure to the particular patho¬
gen, they lacked the serogroup specific antibodies
that protect the host from invasive disease [12].
The specific immune responses that protect the
host from Candida infections are not yet defined.
Identification of non-secretion as a stable host
factor that predisposes the non-immune individual
to these infections provides a basis for investiga¬
tion of the host-parasite interactions involved.
The results of the attachment experiments sup¬
port our hypothesis that heat-stable components
in the body fluids of secretors might inhibit bind¬
ing of an adhesin on the yeast. Boiled saliva from
secretors inhibited attachment of the blastospores
of both 3091 and 3118c to buccal epithelial cells.
The controls for the attachment studies, the num¬
bers of blastospores per cell in the absence of
saliva, varied with each experiment. Inhibition
also varied with saliva from different donors. This
might be due to the varying amounts of blood
group antigens present in the saliva of secretors of
the different ABO groups [13] or the conditions
under which the saliva was collected, e.g., stimu¬
lated specimens have less blood group antigen
than unstimulated specimens [14-16].
Our epidemiological observations of a higher
proportion of non-secretors among patients with
invasive pneumococcal and haemophilus infec¬
tions were complemented by those of Andersson
and coworkers [17] who found that glycocom-
pounds from pooled human milk were able to
inhibit binding of these pathogens to epithelial
cells. The Lewis b. and H antigens common to the
body fluids of most secretors are candidates for
the inhibitory substance(s). Recent work from our
laboratory suggested that Lewis b is not the com¬









Controls * 334 89 (26.6)
Total patients 174 85 (48.9) 24.069 < 0.0005
Genital infection
pregnant 30 17 (56.7) 10.608 < 0.005
history of
recurrent
infection 101 41 (40.6) 6.549 < 0.025
Oral infection 43 27 (62.8) 21.697 < 0.0005
* local blood donors.
The enhanced binding observed with non-secre-
tor saliva was an unexpected finding. It helps to
explain the report that a number of the fresh
saliva specimens from which specific anti-Candida
antibodies had been adsorbed increased the bin¬
ding of the yeast to epithelial cells [20]. This
phenomenon was found with approximately 25%
of their donors, the expected proportion of non-
secretors in an unselected population.
Binding of microorganisms to epithelial cells
[21] and phagocytic cells [22,23] by lectin-like in¬
teractions has been reported by a number of
groups. Although there is no direct evidence as yet
that the carbohydrate moieties of ABO or Lewis
blood groups act as receptors for microorganisms,
we are investigating the possible role of these
antigens as receptors not only for Candida but also
for other microorganisms.
The high proportion of non-secretors among
immunocompromised individuals with Candida in¬
fections suggests that if specific immunity to these
pathogens is absent or transiently reduced, the
ability to secrete the ABO antigens plays a role in
the innate defences of the host against these op¬
portunistic infections. Identification of non-secre¬
tors among immunocompromised patients such as
those with antibody to HIV might help identify
those at particular risk of superficial Candida in¬
fections and perhaps other opportunistic infec¬
tions.
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1. SUMMARY
This study tested the hypothesis that the Lewis a
blood group antigen found predominantly on the
cells of non-secretors might be one of the recep¬
tors for Candida species. Binding of strain 3118C
to epithelial cells from either secretor or non-
secretor donors was not inhibited by treating the
cells with anti-Lewis a or anti-Lewis b antisera.
Binding of strain 3091 to non-secretor cells was
inhibited by pretreating the cells with anti-Lewis a,
but this was not observed for secretor cells.
The results suggest that Lewis a might be one
of the receptors for some yeast strains.
2. INTRODUCTION
In our epidemiological studies of patients with
either oral or vaginal infections due to Candida
species we have reported a significant increase in
the proportion of individuals who are non-secre¬
tors of the ABO blood group antigens [1-3]. Here
we present evidence for one of the hypotheses
Correspondence to: S.J. May. Department of Bacteriology, The
Medical School, University of Edinburgh, Edinburgh, U.K.
proposed to explain the host-parasite interactions
underlying these observations, that the Lewis a
antigen is one of the receptors for pathogenic
strains of Candida.
Glycoproteins that mediate attachment of
Candida blastospores to epithelial cells have been
described. Binding of various strains by these ad-
hesins can be inhibited by monosaccharides, some
by fucose and others by V-acetylglucosamine [4],
Since fucose is the immunodominant sugar of the
Lewis a antigen, we predicted that pretreatment of
epithelial cells of non-secretors might inhibit bind¬
ing of some strains of Candida.
If this proposal is correct, the ability of the
Lewis antigens to adsorb on to the cell surface
might explain our observation that pre-treatment
of blastospores with non-secretor saliva enhanced
their binding [1-3]
3. MATERIALS AND METHODS
Candida strains 3091 and 3118C originally iso¬
lated from patients with oral infections were kindly
provided by Dr. M.V. Martin. Liverpool Univer¬
sity. They were maintained on egg storage slopes
at room temperature. Overnight cultures grown on
Sabouraud's agar were used to prepare suspen-
0920-8534/89/$03.50 © 1989 Federation of European Microbiological Societies
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sions of blastospores (2 x 106 ml). Buccal epi¬
thelial cells (BEC) were obtained from a secretor
and a non-secretor, both of blood group B. The
BEC were washed once in Dulbecco's phosphate
buffered saline plus supplement B containing
calcium and magnesium ions (0.9 mM and 0.5
m\l respectively) (DPBS + B). They were divided
into 3 aliquots and an equal volume of DPBS + B
(control), anti-Lewis a or anti-Lewis b antisera
(Behring) added. After incubation at 37° C for 1
h, the cells were washed 3 times by centrifugation
(400 x g for 10 min) with DPBS + B and adjusted
to a final concentration of 2 X 105 ml.
The attachment assay was performed by a mod¬
ification of the method described by Kimura and
Pearsall [5]. Duplicate samples of each control and
test were prepared by mixing equal volumes (100
/il/ml) of the BEC and the blastospores. After
incubation at 37° C for 60 min in an orbital
incubator (100 rpm), the mixtures were washed 3
times by centrifugation at 400 X g and resus-
pended in 50 jal of fresh DPBS + B. Slides were
prepared with 20 jal of each sample, air-dried,
fixed with methanol and Gram-stained. The num¬
bers of adherent yeasts on 60 individual cells were
counted on each slide.
The results of these experiments were com¬
pared by Wilcoxon's rank sum test [6], In view of
the recommendation of Rosenstein et al. [7], the
results obtained with both the means and medians
were compared in these analyses.
4. RESULTS
Table 1 summanzes the results of 9 experi¬
ments with BEC obtained from a secretor donor
and Table 2 the results of 9 experiments with BEC
obtained from a non-secretor donor. The same
statistical values were obtained with either the
means or the medians. Treatment of BEC from
either donor with anti-Lewis b antiserum did not
alter the attachment of either strain, 3091 or
3118C, compared with the control. Treatment of
Table 1
Attachment of strains 3091 and 3118C to secretor buccal epithelial cells (BEC) pre-treated with anti-Lewis ' or anti-Lewis b antisera
Serotype Mean * number of yeasts per BEC following pre-treatment of secretor BEC
DPBS anti-Le * P-value * DPBS anti-Le b P-value *
3091 109 122 NS l09 TT3 NS
3118C 2.61 1.94 NS 2.61 2.53 NS
DPBS. Dulbecco's PBS + B supplement.
Le a. Lewis *; Le b, Lewis b.
* Mean number of yeasts per BEC from 9 experiments.
* Wilcoxon's Rank Sum Test; NS, not significant.
Table 2
Attachment of strains 3091 and 3118C to non-secrelor buccal epithelial cells (BEC) pre-treated with anti-Lewis " or anti-Lewis b
antisera
Serotype Mean * number of yeasts per BEC following pre-treatment of non-secretor BEC
DPBS anti-Le * P-value + DPBS anti-Le b P-value *
3091 2.48 1.69 <0.05 2.48 1.91 NS
3118C 1.96 1.95 NS 1.96 1.95 NS
DPBS, Dulbecco's PBS + supplement.
Le Lewis Le b, Lewis b.
* Mean number of yeasts per BEC from 9 experiments.
* Wilcoxon's Rank Sum Test; NS, not significant.
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BEC from the non-secretor donor with anti-
Lewis a antiserum significantly reduced the
binding of strain 3091 but not strain 3118C blas-
tospores compared with the control. Treatment of
the BEC from the secretor donor with anti-Lewis a
antiserum did not alter the attachment of either
strain.
5. DISCUSSION
Significant inhibition of binding of the blas-
tospores to BEC was observed only for non-secre¬
tor cells pre-treated with anti-Lewis a antisera.
These results were obtained only with 3091, indi¬
cating that there might be an adhesin on this
strain that can bind to the Lewis a antigen.
Lewis b does not appear to be the receptor for
either strain tested. This suggests that it is not the
component in secretor saliva that reduces binding
of the blastospores to epithelial cells [3]. The H
antigen is a possible candidate for the inhibitory
substance, but we have been unable to demon¬
strate adsorption of the H antigen from secretor
saliva by haemagglutination inhibition assays for
either 3091 or 3118C or 10 other strains of Candida
examined (MacLean and Blackwell, unpublished
observations).
Unlike the ABO antigens, the Lewis antigens
are not structural components of the host cells.
They are adsorbed on to the cells from body
fluids. If a lectin-like adhesin on blastospores can
recognize Lewis a antigens in the body fluids of
non-secretors, the following interactions might oc¬
cur. The yeast could bind directly to the Lewis a
antigen on the surface of an epithelial cell. Alter¬
natively, the carbohydrate moiety of the Lewis a
antigen in secretions could bind to the adhesin on
the blastospore and then become attached to an
epithelial cell by the normal adsorption processes.
This model explains our observations that pre-
treatment of blastospores with non-secretor saliva
increased binding of the yeast compared with con¬
trols pre-treated with DPBS -I- B.
Susceptibility to superficial Candida infections
is multifactorial as is protection against these op¬
portunistic pathogens. Our results suggest that the
ability to secrete ABO blood group antigens is one
of the host's innate defence mechanisms. The
non-secretor is at a disadvantage in two respects:
(1) absence of the substance(s) in secretor saliva
that inhibit binding of the blastospores of some
strains to epithelial cells and (2) presence of an
antigen on his cells that is a receptor for the
adhesins on some strains of Candida blastospores.
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1. SUMMARY
Epidemiological evidence is summarized for as¬
sociations of ABO blood group and secretor status
with susceptibility to invasive disease due to
capsulate organisms responsible for the majority
of bacterial meningitis. Host-parasite interactions
that might underly these findings are proposed
and evidence to support or refute them provided.
2. INTRODUCTION
Bacterial meningitis is still a major health prob¬
lem in both western and developing nations. In
the United Kingdom at least 1 child in every 1000
develops acute bacterial meningitis by the age of
10 [1]. Approximately 75% of all these infections
are caused by three species: Neisseria meningitidis.
Correspondence to: C.C. Blackwell. Department of Bacteriol¬
ogy, The Medical School. University of Edinburgh. Edinburgh.
U.K.
Haemophilus influenzae and Streptococcus pneumo¬
niae. Each of these organisms has in common
polysaccharide capsules that appear to play a role
in pathogenesis. Protection against invasive dis¬
ease caused by these strains is associated with the
presence of opsonizing or bactericidal antibodies
specific for the invading strain and an intact com¬
plement system. The natural development of anti¬
bodies to these organisms is reflected in the age
range in which these infections are most prevalent.
6 months to about 4.5 years. These are infants and
young children in whom protective maternal anti¬
body has waned and who are not yet able to
produce an effective long-term response to poly¬
saccharide antigens [1],
Of all the diseases for which an association
with secretor state has been observed, bacterial
meningitis has provided the clearest model on
which to test several of the suggested hypotheses.
Regardless of age. the compromises in the specific
immune defences of the host against these
organisms is well defined. The majority of individ¬
uals with these infections lack protective antibod¬
ies to the invading pathogen, and a minority have
0920-8534/89/S03.50 £ 1989 Federation of European Microbiological Societies
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congenital defects in either thetr complement or
properdin systems [2.3]. The genetic factors that
predispose the non-immune individual to resis¬
tance or susceptibility to these diseases are only
beginning to be elucidated. There are small num¬
bers of rare individuals in whom complement
components are absent or less efficient, but more
common genetic markers, ABO blood group and
secretor status, appear to be associated with sus¬
ceptibility to these infections.
3. ABO BLOOD GROUPS
Reed et al. [4] found that among 88 patients
with pneumococcal disease and 16 carriers of the
organism there was a significantly lower propor¬
tion of group B individuals. They suggested that
the anti-A isohaemagglutinins of B individuals
were able to act as natural antibodies against these
bacteria. Their studies revealed that pneumococci
could acquire either A or B antigens if the ap¬
propriate red blood cells were present in the growth
medium. In the same paper they reported that 5 of
7 strains tested expressed antigens that cross-
reacted with A antigen even if the bacteria were
grown on medium containing B blood. In vitro
assays with lysed bacteria demonstrated an en¬
zyme capable of altering B antigen to the A-like
antigen.
They interpreted their epidemiological and
laboratory findings as follows. Some strains of
pneumococci can incorporate A antigens from
tissues and fluids of group A hosts, but the host
lacks anti-A antibodies. Group O blood endows
most strains with little if any substances that will
cross-react with A or B antigens. Consequently,
the anti-A and anti-B isohaemagglutinins of group
O individuals seldom or never act as natural anti¬
bodies for these strains. Individuals of group AB
lack both isohaemagglutinins, so protective
humoral defences among individuals of blood
groups A, O and AB depend on specific anti-
pneumococcal antibodies. The low proportion of
group B individuals with these infections is depen¬
dent on (1) the presence of anti-A antibodies, (2)
the ability of the invading strain to convert B
antigens to A antigens and (3) the ability to incor¬
porate this cross-reactive substance into the
bacterial cell envelope.
The congruence of the meningitis belt of central
Africa with the largest area in which there is an
unusually high proportion of the population with
the blood group B gene is a clue that we are
pursuing with colleagues in northern Nigeria [5].
Although the B gene is found in about 25% of the
population in the area studied, there does not
appear to be a higher proportion of individuals
with the B gene among the 40 patients with
meningococcal infection so far examined [6].
4. SECRETOR STATUS
Epidemiological evidence from studies in the
United Kingdom, Iceland and Nigeria suggest that
there is an association between non-secretion and
susceptibility to invasive disease caused by menin¬
gococci. pneumococci and haemophilus [6-8] (Ta¬
ble 1). In most western European populations, the
proportion of non-secretors is 20-25% [9], In areas
where there have been prolonged outbreaks of
meningococcal disease and where the secretor
status of the population has been determined
(northern Nigeria and Iceland), there are unusu¬
ally high proportions of non-secretors. A similar
pattern was found in Stonehouse, Gloucestershire
which was investigated during a prolonged out¬
break of disease due to a serogroup B serotype
15 : PI.16 sulphonamide resistant (B15R) strain of
meningococci. The proportion of non-secretors in
Stonehouse (32.7%) was significantly higher than
that of the surrounding area (23.4%) [10],
4.1. The role of secretor status in host defences
against bacterial meningitis
We have examined several of the hypotheses
suggested to explain how secretor status might
effect both innate defences such as the initial
colonization of the host by these organisms and
the immune responses to these bacteria.
4.2. Secretor status and carriage
The significant increase in the proportion of
non-secretors among patients with these infections
suggested a parallel with rheumatic fever epide-
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Table 1
Proportion of non-secretors among patients with invasive in-
fections due to .V menitngittdis, H influenzae tvpe b and Strep
pneumoniae





Controls 334 89 (26.6) <0.005
Patients 26 18 (69)
Slonehouse
Controls 111 134 (32.7)
Patients 13 7 (54)
Iceland
Controls 228 92 (41.2) <0.05
Patients 98 53 (54)
Nigeria
Controls 186 92 (49 5) <0.01
Patients 42 31 (73.3)
H. influenzae
Iceland
Controls 228 94 (41.2) < 0.005
Patients 43 29 (67)
Strep pneumoniae
Scotland
Controls 334 89 (26.6) < 0.01
Patients 47 22 (47)
miology. Non-secretors were found to be over-rep-
resented among patients with rheumatic fever and
also among individuals who were carriers of the
group A Streptococcus pyogenes [11]. The recent
study of meningococcal carriage in Stonehouse
provided an opportunity to examine this hy¬
pothesis [12].
There was not an increased proportion of non-
secretors among carriers of the B15R meningo¬
cocci. Of the 67 residents who were carriers of the
outbreak strain, 20 (30%) were non-secretors.
Among 459 carriers of meningococci other than
the outbreak strain, 132 (29%) were non-secretors.
During a particular period of time, non-secretors
do not appear to be more likely to be carriers than
secretors. The effect of secretor status on long-term
carriage has not yet been assessed [10].
Carriage of meningococci can be influenced by
the presence of serum antibodies specific for the
capsular antigen. Immunization of recruits with
group C polysaccharide vaccine reduced carriage
of serogroup C but not other serogroups among
the immunized population [13]; and. among Greek
recruits, presence of antibodies to serogroup B in
an individual at the time of induction reduced the
probability of becoming a carrier [14], The infor¬
mation regarding the specific antibody levels of
carriers and controls to the B15R strain is not
complete, so the question regarding influence of
secretor status on carriage in the non-immune host
is not yet answered.
4.3. The IgA levels of secretors and non-secretors
Non-secretors have been reported to have lower
levels of both salivary [15] and serum IgA [16].
Since IgA is thought to play a role in reducing
colonization by pathogens, the lower levels of
salivary IgA reported for non-secretors [15] sug¬
gested specific immune responses at the mucosal
surfaces of non-secretors might be compromised
compared with those of secretors. Material col¬
lected in the Stonehouse survey allowed us to test
this hypothesis. Our examination of salivary IgA
levels with commercially available immunodiffu¬
sion plates did not confirm these earlier observa¬
tions. There was no difference in the mean levels
of IgA in the saliva of 165 secretors (2.1 IU/ml)
compared with 109 non-secretors (1.9 IU/ml) from
whom no neisseriae were isolated. Compared with
non-carriers, carriers of meningococci, 168 secre¬
tors (3.2 IU/ml) and 92 non-secretors (3.7 IU/ml),
had significantly raised levels of salivary IgA [17].
Both secretor and non-secretor carriers of Neis¬
seria lactamica had salivary IgA levels comparable
to those of non-carriers (Fig. 1).
In acute sera, antibodies to capsular polysac¬
charides of meningococcal serogroups A and C
and to type b haemophilus are predominantly IgA
[18]. Purified IgA from patients with infections
due to meningococcal serogroups B. Y, or C in¬
hibited complement mediated bacteriolysis by IgG
and IgM isotypes [19]. Purified IgG and IgM
antibodies to type b H. influenzae capsular poly¬
saccharide are opsonic and bactericidal, but IgA
antibodies to this antigen are not [20].
In an epidemiological study of children in
Gambia during an outbreak of meningococcal dis¬
ease, measurement of total immunoglobulin levels
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Fig. 1. Salivary IgA levels of secretors and non-secretors among
non-carriers, carriers of V. meningitidis and carriers of .V
lactamica.
cases had a higher mean IgA value than did
controls' [21]. We had found higher levels of total
serum IgA among non-secretor women with recur¬
rent UTI [22]. If total immunoglobulin levels partly
reflect antibodies specific for the colonizing strain,
these increased levels of IgA antibodies among
non-secretors might effectively compete with the
complement fixing isotypes for binding sites on
the invading bacteria.
We were able to confirm the early report of
lower levels of serum IgA among non-secretors
[16]. Among Stonehouse residents from whom no
neisseria were isolated the mean serum IgA levels
for 148 secretors was 115 IU/ml which was sig¬
nificantly higher than that for 102 non-secretors,
102 IU/ml ( P < 0.025). Compared with the secre-
tor control, there was no significant difference in
the mean serum IgA of 101 secretors carrying
serogroupable strains (116 lU/ml) or 66 carriers
of non-serogroupable strains (119 IU/ml). Com¬
pared with non-secretor controls. 50 non-secretors
carrying serogroupable strains had a significantly
higher mean serum IgA level (130 IU/ml) (P <
0.0025), but the difference between the non-car¬
riers and the 32 carriers of non-serogroupable
strains (85 IU/ml) was not significant.
The immune response of the host has been
implicated to play a role in the pathogenesis of
these infections [19], In view of the possible role of
IgA to polysaccharide antigens acting as blocking
antibodies competing with the complement fixing
isotypes and subclasses, the immune responses of
secretors and non-secretors to these capsulate
organisms need to be compared. Studies of the
immune responses of secretors and non-secretors
to polysaccharide vaccines and polysaccharide-
protein conjugates might provide information on
possible problems associated with their develop¬
ment.
4.4. Predisposing infections and secretor status
It has been suggested that viral and myco¬
plasma infections might act as predisposing fac¬
tors for bacterial meningitis [23]. Pneumococcal
pneumonia following influenza is a classic exam¬
ple of viral infection predisposing humans to inva¬
sive disease due to capsulate bacteria, and a simi¬
lar pattern has been found for invasive disease due
to Haemophilus influenzae suis following swine
influenza in pigs [24]. Although there are several
reports of associations between ABO blood groups
and susceptibility to natural or experimental viral
infections [25-27], there is no published evidence
that non-secretion is associated with susceptibility
to viral infections. It is, however, a line of investi¬
gation that might provide new insights into the
pathogenesis of meningococcal disease.
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5. APPLICATION OF THESE STUDIES
Protection against several serogroups of these
bactena can be elicited by immunization of adults
and older children with capsular polysaccharide
antigens. The protection elicited is specific only
for the serogroup from which the polysaccharide
was prepared; and. in infants and very young
children, these have not been found to be effective
immunogens. The increase in the proportion of
non-secretors is found among patients with men¬
ingococcal disease due to each of the serogroups
A, B and C and also among patients with invasive
disease due to Sir. pneumoniae and type b
haemophilus. By determining the host-parasite
interactions responsible for this increased suscept¬
ibility of non-secretors, we might identify a new
approach to prevention of bacterial meningitis
that circumvents the problems associated with
capsular polysaccharide antigens and the narrow-
spectrum of serotype-specific vaccines.
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SUMMARY The inability to secrete the water-soluble glyco¬
protein form of the ABO blood group antigens is a genetic
characteristic associated with susceptibility to superficial fungal
infections and aiso insulin-dependent diabetes meilitus iIDDMl
As oral carnage of Candida albicans in heaithy aduits is associ¬
ated with non-secretion, we examined oral carnage of yeasts
among 2"5 patients attending diabetic outpatient clinics. 13"
with IDDM and 138 with non-insuiin depenuent diabetes
meilitus iNIDDM) with reference to ABO biood group, secretor
status and yeast species.
Of the 166 yeast isolates. 109 (66-T\,) were C. albicans, a lower
proportion compared with 94", reported for heaithy individuals.
There was no association between ABO blood group and
carnage. There was no increase in the proportion of non-
secretor earners of C. albicans among patients with IDDM: but
among those with NIDDM. 44°; of non-secretors were earners
compared with 31°, who were non-carriers |p<t>0h. The
results are discussed in the context of host-parasite interactions
influencing colonization.
Key words: Insuiin-dependent diabetes meilitus. non-insuiin
depenuent diaoetes meilitus. Candida albicans. non->ecretion
Introduction
Examination of genetic factors associated with suscepti¬
bility to infectious agents is providing new insights into
the host-parasite interactions that resuit in disease. One
of these characteristics, non-secretion of the ABO biood
groups antigens, has been associated with susceptibility to
a number of infectious diseases (1-6) and some auto¬
immune diseases (including insuiin dependent diabetes
meilitus) for which infectious triggers have been postulated
{7- 10). The carbohydrate antigenic determinants of ABO
blood groups are found in two forms: giycolipids that are
part of the structure of the host ceil: and water-soluble
glycoproteins that are present in body fluids such as saliva
and urine. The ability to secrete the glycoprotein form is
controlled by a singie gene on chromosome 19. The
majority of individuals in western European populations
are secretors (75-60°,,). while the minority i20-25°o)
express the recessive non-secretor phenotype ill. 12).
CurresDonatnct: Dr. C. C. Blackwell. Department of 8actenology. The
Medical School. University of Edinourch. UK.
One hypothesis suggested to explain the increased
susceptibility of non-secretors is that they are more readiiv
colonized by some pathogenic species. Epidemiological
evidence for this hypothesis was summarized for patients
with rheumatic fever by Haverkorn and Gosiings i2).
There is a signuicancly higher proportion of non-secretors
among patients with rheumatic fever and aiso among
earners of the causative organism, group A Streptococcus
pyogenes. Carnage of Candida albicans among healthy
subjects has been found to be significantly associated with
blood group O and. independently, with non-secretion of
the A BO blood group antigens 113).
Our earlier studies have found a significant increase in
the proportion of non-secretors among non-diabetic
patients with recurrent oral or vaginal Candida infections
(14). AyC. albicans, often causes oral or vaginal infections
among patients with diabetes, we examined a group of
275 patients with diabetes for oral carnage of these fungi.
ABO blood group and secretor status to determine if
there were similar associations between Candida carnage,
blood group O and non-secretion reported for heaithy
individuals.
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Sl3jrcts and Methods
Patients (275i attending routine oul-natient climes participated in the
stadv. None of the patients was admitted to hospital or being treated for
superficial fungal infections. Patients who had insulin dependent dia-
betestlDDMl were classified by insulin dependence, clinical history and
family history of the disease. Those with non-msuiin dependent diaoetes
(N(DDM) were not dependent on insulin.
ABO and Lewis groups were determined by agglutination of hep-
anmzed blood sampies and the secretor status by the haemaggiutination
inhibition assay from saliva samples 11 ft.
A quantitative mouthwash technique was used to examine carnage of
Candida. The participants swilled 10 ml of stenle saline in their mouths
for 1 min and returned the wash to a stenle container. The sample was
processed within 2 hr of collection. Each specimen was concentrated by
centnfugation and resuspension of the pellet in 1 ml stenle saline:
002 ml of the matenal was inoculated on malt agar plates. The plates
were incubated at 3TC for 48 hr in an atmosphere of J-ION CO;. The
colonies were counted and the species determined by germ tube pro¬
duction and API Candida tAPI 20C1
In order to compare our results for patients with IDDM or NIDDM
with those reported for healthy individuals, the definition of Burford-
Mason era!. (13) for non-earner was used. Non-earner status was
assigned to a patient if no yeast colonies were isolated from the
quantitative mouthwash.
The results were analyzed by the X; test.
Results
No veast was isolated from 115 (42"J of the 275 patients
examined, but one or more species of yeast was obtained
from 160 l5S"J patients. Yeasts were isolated from 84
|6I"„) of the 157 patients with IDDM and 76 (55u„l of the
158 patients with NIDDM. Among patients with IDDM.
the proportion of earners was 65",, for secretors and 56°u
for non-secretors. Among those with NIDDM. 49" u of the
secretors were carriers as were 68",, of non-secretors.
These differences in the proportions of non-secretors in








no. 1™,.) no. l"J
Secretor 59 i65> 29 i35i an (49) 99 (51)
Non-secretor 30 i56i 29 |9j| 23 (68) 13 (32)
Total 39 1611 53 (39) 76 (55) 62 (95)
Table 3 Secrctor aatus of earners of C. athuani compared with ihut
of nun-curriers
IDDM XIDOM
Secretor .V(Xt-s*cnrfw Secretnr Xon-iec'retor
no. 1 "J no. no. CJ n». I"J
Non-earners 29 (55) 29 (951 99 (79) 13 (211*
C. albicans 38 (67) 19 (33) 29 (56) 23 (94|*
•p<00l.
the carrier and non-carrier groups were not statistically
significant (Table 1).
More than one species was isolated from six of the
patients. Of the 166 isolates. 109 (65-T0^) were C. albicans.
and the remaining 57 (34-5n0) were predominantly other
strains of Candida or Torulopsis. six were not identifiable
(Table 2).
Examination of the data for patients with IDDM found
no significant differences in the proportions of non-
secretors among individuals from whom no yeast was
isolated |45°0) compared with earners of C. albicans 133"0).
Although the proportion of secretors with IDDM carrying
C. albicans was higher (67°0) than secretors from whom
no yeasts were isolated (55°,,). the difference was not
statistically significant iTuble 5).
Among patients with NIDDM there was a significant
increase in the proportion of non-secretors from whom
C. albicans was isolated 144",,) compared with non-
secretors who were non-carriers i21°„) l.X: =6-7. p < 0-01):
however, there was no significant difference in the pro¬
portions of secretors who were earners of C. albicans
(56",.) compared with secretors who were non-carriers
(79"„)(Table 5).
There was no significant difference in the distnbution of
A or O blood groups between patients with diabetes who
were earners compared with non-earners of C. albicans.
There were not enough patients of blood group B or AB
for statistical analysis lTable4i. Among patients with
NIDDM there was. however, a significantly higher pro¬
portion of non-secretors among group O carriers of
C. albicans 115 26. 50°J compared with the proportion of
non-secretors among group O patients from whom no
yeasts were isolated 18 56.22° Ip < 0-05L A similar pattern
was observed for blood group A. 6 of the 15 earners (40°
Table 2 Yeasts isolated from secretors and non-secretors with IDDM or NTDDV1
IDDM XIDDM
Secretor Xon-tecretor Seiretor Xon-iecrctor
Total no. t"J nii. ("„) Total no. ("„) no. ("„)
Yeasts 36 55 |64) 31 (361 SO 50 ( 63) 30 ( 3-0
C. albican* 57 38(671 19 (33) 52 29 i5bl 23 l-U)
Others 29 17(591 12(911 2S 21(75) 7(25)
002 BLACKWELL et al.
Tabic 4 Distribution of 0 and A blood groups among







Non-carrters 04 26 (59) IS 1411
C. albicans J4 31 157) 23 1431
NIDDM
Non-earners 54 36 167) IS (33)
C. albicans 4! 26 163) 15 (37)
Blood donors 277 173 |62) 104 1381
were non-secretors but oniv 3 of the 19 non-carriers
(16*0]L The numbers are too small for analysis by the X2
method. This pattern was not observed among patients
with IDDM.
Discussion
The proportion of 275 diabetics from whom yeasts were
isolated l53°0) is similar to that reported in other studies
116. 17) and higher than that for healthy controls 130°,,)
113). There was a higher proportion of earners among
non-secretors (58 95. 61",,) compared with secrctors who
were carriers 1102 130. 55",,) but this was not statistically
significantiTabie I).
Compared with healthy controls, there were differences
in the species of yeasts isolated from patients with dia¬
betes: 94"., of those from healthy subjects were C. albicans
113) compared with 65-7",, from diabetics. The remaining
34-3";, of isolates from diabetics w ere mainly other species
of Candida and Toruiopsis. The lower proportion of
C. albicans and an increase in the more unusuai species of
yeasts parallel the pattern found among individuals with
antibody to the human immunodeficiency virus iHIV)
(Wrav. unpublished observations). This might reflect the
susceptibility of immunocompromised individuals to
organisms that are not usually carried by or pathogenic in
the healthy host.
Analysis of the data by type of diabetes yielded results
that do not agree with the report by Lamev ct al. |I7).
They found no association between non-secretion and
carnage of Candida among 58 patients with IDDM or 50
with NIDDM: however, the numbers of patients in their
study were less than half the number examined here and
there was no differentiation of C. albicans from other
species. Comparison of their results with ours or those of
Burford-Mason and colleagues is difficult.
Analysis of the figures for earners of C. albicans with
non-earners was performed to determine if there was a
pattern similar to that obtained for healthy controls 113).
Although there was no significant difference in the pro¬
portion of secretors or non-secretors with IDDM who
were carriers, there was a sizniticant increase in the
proportion of non-secrctors with NIDDM who were
earners of C. albicans I Table 3).
In contrast to the results of Burford-Mason at al. 113).
we found no association between carnage of C. albicans
and blood group O among patients with IDDM or
NIDDM. There was. however, a significantly higher pro¬
portion of O non-secretors among the NIDDM carriers
compared with those of blood group 0 who were not
earners. A similar pattern was observed among patients
of blood group A with NIDDM. but the difference was
not statistically significant This pattern was not observed
for patients with IDDM.
I This study suggest^an association between carriage of
C. albicans and non-secretion similar to that reported for
healthy subjects is found among patients with NIDDM
but not among those with IDDM. The host-parasite
interactions that influence carriage in the non-diabetic
individuals appear to be similar to those in patients with
NIDDM. The lower proportion of non-secretors among
patients with IDDM who were carriers of C. albicans was
unexpected and might be explained by investigation of
their specific immune responses to these organisms.
In a group of women with recurrent urinary tract
infections who were followed for 20 yr. non-secretors had
significantly higher levels of total serum IgA and IgG than
secretors. Improvement, judged as fewer episodes of in¬
fection during the second decade compared with the
number during the first decade of the study, was associated
with higher levels of total serum IgA in the non-secretors.
We suggested this might reflect a greater dependency of
non-secretors on specific immune responses for protection
against these infections 118).
Decreased isolation of C. albicans from vaginal speci¬
mens is associated with high lev eis of specific anti-candida
serum IgA. but not anti-candida serum IgG il9). Studies
of the specific humoral immune responses of patients with
NIDDM or 1DDM to C. albicans are underway to deter¬
mine if these differ between the two patient groups and
what role these responses play in colonization with re¬
spect to secretor status.
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Secretor State and Susceptibility to Recurrent Urinary Tract Infections
C C Black well. S. J. May, C J. Maccallam,
R. P. Brcttle, and D. M. Weir
From the Deportment oj Bacteriology. The Medical School
University of Edinburgh, and the Infectious Disease Unit,
City Hospital, Edinburgh, Scotland
The inability to secrete the water-soluble form of the ABO blood group antigens is as¬
sociated with susceptibility to a number of bacterial and fungal infections and to recur¬
rent urinary tract infections (UTI) in women and appears to influence development of
kidney scarring in young children. Three hypotheses are proposed to explain these obser¬
vations, and evidence is provided to support or refute these suggestions. The hypothesis
was tested that increased susceptibility of nonsecretors to recurrent UTI might be due
in part to their reported lower levels of serum and secretory IgA. In contrast, among women
observed for 20 years, the toul serum IgA and IgG levels of 70 nonsecretors (125.4 and
139.7 lU/mL, respectively) were significantly higher than those for 111 secrctors (103 and
118 IU/mL, respectively). IgA levels for both secretors and nonsecretors were significantly
higher than those for 100 age-matched women in a prospective study group. Nonsecretors
who had improved (fewer episodes of infection during the second decade of study) had
significantly higher levels of both IgA (P < .0025) and IgG (P < .025) than did secmors
who had improved. The possible role of the immune response of nonsecTetors in both
protection from reinfection and pathogenic sequelae of UTI is discussed.
Although a great deal of information has been ob¬
tained regarding the genetics and molecular biology
of the uropathogenic Escherichia coli strains, infor¬
mation regarding stable susceptibility factors of the
host is much more limited. It has been suggested that
the secretor state of the host might be associated with
susceptibility or resistance to infectious agents (1, 2).
The ability to secrete the water-soluble glycoprotein
forms of ABO blood group antigens is a stable char¬
acteristic controlled by a single gene (Se) inherited
in a Mendelian dominant pattern. The recessive, non-
secretor phenotype is expected in 251% of an out-
bred population; however, this figure can vary with
different ethnic groups [3-5]. Secretor state does not
alter with changes in the environment or age.
Our research group and other workers have found
significantly higher proportions of nonsecretors
among patients with cholera [6], superficial Candida
infections [7, 8], meningococcal meningitis, invasive
This project was supported by a grant from the Scottish Home
and Health Department (K/MRS/30/C449).
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ries of the City Hospital for their assistance, and to the Edin¬
burgh and Soulh-East Scotland Blood Transfusion Service for
reagents used in this study.
Please address requests for reprints to Dr. C. C. Blackwell,
Department of Bacteriology, The Medical School, Edinburgh EH8
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pneumococcal disease [9], invasive infections due to
type b Haemophilus influenzae [10], recurrent uri¬
nary tract infections (UTI) [11-13], and two diseases
for which infectious etiologies have been proposed,
ankylosing spondylitis [14] and type 1 diabetes mel-
litus [15].
Although a number of these observations were
made in the 1960s, these epidemiologic Findings of
association between secretor state, ABO blood
groups, and infectious diseases were not used as a
basis for investigation of the underlying host-parasite
interactions. The only hypothesis suggested at the
time was that the isohaemagglutinins might act as
"natural" antibodies against microorganisms with
surface antigens cross-reactive with A or B. The rec¬
ognition of lectin interactions between host and para¬
site provided the basis for a number of new hy¬
potheses.
The secretor gene is involved not only in the secre¬
tion of A, B, and H antigens into body fluids but
also with the expression of the Lewis blood groups
[16]. The distribution of ABO and Lewis antigens
in body fluids is shown in table 1. The body fluids
of secretors (e.g., urine and saliva) will contain the
ABO antigens of the individual, a small amount of
Lewis a antigen, and a much greater proportion of
Lewis b antigen. The body fluids of nonsecretors
contain only Lewis a antigens. These differences sug¬
gested the first two of the three hypotheses we pro¬
posed to explain the host-parasite interaction under-
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Table 1. Distribution of the glycoprotein forms of
ABO and Lewis antigens in body fluids of secretors
and nonsecretors.
ABO and Lewis antigens
A B H Le* Le"
Secretor + /0* +■ /0* + +
Nonsecretor 0 0 0 ■f 0
• Dependent on presence of A or B gene.
* Some Le* present in secretors.
lying the increased susceptibility of nonsecretors to
infections (table 2).
Hypothesis I: The inhibition hypothesis. In
1975, Williams and Gibbons reported that salivary
glycoprotein with blood group activity were able to
inhibit and even reverse binding of Streptococcus
salivarius to epithelial cells (17). A similar effect has
been observed by Holmgren and co-workers for
glycocompounds in pooled human milk, a rich
source of blood-group antigens. In vitro these heat-
stable compounds were able to inhibit adhesins on
enteropathogenic strains of EL coli and Vibrio
cholerae. They found that mannose-resistant but not
mannose-sensitive binding was inhibited by these
substances [18].
We predicted that the ABO or Lewis b antigens
in body fluids of secretors might be able to inhibit
binding of microbial adhesins. In attachment studies
with Candida, we were able to demonstrate inhibi¬
tion of binding of the yeast to epithelial cells with
boiled saliva from secretors but not with saliva from
nonsecretors (7, 8]. Andersson and co-workers have
reported inhibition of binding of Streptococcus pneu¬
moniae and H. influenzae by preincubating the bac¬
teria with heat-stable glycocompounds from pooled
human milk [19]. Their findings complement our
epidemiologic studies in which we found an increased
incidence of nonsecretors among patients with dis¬
eases caused by these bacteria [9, 10]. Our recent
studies have found that several strains of E. coli iso¬
lated from infected urine can adsorb H antigen from
body fluids (C. C. Blackweli, unpublished observa¬
tions). If interactions similar to those in the in vitro
experiments occur in vivo, secretors might be less eas¬
ily colonized if the glycocompounds in their body
fluids are able to inhibit lectin-Iike adhesins on the
surface of the bacteria.
Hypothesis 2" The receptor hypothesis. The second
hypothesis suggested that the Lewis a antigen is one
of the receptors for uropathogenic strains. There is
indirect evidence for this from three sources. Lorn-
berg and co-workers have reported a significant in¬
crease in binding of strains with the mannose-resistant
adhesins that recognize the a-D-Gal-(l—4)-0-D-Gal
conformation (mannose-resistant [MR]:globoseries
[GS] adhesin) to nonsecretor cells. The host-parasite
interactions proposed to explain these observations
is that the fucosyl transferase controlled by the secre-
tor gene might modify molecules surrounding the
receptors in the P antigen or the receptors themselves
[20]. Since strains with the MRmon-GS fimbriae also
were bound in greater numbers to the nonsecretor
cells, we suggest an additional mechanism: that the
Lewis a antigen found on nonsecretor cells is one
of the receptors for adhesins on the surface of £ coli.
Our studies indicate that Lewis a antigen is one of
the receptors for Candida species [21]. We also found
that pretreatment of the yeast with boiled saliva from
nonsecretors significantly enhanced the binding of
the yeast to epithelial cells [7, 8]. In 1982 Epstein
and co-workers reported that preincubation of
blastospores with a proportion of saliva samples
from which specific antibodies to Candida had been
adsorbed enhanced their binding to epithelial cells
[22]. Saliva from r*20th-25th of their donors had
this property, the proportion of nonsecretors pre¬
dicted for an outbred population.
The nature of the Lewis antigens suggests the fol¬
lowing model. Unlike the ABO antigens, the Lewis
antigens do not form part of the structure of the cell.
They are adsorbed from body fluids onto the sur¬
faces of cells. If there are adhesins on £ coli that
recognize Lewis antigens, the following interactions
might occur: (/) the bacteria could bind directly to
the epithelial cell via Lewis antigens or (2) the car-
Tabte 2. Three hypotheses proposed to explain the host-
parasite interactions underlying increased susceptibility
of nonsecretors to infections.
(1) The carbohydrate moiety of glycoproteins present in the body
fluids of secretors can bind to leclin-like adhesins on micro¬
organisms, decreasing their ability to adhere to and colonize
a mucosal surface.
(2) The Lewis a antigen found in significant quantities only on
the cells of nonsecretors is a receptor for some microbial
adhesins.
(3) The reported lower levels of serum and secretory IgA found
in nonsccretors leads to a compromised state at their mucosal
surfaces.
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bohydrate moiety of free Lewis antigens in body
fluids might bind to the adhesin and then be ad¬
sorbed onto the cell surface We have evidence for
this model with Candida albicans and are presently
investigating it with E. coli isolates.
Hypothesis 3: The deficient immune response hy¬
pothesis. The third hypothesis is based on reports
of lower levels of scrum and secretory IgA in non-
secretors (23, 24], If nonsecretors have lower levels
of these antibodies that are classically associated with
protection of the mucosal surfaces, their host de¬
fenses against UTl might be compromised. In com¬
parison with age-matched controls, young girls with
recurrent UTI have been found to have lower levels
of total secretory IgA [25].
In the present paper we report our epidemiologic
survey of 718 women with recurrent UTI and discuss
our results in the context of the secretor states re¬
ported for 77 young Swedish girls with pyelonephritis
followed by the research groups in Goteborg. We also
present the data from our experiments in which we
tested our third hypothesis - that nonsecretors are
unable to produce an effective IgA response.
Patients and Methods
The population examined consisted of 718 women
referred to the Pyelonephritis Clinic, City Hospital,
Edinburgh, for specialist investigation of recurrent
UTI. The women in both the patient and control
groups are mainly of Celtic and Norse backgrounds;
there is not a substantial immigrant population in
this area. This population was divided into a prospec¬
tive group of 516 women referred to the clinic dur¬
ing or after 1982 when the study began and a retro¬
spective study group of 202 women followed by the
clinic for 20 years. The control groups was 334 blood
donors 18-65 years old (11].
TVvo hundred women in the retrospective study
were divided into the following groups according to
information in their clinical records (for a detailed
account of this group see [26]): 54 women with re¬
nal scars as determined by pathological examination
after nephrectomy (19 patients) or radiologic evidence
(35 patients) and 146 with a history of recurrent UTI
but no radiologic evidence of scarring. Voiding cys-
tograms were not performed for all patients since
these are considered invasive procedures not justifi¬
able for routine examinations. The mean age of the
women with renal scars was 50.5 years (range, 23-74
years) and that of the women with no evidence of
scars was 54 years (range, 27-84 years). The differ¬
ence in ages was not statistically significant (26].
Patients were considered to have improved if they
had fewer documented episodes of infection during
the second decade as compared with the first decade
and not to have improved if they had more episodes
of infection during the second decade than in the
first decade. There were also a group of women for
whom there was no change in the numbers of infec¬
tions during the two decades. Among the group with
renal scars, the mean number of infections for 42
patients during the first decade was five (range, 1-20)
and was 2.5 (range, 0-10) for the second decade. For
the group with no evidence of renal scarring, the
mean number of documented infections for 96 pa¬
tients during the first decade was 4.6 (range, 0-23)
and was 2.8 (range, 0-35) for the second decade [26],
Secretor state was determined by the hemagglutin-
ation-inhibition assay described by Mollison (27],
and the total serum IgA and IgG levels were deter¬
mined with Behring Nor-partigen immunodiffusion
plates. Total IgA and IgG levels were determined be¬
cause from our epidemiologic studies there appeared
to be no single strain or antigen associated with or¬
ganisms causing recurrent UTI among these women
[28]. The values for IgA and IgG were recorded in
international units (IU).
The results for the women in the retrospective
group were compared with those obtained for 100
age-matched women from the prospective study
group recently referred to the clinic In the analysis
of these results with reference to secretor state, im¬
provement, and renal scarring, we used data obtained
for women 23-64 years old since the age range for
which the Nor-partigen plates were standardized is
16-64 years (29].
The x' test was used to compare the incidence of
nonsecretors in the study with the incidence we re¬
ported for local blood donors (26.6^#) [11]. Student's
t test was used to compare IgA and IgG values for
the different patient categories.
Results
The secretor states for the patients in the various cat¬
egories are shown in table 3. A significantly higher
proportion of women referred to the clinic for inves¬
tigation of recurrent UTI were nonsecretors as com¬
pared with the proportion among the local control
population. This increase was seen in the group with
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Table 3. Proportion of nonsecretors among women
referred for investigation of recurrent urinary tract in¬
fection.
No ■ <W)
Category (no.) nonsecretors P
Total (718) 250 (34 8) <01
Prospective group (516) 172 <33 3) <05
Retrospective group (202) 78 (38 6) <01
Without renal scars (146) 53 (36 6) <05
With renal scars (54) 23 <42.6) <05
Improved (127) 47 (37) <05
Not improved (50) 20 (40) NS
No change (22) 10 (45.5) NS
Controls (334) 89 (26.6)
NOTE. NS = not significant.
renal scarring, those with no evidence of scarring,
and those who had improved over the 20 years. There
were 29 women with juvenile onset of symptoms,
5l*h were nonsecretors (P < .05).
Table 4 compares the total serum IgA and IgG lev¬
els for the different patient categories. In contrast
to our prediction, the mean IgA level for nonsecre¬
tors was higher than that for secretors as was the
mean IgG level. The increased levels of IgA for non¬
secretors were found for the group as a whole, for
patients with renal scarring, for those with no evi¬
dence of scarring, and for those who had improved
over the 20 years. This difference between the IgA
levels of secretors and nonsecretors was not observed
among the patients who had not improved or among
those for whom there was no change in the incidence
of infections over the two decades.
The differences were not due to the age of the
population. Comparison of these figures with those
obtained for the age-matched group of women re¬
cently referred to the clinic indicated that these differ¬
ences between secretors and nonsecretors were found
only in the group of women who had had these in¬
fections over a long period. Both IgA and IgG values
for women in the retrospective study were higher than
those for the age-matched women in the prospective
study (table 5).
The immunoglobulin levels were analyzed with
reference to the presence or absence of renal scar¬
ring. Among the women with no evidence of renal
scarring, the only statistically significant difference
found was the increased IgA levels for nonsecretors
who had improved as compared with the levels for
secretors who had improved. Although the mean for
Tabic 4. Geometric means of total serum IgA and IgG

















































Nonsecretor (9) 112 153.1
NOTE. NS = not significant.
IgA was higher for the nonsecretors who had im¬
proved than for those who had not improved, this
difference was just outside statistical significance (ta¬
ble 6).
The pattern observed among the women with
scarred kidneys was more complex (table 7). Both
IgA and IgG levels for the improved nonsecretors
were significantly higher than those for the improved
Table 5. Geometric means of total serum IgA and IgG



















NOTE. NS = not significant.
Tabic 6. Geometric means of total serum IgA and IgG
levels from secretors and nonsecretors without renal scars



















136 NS 168.3 NS
Mean value (healthy Central
Europeans 15-64 years old) 125 144
NOTE. NS = not significant.
secretors. The IgG levels of secretors who had not
improved are intriguing. Although the numbers are
small, four of the five patients in this category had
unusually low levels of IgG as compared with the
mean reported for central Europeans; 144 IU/mL (29].
Discussion
The results of this study refute our hypothesis that
recurrent UTI among nonsecretors is due to their in¬
ability to mount an effective immune response. The
Table 7. Geometric means of total serum IgA and IgG
levels of secretors and nonsecretors with renal scars with















149.5 NS 149.4 <05
Mean value (healthy Central
Europeans 15-64 years old) 125 144
NOTE. NS = not significant.
results indicate that the increase in the proportion
of nonsecretors among patients with recurrent UTI
is not associated with an inability to produce IgA
antibodies. Nonsecretors appear to be more depen¬
dent on their specific humoral responses than are
secretors, perhaps because the innate protection as¬
sociated with the secretor gene is absent.
A similar pattern was found in a separate study
in which the total immunoglobulin levels in serum
and saliva of carriers of Neisseria meningitidis w*re
compared with those of non-carrier controls
matched for age, sex, and secretor state. We were un¬
able to confirm the reported lower levels of salivary
IgA in nonsecretors in either the carrier or control
groups; however, the levels of IgA in the saliva of
carriers of both secretors and nonsecretors were dou¬
ble the levels in the controls (30). Because the coloni¬
zation/carriage of mucosal pathogens was not as¬
sessed, it is difficult to comment on the report of
lower levels of IgA in the vaginal secretions of young
girls with UTI as compared with those of age-
matched girls with no history of UTI [25]. There was
a significant increase in levels of total serum IgA in
the nonsecretor carriers as compared with those of
the nonsecretor controls. These higher levels of IgA
were elicited by the capsulate, serogroupable strains
but not by the nonserogroupable, nonpathogenic
strains (30].
The presence or absence of serum antibodies spe¬
cific for certain pathogens appears to influence their
carriage on the host's mucosal surfaces. A reduction
in the carriage of serogroup C N. meningitidis fol¬
lowed the immunization of recruits with group C
polysaccharide vaccine (31], and the probability of
becoming a carrier of serogroup B meningococci was
greater in recruits who lacked detectable antibodies
to serogroup B at induction (32]. Candida albicans
was isolated more frequently from women with low
levels of specific anti-Candida serum IgA but not
from those with low levels of specific anti-Candida
IgG (33]. Gough and co-workers found a significant
correlation between anti-Candida IgA in serum and
secretions (34]. If a similar response is elicited by in¬
fecting E. coli strains, the increased levels of serum
antibodies might reflect increased levels of these at
the mucosal surfaces.
Determination of the antigens against which the
raised levels of IgA are directed might provide clues
to those that induce protection. Regardless of age
of onset of UTI or of the therapy prescribed, the
majority of the patients had improved over the 20
years, and improvement was associated with higher
levels of IgA. The patient from whom the most iso¬
lates (12) were obtained during the study is a secre-
tor, but her IgA levels were low (85.4 IU/mL) and
her IgG levels average (144 lU/mL).
The ability to secrete the ABO blood group anti¬
gens appears to play a role in the host's innate
defenses against a number of infectious agents, par¬
ticularly those that affect nonimmune children [9,
10) and adults who are immunocompromised in
some way [7, 8). The proportion of nonsecretors is
significantly increased among patients with invasive
infections due to pneumococci, meningococci, or
type b Haemophilus [9, 10). These are diseases that
are prevalent in children during the vulnerable period
(6 months to 5 years) when maternal antibodies have
declined and the child's own immune responses are
not well developed [351. Most UTI that result in kid¬
ney scars occur during this time (36). There was a
significant increase in the proportion of nonsecre¬
tors among our patients with juvenile onset of symp¬
toms (51^) and among those with renal scars
(42.6V*). In a study of 77 Swedish children, there was
a significant increase in the proportion of nonsecre¬
tors (40V#) among those who developed kidney scars
following UTI [37).
These observations suggest the following interac¬
tions. In the nonimmune secretor, the secreted gly¬
coproteins might limit the numbers of bacteria at
the attachment/colonization step of the pathogenic
process. These small numbers of bacteria might elicit
a modest inflammatory response and also induce
specific antibodies. In the nonimmune nonsecretor,
colonization might not be inhibited but might be
actively enhanced via the interactions with Lewis
a antigen, as suggested by our in vitro studies of Can¬
dida and by the increased attachment of uropatho-
genic E. coli to nonsecretor cells (20). The larger
numbers of colonizing bacteria might multiply in the
absence of specific immune protection and induce
a strong inflammatory response. If this takes place
in the kidney, scarring might result.
The recent report of Johnson et al. (38) suggests
that the specific immune responses of the host might
also contribute to the pathogenesis of scarring. Bind¬
ing of IgA-containing immune complexes by tissue
macrophages in the lung elicits production of reac¬
tive oxygen radicals, resulting in significant damage
to surrounding tissues. We have suggested that if the
immune responses in children parallel those observed
in adults, the higher levels of IgA and IgG found
in nonsecretors might contribute to pathogenesis of
renal scarring by similar mechanisms (39). There are
reports of local production of IgA in the urinary tract
and significant levels of both IgA and IgG in the
urine of children with pyelonephritis (40). If com¬
plement is present, IgG-containing complexes also
can elicit tissue damage (41).
The pathogenesis of UTI is multifactorial. The
finding that nonsecretion of the ABO antigens is as¬
sociated with recurrent infections provides a stable
host marker for investigation of interactions between
the nonspecific defenses and the immune responses
to the infecting organism, both in the initiation of
infection and possible pathogenic sequelae.
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SUMMARY
A survey of ABO blood groups, secretor status and smoking habits among 389
students and staff of a school in which there was an outbreak of meningococcal
disease found no difference in the distribution of the ABO blood groups but a
significantly higher proportion of non-secretors (376%) in the population
examined compared with that reported for previous surveys of the neighbouring
population in Glasgow (26-2%) (P < 0-0005). There was also a significantly higher
proportion of non-secretors among carriers of meningococci (47 %) compared with
non-carriers (32%). Increased carriage of meningococci among non-secretors
might contribute to the increased susceptibility of individuals with this genetic
characteristic to meningococcal disease observed in previous studies. Although
passive exposure to cigarette smoke has been associated with meningococcal
disease, there was no association between passive smoking and carriage. There
was, however, a significant association between active smoking and carriage.
INTRODUCTION
In December 1988 there was an outbreak of disease due to a serogroup B
serotype 4 PI. 15 sulphonamide-resistant strain of Neisseria meningitidis in
Airdrie, Lanarkshire. There were five cases of the disease among students at the
Airdrie Academy; one teacher developed the disease and died. Four of the cases
occurred in the second year, three of these in one form. A child who attended
another school was also infected.
During the week before the Christmas/New Year recess, teams from the
Infectious Diseases Unit at Monklands District General Hospital and the
Depart ment of Community Medicine screened 1492 students and staff for carriage
of meningococci, and issued each with a course of rifampicin (600 mg bd for 2
days). During the second week of January 1989 when the school had reopened, a
selected group of students and staff was retested for carriage of meningococci and
I
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specimens of blood and saliva were also obtained. In addition, participants were
interviewed about smoking habits or passive exposure to cigarette smoke that has
been associated with meningococcal infections.
The genetically determined inability of an individual to secrete the glycoprotein
form of his ABO blood group antigens (non-secretion) is associated with
susceptibility to meningococcal infection [1]. Prolonged outbreaks of meningo¬
coccal disease have occurred in areas where there are higher proportions of non-
secretors [2. 3]. In this study we determined if there is also a higher proportion of
non-secretors in a population in which there was a single short outbreak of the
disease. In the study in Stonehouse. Gloucestershire we found an increase in the
proportion of non-secretors among carriers of meningococci within the community,
but this was not significantly different from the proportion of non-secretors from
whom no meningococci or Neisseria lactamica were isolated. In this study we
determined if there is a higher proportion of non-secretors among carriers of
meningococci within the school population.
Several environmental factors have been associated with susceptibility to
meningococcal disease: passive exposure to cigarette smoke [4, 5]; overcrowded
accommodation [6]; poverty and lower social class [7]; strenuous physical activity
[5]; predisposing viral infections [8-10]. As the population affected was old enough
to have enough smokers for statistical analysis, the effects of smoking or passive
exposure to cigarette smoke on carriage of meningococci among students and staff
was examined.
SUBJECTS AND METHODS
In December 1988, as part of an urgent public health measure to administer
prophylactic antibiotics, 1492 staff and students at the Airdrie Academy were
screened for carriage of meningococci bv nasopharyngeal swabbing. In January
1989, 389 selected individuals at the school were screened for carriage of
meningococci. From the second year class, 201 of the 226 pupils were examined as
this was the year in which 4 of the 5 cases among the children occurred. From the
other five classes, 85 carriers plus a group of 85 non-carriers from the same form
matched as closely as possible for age and sex were examined: year one, 25
students; year three, 39 students; year four, 68 students; year five, 29 students;
year six, 9 students. From the staff, there were ten members who were carriers
matched as closely as possible for age and sex with eight non-carriers with similar
duties in the school. Each participant supplied a saliva sample (5 ml), and 10 ml
of blood was obtained from 371.
ABO and Lewis blood groups were determined by agglutination of blood
specimens with monoclonal antibodies. Because the haemagglutination inhibition
test for secretion with saliva can yield ' false' secretors if contaminated with blood,
the Lewis test was used to determine secretor status: secretors express Lewis6 and
non-secretors express Lewis". The nasopharyngeal swabs were cultured on GC
selective medium (NYC/Thayer Martin medium) and A*, meningitidis identified by
Gram stain, oxidase test and the Gonochek II system (EY Laboratories). The
serogroup, serotype and sensitivities to sulphonamide and rifampicin were
determined at Ruchill Hospital, Glasgow.
Each participant in the January survey was interviewed to obtain information
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regarding smoking habits and exposure to cigarette smoke. The information was
coded and analyzed with the laboratory results by a Database II programme.
Because all the participants could not be matched for sex, the results were
compared by the x2 test rather than McNemar's test.
RESULTS
Among the 1492 students and staff tested in December 1988 AT. meningitidis was
isolated from 126 (8 4%). There were 11 isolates which were serogroup B or non-
groupable with increased resistance to sulphonamide and with the serotype
and/or subtype of the outbreak strain; 6 of these were isolated from students in
the form (2A) where 3 of the 5 cases occurred. In December none of the isolates
was resistant to rifampiein; however, in January 3 of the 13 isolates, including 2
with characteristics of the outbreak strain, were resistant to rifampicin.
.4.60 blood group distribution and secretor status of the school population
Blood specimens were obtained from 371 students and staff. The distribution of
the ABO groups is shown in Table 1; this does not appear to differ markedly from
that observed in earlier studies for either Edinburgh [11] or Glasgow [12].
The distribution of the Lewis"/non-secretors and the Lewis^/secretors in the
population tested does differ significantly from the figures reported earlier for
Edinburgh [11] (x* — 9-03, P < 0-005) and Glasgow [13] (^2 = 1214, P < 0 0005)
(Table 2). Among the 185 students in the second year class whose red cells
expressed Lewis antigen. 65 (35%) were Lewis°/non-secretors, a significantly
higher proportion compared with the figure for nearby Glasgow (^2 = 4-81, P <
0-05). In form 2A where 3 of the 5 cases among the students occurred, 13 of the
26 ( 50%) children tested were non-secretors; but this was not significantly
increased compared with the other forms in year 2. Only 2 of the 5 cases were non-
secretors.
Specimens were obtained from 109 individuals who had been carriers in
December. There were 51 non-secretors (47%) among the carriers compared with
83 non-secretors among the 262 non-carriers (32%) (^2 = 4-94, P < 005). The
majority of these strains did not have the characteristics of the outbreak strain.
Specimens were obtained from 10 of the 11 students who were carriers of isolates
with characteristics of the outbreak strain; 6 of the 10 carriers were non-secretors.
Meningococci were isolated from 13 of the 389 tested in January and 5 of the
carriers were non-secretors (385%). The outbreak strain was isolated from 2
students, one secretor and one non-secretor. both of whom had received rifampicin.
Smoking and carriage of meningococci
There was no association between passive exposure to cigarette smoke (father
and/or mother smokers) and carriage; but there was an association between
students' smoking habits and carriage. There were 17 carriers among the 37
students who were smokers (46%) compared with 87 carriers among 349 students
who were non-smokers (25%) (y2 = 6 48, P < 0-025) (Table 3). Four (31 %) of the
13 students who were carriers in January were smokers. In the December survey,
6 of the 10 members of staff who were carriers were smokers, but none of the eight
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Table I. Comparison of the distribution of ABO blood groups for the Airdrie




A A A A
No. (%) No. (%) No. (%) No. (%)
Airdrie 118 (32) 47 (13) 198 (53) 8 (2)
Glasgow 1906 (32) 637 (11) 3177 (54) 178 (3)
Edinburgh 104 (31) 42 (13) 173 (52) 15 (4)








No. (%) No. (%) y1 P
222 (62-4) 134 (37-6) — —
371 (73-8) 132 (26-2) 1214 <0-0005
245 (73-4) 89 (26-6) 9-03 <0005
Table 3. Carriage of meningococci among smokers and non-smokers
Carrier Non-carrier
No. (%) No. <%)
Smoker (37) 17 (46) 20 (54)
Non-smokers (349) 87 (25) 262 (75)
Total 104 282
non-carrier controls from the staff were smokers. The proportion of girls who
smoked 27/208 (13%) was significantly higher than that of boys who smoked
10/171 (6 %) (y2 = 4-64, P < 0-05). The proportion of carriers was, however,
similar for both boys and girls, 47/171 (28%) and 57/208 (27%) respectively.
DISCUSSION
The proportion of non-secretors in most western European populations is
20-25% [14]. In areas where there have been prolonged outbreaks of meningo¬
coccal disease such as Iceland, Nigeria and Stonehouse in Gloucestershire, we have
found increased proportions of non-secretors [2, 3]. The present study provided an
opportunity to determine if the same pattern would be found in short localized
outbreaks. Although the distribution of the ABO blood groups was similar to that
previously reported for Glasgow and Edinburgh (Table 1), the proportion of
Lewis" non-secretors was 37 6% among the staff and students tested, significantly
higher than those previously reported for Glasgow (26-2%) [13] or Edinburgh
(26 6%) [11] (Table 2). This increase in the proportion of Lewis°/non-secretors is
similar to that observed among the residents of Stonehouse, Gloucestershire
(32-7%) compared with blood donors in the south west region (23 4%) [3].
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In the survey reported here, there was a significant increase in the proportion
of non-secretors who were carriers of meningococci (47%) compared with that
among the non-carriers (32%). In the Stonehouse study, the proportion of non-
secretors among carriers did not differ significantly from that of the participants
from whom no neisseria were isolated [3].
The main reason for the difference in the two studies is probably an
underestimate of the proportion of non-secretors among the carriers in the
Stonehouse survey [15]. The secretor status of each of the participants in the
Stonehouse survey was determined from the saliva specimen collected. Blood
contamination of saliva specimens can result in false 'secretors', so the Lewis
blood group was determined for a proportion of the blood specimens as a control
for secretor status. Although the ABO blood group was determined for each
specimen at the time of collection, the large number of individuals examined in the
Stonehouse survey (>6000) limited the determination of the Lewis blood group to
every eighth specimen.
For the specimens obtained in the Stonehouse study, the results of the saliva
and the Lewis blood group agreed for more than 92% of the pairs of specimens
tested. In the report on the Stonehouse data, it was emphasized that agreement
between the two tests was closest in the areas of the town where socioeconomic
conditions were better [3]. Differences between the blood and saliva tests
indicating 'false' secretors occurred significantly among the specimens obtained
from residents of Park Estate and Verney Fields where (a) 14 of the 15 cases of
meningococcal disease occurred [15], (b) the carrier rates for both outbreak and
non-outbreak strains were higher [16] and (c) the socioeconomic indicators were
lower [15]. Blood in saliva might be due to poor oral hygiene, periodontal disease
or smoking; each can affect the integrity of the oral mucosa and each is associated
with poorer socioeconomic conditions.
The results of this study provide evidence for our hypothesis that one of the
factors contributing to the susceptibility of non-secretors to meningococcal
disease is increased carriage of these bacteria among such individuals. This
parallels the reports of increased proportions of non-secretors among patients with
rheumatic fever and among carriers of Streptococcus pyogenes [17]. A significant
increase in the proportion of non-secretors has also been found among healthy
carriers of Candida albicans [18], and we have found a similar pattern among
patients with non-insulin dependent diabetes mellitus [19].
Passive smoking is associated with meningococcal disease [4, 5], but we found
no association with passive exposure to cigarette .smoke (mother and/or father
who were smokers) and carriage of meningococci. There was however, a significfant
increase in the proportion of carriers among smokers (46%) compared with that
among non-smokers (25%) (P < 0-025). The higher proportion of girls who were
smokers (13%) compared with boys who were smokers (6%) agrees with the
recently reported trends of increased smoking among teenage girls [20].
A slightly higher proportion of males to females has been noted among carriers
of meningococci; in the study of Cartwright and co-workers [16] the ratio was 3:2,
males: females. If smoking has a significant effect on carriage, in the population
examined in the present study, the higher proportion of girls who smoked might
contribute to the similar proportions of boys (28%) and girls (27%) who were
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carriers. Analysis of smoking and secretor status among carriers and non-carriers
indicate that these are two independent factors affecting carriage.
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rejection episode needing treatment during the first postoperative
month (controls tts UDCA treated group, p <0-01, Fisher's exact
test). Patients have been followed for a median of 5 months (range
3-8) and controls for 12 months (range 3-15 months).
Aminotransferases were significantly lower in the LDCA-treated
patients than in controls 1 month after transplantation (table).
The lack of acute rejection in the UDCA treated liver transplant
recipients cannot be explained by improved surgical technique
since the liver transplant programme and the surgeons in our unit
have not changed since 1985 In addition, the lmmunosuppressaon
protocol remained the same throughout 1989
We used UDCA to achieve a less toxic bile acid pool which would
protect the hepatocytes and prevent cholestasis.1-' UDCA has a
direct protective effect on hepatocytes in both in-vivo and in-vitro
studies.* Calmus and coworkers' have shown that UDCA reduces
class 1 H1A-antigen expression on hepatocytes in patients with
primary biliary cirrhosis HLA class 1 antigens are not usually
expressed on the hepatocytes,• but this effect of UDCA indicates
that H may also have other immunoeffects and the potential to alter
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Meningococcal disease: high virulence and
low transmission
Sir,—Dr Knight and his colleagues (May 19, p 1182) suggest that
the prolonged outbreak of meningococcal disease in the Gloucester
area and in Plymouth might be due to local environmental factors, a
genetically susceptible population, or a more virulent strain of the
organism. Their evidence indicates that isolates from patients in
these two areas are from a single clone, a sulphonamide-resistant,
serogroup B, serotype 15, serosubtype PI.16 strain of Neisseria
meningitidis (B15/16 R). They suggest that this strain has remained
localised in these regions because it is of increased virulence but
poorly transmissible.
Individuals who are genetically incapable of secreting the
water-soluble form of their ABO blood group antigens (non-
secretors) are significantly over-represented among patients with
meningococcal disease1 and among carriers of meningococci.' We
showed a significant increase in the proportion of non-secretors in
Stonehouse, the Gloucestershire town where there has been an
unusually high attack rate of disease due to the B15/16R strain,"
and in a Scottish school population in which there was an outbreak
due to a serogroup B, serotype 4, serosubtype PI. 15, sulphonamide-
resistant strain (B4/15R).1
100 individuals from the Plymouth area were examined for their
Lewis blood group antigen as controls for a study of the Lewis
phenocype among patients with breast cancer.' Non-secretors can
Outbreak Total La*/non secretOf
location strain La*/La* (no [%]> p value
South west
Blood donors 632 148 123-4J
Stonehouse B15 16R 411 134 13261 <0-005
Plymouth B15/16R 91 34 13741 <0-0005
Scotland
Glasgow 503 132 126 2)
Airdnc Academy B4,15R >56 134/37 6/ <00005
express only Lewis* and secretors express Lewisb. If the controls are
representative of the Plymouth population, the proportion of
Lewis* non-secretors is significantly higher (37 6%) than that of
blood donors in the south west region (chi-squared test p < 0-0005;
table).
In addition to the hypothetical increased virulence and poor
transmissibility of the B15/16R done, we suggest that the higher
proportion of the genetically susceptible non-secreton in the two
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DNA probes for typing Neisseria
meningitidis
Sir,—We were most interested in the use of a DMA probe to
investigate genetic heterogeneity among Neisseria meningitidis
B15P1.16 strains, described by Dr Knight and colleagues (May 19,
p 1182). They used a probe that detects a small (2 kb) repeated
sequence and we are not certain that the results obtained using this
probe are epidemiologically valid. The B15P1.16 sulphonamide-
resistant strains that are prevalent in the UK and elsewhere have
been shown to be donally related by isoenzyme electrophoresis but
it is reasonable to expect that there are degrees of genetic
heterogeneity within this done that will be large enough to code for
variations in surface components and possibly virulence factors. We
have been using a randomly selected probe prepared from a
genomic library of B15P1.16 prepared in XWesXB phage to type
meningococci by restriction fragment length polymorphisms
(RFLPs). This probe appears to react with all meningococci that we
have tested and has a high degree of discrimination and
reproducibility. When we applied this probe to B15P1.16 strains
collected over the past decade from many parts of the UK we
obtained results that differ from those of Knight et al and lead to a
fundamentally different interpretation. In short, we find that there
are two main variants of the B15P1.16 strains scattered about the
UK and that the Plymouth strains have a different RFLP pattern to
the Gloucester strains. The difference is demonstrable in isolates
from 1982 and has remained stable and detectable through to the
1990 isolates.
We have also had the opportunity to use a monoclonal antibody
(prepared by Dr J. E. Hedkeb, Southampton) that detects a point
mutation in the class I outer membrane protein PI.16 on the
B15P116 isolates. With this entirely different approach the
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SECRETOR STATUS AND INFECTION IN PATIENTS
WITH GRAVES' DISEASE
A.D. TOFT", C.C. BLACK.WELL*"", A T. SAADI" + . P. WU",
P. LYMBERP + ", M. SOUDJIDELLU *+ and D M. WEIR" +
Departments of Medicine* and Bacteriology* *, The Medical School, University of
Edinburgh, Edinburgh, Scotland, and Hellenic Institute Pasteur* * *, Athens, Greece
We have demonstrated that the inability to secrete the water soluble glycoprotein form of the ABO blood
group antigens into saliva is significantly more common in patients with Graves' disease than control
subjects (40% vs 27%; P < 0.025) but not among those with Hashimoto's thyroiditis or spontaneous
primary atrophic hypothyroidism. Non-secretion is associated with increased susceptibility to infection and
to asymptomatic carriage of some microorganisms.
Although Yersinia enteroeolitica has been found to express antigen cross reactive with the TSH receptor,
we did not find an increased prevalence of Yersinia species in the faeces of 107 patients with Graves' disease.
The isolation rate ( < 1%) was similar to that observed in the local population tvith diarrhoeal illness.
Salivary IgA levels determined by whole cell ELISA with Y. enteroeolitica 03 were not elevated in the
majority of specimens examined. The results suggest that, in contrast to reports from Scandinavia, there
is no strong evidence that yersiniae play a role in the pathogenesis of Graves' disease among patients in
South east Scotland.
Non-secretors are significantly over represented among patients with several other autoimmune diseases;
however, with the exception of antitubulin antibodies, non-secretors with Graves' disease did not have
more antibodies to other human antigens than secretor patients.
KEY WORDS: Graves' disease, non-secretors. Yersinia enterocolitica. Salivary IgG.
INTRODUCTION
Although there is considerable debate about the host-parasite interactions involved,
there is a growing body of evidence that infectious agents play a role in triggering
several autoimmune diseases. One of the hypotheses put forward to support this
proposal is that of molecular mimicry: there are antigens present on micro-organisms
that are cross-reactive with those of human tissues. As these cross-reacting antigens
are widespread among different species of microorganisms, some additional genetic
or environmental factors have been proposed to be involved in the aetiology of these
autoimmune diseases.
Two different sets of genetic factors have been identified. Compared with
unaffected individuals, the distributions of the HLA antigens among patients with
certain autoimmune diseases suggest that affected individuals differ in their immune
responses [Table 1]. Our research group has found a second genetic factor outside the
HLA system to be over-represented among patients with several autoimmune diseases
for which infectious aetiologies have been suggested. This is non-secretion, the
•Corresponding author.
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Table 1 HLA antigens associated with autoimmune diseases for which infectious triggers have been
proposed
Disease HLA marker's)
ankylosing spondylitis B27 HI
reactive arthritis 827 [2. 3]
palmoplantar pustulosis B8. CW7. DR3 (51
insulin dependent diabetes B8. BIS. DR3. DR4 (61
Graves" disease B8. DR3 [71
inability of an individual to secrete the water-soluble form of his ABO blood group
antigens into body fluids such as saliva or urine. The carbohydrate moieties of the
ABO blood group antigens and the closely related Lewis blood group antigens exist
in two forms. The glycolipid form is found as part of the structure of cell membranes;
the glycoprotein form is found in the body fluids and secretions. As the secretor gene
(Se) is inherited in a dominant pattern, approximately 75-80% of most European
populations are secretors while 20-25% express the recessive non-secretor phenotype.
The secretor gene also influences expression of the Lewis blood group antigens;
non-secretors produce only Lewis3 and secretors express small amounts of Lewis3 but
mainly Lewisb. This provides a check on secretor status which is usually determined
by a haemagglutination inhibition assay. The ABO and Lewis blood group antigens
found on cells and in body fluids of secretors and non-secretors are compared in Table
2
Non-secretors are significantly over-represented among patients with infections due
to a variety of bacteria and fungi [Table 3] (for review see89); and non-secretors are
also over-represented among asymptomatic carriers of Streptococcus pyogenes.
Neisseria meningitidis and Candida albicans'^12.
Investigation of secretor status of patients with autoimmune diseases for which
infectious aetiologies have been proposed suggest that non-secretion plays a part in
susceptibility to a variety of these conditions [Table 3]. Antigens or microoriganisms
that cross-react with host tissues have been suggested to play a role in triggering
several diseases [Table 5]; and. in three of these conditions, an association with
non-secretion has been identified: rheumatic fever, seronegative arthropathies and
Graves' disease.
The evidence for an infectious trigger, particularly Yersinia, in Graves' disease is
summarized in Table 6. Although there is not usually clinical evidence or history of
diarrhoeal disease preceeding this condition, we examined the following hypotheses.
1. If Yersinia is one of the triggers for Graves' disease, we might find cultural or
Table 2 Blood group antigens in secretors and non-secretors
BG antigen Secretors
On cells In secretions
Non-secretors
On cells In secretions
H (A/B) + 4- + —
LewisJ - ( + )* - < + )* + +
Lewisb + — -
•Present in small quantities
INFECTION IN PATIENTS WITH GRAVES' DISEASE 281
Table 3 Infectious agents to which non-secretors are more susceptible
CRAM-POSITIVE Streptococcus pyogenes
Streptococcus penunwniae
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serological evidence of carriage of these bacteria among patients on their referral
to the endocrinology clinic
2. As non-secretors are over-represented among patients with several autoimmune
diseases, there is not a specific bacterial species involved in the aetiology of
Graves' disease; but. non-secretors are more likely to produce autoantibodies to
a variety of self antigens.
METHODS
Patients
One hundred and seven patients with Graves' disease were studied who had been
referred consecutively as new patients to the same physician (ADT) at the Endocrine
Clinic. Royal Infirmary , Edinburgh, were included in the study. There were 89 females
and 18 males with a mean age of 46.2 + SE8.1 years. The diagnosis of Graves'
disease was based on the demonstration of raised serum concentrations of free
thyroxine and/or total triiodothyronine and undetectable thyrotrophin (TSH)
measured by radioimmunoassays3030. At least one of the following was also present:
diffuse goitre with an overlying bruit; exophthalmos; pretibial myxoedema; and a
concentration of TSH-receptor antibodies in the serum in excess of 5 units per litre31.
Table 4 Autoimmune diseases and non-secretion
Disease Association with non-secretion
Rheumatic diseases
rheumatic fever yes [10]
ankylosing spondylitis yes (131
reactive arthritis yes [13]
palmoplantar pustulosis yes [14]
rheumatoid arthritis no [14]
psoriasis no [15]
psoriatic arthropathy yes [15]
Endocrine diseases
diabetes (undifferentiated) yes [16]
insulin dependent diabetes yes [17]
non-insulin dependent diabetes no [17]
Graves' disease yes [18]
Hashimoto's thyroiditis no [18]
primary atrophic hypothyroidism no [18]
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Table 5 Bacteria with antigens crossreactive with host tissues
Disease Microorganism antigen
rheumatic fever Streptococcus pyogenes myocardium (19)




myasthenia gravis Yersinia enterocolitica acetylcholine
receptor (21)






ABO and Lewis blood groups of patients were determined by agglutination with
monoclonal antibodies provided by the Edinburgh and South East Scotland Blood
Transfusion Service.
Isolation and identification of Yersinia spp. from stool specimens
Each stool specimen was inoculated onto agar selective for yersiniae. cefsulodin-
irgasan-novobiocin (C.I.N.) After 24 h at 28°C. the colonies with a typical dark red
"bull's eye" surrounded by a transparent border were subcultured onto blood agar
and incubated at 28°C overnight. Gram-stain, oxidase and urease tests were done with
colonies from the blood agar plate. Urease positive, oxidase negative colonies were
examined with API 20E strips.
As cold enrichment results in a selective growth of yersiniae at the expense of other
enterobacteria, the stool samples were incubated at 4°C for 3 weeks and were cultured
again on C.I.N, media.
ELISA for total IgA in saliva
Saliva specimens from patients with Graves' disease were examined by enzyme linked
immunosorbent assay (ELISA). A pool of 50 saliva specimens obtained from
individuals with no endocrine disease was used as a standard for the study.
Rabbit anti-human IgA (Behringer) was diluted in coating buffer (50 mM sodium
carbonate buffer. pH 9.6) and 100 p\ of a 1/500 dilution were added to individual wells
Table 6 Evidence for infectious triggers in autoimmune thyroid disease
1. Antibodies to Yersinia are often found in sera of patients with
thyroid disease25"-'
2. Saturable binding sites for TSH have been demonstrated on
Yersinia and commensal Gram-negative and gram-positive
bacteria-2'-4
3. Affinity studies suggest bacterial proteins were the
immunogen for antibodies reactive with the TSH receptor24
4. The rat model autoimmune thyroid disease suggests norma!
flora of the animals play a role in triggering the disease2"
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of Immulon IV Ml29 D plates (Dvnatech). The plates were incubated at 4°C
overnight then washed 3 times with washing buffer. 0.01 M phosphate buffer saline
(PBS) with 0.1% bovine serum albumin (BSA) and 0.05% Tween 20. Blocking buffer
PBS with 1% BSA (lOOpl) was added to each well. and. after 30mins incubation at
room temperature, the plates were washed 3 times.
Saliva specimens diluted 1/1000 in PBS (lOOpl) were added to the plates and
incubated for 2hrs at room temperature. The plates were washed 3 times and lOOpl
of a 1/100 dilution of rabbit anti-human Ig.A (x-chain) conjugated with horseradish
peroxidase (HRP) (DAK.O) were added to the wells and incubated for 2hrs. The
plates were washed 3 times and 50 pi of the substrate. 40 mg of ortho-phenyle-
nedamine (OPD) in 100 ml of 0.1 phosphate citrate buffer (pH 5) activated with 40 pi
of 30% H-0:. were added to the wells and incubated for 20mins in the dark at room
temperature. The reaction was stopped by adding 50 pi of 12.5% sulfuric acid to each
well. The plates were read at 490 nm optical density using a Dynatech MR700
Microplate reader. All specimens were tested in duplicate.
Detection of salivary IgA specific for Yersinia enterocolitica 03 and Escherichia coli
Y enterocolitica 03 (Y03). the most common yersinia serotype observed in European
populations, obtained from Dr. M.F. Hanson. Central Microbiological Laboratory.
Edinburgh was maintained at room temperature on egg storage slopes. An E. coli
strain was isolated from a stool specimen on MacConkey agar and stored on egg
storage slopes. Y03 was grown on CIN medium at 28°C for 24hrs and E. coli was
grown on MacConkey's medium at 37°C for 24hrs. Bacteria were suspended in 2%
formal saline for 30min. after which heavy suspensions were prepared in coating
buffer and kept at 4°C. The numbers of bacteria per ml were standardized by optical
densities at 540 nm; an optical density of 1.00 was used for each of the organisms.
Bacteria in coating buffer (100pi) were added to wells of the ELISA plates and
incubated overnight at 4°C. All other procedures were carried out at room tem¬
perature. The plates were washed 3 times with washing buffer and lOOpl of blocking
buffer was added to each well. After incubation for 30 minutes the blocking buffer was
removed, the plates washed 3 times and 100pi of a 1/10 dilution (PBS) of the saliva
specimens were added to the wells and incubated for 2 hrs at room temperature. From
this point the procedure used for determination of total saliv ary IgA was carried out.
All specimens were tested in duplicate.
Saliva specimens with high OD readings in the screening assay for antibodies to
Y03 were mixed with an equal volume of a heavy suspension of Y03 or an equal
volume of saline and the suspensions w ere incubated overnight at 4°C. The tubes were
centrifuged at 3.000 x g and the supernatants tested in the ELISA for presence of
antibody to Y03.
Measurement of autoantibodies
Sera from 66 secretors (38 from the present study and 28 from a previous study) and
47 non-secretors (20 from the present study and 27 from a previous study) were
examined by ELISA for the presence of IgA and IgG antibodies against a panel of
autoantigens: thyroglobulin. insulin, single-stranded DNA (SS DNA) double-strand¬
ed DNA (DS DNA). actin. tubulin, myosin, keratin and collagen type I and the
hapten trinitrophenol (TNP)3"33. Igm rheumatoid factors were detected by the
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Waaler-Rose test and antibodies to microsomal antigens by a passive haemagglutina-
tion technique. The results were expressed as the percentage absorbance (optical
density) of the test serum compared with the reference pool (defined as 100%).
Specimens with adsorbance values 3 standard deviations (3SD) (usually > 300%)
above the mean value for normal levels were considered to be positive.
RESULTS
Secretor status and autoimmune thyroid disease
In our previous study, patients with autoimmune thyroid diseases - Graves' disease,
Hashimoto's thyroiditis and primary atrophic hypothyroidism (PAH) were examined
for the distribution of their ABO blood groups and secretor status. There was no
unusual distribution of the ABO blood groups among the three patient groups. There
was. however, a significant increase in the proportion of non-secretors among those
with Graves' disease but not among those with Hashimoto's thyroiditis or PAH
[Table 7],
Isolation of versiniae
Fresh stool specimens from 107 patients with Graves' disease were cultured by
standard methods described above. The specimens were cultured a second time after
incubation at 4°C for 3 weeks to enrich for yersiniae. Only one isolate was obtained,
a Y. enterocolitica serotype 03. an isolation rate of < 1%.
Salivary antibodies to yersiniae
There was a very wide range of ELISA values in the assay for Y03 and for the strain
of E. coli examined. Not all the low ELISA readings for Y03 were associated with
low levels of total salivary IgA [Figure 1], Adsorption of saliva with high values for
Y03 with the test strain resulted in a marked reduction in the levels of IgA detected
in the assay [Table 8], The antibodies were not totally specific for Y03 as adsorption
with E. coli and Neisseria meningitidis also partly reduced the levels of antibody
detected, suggesting some of the response might be due to cross-reactivity among
Gram-negative bacteria.








60 (60) 40 (40) < 0.025
Hashimoto's thyroiditis
(n = 30)
21 (70) 9 (30) NS
PAH
(n = 35)
25 (71) 10 (29) NS
Controls 245 (73) 89 (27)
(n = 334)
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Table 8 Salivarv IgA levels in whole cell ELISA for K enteroeolitiea 03 before and after adsorption with
the test strain
Patient number ELISA reading
unadsorbed absorbed
57 .803 -0.040
69 .436 - 0.005
92 > 2 .000 1.023
Autoantibodies in patients with Graves' disease
None of the sera from patients with Graves' disease contained rheumatoid factors.
The proportions of secretors and non-secretors with levels of antibodies to
microsomal antigens > 1/100 were 41% and 36% respectively.
The results for the ELISA against the various antigens are shown in Table 9 and
10. None of the patients sera had antibodies to collagen. There was no significant
difference between the proportions of secretors and non-secretors with IgA antibodies
to any of the antigens examined [Table 9], There appear to be more non-secretors with
IgA antibodies to thyroglobulin than secretors. but larger numbers of patients need
to be screened to confirm this trend. The only significant difference in IgG auto¬
antibodies of secretors and non-secretors was that the sera of a higher proportion of
non-secretors contained anti-tubulin autoantibodies [Table 10].
DISCUSSION
Our studies suggest that although yersiniae might be the bacteria expressing antigens
cross-reactive with the TSH receptor in some populations, it is not obviously the
source of these antigens in the Scottish patients examined. We isolated only one strain
from stool specimens from 107 patients with Graves' disease. An isolation rate of
< 1% is similar to that observed among patients in the Edinburgh area examined for
diarrhoea! disease [Dr. M.F. Hanson, personal communication]. Yersinia are not
Table 9 IgA autoantibodies in patients with Graves' disease







DS DNA 0 0
SS DNA 6 8.5




COLLAGEN I 0 0
TNP 6 i
"0 05 > p < 0.1 (not statistically significant)
*Elisa reading > 3SD above normal range
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Table 10 IgG autoantibodies in patients with Graves' disease
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ANTIGEN °'o Patients Kith autoantibodies'
secretor non-secretor
n = 66 n = 47
THYROGLOBULIN 53 47
INSULIN 13.6 10.6
DS DNA 1.5 0





COLLAGEN I 0 0
TNP 7.6 17
"P <0 05
•Elisa reading > 3 SD above normal range
common pathogens in Great Britain and the carriage rate among patients with
Graves' disease is not increased. Byfield and colleagues found antigens cross-reactive
with the TSH receptor to be present on £. coli and other species that form the normal
flora of the bowel34. Studies are underway to examine faecal flora of patients with
Graves' disease for presence of bacteria with these antigens.
The results for salivary IgA specific for yersiniae were not conclusive. Although a
number of specimens appeared to have high levels of IgA for Y03 [Figure 1] [Table
8], adsorption of the saliva specimens with £. coli and N. meningitidis suggest the
probability of cross-reactions with other Gram-negative flora cannot be excluded.
Screening of sera from these patients for antibodies to the plasmid coded proteins
described by Wenzel and colleagues3 might provide more specific serological
evidence.
Although non-secretors are significantly over-represented among patients in studies
of a variety of autoimmune diseases, we have found no evidence for our second
hypothesis: non-secretors have significant amounts of autoantibodies to a greater
number of self antigens than secretors. None of the patients with Graves' disease had
autoantibodies to rheumatoid factor or type I collagen. Similar proportions of
secretors and non-secretors had significant levels of IgA or IgG antibodies to insulin,
TNP, SS DNA. DS DNA actin, myosin, and keratin. The only significant difference
between secretors and non-secretors was the higher proportion of non-secretors with
IgG antibodies to tubulin, an autoantibody reported to be increased among patients
with autoimmune thyroid disease34.
We have found an association between non-secretion and some organ specific
autoimmune diseases (Graves' disease and insulin dependent diabetes mellitus). Our
studies of non-organ specific autoimmune conditions such as rheumatoid arthritis and
psoriasis have not found this pattern. If infectious agents act as triggers for the
organ-specific diseases, the higher proportion of non-secretors with these conditions
might reflect their initial susceptibility to bacteria that express the cross-reactive
antigens. Colonization with these bacteria might not result in clinical symptoms of
infection but might precipitate the sequence of immunological interactions resulting
in production of autoantibodies associated with these diseases.
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Semi-Quantitative Determination of H Type 1 and I^pe 2 Antigens
on Buccal Epithelial Cells and in Saliva of Secretors and Non-
Secretors
A. Rahat, J. Stewart, C. C. BlackweU, D. M. Weir
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Abstract. The amount of H antigens on buccal epithelial cells (BEC) of secretors and non-secretors was measured by
flow cytometry. H type 1 and H type 2 on BEC were detected with fluorescein-labeDed Ulex europaeus lectin, and H type 2
was measured with mouse monoclonal antibody. Between 3.5 and 6 times more H antigen was detected on cellls from
secretors compared with cells from non-secretors. The level of H type 2 was the same on BEC of secretors and
non-secretors. Adsorption of H type 1 antigen from secretor saliva onto non-secretors BEC was demonstrated. A simple
and sensitive ELISA method was developed for the determination of H in saliva with biotin-labelled Ulex lectin. This
system provides a simple means for measuring the amount of H present in saliva and for the determination of secretor
status.
Introduction
The H blood group antigen found on various epithelial
cells has been proposed to have a role in the susceptibility
of non-secretors to bacteria] infection [1]. It has been sug¬
gested that this molecule might be an attachment site for
some micro-organisms. As a first step in the investigation of
this hypothesis, we developed sensitive methods for mea¬
suring the two main types of H antigen found on BEC and
in saliva.
H type 1 and H type 2 differ in their chemical composi¬
tion, the genes that control their expression and their sites
of production [2]. H type 1 is the main type of H antigen
found in secretions. It is produced by fucosylation of type 1
precursor chains. The fucosyltransferase that synthesizes H
type 1 is coded for by the secretor gene [3]. This antigen is
not found in secretions of non-secretors, since they lack the
secretor gene.
The expression of H type 2 antigen as part of the cell
membrane in different tissues is independent of secretor
status. The H gene codes for a fucosyltransferase that pref¬
erentially uses type 2 precursor chains [3]. Previous studies
have shown that H type 1 and/or H type 2 antigens can be
detected on the surface of buccal epithelial cells (BEC) and
in saliva [4-7].
In the present study we measured the amount of H
antigen on BEC in suspension by flow cytometry. By this
method we were able: (1) to compare the expression of the
two antigens in secretors and non-secretors and (2) to in¬
vestigate the uptake of H antigen present in saliva onto
BEC. The amount of H antigen in saliva (of secretors and
non-secretors) was determined by a simple enzyme-linked
immunosorbent assay (ELISA).
Materials and Methods
Subjects. The ABO blood group* of 34 donors were determined
from heparinized blood sample* by slide agglutination with monoclonal
antibodies (Scottish National Blood Transfusion Service). Their secre-
tor status was determined by the baemagglutination inhibition assay
with tahva [8], i
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Fig.L Flow cytometric determination of H on BEC from secreton
(•) and non-seere tori (O). Bar* represent mean±l SEM.
Collection ofBEC. BEC from healthy individuals were collected by
rubbing the inside of the cheek with cotton rwab«. To remove the cells,
swabs were rinsed in 20 ml Dulbecco'i phosphate-buffered saline con¬
taining Ca:* and Mg1* ions, 0.9 and 0.4 mAf, respectively (DPBS + B).
The cells were washed twice in DPBS+B (300g for lOmin) and their
concentration adjusted to 2-5 x 105 cells/ml.
Collection of Saliva. Saliva was collected from healthy individuals
and the samples were centrifuged at 1,000 g for 20 min. The super¬
natant was collected, boiled for 20 min, recentrifuged and stored at
-20*C until used.
Detection ofH Antigen on BEC. The total amount of H (type 1 and
type 2) was detected by fluorescein isothiocyanate (FITC) conjugated
Ulex europaeus (UEAI), Sigma, Poole, Dorset, UK). H type 2 was
measured using mouse monoclonal antibody (moAb) Im92/90, provid¬
ed by Dr. R.H. Fraser, Glasgow, UK, and West of Scotland Blood
Transfusion Service [9). The antibody was purified on Synsorb H type 2
(Synsorb Chembiomed Ltd., Alberta, Canada) and conjugated with
FTTC by the method of Johnson and Holborow (10]. Two hundred
microlitres of BEC were mixed with an equal volume of UEAI, moAb
or buffer in a 5-ml culture tube and incubated at 37*C for IS min with
continuous shaking. The cells were washed three times with DPBS+B
(300 g for 10 min) and fixed with 1% buffered paraformaldehyde [U].
Analysis was done on an EPICS *C flow cytometer (Coulter Electron¬
ics, Luton, UK) equipped with a 5-watt laser using a power output of
300 mW at 488 nm. The BEC were selected from a display of forward
angle light scatter versus 90* light scater by means of a bit map. More
than 3,000cells were analysed from each sample. The percentage of
cells showing fluorescence greater than the background level was rec¬
orded on a one-parameter histogram, measuring fluorescence on a
logarithmic scale. The mean fluorescence channel values for the posi¬
tive cells were acquired from a one-parameter histogram, measuring
fluorescence on a linear scale.
Adsorption of H Antigen from Saliva. BEC from seere tors or non-
seere tors were mixed in 5-ml test tubes with equal volumes of undiluted
secretor saliva from a blood group 0 donor. The tubes were shaken for
lh at 37*C and washed twice with DPBS+B (300 g for 10 min). The
amount of H antigen on the cells was determined using UEAI and
moAb as described above.
Detection of H Antigen in Saliva. The wells of polystyrene micro-
titres plates (M129B Dynatech, Billingburst, Sussex. UK) were coated
overnight at 4*C with 100 pi of tenfold dilutions of saliva in 50 mM
sodium carbonate buffer (pH 9,6). All further procedures were carried
out at room temperature. The wells were washed three times with
0.01 M phosphate-buffered saline (PBS) containing 0.1% bovine serum
albumin (BSA) + 0.05% Tween 20 (washing buffer). The wells were
blocked with 150 pi of PBS containing 1% BSA (blocking buffer) for
15 min. The buffer was then removed and the wells were washed twice
with washing buffer. One hundred microlitres of 5 pg/ml UEAI biotin
labelled (Sigma, Poole, Dorset, UK), diluted in blocking buffer, were
added to each well for 30 min. After 3 washes, 100 pi of 1/100 dilution of
streptavidin biotinylated horseradish peroxidase complex (Amersham,
Amersham, UK) in blocking buffer were added for 20 min. The wells
were washed three times, and 100 pi of substrate solution containing
40 mg O-phenylenediamine and 40 plHjO; (30%) in 100 ml of 0.1 M
phosphate citrate buffer (pH 5) were added. The reaction was allowed
to develop in the dark fix 20 min and stopped by adding 50 pi of 12.5%
H^O«. Absorbance at 490 nm was measured using a Dynatech plate
reader (Dynatech, Billinghurst, Sussex, UK). Samples were run in
duplicates and the readings averaged.
Statistics. Student's t test was used for all statistical analysis.
Results
Figure 1 shows the levels of H antigen detected with
UEAI on BEC of secretors and non-secretors by flow cy¬
tometry. The total amount of H antigen on BEC was be¬
tween 3.5 and 6 times greater for secretors than for non-
secretors, depending on UEAI concentration. This differ¬
ence was statistically significant for the three concentra¬
tions of UEAI used in this study (p<0.001). Almost all the
cells (90-99%) in the two populations expressed the H
antigen; but a greater amount of antigen, as determined by
mean channel, was present on secretor cells (fig. 2).








2s K 8 dc.
There was no significant difference in the amount of H
type 2 on BEC of seere tors and non-secretors as detected
by moAb (fig. 3).
After incubation of BEC from non-secretors with secre-
tor saliva, there was a statistically significant increase
(p<0.005) in the amount of H antigen detected by UEAI
(table 1). There was no significant change in the levels of H
when secretors cells were incubated with se ere tor saliva
(table 1). No significant difference was found in the amount
of H type 2 antigen on the cells of either secretors or non-
secretors after they were incubated with saliva (table 1).
Table L Adsorption of H from secretors' saliva ODto BEC
Secretor cells Non-seeretor cells

















Detection of H with UEAI and monoclonal anti-H type 2 on BEC
from secretors and non-secretors before (B) and after (A) incubation
with secretor saliva. The results represent the mean fluorescence chan-
nel±l SEM of 4 experiments.
*
p<0.005 n,.i Determination of H type 2 on BEC from secretors (•) and
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Flj. 4 Measurement of H in saliva from secretors (•) and non
seere too (O) by ELISA. Bars represent meantl SEM.
By ELISA, H antigens in saliva of secretors can be
detected even at a dilution of 10s (fig. 4). In contrast, non-
secretors saliva contains significantly lower levels of H
(p<0.001).
Discussion
TVo sensitive methods for the determination of H anti¬
gen have been developed in this study. Flow cytometric
analysis of BEC with UEAI allows measurement of the
total amount of H antigen, and with moAb, the amount of
H type 2 antigen can be determined. The biotin streptavi-
din ELISA can be used to measure the amount of H in
saliva.
Previous studies have reported that secretors express
more H antigen on their BEC compared with non-secretors
(5, 7], By the method used in this study, we have confirmed
this observation; furthermore, the mean fluorescence level,
as measured on a linear scale, indicates the amount of
antigen found on the cells. By comparing the mean fluo¬
rescence for secretors with non-secretors, we have deter¬
mined the magnitude of this difference.
UEAI detects both H type 2 and H type 1; it can agglut¬
inate red block cells by their H type 2, and this agglut¬
ination can be inhibited by H type 1 in secretor saliva. As
reported by Hindsgaul et al. [12], this lectin does not react
with native H typel determinant but with deacetylated H
type L Therefore, the definition of secretor status is based
on deacetylated H type 1 and not the native structure. How¬
ever, when H type 1 is mentioned in this study, it actually
refers to the deacetylated form, since Ulex europaeus was
used for the detection of H.
According to our results, virtually all BEC from the two
populations express the antigen. However, depending on
the concentration of UEAI used, secretors have on average
between 3.5 and 6 times more H antigen on their BEC
surface than non-secretors. In contrast, there was no differ¬
ence in the amount of H type 2 detected by the moAB on
cells of secretors compared with non-secretors. The differ¬
ence in the level of H on BEC from the two groups appears
to be due to H type L This observation is in agreement with
the view of Oriol et al. [3]. According to this theory, there
are two fucosyltransferases responsible for the production
of H antigen: one, controlled by the secretor gene, prefer¬
entially reacting with typel chains, and the other, con¬
trolled by the the H gene, preferentially reacting with
type 2 chains. Since both secretors and non-secretors ex¬
press the H gene product, no difference was found in the
amount of H type 2 on cells of secretors compared with
non-secretors. In this study the increased amount of H on
secretors' cells is attributed to H type 1 resulting from the
action of the secretor gene product.
Incubation of non-secretor cells with secretor saliva
showed that the H antigen can be adsorbed from saliva onto
the cell surface. The increase in the amount of H was
detected with UEAI and not with anti-H type 2. These
results suggest that H typel antigen present in secretor
saliva is adsorbed onto their cell surface through a mecha¬
nism similar to that described for the Lewis antigen [13].
This explains the difference found in the amount of H type 1
between secretors and non-secretors. Although, as suggest¬
ed by Le Pendu et al. [6], the secretor gene product may be
able to fucosylate precursor type 2 chain, the results pre¬
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simple means of determining secretor status, providing a
quicker and more reliable method than the haemagglu-
tination inhibition test. Using 1/10 dilutions of saliva speci¬
mens, the large difference in the amount of H between
secretors and non-secretors was clearly demonstrable. The
small amount of H detected in non-secretors saliva is prob¬
ably due to H type 2 antigen derived from epithelial cells or
contaminating blood cells.
The methods in this study have been developed in order
to investigate the role of blood group antigens as receptors
for bacteria. The ELISA was used to investigate the ability
of bacteria to adsorb H antigen from suspensions. By flow
cytometry, we were able to determine the amount of anti¬
gen found on BEC and correlate it with bacterial attach¬
ment to BEC (manuscript in preparation).
There are additional applications for this method to
studies in oncology. The blood group antigens normally
present in the epithelium are reported to be partially or
completely lost by neoplastic cells [14-16]. Accurate deter¬
mination of blood group antigens expressed on cells using
the method described in this paper might be useful in early
diagnosis of malignancies as previously suggested [17-19].
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The in vitro binding of four Helicobacter pylori strains to human gastric mucin was studied with an
enzyme-linked immunosorbent assay. All four strains were found to bind to purified mucin. Neuraminidase
treatment and nonspecific oxidation of mucin decreased bacterial adherence to the macromolecule. Mucin
preparations were also found to inhibit attachment of H. pylori to HEp-2 monolayers.
The human gastrointestinal tract is covered with a contin¬
uous layer of mucus which act as a protective barrier for the
underlying mucosa. The main component of mucus is a
high-molecular-weight (>2 x 106) glycoprotein (mucin).
Interactions between bacterial pathogens and mucins de¬
rived from humans and animal species have been reported in
several studies (8,11,13,15). Colonization of gastric mucosa
by Helicobacter pylori is associated with chronic active
antral gastritis and peptic ulceration (1,2). The organism can
be detected both attached to the gastric epithelial cells and
free in the mucous layer (3, 6). In the present work, we
studied some characteristics of H. pylori binding to human
gastric mucin as well as the ability of mucin preparations to
inhibit the adherence of the microorganism to HEp-2 cells.
Four H. pylori strains—Wll, W82, W83, and W114—
cultured from gastric-biopsy samples were used. The strains
were characterized by colony and Gram stain morphology
and production of urease, catalase, and oxidase. Mucosal
scrapings of the fundus and pyloric antrum of stomachs
obtained postmortem from two individuals with no history of
gastrointestinal disease were used for the purification of
gastric mucin. Mucin was purified as previously described
(16) by equilibrium density gradient centrifugation in CsCl
(twice) followed by filtration on a Sepharose 2B column
(Pharmacia Fine Chemicals, Uppsala, Sweden). Purified
mucin harvested from the void volume fractions of the
column was dialyzed against distilled water, lyophilized.
quantitated by dry weight, and stored at -70°C. Before use,
mucin preparations were dissolved in phosphate-buffered
saline (PBS; pH 7.4) at a final concentration of 400 pg/ml.
The absence of low-molecular-weight material was con¬
firmed after the final preparation was run on a sodium
dodecyl sulfate-polyacrylamide gel (4% stacking gel, 12%
resolving gel) under nondenaturing conditions and stained
with silver. In addition, 1-mg portions of purified mucin in
2.5 ml of PBS were either treated with 0.5 U of Clostridium
perfringens neuraminidase type V (Sigma Chemical Co., St.
Louis, Mo.) per ml for 15 min at 37°C or oxidized nonspe-
cifically with sodium metaperiodate (5 mg/ml) at 4°C for 30
min in the dark.
Bacterial binding to intact, neuraminidase-treated, and
mctaperiodate-oxidized mucins and the abilities of these
three different mucin forms to inhibit bacterial adherence to
HEp-2 cells were evaluated by an enzyme-linked immuno-
* Corresponding author.
sorbent assay (ELISA) utilizing anti-//. pylori rabbit serum
prepared as previously described (12). A series of prelimi¬
nary experiments with strain Wll were performed to deter¬
mine whether ELISA readings corresponded to the number
of bacteria on immobilized mucin and on HEp-2 cell mono¬
layers. A good correlation between the ELISA readings and
the numbers of bacteria counted microscopically was evi¬
dent (Fig. 1). Also, in the same experiments, various param¬
eters were probed in order to define the appropriate condi¬
tions for the experiments.
Wells of polystyrene microdilution plates (Nunc-Immuno-
plate Maxisorp; Nunc Inc., Roskilde, Denmark) were coated
overnight at 4°C with 100 pi of untreated mucin. Mucin was
omitted from control wells. After unbound material was
washed off, the remaining sites in the mucin-coated and
control wells were blocked with 4% (wt/vol) skim milk for 3
h at room temperature. Serial dilutions of bacteria in PBS
were then added (100 pi per well). The initial suspension was
adjusted to 109 CFU/ml. The plates were incubated for 2 h at
37 C under microaerophilic conditions. Unbound bacteria
were removed by four washes with PBS containing Tween
20 (0.05% (vol/vol)). Anti-//. pylori immune serum (100 pi,
1/1,000 dilution) was then added. After incubation for 30 min
at 37°C, the wells were washed with PBS-Tween 20 and
incubated with 100 pi of a 1/2,000 dilution of swine anti-
rabbit immunoglobulins conjugated to peroxidase (Dako
Immunoglobulins, Glostrup, Denmark) for 30 min. After the
washes, 100 pi of an O-phenylenediamine solution (0.4
mg/ml) containing 0.4 pi of H202 (30% [vol/vol]) per ml was
added as substrate and incubated at 37°C. After 10 min, the
reaction was stopped with 100 pi of 1 N H2S04, and the A490
was recorded in a MR5000 MicroELISA Autoreader
(Dynatech Laboratories, Inc.).
Differences in bacterial binding to mucin after neuramini¬
dase or metaperiodate treatment were estimated by mi-
croaerophilically incubating 5 x 107 PBS-suspended cells
per strain with 20 pg of each mucin type for 30 min at 37°C.
The total volume was 100 pi. In control wells, 20 pg of
gelatin was added. The suspensions were then transferred to
the wells of ELISA plates precoated with mucin and were
incubated further for 90 min. The degree of binding was
evaluated as described above.
The inhibitory effects of mucin preparations on H. pylori
adherence to HEp-2 cells were examined as follows. HEp-2
cells were grown to confluence in 96-well tissue culture
plates (Costar, Cambridge, Mass.). The monolayers were
fixed with 0.25% glutaraldehyde for 10 min at 4°C and treated
4252













—I i 1 1 i 1 1 r—
SxlO* 10> Sxio* 10* 5x10* 10" Sx10* 10*
Bacteria / ml
FIG. 1. Correlation of ELISA values with the number of bacteria
bound on mucin (A) and attached to HEp-2 cells (B). ELISA was
performed as described in the text. For direct microscopic counts,
the same procedure was followed except that instead of O-phenyl-
enediamine, diaminobenzidine was used as the substate. Bacteria
were counted with an inverted microscope (magnification, x400).
with 0.1% (wt/vol) gelatin for 1 h at room temperature.
Fixation was necessary to retain monolayers intact through¬
out the multiple washes required for quantitation by ELISA.
Twofold dilutions of each mucin form (50 p.1) at an initial
concentration of 400 p.g/ml were placed in the wells. A
constant amount of each H. pylori strain (approximately 3 x
107 CFU in 50 p.1 of PBS) was then added. After incubation
at 37°C for 2 h under microaerophilic conditions, the plates
were washed five times with PBS-Tween 20. To estimate the
bacterial adherence, the ELISA procedure described above
was followed. After color development was stopped, the
»11 ««2 WO W114
FIG. 2. Inhibition of binding of H. pylori strains to mucin immo¬
bilized in ELISA microplates by intact mucin (open bars), neur-
aminidase-treated mucin (hatched bars), and sodium metaperiodale-
oxidized mucin (stippled bars). Data are presented as the mean
values of five or more assays. Error bars show the standard
deviations of mean values.
liquid content of each well was transferred to ELISA plates
and the A490 was recorded. The results were analyzed by
Student's t test.
All four H. pylori strains were found to bind to untreated
mucin in progressively increasing numbers, reaching satura¬
tion when 5 x 107 CFU was added per well. At the saturation
point, the mean values for ratios of binding to mucin/binding
to blocking agent were 8.1 for strain Wll, 7.6 for W82, 7.3
for W83, and 8.4 for W114. Binding curves were essentially
the same for strains Wll and W82, showing maximum slopes
at between 1 x 107 and 5 x 107 CFU added per well. Binding
slopes were approximately the same between 1 x 106 and 5
x 107 CFTJ per well for both W83 and W114 strains. Binding
ratios at the lower dilution used (106 CFU per well) were
comparable for all strains tested, ranging from 3.2 to 3.8.
Each ratio represents the average of 10 measurements not
differing by more than 5%.
As shown in Fig. 2, incubation of bacteria with each of the
mucin forms in the soluble state decreased bacterial binding
to immobilized untreated mucin. The greatest inhibition was
observed with homologous mucin. Mean inhibition was
substantially less when neuraminidase-treated mucin was
used, but the difference was not statistically significant in
strain W83. Periodate-oxidized mucin affected binding only
slightly, with inhibition percentages never exceeding 18%.
Experiments to assess inhibition of bacterial adherence to
HEp-2 cells (Table 1) showed that in the presence of
TABLE 1. Percent inhibition of adherence of four H. pylori isolates to HEp-2 monolayers by three mucin types
Inhibition of bacterial adherence ( % inhibition ± SD) at mucin concn of":
Strain 200 p.g/ml 100 M-g/ml 50 pg/ml









































* Percent inhibition was calculated as follows: of control - „ in the presence of mucin) x 1001/A<W) of control). Each value is the average of 10 assays.
P values were obtained by comparing inhibition caused by untreated mucin with inhibition caused by each of the two forms of treated mucin. UM. untreated
mucin; NM, neuraminidase-treated mucin; PM, periodate-oxidized mucin; ND. not detected.
" P < 0.01.
r P < 0.05.
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untreated mucin, adherence of all H. pylori strains was
markedly reduced. Increasing concentrations of mucin en¬
hanced the degree of inhibition. Bacterial adherence could
be inhibited with as little as 25 p.g of mucin per ml. Below
this concentration, no inhibition was detected. The inhibi¬
tory effect was significantly lower with neuraminidase-
treated mucin for all but W83 strains. An even greater loss of
inhibitory activity was observed after metaperiodate oxida¬
tion of mucin.
Studies on the adherence properties of H. pylori have
shown it to possess a fibrillar hemagglutinin which recog¬
nizes sialic acid-containing structures on erythrocytes (5)
and on mouse Y-l adrenal cells (4). It has also been found
that mucins of different origin, such as porcine gastric
mucin, bovine submaxillary mucin (10), and human salivary
mucin (9), are able to inhibit H. pylori hemagglutination
activity. Additionally, in the case of human salivary mucins,
removal of sialic acid resulted in a substantial decrease in
their inhibitory effect. These observations might indicate
that outer surface structures of H. pylori interact with sialic
acid-terminated molecules present on gastric epithelial cells
as well as with analogous structures present in soluble form
in the gastric mucous layer.
The present study provides evidence that the organism is
able to bind to human gastric mucin and that this binding
might prevent adherence of the organism to epithelial cells.
Sialic acids appear to be partly responsible for this interac¬
tion. However, nonspecific oxidation of the sugar moieties
of mucin was required to further decrease binding. This
indicates that carbohydrate structures other than sialic acids
also contribute to the binding.
Although we cannot assign any particular role to the
interaction between the microorganism and the gastric mu¬
cin, this interaction might protect against H. pylori by
inhibiting attachment of the organism to the underlying
gastric epithelial cells, thus assisting removal of H. pylori by
the continuous flow of mucus. Alternatively, as has been
suggested for other pathogens (7, 8), attachment of H. pylori
to gastric mucin might facilitate dissemination of the organ¬
ism in the stomach mucous layer and subsequent coloniza¬
tion of the underlying mucosa.
It is believed that the specific characteristics of mucins
and invading microorganisms affect their abilities to interact.
Human gastric mucin appears to be altered in patients with
certain diseases such as gastritis or peptic ulceration (16).
Additionally, as reported by Slomiany et al. (14), H. pylori
can enzymatically degrade mucin, thus altering its physico-
chemical properties. Therefore, the detailed study of H.
pylori interactions with several gastric mucin types may help
explain the colonization and pathogenic processes.
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SUMMARY
Patients (454) referred for gastroscopy to the General Hospital of Athens were
examined to determine (1) if non-secretors were over-represented among patients
with ulcers and (2) is there was an association with ABO blood group or secretor
status and carriage of Helicobacter pylori.
Compared with the local population, among patients with either gastric ulcer
(51) or duodenal ulcer (96) there was a significant increase in the proportion of
those who were blood group O (P < 0-025); however, there were no significant
differences in the proportions of non-secretors. H. pylori was identified in 62% of
the 454 patients: 59-5% of those without evidence of ulcers: 62-5% of those with
gastric ulcer : 88% of those with duodenal ulcer (P < 0 0005). These bacteria were
cultured more often and in higher numbers from patients with duodenal ulcer
(P < 0 025). There was no association between ABO blood group and prevalence
of H. pylori. The prevalence of H. pylori among non-secretors with gastric ulcer
(12-5%) was significantly lower than that for non-secretors with duodenal ulcer
(100%) (P < 0-0005). This was not observed for secretors.
INTRODUCTION
There are reports from the 1950s and 1960s that individuals of blood group 0
and those who are non-secretors of the glycoprotein form of their ABO blood
group antigens are over-represented among patients with gastric or duodenal
ulcers (reviewed by Mourant and colleagues) [1]. Non-secretion is associated with
susceptibility to a number of infectious diseases (reviewed by Blackwell) [2,3] and
with asymptomatic carriage of pathogenic bacteria [4,5] and yeasts [6,7]. Non-
secretors are also over-represented among patients with several autoimmune
diseases for which infectious aetiologies have been postulated [4-11].
A recent review summarized the current evidence implicating Helicobacter pylori
in the pathogenesis of gastroduodenal disease [12]. There is serological evidence
* Corresponding author.
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that the majority (approximately 70%) of the adult Greek population ( > 2.5 years
of age) has been exposed to H pylori [ 13J. In this study we examined ABO blood
groups and secretor status (by means of Lewis phenotype) of patients referred for
gastroscopy to determine : (1) if we could confirm the findings of earlier studies of
associations between ABO phenotype and/or non-secretion and ulcers in a
European population in which there is a high prevalence of H. pylori: and (2) to
test the hypothesis that there might be an association with ABO blood group or
secretor status and carriage of these bacteria.
SUBJECTS AND METHODS
The study population consisted of 4.54 consecutive patients between the ages of
17 and 86 referred for gastroscopy to the Gastroenterology Department of the
General Hospital of Athens for investigation of symptoms of upper gastrointestinal
disease. The majority of the patients had upper abdominal pain (58%). bleeding
(melaena or haematemesis) (18%) or anaemia (11%). For men. anaemia was
defined as red blood cell (RBC) count < 4500000/ml. haemoglobin (Hb) <
14 g/dl and haematocrit (HOT) < 42%. For women, anaemia was defined as RBG
count < 4000000/ml. Hb < 12 g/dl and HC'T < 37%.
For this study, during gastroscopy. three biopsy specimens were taken from the
pylorus. Two specimens for culture were placed in separate containers with 1 ml
of thioglycolate broth under aseptic conditions. A third specimen was fixed in
10% formalin, processed in paraffin and 3 pm sections were cut. The sections were
stained with haematoxylin and eosin and examined by light microscopy for the
presence of H. pylori.
Before culture. 0 8 ml of the broth was removed from the biopsy material and
the specimen was vortexed in the remaining 0 2 ml with 4 or 5 glass beads. The
material (01 ml) was then plated onto Skirrow medium composed of blood agar
base, 7% horse blood, vancomycin (10/<g/ml). trimethoprim (5//g/ml) and
polymyxin B (2-5 IU/ml). Another 01 ml was plated onto medium containing
Columbia blood agar base. 7% horse blood, and Campylobacter pylori supplement
of vancomycin (lO/zg/ml). trimethoprim (5//g/ml), cefsulodin (5//g/ml) and
amphotericin B (5 //g/ml). The plates were incubated in microanaerobic conditions
(Biomerieux system) for 7 days. The numbers of colonies per plate with
characteristic appearance of H. pylori were counted and the numbers scored as
follows: no growth = 0: 1-20 colonies = 1: 21-100 colonies = 2: 101-200 colonies
= 3; > 200 colonies = 4. Colonies with characteristic appearance of H. pylori were
examined by Gram stain and tested for production of oxidase, catalase and urease.
A patient was classified as positive for H. pylori if the organism was identified
either by culture or in the stained biopsy.
ABO blood group for each patient was determined by slide agglutination with
monoclonal anti-A and anti-B antibodies (Scottish National Blood Transfusion
Service) and the Lewis blood group phenotype by standard tube agglutination
with monoclonal anti-Lewisa and anti-Lewisb antibodies (Scottish National Blood
Transfusion Service). Individuals who are non-secretors can express only Lewisa
(Lea) and those who are secretors can express Lewis b (Leb). There is no association
between sex, age and expression of ABO or Lewis phenotypes in adults. The
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results for the patient population were compared with those obtained with the
same reagents for a series of 1248 individuals attending the analytical laboratory
of the Hellenic Institute Pasteur. These were predominantly blood specimens
taken for antenatal screening for antibodies to rubella and toxoplasma. The
proportion of ABO phenotypes was similar to those reported previously for Greek
populations [14. 15]. The proportions of Lea and Leb individuals in the patients
attending the Institute were similar to the proportions of Lea and Leh individuals
identified in a separate study of 891 male military results (Blaekwell. unpublished
results).
Epidemiological data. sex. age. symptoms, medication, smoking, alcohol
consumption, results of biopsy reports, gastroscopy and culture results were coded
and stored in a Data Base III plus data base. Results were analysed with the
explore' statistical package, y2 test incorporating Yates' correction factor or
student's t test.
RESULTS
Patients referred for gastroscopy
Of the 454 individuals (age range 17 -86 years, mean age = 52 years) referred for
gastroscopy. 60% were men (age range 18-86 years, mean age = 52 years) and
40% were women (age range 17-83 years, mean age = 51 years). There were 162
smokers (36%); 126 (78%) were men and 36 (22%) were women. The proportion
of men who smoked was 126/270 (47 %) and of women who smoked 36/181 (20%).
The proportion of individuals in whom H. pylori was identified by culture or by
stained biopsy was 286 (68%). The proportions of men and of women in whom
H. pylori was identified were 68 and 67% respectively. There were no significant
associations when presence of the bacteria was analysed with reference to sex and
smoking or sex and alcohol use.
The distribution of the ABO blood groups and Lewis phenotypes of the patient
population is compared with that of the control population in Table 1.
Patients with ulcers
Results of gastroscopy identified 51 patients with gastric ulcer and 96 with
duodenal ulcer. Among patients with gastric ulcer there were 31 men (61 %) and
20 women (39%). Among the patients with duodenal ulcer, there were 78 men
(81 %) and 18 women (19%) which differed significantly compared with the total
study population (x2 = 14-9. d.f. = 1. P < 0-0005). For both men and women, the
mean age was significantly higher among the patients with gastric ulcers
compared to those with duodenal ulcers (Table 2).
Presence of ulcer was analysed by sex and smoking habits and by sex and
alcohol consumption. Xo correlation was found with either of these factors.
Among patients with ulcers the proportion of those of blood group 0 was
significantly increased compared with other blood groups (not O) (Table 3).
Compared with the proportion of group O in the control population (40%). there
were 29 patients of group O among the 51 patients with gastric ulcer (57%) (x2
= 54. d.f. = 1. P < 0025) and 51 of group O among the 96 patients w ith duodenal
ulcer (53%) (^2 = 6 2. d.f. = 1. P < 0 025). The proportion of patients with gastric
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Table 1. ABO and Lewis phenotypes of patient population and controls
patients Controls
ABO A A
group No. (%) No (%)
A 165 (36) 513 (41)
B 52 01) 183 (15)
0 217 (48) 494 (40)
AB 20 (4) 58 (4)
Lewis phenotvpes
Le-°- 93 (21) 249 (20)
Le-°- 356 (78) 964 (77)
In¬ 5 (U 32 (3)
Table 2. Ages of patients with gastric or duodenal ulcers
Site of
Sex ulcer Age range Mean age
Men Gastric 22-78 56*
Duodenal 22-75 47
Women Gastric 34-77 62+
Duodenal 30-71 52
* t = 2-153. d.f. = 105. P < 0-025.
+ t = 2-460. d.f. = 36. P < 0-01.
Table 3. Distribution of ABO groups among patients with ulcers
Gastric Duodenal
ulcer ulcer Control
(n = 51) (n = 96) (n = 1248)
Blood group % % %
A 31 35 41
B 10 10 15
0 57 53 40
AB 2 1 4
Gastric ulcer O/NOT 0. X 0.-f'IIw < 0 025
Duodenal ulcer O/NOT O . y2 = 6-2. P < 0 025.
ulcer expressing Lea was 16% and those expressing Leb was 84%. Among those
with duodenal ulcer, the proportion expressing Lea was 27 % and those expressing
Leb 73%. The figures for Lewis phenotvpes did not differ significantly from those
of the controls (Table 1).
There were 301 individuals in whom ulcers were not detected and for whom
results of both culture and biopsy were available. H. pylori was identified in 179
(59-5%). The bacteria were identified in 30 of 48 (62-5 %) patients with gastric
ulcer for whom results of both culture and biopsy were available. It was identified
among 82 of 93 (88%) patients with duodenal ulcer. The prevalence of the bacteria
among the patients with duodenal ulcers was significantly higher than that of the
study group (y2 = 19-5, d.f. = 1, P < 0-0005).
Among the patients in whom no ulcer was found, H. pylori was identified in
46 % of those who were group O and 54 % of those who were not group O. H. pylori
was identified in 64% of group O patients with gastric ulcer compared with 60%
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Table 4. Quantitative isolation of H. pylori from patients without ulcers
or gastric or duodenal ulcer
No. bacteria per biopsy
Gastroscopy t *
result No growth 1-20 21-100 101-200 ^ 200
No ulcer 153 40 36 41 38
(n = 308) (50%) (13%) (12%) (13%) (12%)
Gastric ulcer 22 9 6 8 3
(n = 48) (46%) (19%) (12%) (17%) (6%)
Duodenal ulcer 22 20 6 23 22
(n = 93) (24%) (22%) (6%) (25%) (24%)
No ulcer/duode nal ulcer X2 = 28-37.. d.f. = 4. P < 0-0005.
Gastric ulcer/duodenal ulcer x2 — 12-81. d f. = 4. P < 0-025.
among those who were not group 0. The bacteria were identified among 92% of
patients with duodenal ulcer who were group O compared with 88% of those who
were not group O.
Among patients without ulcers. 34 of 59 non-secretors (58%) and 145 of 242
secretors (60%) were positive for the bacteria by either culture or biopsy. Analysis
of the prevalence of H. pylori among non-secretors and secretors with gastric ulcer
revealed significant differences; the bacteria were identified in only 1 of the 8
(12-5%) Lea/non-secretors but in 28 of the 42 (67%) Leb/secretors (y2 = 7-5,
d.f. = 1. P < 0-01). A similar analysis of the prevalence of H. pylori among non-
secretors and secretors with duodenal ulcer revealed a different pattern; the
bacteria were found in all the 24 non-secretors but in only 56 of the 67 (84%)
secretors (y2 = 31. P > 0-05).
Among patients who were non-secretors, the difference in the prevalence of the
bacteria between those with gastric ulcer (12-5%) was significantly lower than
that for this group with duodenal ulcer (100%) (y2 = 22 0. P < 0-0005). Similar
analysis of secretors did not find a significant difference in the prevalence of
H. pylori among patients with gastric ulcer (67%) compared with those with
duodenal ulcer (81%) (y2 = T5. P > 0-05).
H. pylori was cultured more frequently from patients with duodenal ulcer
(76%) than those with gastric ulcer (54%) or those without ulcers (50%). The
proportions of those with 100 or more colony-forming units per biopsy specimen
was 49 % for those with duodenal ulcer compared with 23 % for those with gastric
ulcer (y2 = 12-81. d.f. = 4. P < 0-025) of 25% for those without ulcers (y2 = 28 37.
d.f. = 4. P < 0 0005) (Table 4).
DISCUSSION*
The present study confirms the earlier report from Athens [14] that individuals
of blood group O are significantly over-represented among patients with either
gastric or duodenal ulcers. The proportion of group O subjects in the population
referred to the Institute Pasteur for analyses was 40% which is very similar to the
figures reported by Hirszfeld and Hirszfeld (42%) in 1919 [15] and Merikas and
colleagues (41 %) in 1966 [14]. Compared with patients of the other blood groups
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(not 0), there was a significant increase in the proportion of group 0 individuals
among patients with gastric (57%) or duodenal (53%) ulcers (P < 0025). In
contrast to earlier findings for both British and Greek patients w ith ulcers [14. 16],
there was not a significant association between group 0 and bleeding ulcers
compared with non-bleeding ulcers. The number of patients in the present study
was, however, smaller than those examined in the previous studies.
In this group of patients we were not able to confirm the reported associations
for non-secretion and gastric ulcers (3/10 studies) or duodenal ulcers (13/15
studies (analysed by Mourant and colleagues) [1], The proportion of Lea/non-
secretors in the population referred to the Institute for analyses was 20%. similar
to that found in a separate study of 891 military recruits (21%) (Blackwell,
unpublished results). The proportion of Lea/non-secretors was 16% among
patients with gastric ulcers and 27% among those with duodenal ulcers.
The original association of peptic ulcers with the presence of H. pylori has been
confirmed by some investigators but not by others (reviewed by Buck) [12].
Although cigarette smoking has been identified as a risk factor for ulcers [17] and
smoking is associated with carriage of some microorganisms [5], there was no
association between smoking and presence of H. pylori. The proportion of patients
with gastric ulcers in whom H pylori was identified (625%) did not differ
significantly from that of individuals in w hom ulcers were not detected (59-5%) or
the prevalence of antibodies to these bacteria in the general population of similar
age. Among 458 blood donors (age range 21-50). 70% had serological evidence of
exposure to H. pylori [13]. Among the patients in the study all but nine were 21
years of age or older and the proportion of males (60%) to females (40%) was the
same as the blood donors. The prevalence of H. pylori among patients with
duodenal ulcers (88%) was significantly increased compared with that of the
study population (P < 0-0005).
The results of this study suggest that in Greece where a high proportion of the
population is exposed to H. pylori (1) there is not a significant association between
the presence of these bacteria and gastric ulcers: (2) the numbers of H. pylori
isolated from patients with gastric ulcers did not differ significantly from those
isolated from patients w ithout ulcers (Table 4). It has been reported that if other
causes of gastric ulcer such as the use of the analgesics are excluded, the prevalence
of H. pylori among patients with gastric ulcer approaches 100% [18]. In the
present study only 9 patients were taking high doses of aspirin: 4 of these had
gastric ulcers and H. pylori was isolated from 2.
The increased prevalence of H. pylori among patients with duodenal ulcers and
the larger numbers of H. pylori isolated from these patients (Table 4) suggest the
bacteria might contribute to development of the disease condition. These
observations, the lower mean age of both men (P < 0025) and women [P < 0-01)
with duodenal ulcer (Table 2) and the lower proportion of women with duodenal
ulcer (P < 0 0005) suggest that a more detailed investigation of epidemiological
factors influencing carriage of H. pylori in this population might be of value.
Xo association between presence of H. pylori and blood group 0 was found in
patients w ithout ulcers or those with ulcers. The proportion of non-secretors w ith
gastric ulcers in whom the bacteria were found (12-5%) did not differ signifieantly
from the proportion of non-secretors found in the group with gastric ulcers (16%):
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but, the proportion of non-secretors with duodenal ulcers in whom bacteria were
found (100%) was significantly increased compared with the proportion of non-
secretors among those with duodenal ulcers (27%).
One of the hypotheses suggested to explain the increased susceptibility of non-
secretors to particular diseases is that their mucosal surfaces might be more
readily colonized by the causative microorganisms [2.3]. Xon-secretors are
significantly over-represented among healthy asymptomatic carriers of Strepto¬
coccus pyogenes [4], Neisseria meningitidis [5] or Candida albicans [6.7]. In the
study by Burford-Mason and colleagues [6], non-secretion was associated with
long-term carriage of the yeast. If H. pylori persists for longer periods or is present
in larger numbers in the gastrointestinal tract, this might contribute to the
pathogenic processes leading to ulcers. There were 24 patients in the present study
who were re-examined by gastroseopy because symptoms had recurred or they
had not responded to treatment. At the time of gastroscopv, none was being
treated with bismuth and only one was taking an antibiotic. H. pylori was found
in 4 of the 5 (80%) non-secretors but only 7 of the 19 (37%) secretors. The
proportion of patients with > 100 colony forming units of H. pylori was
significantly higher among the patients with duodenal ulcers; however, the
numbers of patients were too small for statistical analysis by secretor status.
Several studies have reported that the epithelial cells of non-secretors bind
larger numbers of some microorganisms than cells of secretors: uropathogenic
strains of Escherichia coli [19]; C. albicans [20,21]; and meningococci [unpublished
results]. Although bacteria can bind to proteins on epithelial surfaces, carbo¬
hydrates appear to be the receptors recognized by many bacterial adhesins,
probably due to their abundance and variety [22]. There is evidence that blood
group antigens act as receptors for several microorganisms. The P blood group
antigen is a receptor for some uropathogenic strains of E. coli [23]: and the Duffy
blood group antigen acts as a receptor for the malaria parasite Plasmodium
knowlesi [24].
Two blood group antigens common to most individuals have been proposed to
act as receptors for microorganisms, H and Lea [2.3]. H. the antigen of blood
group O, is found on the cells of all individuals except the very rare Bombay
phenotype [25]. The Lewis antigens on epithelial cells are adsorbed from secretions
and reflect those present in the body fluids. Although secretors express Leb
predominantly, some can have substantial amounts of Lea in their body fluids, and
consequently on their epithelial cells [26.27]. The amount of Lea present in
secretors depends on the efficiency of the fucosyl transferase coded for by the
secretor gene [28].
Previous studies by our group have found that buccal epithelial cells of secretors
express 3-6 times more H than those of non-secretors [29]. If H were one of the
receptors for microorganisms, there should be increased attachment to cells of
secretors. A second piece of evidence suggests H is not a receptor for H. pylori. A
gastric glycolipid to which H. pylori binds is also found on red blood cells of
groups. A. B and O: however, this substance is not one of the ABO blood group
glycolipids [30].
There is evidence that glycoproteins containing sialic acids in their sugar
moieties can inhibit binding of H. pylori to erythrocytes. The carbohydrates are
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suggested to bind a fibrillar haemagglutinin [31 J. The inhibitory substances are
found in porcine gastric mucin, to a lesser extent in bovine submaxillary mucin
[32] and in human saliva [33]. Neuraminidase treatment of human saliva reduced
its ability to inhibit haemagglutination. This indicated that sialic residues
contribute to. but are not totally responsible for. the inhibitory effect of the
salivary mucin [33]. The role of Lewis antigens in these interactions is under
investigation.
At present little is known about the distribution or amounts of the Lea antigen
on epithelial cells in the stomach and duodenum. Although non-secretors cannot
produce Leb, secretors can have varying amounts of Lea in body fluids.
Quantitative differences in the amount of Lea present in mucus of secretors and
non-secretors of patients with ulcers compared to those without ulcers have not
been determined. These and other studies are currently underway to test the
hypothesis that Lea might be one of the receptors for H. pylori in the
gastrointestinal tract.
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SUMMARY
Non-diabetic individuals who are non-secretors of blood group antigens are prone
to superficial infections by Candida albicans. In this study, 216 patients with
diabetes mellitus who were denture wearers were examined for the presence or
absence of denture stomatitis. There was an overall trend for non-secretors to be
prone to denture stomatitis compared with seeretors. Stepwise linear discriminant
analysis was used to dissect the contribution of secretor status and other variables
to the development of the disease. Seeretor status was found to be a contributory
factor among patients with non-insulin dependent diabetes but not among those
with insulin-dependent diabetes. The possible reasons for this are discussed.
INTRODUCTION
Chronic atrophic oral candidiasis (denture stomatitis) is solely associated with
the wearing of dentures. The studies of Butdz-Jorgensen [1] and Cawson [2]
established the link between Candida sp. and denture stomatitis. Yeasts were
recovered from over 90% of the lesions and antifungal treatment usually led to
regression of the lesion. Subsequently, numerous studies have examined the
prevalence of and predisposing factors to denture stomatitis [3], Presence and
continuous wearing of dentures at night, availability of sucrose in the oral
environment through dietary intake, traumatic effects of the denture, antibiotics
and corticosteroid treatment, diabetes mellitus and smoking have all been
implicated as potential factors influencing the development of denture stomatitis.
The genetic inability to secrete ABO blood group antigens in body fluids has
been associated with a variety of infectious diseases [4]. Non-diabetic individuals
and pregnant women who are non-secretors are prone to superficial Candida
infections [5]. Non-secretors are also over-represented among carriers of Candida
albicans in normal subjects and patients with non-insulin dependent diabetes
mellitus (NIDDM) [6, 7].
The aims of the present study were:
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(1) To assess the influence of secretor status in the development of denture
stomatitis (DS) among patients with insulin-dependent diabetes (IDDM)
and those with non-insulin dependent diabetes (NIDDM).
(2) To assess the contributions of the following variables to the development of
DS: age; sex; duration of diabetic state; type of diabetes: control of
diabetes measured by glycosylated haemoglobin (HBA,); diabetic complica¬
tions - retinopathy, neuropathy and nephropathy; antibiotics; cortico¬
steroid treatment: smoking; alcohol; presence of dentures at night; type of
denture; denture fit. extension, occlusion, age and hygiene; presence of




A total of 439 subjects attending for routine follow up examination at the
Diabetic Outpatient Department (DOPD), Royal Infirmary Edinburgh were
sampled. An initial pilot study examined 80 individuals and was followed by a
study that sampled 359 individuals between September 1988 and March 1989. The
method of selection was stratified random selection according to sex and type of
diabetes.
Clinical history
Each subject was classified as insulin dependent (IDDM) or non-insulin
dependent (XIDDM) according to the clinical history of onset, requirement for
insulin and progression of the disease. Of the 439 subjects sampled, three could not
be classified.
A full medical history including the presence of diabetic complications
(retinopathy, neuropathy and nephropathy) was obtained during interview and
from the patients' records. A history of medications, with particular reference to
antibiotics or corticosteroid-containing preparations, within the past 6 months
was noted. A social history of alcohol consumption and smoking was recorded.
Subjects were questioned about history of superficial infections due to Candida.
Glycosuria and albuminuria were recorded as persistent if subjects had positive
urine samples on more than two consecutive appointments at the DOPD. None of
the subjects used any oral preparations containing antiseptics within the previous
6 months.
Clinical examination
A thorough oral examination of both soft and hard tissues was carried out by
the same examiner (FZA). Any of the following abnormalities were noted:
gingivitis, periodontitis, angular cheilitis, leukoplakia, median rhomboid glossitis;
fissured, geographic or hairy tongue; and denture stomatitis. Denture stomatis
has the characteristic appearance of chronic erythema of the portion of the palate
underlying the denture. The inflammation is generally diffuse, but may be
associated with fibrous hyperplasia of the palate giving it a granular appearance.
The occlusion, fit, extension and hygiene of a denture where present was recorded
Factors contributing to denture stomatitis 357
as 'good ' or ' poor'. The age of the denture was reeorded as well as whether it was
left out of the mouth at night.
Samples
(1) Venous blood was obtained for ABO blood grouping and Lewis antigen
determination. Analysis for glycosylated haemoglobin (HBA,) and random
plasma glucose carried out routinely were recorded.
(2) Swabs were obtained from five sites of the mouth including the palate and
inoculated immediately into malt broth.
(3) Subjects were requested to rinse with 10 ml of sterile phosphate-buffered
saline (PBS) for 1 min and to return the contents to a sterile container.
Laboratory analysis
All samples were collected between 09.00 and 12.00 h and processed within 1-2
h. ABO blood group was determined by slide agglutination with monoclonal anti-
A and anti-B antibodies (Scottish National Blood Transfusion Service). Secretor
status was determined by the presence of Lewis antigen on red blood cells by tube
agglutination with monoclonal anti-Lewis8 and anti-Lewis" antibodies (Scottish
National Blood Transfusion Service). The haemagglutination inhibition method
with boiled saliva [8] was used to confirm the Lewis antigen results for 159
individuals.
The swabs were incubated at 37 °C for 36—48 h. plated onto malt agar and
incubated for a further 36—18 h.
The mouth rinse was concentrated by centrifugation at 2000 £ and resuspended
in 1 ml of PBS: 20 y \ of the suspension were inoculated onto malt agar plates and
incubated at 37 °C for 36—18 h. The number of colonies per sample were recorded.
Pure colonies were subcultured and identified with the API 200 ALTX.
Additionally all were identified by the conventional methods [9] of germ-tube
production in horse serum, urease test and hyphae production on corn-meal agar
following incubation at 28 °C for 48 h.
Statistical methods
All results were coded and a computerized database was set up to facilitate
analysis using SPSSX. The relationship between prevalence of DS and other
factors was tested by y2 (with Yates' correction) or Wilcoxon rank sum tests.
Stepwise linear discriminant analysis was used to identify which combinations of
factors best predicted the presence or absence of DS.
RESULTS
Oral conditions among the patients examined are summarized in Table 1. Of the
216 denture wearers. 76 (35%) had DS (Table 2). In 18% (14/76) the rinsing
technique failed to isolate any yeasts. Similar results were obtained with the swab
taken from the palate. The species most frequently isolated from the palate of
patients with DS were C. albicans (33/76. 43%). followed by Torulopsis glabrata
(6/76. 8%) and C. tropicalis (3/76. 4%). In 9%. the isolate could not be identified
to a species level. Other species were isolated in 15% (11/76) of DS cases
(Table 3).
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Table 1. Prevalence of oral conditions among diabetic individuals
Prevalence in Prevalence
total population among dentu
screened wearers
Gingivitis 114(28%) 39 (42%)
Angular cheilitis 42 (10%) 25 (12%)
Denture stomatitis 76 (35%) 76 (35%)
Fissured tongue 25 (6%) 15 (7%)
Dry mouth 15 (3%) 13 (6%)
Geographic tongue 11 (3%) 7 (3%)
Median rhomboid glossitis 10(2%) 7 (3%)
Hairy tongue 8 (2%) 5(2%)
Glossitis 7 (2%) 5 (2-3%)
Leukoplakia 2(0-5%) 2(1%)
Table 2. Prevalence of DS among patients with 1DDM or SIDDM
+ DS -DS Total
IDDM 32(41%) 47(59%) 79(100%)
NIDDM 43(32%) 91(68%) 134(100%)
75 138 213
Missing. 3; x' = 120; P = 0-27.
Table 3. Mycological profile of diabetic individuals (Palatal swab)
Denture wearers DS cases
Isolate no. (%) no. (%)
C. albicans 67 (31) 33 (43)
T. glabrata 13(6) 6(8)
T. beigelli 5 (2) 3(4)
C. tropicalis 4(2) 3(4)
C. paratropicalis 3(1) 2(3)
S. cereviciae 2(1) 0(0)
C. stellaloidea 1 (0-5) 1 (1)
T. inconspicita 2(1) 1 0)
C. luscitaniae 1 (0-5) 0(0)
C. humicola 1 (0-5) 0 (0-5)
C. pseudotropicalis 1 (0-5) 1 (1)
Unidentified 24(11) 7 (9)
Missing 5 (2) 2(3)
Other 4(2) 3(4)
No isolate 83 (38) 14(18)
Total 216 76
Secretor status
There was a trend for non-secretors to be prone to DS (Table 4). Among
individuals of blood group O with DS, non-secretors (13/27, 48%) appeared to be
more prone to DS than secretors (19/68, 28%); = 2 69. d.f. = 1. P = 01. This
was not seen among the 73 blood group A individuals. There were 10 (45%) A non-
secretors compared with 15 (29%) A secretors with DS (^2 = 11, d.f. = 1, P =
0-3).
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Table 4. Secretor status and prevalence of DS among patients with diabetes
Denture stomatitis
Patient category'






































category denture No. (%) No. (%) Xs P
Total* Yes 45 (52) 42 (48) 232 < 0-00001
No 7(12) 53 (88)
IDDM Yes 18 (49) 19 (51) 350 0-062
No 3(18) 14 (82)
NIDDM Yes 27 (54) 23 (46) 18-82 < 0-00001
No 4(9) 39 (91)
* Of a total of 216 denture wearers. 43 were recruited during the pilot study and were not
questioned about their denture wearing habits. For 26 individuals this information was not
recorded during the main study period.
Significant associations were found between DS and the following:
Presence of dentures in the mouth at night. Significantly more individuals who did
not remove their dentures at night (45) had DS compared with those who removed
their dentures at night (7) (P < 000001). This was found particularly among
NIDDM individuals (Table 5).
Number of colonies isolated by the mouth rinse technique. Subjects who did not
have DS had significantly fewer colony forming units (median = lOc.f.u./ml)
than subjects with DS (median = 1850 c.f.u./ml. P <0-0001). This was seen
particularly for patients with NIDDM (median = 1500 c.f.u./ml with DS and 25
c.f.u./ml without DS, P = 0-0003). Those with IDDM did not show this
relationship (median = 2400 c.f.u./ml with DS, 502-5 c.f.u./ml without DS, P =
0-07).
Random plasma glucose. Lower values for random plasma glucose were observed
among the 132 patients without DS (median = 9-55 mmol/1) than those observed
for the 72 patients with DS (median = 10 95 mmol/1. Mann-VVhitnev P = 002).
This was seen particularly among individuals with NIDDM (median = 1075
mmol/1 with DS and 9 5 mmol/1 without DS. P — 004). Individuals with IDDM





Table 6. Stepwise discriminant analysis (Wilks)
Cases
Sample predicted (%) Variables isolated
) 62-90% Glycosuria (P < 005)
8182% Denture in at night (P < 001)
No. of yeast colonies (P < 001)
Non-secretion (P < 001)
did not show this relationship (median 11250 mmol/1 with DS and 1015 mmol/1
without DS, P = 0-24).
History of candidiasis. Among individuals with a history of superficial
candidiasis 18/33 (55%) had DS compared with 58/182 (32%) with a negative
history of candidiasis (y2 = 5-33. d.f. = 1, P = 0-02). Separate analysis with
respect to insulin dependency revealed a trend for individuals with a history of
candidiasis to be more prone to DS: for IDDM individuals x2 = 1"2. d.f. = 1,
P = 0 3; for individuals with XIDDM. ~ 3 26. d.f. = 1, P = 007.
Xo significant association was found between DS and the following variables:
sex: age: type of diabetes; control of diabetes (HBA,); duration of diabetic state;
ABO blood group; smoking: alcohol consumption; persistent glycosuria or
albuminuria; denture fit, hygiene, occlusion, age or type (partial or full); presence
of diabetic complications (neuropathy, nephropathy, retinopathy); contraceptive
pill; antibiotics; and corticosteroids (systemic or topical).
In order to determine the relative contributions of variables in the development
of DS. a stepwise discriminant analysis (SPSSX) was used. Initially, all variables
were screened at an F value of 4 (P < 0 05). Analysis was then confined to the
variables isolated as significant to increase the number of cases examined. Table
6 summarizes the contributory variables and the significance of their contribution
in predicting infection. For patients with IDDM. the only variable identified by
the analysis was persistent glycosuria (P < 005). For patients with XIDDM three
factors were identified: denture present at night (/5<001), number of yeasts
isolated (P < 0 01) and non-secretion (P < 0 01).
All forms of the oral conditions listed in Table 1 are more prevalent among the
patients with dentures than those without dentures. Fissured tongue was
encountered in 6% of the diabetic individuals. This figure is similar to that
reported for 2478 dental patients [10]. The prevalence of geographic tongue and
median rhomboid glossitis was slightly higher among diabetics than among dental
and dermatology patients [11]. All the above conditions were much lower in
prevalence than those reported for diabetic individuals by Farman who examined
coloured South Africans [12]. These differences might be due to genetic and/or
environmental factors between the predominantly Xorthern European population
sampled here and that sampled by Farman. Dry mouth was a spontaneous
complaint in only 3% of the samples compared to 34% reported by Sharon and
colleagues [13].
DISCUSSION
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The univariate analysis showed that prevalence of DS was similar among
patients with 1DDM or N1DDM. The prevalence of DS reported (35-2%) is within
the range (24-60%) reported for non-diabetic individuals [3].
C. albicans was isolated from only 43% of the patients with DS. Isolation of C.
glabrata (8%). and other yeasts (28%) from patients with DS indicate that, among
diabetic individuals, species other than C. albicans are an important cause of
disease.
Sex. denture trauma and hygiene [14-19], treatment with corticosteroids [21]
and antibiotics [3], have variably been reported to be associated with DS among
non-diabetic individuals. In this study, both the discriminant and univariate
analyses did not reveal any association between these factors and DS.
Among patients with Candida leukoplakia (CL). smoking is a significant factor
in the pathogenesis of the lesion [20] which develops in sites away from the
denture bearing area. In DS, smoking was not a factor in patients with either
IDDM or XIDDM. This is consistent with the fact that the palate is protected
from the effect of the smoke by the denture.
Control of diabetes as measured by glycosylated haemoglobin (HBA,) was not
associated with DS. Although this was unexpected at first sight, it is well
established that blood glucose levels and salivary glucose levels among diabetic
individuals do not correlate [13].
Discriminant analysis indicates that factors contributing to development of DS
among patients with XIDDM are clearly different from those with IDDM.
Patients with XIDDM who do not remove their denture at night, harbour a large
number of yeasts and non-secretors of blood group antigens are particularly at risk
of developing DS. In contrast, none of these factors influence the development of
DS among individuals with IDDM. This is further supported by the results of the
univariate analysis in which the P value for these factors among IDDM
individuals are consistently higher than the P value among XIDDM individuals.
Although secretor status did not show a significant univariate association with
DS among individuals with X7DDM, it was found to be significant in the
multivariate analysis when adjusted for denture wearing habits and density of
yeast colonization. This suggests that the univariate relationship might have been
obscured by the other two contributory factors.
Persistent glycosuria was the only predictor of DS development among IDDM
individuals. The presence of 111 mmol/1 or more of glucose in the arterial blood
results in the appearance of glucose in the urine. It was unexpected that neither
HBA, nor random plasma glucose were implicated as both are more precise
indicators of glucose availability than glycosuria. The possibility than glycosuria
was a chance isolation cannot be dismissed especially since the significance of this
variable was marginal. It appears that the discriminant analysis was not effective
in identifying variables important to the development of DS among IDDM
individuals.
Xon-secretion of blood group antigens was a significant contributory factor
among XIDDM but not among IDDM individuals. Xon-secretion has been
associated with carriage of yeasts among non-diabetic individuals [6] and patients
with XIDDM [7], This complements the results relating to the development of DS
in these patients. It has been suggested that patients with IDDM are more
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immunocompromized than XIDDM 30 that any protective effect of secretion of
blood group antigens does not make a significant contribution to prevention of
colonization or disease. A previous study [22] did not find an association between
secretor status and DS among diabetics; however, the number of patients
examined was much smaller, there was no differentiation between IDDM and
XIDDM individuals and multivariate analysis was not applied to the data.
Identification of factors contributing to the development of DS among
individuals with IDDM and XIDDM might have implications for treatment of this
condition. Treatment of DS among patients w ith XIDDM might be similar to that
in non-diabetic individuals [23], i.e. removal of denture, especially at night, which
also reduces the density of colonization by yeasts. Among patients with IDDM,
treatment of DS seems likely to depend on improvement of poor diabetic control
reflected in persistent glycosuria.
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radiographs are commonly inadequate for diagnosing
conditions such as spondylitis, metastasis at the base of
a pedicle, and listhesis," and therefore, apparently
normal routine radiographs should not be considered
adequate if the clinical picture indicates important
disease.
It is surprising that so few patients were fully
examined and that so many were not examined before
the radiographs were requested. Although patients
may forget much of what their general practitioner tells
them in a consultation, we consider that most will
remember whether or not they have been examined. At
this unit most patients will have had their examination
performed within a few days of the request so that
elapsed time does not become a major factor in
accuracy of recall. We thus believe that our figures are a
reasonable approximation to the truth. It can only be
that most of the doctors in our sample currently make
their decision to request radiographs based on the
patient's history and that the examination findings are
unlikely to alter this decision one way or the other. We
hope that dissemination of the college guidelines will
help to modify this decision making process.
Few of the general practitioners we contacted were
aware of the college guidelines, and most expressed an
interest in seeing them. Radiologists should strive to
ensure that their local general practitioners are in¬
formed of the guidelines and should discuss their
implications with them.
Despite the pessimism of some authors," there is
evidence that educating clinicians about radiology can
reduce the number of unnecessary examinations,3-''
and in view of the many patients referred to our
department for lumbar spine radiography, we hope
that widespread acceptance of the guidelines will result
in optimal use of radiological services. We also believe
that there is a need for a guided increase in public
awareness regarding the radiation engendered in
diagnostic radiology. Though we do not wish to cause
unnecessary concern, the community as a wholj
benefit from a reduction in medical radiation that
might follow reduced demand from patients to have
radiographic examinations for painful but benign
conditions.
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Association between secretor status and respiratory viral illness
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Objective—To determine whether non-secretion
of blood group antigens is associated with respira¬
tory virus diseases.
Design—Study of secretor status in patients with
respiratory virus diseases determined by an enzyme
linked immunosorbent assay (ELISA) developed to
identify Lewis (Le) blood group antigen phenotypes
(Le* non-secretor; Leb secretor).
Subjects—Patients aged 1 month to 90 years in
hospital with respiratory virus diseases (584 nasal
specimens).
Main outcome measures — Criteria for validation
of ELISA (congruence between results on ELISA
testing of 1155 saliva samples from a previous study
and previously established results on haemaggluti-
nation inhibition (HAI) testing, proportions of Le*,
Leb, and Le~ phenotypes in 872 samples of nasal
washings from a previous study compared with the
normal population). Secretor status of patients
determined by ELISA and viruses isolated.
Results—Agreement between HAI and ELISA for
1155 saliva samples was 97%. Lewis antigens were
detected by ELISA in 854 (97-9%) of nasal washings
(Le* 233 (26-7%), Leb 621 (71-2%), and Le" 18
(2-IV*)) in proportions predicted for a northern
European population. Secretors were significantly
overrepresented among patients from whom
influenza viruses A and B (55/64, 86%; p<0-025),
rhinoviruses (63/72, 88%; p<0-01), respiratory
syncytial virus (97/109, 89%; p<0-0005), and echo-
viruses (44/44, p<0-0005) had been isolated com¬
pared with the distribution of secretors in the local
population.
Conclusion—Secretion of blood group antigens is
associated with respiratory virus diseases.
Introduction
Susceptibility to a variety of bacterial and superficial
fungal infections is associated with the genetically
controlled inability of individual subjects to secrete the
water soluble form of the ABO blood group antigens
into body fluids (non-secretion).1'7 Non-secretors are
also significantly overrepresented among patients with
some autoimmune diseases for which infectious
triggers have been proposed.*" Although studies of
associations between ABO blood groups and suscept¬
ibility to natural or experimental viral infections have
been reported,"'" there are no published studies of
secretor status and viral infection. In this study we
tested the hypothesis that non-secretors might also be
at increased risk of viral illnesses.
Because the quantities of material available from
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agreed with the results of the ELISA for 119 *96%) of
those tested The ELISA correctly identified the Lewis
antigen present in nasal secretions of all 26 laboratory
staff Among the 872 nasal washings obtained from the
Common Cold Unit, Lewis antigens were detected in
854 ,97 9%;: Le1 antigen in 233 (26-7%); Leb antigen
in 621 v71 2%;; and no Lewis antigen in 18 (21%).
This finding does not differ from the distribution of
those phenorypes in most northern European popula¬
tions."
lewis phenotype3 of local population
Among 363 blood specimens from the antenatal
clinic in which the Lewis antigens were detected, 28%
were Le1 antigen positive only and 72% were Leb
antigen positive (tabe II). These results were not
significantly different from the proportions of non-
sccretors (26-6%) and secretors (73 4%) determined in
a previous study by haemagglutination inhibition tests
of 334 samples of saliva from local blood donors.'
lewis phenotype of patients with viral
illnesses
In 192 of the 584 (33%) patients' specimens
examined by ELISA not enough Lewis antigen was
detected for definite classification: 81 showed border¬
line readings, and in 111 no antigen was detectable.
The results obtained with these specimens most prob¬
ably reflect degradation of the antigens due to delays in
their transportation to the laboratory. No virus was
isolated from 38 (20%) of these 192 specimens. Among
the 392 specimens in which either or both Lewis
antigens were definitely detected, no virus was isolated
from 36 (9%) (x*= 12-17, p<0 0005). The proportion
of unclassifiable specimens did not vary significantly
with respect to isolation of any particular virus. As the
specimens giving negative and borderline results for
Lewis antigens could not be classified as being from
secretors or non-secretors they were eliminated from
further analysis.
jari f H—Lewis phenorype and stcreior status ofpatents and controls and results of virus culture
oon-secrrtocV (secrctors)
Source of Odds rauo* (95%












































2 49 I 06 to 6-76)
2-18 ,0-46 to 20-53)
1 17(0-63 to 2-26)
<0 0005 3 20(1 66 to 6-67)
<0 0 1 2-77(1 31 to 6 57)
<0 0005 x (4-41 to*)
>0 05 1 19 0-52 to 2-97)
•Odds ratio compared with local controls.
Table II compares the isolation of viruses from non-
secretors and secretors. Compared with the local
population, there was a significantly higher proportion
of secretors among subjects from whom the following
viruses were isolated: influenza A virus (p<0-05),
rhinovirus (p<001), respiratory syncytial virus
(p<0 0005), and echoviruses (p<0 0005). Although
11 of 13 specimens containing influenza B virus were
from secretors, the numbers were too small to be
significant. This pattern was not observed for the 67
specimens from which parainfluenza virus was isolated
or the 36 from which no virus was isolated. In these two
groups of specimens the proportions that were Leb
antigen positive (secretors) and Le' antigen positive
(non-secretors) were similar to those of the local
population.
Discussion
Determination of Lewis phenotype is a good control
for haemaggluunatjon inhibition assays for ABO
antigens which have been the standard method for
determining secretor status. Agreement between the
Lewis phenotvpes and results of the haemagglutina¬
tion inhibition assay for 1089 saliva specimens was
97%. "False secretors," of LeJ phenotvpe but secretors
by haemagglutination inhibition, were the predomi¬
nant mismatched pairs (27/31, 87%). Results of a
previous study indicate that these are most likely the
result of contamination of saliva by blood owing to
poor oral hygiene or periodontal disease among these
subjects.1' Dilution of small samples to provide enough
material for the haemagglutination inhibition test is
probably the source of the small proportion (0 004%)
of "false non-secreiors," who are of Leb phenorype but
non-secretors by haemagglutination inhibition. The
ELISA method eliminates the problem of contamina¬
tion of non-secretor saliva by red blood cells and it can
be carried out on smaller volumes than those needed
for haemagglutination inhibition. The method also
detected Lewis antigens in 854 (98%) of the 872
specimens from the Common Cold Unit, indicating
that the method can be used to detect these antigens in
diluted nasal secretions.
The nasal washings from volunteers at the Common
Cold Unit were originally collected for determining
secretory antibody Litres and were frozen soon after
collection, which would preserve the Lewis antigens;
analysis of the results found the expected proportion
(2%) of specimens negative for Lewis antigen. The
high proportion of specimens from patients in hospital
with viral illness for which borderline readings were
obtained or in which no Lewis antigen was detected
might be due, in part, to collection techniques and time
taken for transportation and processing the specimens.
Blood group antigens cannot be reliably detected in
saliva kept overnight at room temperature. There was
a significantly higher proportion of unclassifiable
specimens from which no virus was isolated (20%)
compared with the proportion of specimens in which
Lewis antigens were definitely detected but from
which no virus was isolated (9%) (p<0-0005). The
proportion of unclassifiable specimens was not greater
among the very young age groups (<24 months), from
whom nasopharyngeal secretions are usually obtained.
Although the Lewis antigens were correctly identified
in all the samples of transport medium inoculated with
nasal swabs obtained from 26 laboratory staff, secre¬
tions provide a larger quantity of material for isolating
virus and detecting Lewis antigen.
Previous studies found non-secretion to be associ¬
ated with various bacterial diseases and superficial
yeast infections and with carriage of some pathogenic
bacteria or yeasts. These findings contrast with
our present finding in which secretors were over-
represented among those patients with significant
symptoms of respiratory illness and from whom
influenza A virus, rhinovirus, or respiratory syncytial
virus were isolated. Secretors were also significantly
overrepresented among those from whom echoviruses
were isolated; these patients, however, had various
illnesses including meningitis, fever, and vomiting. An
increase in the proportion of secretors was not associ¬
ated with isolation of parainfluenza virus or with the
group of individual subjects from whom no virus was
isolated.
This is the first report of associations between
secretion of blood group antigens and infectious
diseases. There is evidence that the Le1 antigen present
in greater amounts on epithelial surfaces of non-
secretors might be one of the receptors for Candida
species," and studies in progress indicate that this
might be true for Neisseria meningitidis. The hypothesis
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that antigens present only m secretors (Le") or in
higher quantities in secretors H type 1 in addition to H
type 2/' might act as one of the receptors for some
viruses is under investigation.
This work is supported by grants from the Scottish Cot
Death Trust, TEN'OV'US-ScotiatvJ. and the North East
Scotland Meningitis Appeal We thank Dr R H Fraserand Dr
G Inglis from the Glasgow and West of Scotland Blood
Transfusion Service for helpful discussions and for the
monoclonal antibodies used in this study, Dr D A J Tyrell and
Mrs C Brown of the MRC Common Cold L'nn for supplying
specimens of nasal washings, Dr R A Elton for statistical
advice, and Mrs M K Cole for preparing the manuscript.
MWR has a grant from the Overseas Research Student
Awards Scheme.
1 Havcriom MJ. Goslings 1~RO Strrjxocora. ABO Nood froups and iccrctoc
sunn Am] Hum Genet 1969\21.360-75.
2 Chaixlhun A, Das AJhJury CR Possible rode ot blood-group secretory
substances in the attioiogy o< cbodera Trans R Soc Trap Med Hyf
1978.72 664-5
J Kinane DF. Bbckweil CC, Brettic RP. Weir DM, Wimuairr FP. Ehoa RA.
ABO bdood group, scs.itfor state, and susccpribvhrv to recurrent uruiarv
tract infection. BMJ 1982 .285 7-9.
4 Black well CC, Joosdbrur K, Hanson M. Ttxid VIA, Chaudbun AKR.
Matbev B. et al Son-secretwe of ABO bdood group antigens predisposing
to micetwo by Neisseria meningitidis and Streptococcus pneumoniae
Lancet 1986m: 284-5
5 Blackweil CC, Joosdotru K. Hanson MF. War DM Noo-iecrrooo of .ABO
an agens predisposing to tnfectwa by Haemopduius influenzae Lancet
1986.u:6*:
6 Blackweil CC, May SJ, Bret tie RP, .MacGalhim CJ, Weir DM Secretor state
and immunoglobulin levels among women with recurrent unnary tract
infections. J Cltn Lab Immunol 1987;22:133-7
7 Thorn SM. Blackwell CC, MacCaihun CJ. War DM, K_mane DF. Wray D.
Non-secreuor of .ABO bdood group antigens and susccpobtiiry to ui/ecoon
by Candida species. FEMS Microbiol Immunol 1989,7:401-6
* Andersen J Launrzro k Bdoud groups and diabetes met!it us Diabeiej
i9w) f :D-»
9 BlackweU CC. James VS. Weir DM. Gemmell JD Pacnck AW Codlier A.
tt m Se.rrror status of patients with insulin dependent or acn insulin
dependent diabetes meUirus RMJ '.917.295 1024-5
10 CWbeT A Patrick AW. Toft AD. Bbcirwell CC. James VS. Weir DM
Increased prevalence of non-secretori n paurnis with Graves ,1^
evidence for an infective aetwdogv BM] 1988.296 1162
11 Shinebaum R. Blackw«U CC. Foruer PJG. Hursi NP Weu DM. N'uJti G
Son-sec rethjo of' ABO hdood group antigens as host susceptibilirv factor ui
ihe spood> lanhropathies BM] i9g" J94 208-10
12 Black well CC Genetic susccpribdirv to infectious agents Proceedings of ike
Royal CiWirfr ofPhysicians of Edinburgh 1989 .19 129-35
13 .Mackenzie JS. FimmeU PJ The effect of ABO bdood groups on the incidence
of ep*detruc influenza and oo the response to live attenuated and detergent
split JiBurnza \~mxsam. Journal j( Hvfsetw 19"* JO 21-30
14 McDonald JC. Zuckrrman AJ. .ABO bdood groups and acute rrspuatorv virus
disease BM] 1962 Ji 89-90
15 Porter CW Haernaggluunation inhibition anubodv to various influenza
viruses and adenoviruses in individuals of bdood groups A and O Jotamal of
Hygiene 1969:67 67-74.
16 MoUisoo PL. Blood transfusion a* i Itnu jJ medicine 6th ed Oxford Blackwell.
1979 414-12
17 Blackwey CC. War DM, James VS. Cammght KAV. Smart JM. Jones DM.
The Sronehouse studs sec retor siarus and carnage of Neisseria meningitidis
and Ncssena lactamica Epidemiol Infect 1989.192:1 -10
18 Mourant AJE, Kopec AC, Dottumewska-Sobczak K. The Msmbuaon of the
human blood groups and other polymorphisms London: Oxford L'niversiry
Press. 1976
19 Burford-.Mason AP. Wedsby JCP. WiUoughbv JMT Oral carriage of Candfcia
albicans, ABO bdood group and secretor status in healthy individuals.
] Met Vet Mycoi 198* J6 49-56
20 Blackwefl CC. AJy FZM, James VS. Weir DM, Collier A. Patrick AW. et ai
Blood group, secretor surus and oral carnage of veasts among patients with
diabetes meilirus Diabet Res 1989-.12:101-4
21 Blackwcfl CC, War DM. James VS. Todd WT.A. Banarvala N. Chaudhun
AKR. a al Secretor sums, smodung and carriage of Neisseria metungiudis.
Epidemiol Infect 1990,104:203-9
12 May SJ. Blackweil CC. War DM Lewis1 bdood group antigen, a receptor for
Candida spcoes. FEMS Microbiol Immunol 1989.47-407-10.
23 Rabat A, Stewart J, Blackweil CC, Weu DM. Semi-quanta live detenmnaooo
of H rvpe 1 and type 2 anugens an buccal epithelial ceils and in saliva of
secreiors and ooo-secretors. Vox Song 1990,57:101-5.
Accepted I?July 1991)
Mode of delivery after one caesarean section: audit of current
practice in a health region
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Objective—To audit the subsequent obstetric
management of women who had had one previous
baby delivered by caesarean section.
Design—Retrospective analysis of a regional
obstetric database.
Setting—Data derived from the 17 obstetric units
in North West Thames region.
Subjects—1059 women who delivered a singleton
fetus of at least 37 weeks' gestation with a cephalic
presentation in 1988 who had a history of one
previous caesarean section and no other deliveries.
Main outcome measures—Mode of delivery, post¬
natal morbidity, and duration of hospital stay.
Results—395 (37%) women were delivered by
elective repeat caesarean section and 664 (63%) were
allowed a trial of labour. Maternal height and birth
weight of the previous infant differed significantly
between those who were and those who were not
allowed to labour. 471 (71%) of those allowed to
labour achieved a vaginal delivery. In individual
units there was no significant correlation between
the proportion of patients allowed to labour and the
rate of the successful trial of labour. There was a
trend towards greater success rates in units that
allowed a longer duration of labour (p<0-05) and
units with greater use of oxytocin for augmentation
of labour (not significant). Both elective and intra¬
partum caesarean section was associated with a
significantly higher rate of postnatal infection than
vaginal delivery (14-7% and 16-0% v 3-4%).
Conclusions—In patients with a history of
caesarean section there is no evidence that the
likelihood of successful vaginal delivery after trial of
labour is modified by the proportion of such patients
allowed the option of attempted vaginal delivery.
Until selection criteria of adequate prognostic vahie
can be identified a more liberal approach to allowing
women a trial of labour seems justified.
Introduction
The rising incidence of caesarean birth in Britain
and elsewhere is a cause for concern both in terms of
the associated increase in clinical and social morbidity
for the mother and increased cost to the health service.
Repeat caesarean section makes a major contribution
to the overall rate of caesarean section. One strategy for
reducing the rate of caesarean birth, therefore, is to
allow women with a history of lower segment caesarean
section the option of a trial of labour in their next
pregnancy unless there are specific contraindications.
Many studies attest to the safety of a properly
conducted trial of labour in women who have pre¬
viously delivered by caesarean section, and successful
vaginal delivery can be expected in around two thirds
of such cases. In a comprehensive review Lavin et al
concluded that a properly managed trial was associated
with an acceptably low incidence of scar dehiscence
and perinatal mortality.' Furthermore, no maternal
deaths were identified. This is in contrast to the
recognised contribution of repeat elective caesarean
section to maternal mortality.'
Factors known to influence the outcome of a trial of
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complications in giant cell
arteritis
Jacques De Keyser, Nina De Klippel,
Guy Ebinger
Platelet counts may be raised in giant cell anenus ; but
the clinical relevance of this has not been examined.
We have investigated the possibility of an association
between thrombocytosis and ocular or cerebral
ischaemic events in giant cell arteritis.
Patients, methods, and results
We reviewed the medical records of patients with a
diagnosis of giant cell arteritis who were admitted to
the University Hospital of the Vrije Universiteit
Brussel between 1984 and 1989. The diagnosis was
based on clinical features, laboratory data (raised
erythrocyte sedimentation rate), biopsy findings in
temporal arteries, good response to corticosteroid
treatment, and subsequent course. The study popula¬
tion consisted of 56 patients (31 women, 25 men)
aged 60-89 years (mean 75 6 (SD 6 3)). Platelet count
was determined as routine with an automated counter
(normal range 150-400 x 1071) before corticosteroid
treatment.
Patients were assigned to one of two groups based on
the presence or absence of transient or permanent
visual loss, transient cerebral ischaemic attack, or
stroke. Age and sex distributions of the groups were
similar (table). Eighteen patients (32%) had a history
of ischaemic complications. Transient or permanent
visual loss occurred in 13, transient cerebral ischaemic
attacks in seven (all in the vertebrobasilar system), and
stroke in two (one patient died from a brain stem
infarction and the other had an infarction in the
territory of the middle cerebral artery).
In the whole study population thrombocytosis
indtngs in 56 patients uith giant cell aneruis
Patients with ocular or Patients with no ocular or
cerebral ischaemic events cerebral ischaemic events
n=18) (n = 38
ledian age •;years. (SD 76 5) 75i7)
'o H i of women 1161) 20 53)
[©(%) with thrombocytosis platelet count >400* 10*1; 11 61)" 10 26
ledian platelet count xl(T1> SD (rangej 475 -125) [309-710]*** 338 ;96 [163-597]
ledxan erythrocyte sedimentation rate mm in first hour)
vSD [rangeft 95 6 31 4) [22-138] 91 -3 *22-9) [38-134]
ledian haemoglobin concentration tg/1) SD [range] 109 22)[77-149] 114.18)[77-151]
p<001 <X ***p<0-001 Mann-Whitney L' test . jW cstergren.
vplatelet count >400x 1071) was found in 21 patients
,37 5%). Linear regression analysis showed no correla¬
tion between platelet count and erythrocyte sedimen¬
tation rate i.r=0 06; or haemoglobin concentration
r=0T5). There was no relation between thrombo¬
cytosis and positive biopsy findings in temporal
arteries. In 13 patients with thrombocytosis platelet
counts were remeasured rwo to three weeks after corti¬
costeroid treatment had been started; values had
returned to normal in all.
The group with ischaemic complications had a
significantly higher prevalence of thrombocytosis
^p<001) and a higher median platelet count (p<0001)
than the group without ischaemic complications
(table).
Comment
Thrombocytosis in giant cell arteritis results from an
increased production of platelets.-' Our results show an
association between thrombocytosis and the occur¬
rence ofocular and cerebral ischaemic complications in
giant cell arteritis.
Reactive thrombocytosis has been detected in various
other inflammatory diseases, such as rheumatoid arth¬
ritis, ankylosing spondylitis, and inflammatory bowel
disease.' The exact underlying mechanism responsible
for the increase in platelet production is unknown. A
first possible explanation for our findings is that
thrombocytosis in giant cell arteritis reflects a more
severe degree of vasculitis. We found no correlation
between platelet count and erythrocyte sedimentation
rate.
A second possibility is that thrombocytosis might
contribute to the ischaemic complications in giant cell
arteritis. However, there have been no convincing
reports that ischaemic manifestations occur as a direct
consequence of reactive thrombocytosis in other dis¬
orders, at least not with the rather moderate increases
in platelet count detected in our patients. The lumen of
arteries affected by giant cell arteritis is usually
reduced by severe thickening of the intima, and
thrombosis is often found at the site of active inflam¬
mation.' J-" Hence we cannot exclude the possibility
that in some patients with giant cell arteritis thrombo¬
cytosis may be pathologically significant in narrowed
inflamed arteries.
1 Calami! KT, H under GG. Clinical manifestations of giant-cell temporal,
arteritis. Clm Rkrum Du 1980;* 389-103.
2 Bengrssoo 8-A, Malmvall B-E Giant ceil arteritis. Acta Med Scand 1982;suppi
No 658:1-102.
3 SelroosO. Thrombocytosis. Acta Med Scand 1973;193:431-6.
4 Goodman B. Temporal arteritis. Am J Med 1979;47:839-5 2.
5 Reich KA. Giansiracusa DF. Stroogwater SL. Neurologic manifestations of
giant-cell arteritis. Am J Med 1990 J9:67-72.
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Secretor status and heterosexual
transmission of HIV
C C Blackwell, V S James, S Davidson, R Wyld,
R P Brettle, R J Robertson, D M Weir
intercourse the proportions of secretors and non-
secretors would reflect that of the local population as
these routes of transmission bypass normal mucosal
defences.1;
We examined the hypothesis that among subjects
exposed to HIV through heterosexual activities a
significantly higher proportion of sebretors would




In contrast to previous studies on bacterial diseases and
superficial fungal infections, in which non-secretors of
the ABO blood group antigens were significantly
overrepresented,'•' we found a higher proportion of
secretors among patients with some viral illnesses.'
Previously, we predicted that among patients who
acquired HIV through intravenous drug use or anal
Subjects, methods, and results
We studied 219 subjects: 151 (99 men and 52
women) who acquired HIV through drug use; 14
homosexual or bisexual men; and 54 (15 men and 39
women) whose only risk factor when they entered the
study was heterosexual intercourse with a partner
infected with HIV.
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Secretor status was determined from specimens of
saliva by an enzyme linked immunosorbent assay
EL1SA, for Lewis Le blood group antigens.' The
proportions of secretors and non-secretors among
participants in the study were compared with those of
363 women attending antenatal clinics secretors 72%,
non-secretors 28%;.' The / test incorporating Yates's
correction factor was used to analyse the results. Odds
ratios and 95% confidence intervals were calculated by
the exact method.
There were 148 (68%) secretors and 71 (32%) non-
secretors in the study. This did not differ significantly
from the proportions of secretors 172%) and non-
sccretors 28%) in the local population.' The pro¬
portions of secretors and non-secretors were not
significantly different among the patients with HIV
who had acquired the virus by drug use or homosexual
or bisexual activities (table).
Among the 54 participants at risk through hetero¬
sexual intercourse, 26 were positive for the virus and 28
remained uninfected. The proportions of secretors
(70%) and non-secretors (30%) in this group did not
differ from those in the other groups of patients with
HIV or in the local population. In the 26 participants
who had acquired the virus 23 (88%; were secretors
and three (12%) were non-secretors, and in the 28 who
remained uninfected 15 (54%) were secretors and 13
(45%) were non-secretors (x'=6'29, p<0 025).
Comment
These results agreed with the original predictions.
The proportions of secretors and non-secretors were
not different among subjects who had acquired the
virus by intravenous drug use or by anal intercourse,
routes which circumvent mucosal defences.'2
In the accompanying paper (p 815/1 we found a
eretor status and HIV category
Le* anagen positive £aI1
r>2S
Total non-secretor secretor Odds ratio* (95%
tegory No No (V No (%) confidence interval)
enrols antenatal clinic 363 103'28; 260 ;72"
V positive subjects:
Total 191 58 30: 133 70 0 91 0 61 to 137)
nuravenous drug users 151 52 '34: 99 66 0 /5 0 49 to 1-16)
-iomosexual or bisexual men 14 3 (21) 11 (79} 1 45 0 37 to 8 26)
terosexuai partners of HIV positive
ub»ects:
4TV positive 26 3(12; 23(88, 3 03 0 89 to 16 10)
■CIV negative 28 13 46 15(54) 0-46 0 20 to 109)
ids ratio compared with local controls.
significantly higher proportion of secretors among
patients with symptoms of viral disease from whom
influenza A and B viruses, rhinoviruses, respiratory
syncytial virus, or echoviruses were isolated. If it is
assumed that these patients were not immune to the
virus at the time of exposure, secretion of ABO blood
group antigens seems to be associated with develop¬
ment of disease due to these particular viruses, which
enter the host via mucosal surfaces. Among the
subjects who seemed to have acquired HIV by hetero¬
sexual intercourse the proportion of secretors was
higher than among those who acquired the virus by
intravenous drug use or homosexual intercourse ;88%
v 67%) fy-' = 4 068; p<0 05;. The significantly lower
proportion of secretors among the group exposed to the
virus who remained uninfected suggests that non-
sccretors might be less susceptible to acquiring the
virus through heterosexual intercourse.
Most work on transmission of HIV has been on
factors associated with infected subjects rather than
their sexual contact's).' Secretor status is a character¬
istic easily determined by non-invasive inexpensive
procedures. Inheritance and expression of secretor
status are independent of sex, age, or environmental
factors. Examination of secretor status might be
valuable in analysing the apparent variability of other
epidemiological factors associated with heterosexual
transmission of HIV.
Elucidation of the interactions underlying the
apparently increased susceptibility of secretors to
acquiring HIV through mucous membranes might
lead to new approaches in preventing infection through
heterosexual intercourse.
This study was supported by grams from the Medical
Research Council ,SKj9006813) and from The Wellcome
Trust (180461.5). We thank the medical and nursing staff of
the infectious diseases unit for their help; the patients and
their partners for their help and patience, without which the
study would not have been possible; Dr R A Elton for
statistical advice; Miss D A C Mackenzie for technical help;
and Mrs M K Cole for preparing the manuscript.
1 Blackweil CC. The rote of ABO Mood groups and secretor sums in host
defences. FEMS MurroFtof Immunol 1989;47:341-50.
2 Black-well CC. Genetic susceptibility to infectious agents. Procttdmfi of ike
Royal CoUtft of Pkyncians ofEdviburfk 1989;19:129-38.
3 Raza MW, BlackweU CC, MoJyneaux P, James VS, Ogilv* MM, Ingiis JM,
etai. Secretor status and viral illnesses. BMJ 1991.303:815-8.
4 European Studv Group Risk factors for male to female transmission of HIV'
BMJ 1989 J98 411-5.
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ONE HUNDRED YEARS AGO
A very valuable find of skeletons has been made in Egypt
by Mr. Flinders Peuie, who has recently opened a number
of tombs previously intact at Medurn, belonging to the
beginning of the fourth dynasty. This is the earliest known
date of Egyptian remains, and that to which the Egyptians
ascribe themselves. The skeletons are well preserved, but
tender and friable. Some of them bear unmistakable
evidence of rheumatic changes, and consequently indicate
that at that very remote period man was subject to and
suffered from this, as is now shown from its antiquity,
venerable disease. N'o ornaments or objects of an, except
occasionally some rough pottery or a wooden headrest,
were found with these remains. The greater number were
interred in a contracted position with the knees drawn up
to the breast, even when the tomb was long enough to
allow burial in the extended position, the body placed on
the left side, wrapped in linen cloth, the head always to the
north and the face to the east. A few, however, apparently
the bodies of the highest class or race, were interred in the
extended position along with vases of stone or pottery
and headrests. At this period there is no trace of mummi¬
fication. The essential difference in the mode of interment
seems to point to difference of race, and it is probable that
the contracted burials are those of the prehistoric race of
Egypt, while the dynastic race were interred with the
body extended. It is extremely interesting to find these
contracted burials common at so early a date in Egypt, as a
similar mode was adopted by the earliest inhabitants
of Great Britain. Mr. Pelrie has brought the skeletons to
England, and deposited them at the College of Surgeons,
where they are being treated so as to strengthen them
and render them available for the anatomical investiga¬
tion which Mr. Petrie intends lo have made in order to
determine, if possible, their ethnographical affinities.
When this is done we shall doubtless also have a full
description of any pathological condition which may be
present.
(British MedicalJournal 1891;ii:658)
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In Vitro Binding of Helicobacter pylori to Human Gastric Mucin
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The in sitro binding of four Helicobacter pylori strains to human gastric mucin was studied with an
enzyme-linked immunosorbent assay. All four strains were found to bind to purified mucin. Neuraminidase
treatment and nonspecific oxidation of mucin decreased bacterial adherence to the macromokeule. Mucin
preparations were also found to inhibit attachment of H. pylori to HEp-2 monolayers.
The human gastrointestinal tract is covered with a contin¬
uous la\ er of mucus which act as a protective bamer for the
underlying mucosa. The main component of mucus is a
high-molecular-weight (>2 x 10") glycoprotein (mucin).
Interactions between bacterial pathogens and mucins de¬
ns ed from humans and animal species have been reported in
several studies (8. 11. 13.15). Colonization of gastnc mucosa
by Helicobacter pylori is associated with chronic active
antral gastntis and peptic ulceration (1.2). The organism can
be detected both attached to the gastric epithelial cells and
free in the mucous layer (3. 6). In the present work, we
studied some characteristics of H. pvlori binding to human
gastric mucin as well as the ability of mucin preparations to
inhibit the adherence of the microorganism to HEp-2 cells.
Four H. pylori strains—Wll, W82. W83. and W114—
cultured from gastric-biopsy samples were used. The strains
were characterized by colony and Gram stain morphology
and production of urease, catalase. and oxidase. Mucosal
scrapings of the fundus and pyloric antrum of stomachs
obtained postmortem from two individuals with no history of
gastrointestinal disease were used for the purification of
gastric mucin. Mucin was purified as previously described
(16) by equilibrium density gradient centrifugation in CsCI
(twice) followed by filtration on a Sepharose 2B column
(Pharmacia Fine Chemicals. Uppsala. Swedeni. Purified
mucin harvested from the void volume fractions of the
column was dialyzed against distilled water, lyophilized.
quantitated by dry weight, and stored at -70:C. Before use.
mucin preparations were dissolved in phosphate-buffered
saline iPBS: pH 7.4) at a final concentration of 400 pgml.
The absence of low-molecular-weight material was con¬
firmed after the final preparation was run on a sodium
dodecyi sulfaie-polyacrylamide gel (4T stacking gel. 12T
resolving gel) under nondenaturing conditions and stained
with silver. In addition. 1-mg portions of purified mucin in
2.5 ml of PBS were either treated with 0.5 U of Clostridium
perfringens neuraminidase type V (Sigma Chemical Co.. St.
Louis. Mo.) per ml for 15 min at 37*C or oxidized nonspe-
cifically with sodium metaperiodate (5 mgml) at 43C for 30
min in the dark.
Bacterial binding to intact, neuraminidase-treated. and
metapenodate-oxidized mucins and the abilities of these
three different mucin forms to inhibit bacterial adherence to
HEp-2 cells were evaluated by an enzyme-linked immuno-
* Corresponding author.
sorbent assay (ELJSA) utilizing anti-H. pylori rabbit serum
prepared as previously described (12). A series of prelimi¬
nary experiments with strain Wll were performed to deter¬
mine whether ELISA readings corresponded to the number
of bacteria on immobilized mucin and on HEp-2 cell mono¬
layers. A good correlation between the ELISA readings and
the numbers of bacteria counted microscopically was evi¬
dent (Fig. 1). Also, in the same experiments, various param¬
eters were probed in order to define the appropriate condi¬
tions for the experiments.
Wells of poly styrene microdilution plates (Nunc-Immuno-
plate Maxisorp; Nunc Inc.. Roskilde. Denmark) were coated
overnight at 4°C with 100 pi of untreated mucin. Mucin was
omitted from control wells. After unbound material was
washed off. the remaining sites in the mucin-coated and
control wells were blocked with 49c (wt/vol) skim milk for 3
h at room temperature. Serial dilutions of bacteria in PBS
were then added (100 pi per well). The initial suspension was
adjusted to 109 CFU/ml. The plates were incubated for 2 h at
37CC under microaerophilic conditions. Unbound baciena
were removed by four washes with PBS containing Tween
20 (0.05T [voL vol]). Anti-H pylori immune serum (100 pi.
1 1.000 dilution) was then added. After incubation for 30 min
at 37=C. the wells were washed with PBS-Tween 20 and
incubated with 100 p.1 of a 1 2.000 dilution of swine anti-
rabbit immunoglobulins conjugated to peroxidase (Dako
Immunoglobulins. Glostrup. Denmark) for 30 min. After the
washes. 100 pi of an O-phenylenediamine solution (0.4
mgml) containing 0.4 pi of H-CK GOT [voLvol]) per ml was
added as substrate and incubated at 37°C. After 10 min. the
reaction was stopped with 100 pi of 1 N H-SO.,. and the Ai<n
was recorded in a MR5000 MicroELISA Autoreader
iDynatech Laboratories. Inc.).
Differences in bacterial binding to mucin after neuramini¬
dase or metaperiodate treatment were estimated by mi-
croaerophilicaily incubating 5 x 107 PBS-suspended cells
per strain with 20 pg of each mucin type for 30 min at 37°C.
The total volume was 100 pi. In control wells. 20 pg of
gelatin was added. The suspensions were then transferred to
the wells of ELISA plates precoated with mucin and were
incubated further for 90 min. The degree of binding was
evaluated as described above.
The inhibitory effects of mucin preparations on H pylori
adherence to HEp-2 cells were examined as follows. HEp-2
cells were grown to confluence in 96-well tissue culture
plates (Costar. Cambridge. Mass.). The monolayers were
fixed with 0.25T glutaraldehyde for 10 min at 4°C and treated
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FIG. 1. Correlation of ELISA values with the number of bacteria
bound on mucin (A) and attached to HEp-2 cells (B). ELISA was
performed as described in the text. For direct microscopic counts,
the same procedure was followed except that instead of O-phenyl-
enediamine, diaminobenzidine was used as the subslate. Bacteria
were counted with an inverted microscope (magnification, x400).
with 0.1% (wt/vol) gelatin for 1 h at room temperature.
Fixation was necessary to retain monolayers intact through¬
out the multiple washes required for quantitation by ELISA.
Twofold dilutions of each mucin form (50 p.1) at an initial
concentration of 400 jig/ml were placed in the wells. A
constant amount of each H. pylori strain (approximately 3 x
107 CFU in 50 p.1 of PBS) was then added. After incubation
at 37°C for 2 h under microaerophilic conditions, the plates
were washed five times with PBS-Tween 20. To estimate the
bacterial adherence, the ELISA procedure described above
was followed. After color development was stopped, the
W11 W«2 WIS W 114
FIG. 2. Inhibition of binding of H. pylori strains to mucin immo¬
bilized in ELISA microplates by intact mucin (open bars), neur-
aminidase-treated mucin (hatched bars), and sodium metaperiodate-
oxidized mucin (stippled bars). Data are presented as the mean
values of five or more assays. Error bars show the standard
deviations of mean values.
liquid content of each well was transferred to ELISA plates
and the A490 was recorded. The results were analyzed by
Student's t test.
All four H. pylori strains were found to bind to untreated
mucin in progressively increasing numbers, reaching satura¬
tion when 5 x ft)7 CFU was added per well. At the saturation
point, the mean values for ratios of binding to mucin/binding
to blocking agent were 8.1 for strain Wll, 7.6 for W82, 7.3
for W83, and 8.4 for W114. Binding curves were essentially
the same for strains Wll and W82, showing maximum slopes
at between 1 x ft)7 and 5 x 107 CFU added per well. Binding
slopes were approximately the same between 1 x ft)6 and 5
x 107 CFU per well for both W83 and W114 strains. Binding
ratios at the lower dilution used (106 CFU per well) were
comparable for all strains tested, ranging from 3.2 to 3.8.
Each ratio represents the average of 10 measurements not
differing by more than 5%.
As shown in Fig. 2, incubation of bacteria with each of the
mucin forms in the soluble state decreased bacterial binding
to immobilized untreated mucin. The greatest inhibition was
observed with homologous mucin. Mean inhibition was
substantially less when neuraminidase-treated mucin was
used, but the difference was not statistically significant in
strain W83. Periodate-oxidized mucin affected binding only
slightly, with inhibition percentages never exceeding 18%.
Experiments to assess inhibition of bacterial adherence to
HEp-2 cells (Table 1) showed that in the presence of
TABLE 1. Percent inhibition of adherence of four H. pylori isolates to HEp-2 monolayers by three mucin types
inhibition of bacteriaJ adherence (% inhibition ± SD) at mucin concn of*.
Strain 200 (ig/ml 100 jig/ml 50 jj-g/ml









































" Percent inhibition was calculated as follows: [(j44go of control - in the presence of mucin) x 100JM49O of control). Each value is the average of 10 assays.
P values were obtained by comparing inhibition caused by untreated mucin with inhibition caused by each of the two forms of treated mucin. I'M. untreated
mucin; NM, neuraminidase-treated mucin; PM. periodate-oxidized mucin; ND, not detected.
b P < 0.01.
f P < 0.05.
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untreated mucin, adherence of all H. pylori strains was
markedly reduced. Increasing concentrations of mucin en¬
hanced the degree of inhibition. Bacterial adherence could
be inhibited with as little as 25 of mucin per ml. Below
this concentration, no inhibition was detected. The inhibi¬
tory effect was significantly lower with neuraminidase-
treated mucin for all but W83 strains. An even greater loss of
inhibitory activity was observed after metaperiodate oxida¬
tion of mucin.
Studies on the adherence properties of H. pylori have
shown it to possess a fibrillar hemagglutinin which recog¬
nizes sialic acid-containing structures on erythrocytes (5)
and on mouse Y-l adrenal cells (4). It has also been found
that mucins of different origin, such as porcine gastric
mucin, bovine submaxillary mucin (10), and human salivary
mucin (9), are able to inhibit H. pylori hemagglutination
activity. Additionally, in the case of human salivary mucins,
removal of sialic acid resulted in a substantial decrease in
their inhibitory effect. These observations might indicate
that outer surface structures of H. pylori interact with sialic
acid-terminated molecules present on gastric epithelial cells
as well as with analogous structures present in soluble form
in the gastric mucous layer.
The present study provides evidence that the organism is
able to bind to human gastric mucin and that this binding
might prevent adherence of the organism to epithelial cells.
Sialic acids appear to be partly responsible for this interac¬
tion. However, nonspecific oxidation of the sugar moieties
of mucin was required to further decrease binding. This
indicates that carbohydrate structures other than sialic acids
also contribute to the binding.
Although we cannot assign any particular role to the
interaction between the microorganism and the gastric mu¬
cin, this interaction might protect against H. pylori by
inhibiting attachment of the organism to the underlying
gastric epithelial cells, thus assisting removal of H. pylori by
the continuous flow of mucus. Alternatively, as has been
suggested for other pathogens (7, 8), attachment of H. pylori
to gastric mucin might facilitate dissemination of the organ¬
ism in the stomach mucous layer and subsequent coloniza¬
tion of the underlying mucosa.
It is believed that the specific characteristics of mucins
and invading microorganisms affect their abilities to interact.
Human gastric mucin appears to be altered in patients with
certain diseases such as gastritis or peptic ulceration (16).
Additionally, as reported by Slomiany et al. (14), H. pylori
can enzymatically degrade mucin, thus altering its physico-
chemical properties. Therefore, the detailed study of H.
pylori interactions with several gastric mucin types may help
explain the colonization and pathogenic processes.
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SUMMARY
Greek military recruits (993) were examined for carriage of meningococci during
July 1990. Blood, saliva and throat swab specimens were obtained and each
recruit answered a questionnaire providing information on age, education (a
measure of socioeconomic level), place of residence, smoking habits and recent
infections.
The overall carriage rate was 25% but differed between the two camps: 79/432
(18%) in Camp A and 168/561 (30%) in Camp B (P < 0-0005). In Camp B. there
were significantly higher proportions of recruits who were non-secretors
(P < 0-0005), and/or heavy smokers (P < 0-0005). They were also younger (< 19
years old) (P < 0-001), and on the whole had fewer years of education (P < 0-0005).
By univariate analysis, carriage was significantly associated with smoking. By
multiple logistic regression analysis, carriage was associated with smoking
(P < 0-001), age (P<0"01) and the camp in which the recruits were based
(P < 0-01). Among recruits in Camp B, 15/38 (40%) of those with recent viral
infections were carriers compared with 30% for the camp in general.
INTRODUCTION
Following the epidemic of meningitis during the 1960s, the incidence of
meningococcal disease in Greece declined steadily until 1988. Since 1988, the
number of cases reported to the Ministry of Health has increased: in the first 6
months of 1990, there were 102 cases compared with 87 for all of 1989 (Table 1).
This apparent increase in disease due to Neisseria meningitidis prompted the
present work as the last study of meningococcal carriage in a Greek population
was carried out before elucidation of some of the genetic and environmental
factors affecting carriage [1].
Epidemiological studies have shown that non-secretors, individuals incapable of
secreting the glycoprotein form of their ABO blood group antigens, are
significantly o%'er-represented among patients with meningococcal disease [2, 3]
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Table I. Incidence of meningococcal disease in (Ireece
Deaths
Year No. eases no. ("«)
1 908 1094 48 (4 5)
1973 795 39(5-1)
1978 2S(i 18 (ti-3)
1983 102 9 (8-8)
1985 105 8 (5 7)
1981) 88 7 (7 9)
1987 85 4 (4-7)
1988 79 2 (20)
1989 87 8 (0-9)
I99U 102
(1st 0 months)
and among carriers in a school population [4]. Prolonged outbreaks have occurred
in countries such as Iceland and in areas of Britain [5. li] where the proportion of
non-secretors is significantly higher than the proportion (20-25%) predicted for
European populations [7].
Environmental factors have also been suggested as playing a role in
susceptibility to meningococcal disease (8. 9] or carriage of the bacteria. Smoking
or passive exposure to cigarette smoke has been associated with isolation of
Xeisseria meningitidis from healthy asymptomatic adults and teenagers [4. 10].
Virus infections have been suggested as predisposing factors for susceptibility to
meningococcal disease [11] and to carriage of potentially pathogenic bacteria [12].
In the study reported here we wished to determine: (1) if isolation of
meningococci was associated with non-secretion in the populations examined: (2)
if smoking was associated with carriage in a closed population: (3) if an upper
respiratory tract or other infection might be a factor contributing to carriage of
meningococci : (4) if there might be geographical regions in Greece in which there
are higher proportions of non-secretors and if the prevalence of meningococcal
disease was increased in these areas.
Sl"B.F E< TS AND METHODS
Greek military recruits (993) from two camps, one at Athens and another at
Avlona. were examined for carriage of meningococci during the third week of.July
1990. Ethical permission for the study was granted by the .Ministry of Defence. An
explanation of the purpose of the study and the specimens required was part of the
questionnaire and each subject signed his consent to participate in the study. The
recruits came from all regions of Greece except the Ionian islands, and had been
in the camps from 3 to 5 days at the time of the study. Throat swabs, blood and
saliva specimens were obtained. Throat swabbing was carried out by the same four
members of the team on both occasions (('.('. B.. G.T.. A. M.. D. M. \Y.). Blood was
not obtained from a number of recruits who fainted because of the unusually high
temperature (41 °C). Each recruit filled in a questionnaire providing information
on age. occupation, education level, places of residence and birth, smoking habits,
and recent infections. A member of the research team checked the form to ensure
all categories had been completed and to answer any questions. This information
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and results of laboratory examinations were coded for confidentiality and stored
in a Database .4 plus data base. The information on the data base was recalled and
cheeked with the original questionnaire.
ABO blood group was determined by slide agglutination with monoclonal anti-
A and anti-B antibodies (Scottish National Blood Transfusion Service): Lewis
blood group was determined by tube agglutination with monoclonal anti-Lewis3
(Loa) and anti-Lew ish antibodies (Scottish National Blood Transfusion Service).
Non-secretors can express only Lea. but secrefors express Leb. The blood
s|K'cimens were centrifuged on the day of collection and the plasma stored at
— JO °C.
Throat swabs were plated directly onto modified New York City medium [13|
and incubated for 48 h. Colonies were examined for oxidase production. Cram
stain and carbohydrate utilization.
Two-way frequency tables were analysed by y2 tests with Yates" correction in
the case of 2x2 tables. Multiple logistical regression was used to examine the
association between carriage rates and other factors adjusted for each other.
RKSCLTS
Isolation of N. meningitidis
A", meningitidis was isolated from 247 (25'Co) of the 993 recruits examined. The
carriage rate differed significantly between the two camps. There were 79 isolates
obtained from 432 recruits (18%) in the camp at Athens compared w ith 168 from
the 561 (30%) at Avlona (y2 = 17 54: P <00005).
Characteristics of the two populations
Distribution of ABO and Lewis blood group phenotypes
There was no difference in the distribution of the ABO blood groups between the
two camps. Among the recruits who expressed Lewis antigen, there was a
significantly higher proportion of Lea/non-secretors in the camp at Avlona.
140/534 (26%). compared with that in the camp at Athens. 60/390 (15%)
(y2 = 14-96. P < 0-0005).
Age and education
The ages of the two populations differed significantly. The median age was 19
for both camps: however, there was a higher proportion of recruits under 19 in the
camp at Avlona (4%) than in that at Athens (1 %) (y2 = 12-9(5. P < 0-001).
There was also a significant difference in the level of education of the recruits in
the two camps, particularly at the two extremes. Among the recruits at Avlona
14% had only 6 years of schooling compared with 7% among those at Athens:
and. only 2% of the recruits at Avlona had attended university while 7 % of those
at Athens had done so (y2 = 30-32. df = 4. P < 00005).
Smoking
There was no significant difference between the proportion of smokers in the
Athens camp (62%) and in Avlona (68%): but there were significantly more
heavy smokers (> 30 cigarettes a day) in Avlona (y2 = 27 (54. df = 4. P < 0-0005)
(Table 2).
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Table 2. Cigarette consumption in the two recruit groups
Athens Avlona
(n = 431) (n = 560)
cigarettes/day No. (%) No. (°/o)
0 166 (38) 182 (32)
1-10 53 (12) 63 (11)
11-20 127 (29) 133 (24)
21-30 62(14) 96 (17)
> 30 23 (5) 86 (15)
Table 3. Carriage rates and cigarette consumption
cigarettes/ Carriers Non-carriers
day Total no. (%) no. (%)
0 355 56 (16) 299 (84)
1-10 116 29(25) 87 (75)
11-20 260 66 (25) 194 (75)
21-30 157 44 (28) 113 (72)
> 30 109 40(37) 69 (63)
Prevalence of other infectious diseases
Only 59 of the recruits reported symptoms of upper respiratory tract infections
(URTI) within the previous 2 weeks, 21 of the 432 at Athens (4 9%) and 38 of the
561 (6-7%) at Avlona.
Factors associated with carriage of meningococci
There was no difference in the proportions of carriers among the four ABO blood
groups. The proportion of carriers among Lea/non-secretors (22 % at Athens, 32 %
at Avlona) was higher than that among Leb/secretors (17% at Athens, 30% at
Avlona), but the difference was not significant.
The proportion of carriers was significantly higher among smokers and was
greatest among those smoking more than 30 cigarettes per day (Table 3)
(x2 = 2319, df = 4, P < 00005). Although the proportion of carriers was
significantly increased among smokers in both camps (Athens, \2 = 542, df = 1,
P < 0-05; Avlona x2 — 9-05, df = 1, P < 0 01), when the data for carriers were
analysed by test, there was no significant difference between the two camps
associated with numbers of cigarettes per day (^2 = 9 482, df = 4, P > 0 05)
(Table 4).
Meningococci were isolated from 17 (29%) of the 59 recruits who had symptoms
of URTI, 2 of the 21 (9-5%) at Athens and 15 of the 38 (39-5%) at Avlona. Among
the 15 at Avlona from whom meningococci were isolated, 6 (40%) were Lea/non-
secretors compared with 4 (20%) Lea/non-secretors among the 20 with recent
symptoms of URTI but from whom no meningococci were isolated. The numbers
of recruits with symptoms of URTI were too small for statistical analysis.
Multiple logistic regression analysis identified three main factors which were
significantly associated with carriage: smoking (P < 0-001); age less than 19 years
(P < 0-01) and the camp in which the recruits were based (/5<0-01). Various
Meningococcal carriage in Greek recruits 445
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No. cigarettes/ Total Carriers Total Carriers
day No. (%) No. (%) No. (%) No. (%)
0 166 (38) 20(27) 182 (32) 36 (22-5)
1-10 53 (12) 10 (13) 63 (11) 19 (12)
11-20 127 (29) 26 (35) 133 (24) 40(25)
21-30 62 (14) 15 (20) 96 (17) 29(18)
> 30 23 (5) 4 (15) 86 (15) 36 (22-5)
Total 431 75 560 160
combinations of categories were tested for difference in carriage rate when
adjusted for these three factors but no other variables were found to be significant.
Regional variations in ABO and Lewis blood group antigens
There was no difference in the distribution of the ABO blood groups in the two
major population centres, Athens and Eastern Macedonia. There was, however, a
significantly higher proportion of Lea/non-secretors. 54/183 (29 5%) among the
recruits from Eastern Macedonia compared with those from Athens. 35/235
(15%) (x2 = 12-25, P < 0-0005).
DISCUSSION
As expected, compared with carriage rates reported for civilian populations
(5-8% for Greek secondary school children), there was a higher proportion of
carriers (25%) among the recruits examined in this study. This figure is similar to
that found for a British military establishment (23%) [14J but slightly lower than
that found in the 1970s for Greek military recruits (33%) [1]. The significant
difference in the proportion of carriers between the two camps, 18% at Athens
compared with 30% at Avlona (P < 0-0005), was not anticipated.
Smoking [4, 10], passive exposure to cigarette smoke [10], secretor status [4]
and age [15] have all been reported to be associated with carriage of meningococci.
The distribution of the ABO blood group phenotypes did not differ between the
two camps and were similar to those we found in a previous study [16] and that
reported by Hirzfeld and Hirzfeld in 1919 [17]. Several of the factors examined in
the study varied between the two camps. Compared with the recruits at Athens,
among those at Avlona where there was a significantly higher proportion of
carriers of meningococci, there were significantly more heavy smokers, non-
secretors, younger recruits (less than 19 years old), and recruits of lower
socieconomic groups as assessed by years of education.
Smoking was the factor most strongly associated with carriage in both
univariate and multivariate analyses. It has been suggested that the higher
proportion of smokers and heavy smokers among military personnel [18] might
contribute to the increased prevalence of meningococcal disease and the higher
rates of carriage among military recruits. The proportions of smokers in the two
camps. 62 and 68%. were higher than the 47% found in a previous study among
Greek male patients referred for gastroscopy [15]. In Britain smoking is associated
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with socioeconomic status: unskilled individuals arc more likely to smoke than
those in professional groups [10]. A similar pattern was observed among the
recruits: those with fewer years of education were more likely to be smokers.
In a previous study of teachers and pupils in a Scottish secondary school
following an outbreak of meningitis, we found an association between non-
secretion and carriage of meningococci [4]. In the present study, in both camps,
the proportions of non-sccretors were increased among carriers: but. these
differences were not significant compared with the secretors among carriers.
Assessment of both host and parasite characteristics might elucidate the
differences in association with secretor status. The majority (35*5%) of serotypable
strains among the 121 isolates in the Scottish study were serotype 4: and 55% of
the carriers of this serotype were non-secretors. Only 9 (18%) isolates in the
present study were serotype 4. but 37 5% of the carriers were non-seeretors. The
proportion of non-seeretors among carriers of serotype 14 isolates was 25 and 22%
for the Scottish and Greek populations. A similar pattern was observed for non-
serotypable isolates.
The multiple logistic regression analysis identified age (those less than 19 years
of age) to be a significant variable (P < 0-01). This agrees w ith the findings for
carriers in the Stonehouse survey. The highest proportion of carriers w as found in
the 15-19 year age group [15].
There is evidence that viral infections can predispose individuals to carriage of
potentially pathogenic bacteria [12]: and binding of streptococci and staphy¬
lococci to cell surfaces is enhanced in experimental models examining infection
with influenza virus [20. 21 ]. The present study was carried out in July w hen there
is a low prevalence of upper respiratory viral infections: however, of the 59
recruits with symptoms of virus infection. 29 % w ere carriers. This was particularly
apparent among recruits at Avlona w here the carriage rate was 30% overall but
nearly 40% among those with virus infections. In a recent study, a higher
proportion of patients with meningococcal disease had a history of flu-like illness
than age- and sex-matched controls: however, the differences were not statistically
significant [22]. A second study of recruits was undertaken in January 1991 to
assess carriage w hen viral infections are more prevalent: the analysis of this study
is not complete at present.
In two areas of Britain where there have been prolonged outbreaks of
meningococcal disease, the proportions of non-secretors have been reported to be
higher than the 20-25% predicted for European populations [5. 6]. In this study
we found a significantly higher proportion of recruits from Eastern Macedonia
were non-seeretors (29 5%) compared w ith the other major centre of population.
Athens (15-3%). As there are anecdotal reports that meningococcal disease is more
prevalent in Macedonia, the numbers of cases reported to the Ministry of Health
from these two areas is now being closely monitored.
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SUMMARY
Usage of antibiotics in southern Europe is less well regulated than in northern
countries. The proportion (48%) of meningococci in Spain insensitive to penicillin
(MIC ^ 01 mg/1) prompted this investigation of antibiotic sensitivities of isolates
from Greek patients with meningitis (31) and carriers (47 school-children and 472
recruits). The agar dilution method was used to determine MIC to penicillin G
(PX), sulphamethoxazole (SU). rifampicin (RF), cefaclor (CF) and ciprofloxacin
(CP).
The proportion of isolates insensitive to PX was 48% for isolates from patients,
19% from school-children and 366% from recruits. Resistance to SU
(MIC > 16 mg/1) was found in 16% of those from patients, 10-6% from children
and 40% from recruits. Xone of the isolates from patients was resistant to RF
(^ 1 mg/1) but 6% of those from carriers were. Resistance to CF (^ 4 mg/1) was
found in 9-2 % of patient isolates, 6 4 % from children and 23-7 % from recruits. All
isolates except one were sensitive to CP (MIC range < 0-0015 — 0 125 mg/1).
Resistances to PX, SU and RF were analysed by serogroup, serotype and
subtype of the bacteria. The proportion of resistant isolates showed some
variation between different areas of Greece, but it was not statistically significant.
INTRODUCTION
As part of the surveys of isolates of meningococci from patients and carriers in
Greece, the antibiotic sensitivities of these bacteria to some common antibiotics
were determined. There are reports of Neisseria meningitidis with reduced
sensitivity to penicillin isolated from patients in Spain [1, 2], South Africa [3], and
the United Kingdom [4, 5]. A small proportion of these penicillin-insensitive
isolates has also been found among those obtained from carriers in the United
Kingdom [4], In view of the increasing prevalence of penicillin-insensitive isolates
* Author for correspondence.
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in Spain and the similar antibiotic policies of both Spain and Creece. it was
predicted that there might be significant numbers of (Ireek isolates with decreased
sensitivity to penicillin and other antibiotics.
The objectives of the study were: (1) to compare levels of sensitivities for
isolates obtained from patients with those obtained from carriers : (2) to determine
if the proportion of [lenieillin-insensitive isolates is comparable to that reported
for Spain : (3) to assess the distribution of resistant isolates in the different regions
of (ireeee: (4) to determine if antibiotic resistances are associated with particular
serogroups. serotyfies or subtyjies.
ISOLATES
Meningitis rates
Thirty-one isolates from children aged 1 month to 11 years were provided by the
microbiology laboratory of the "Aglia Kyriakou Paediatrie Hospital. All eases
were sporadic and occurred during 1989-91.
< 'arrims
Four hundred and seventy-two isolates were obtained during 1990— 1 from
healthy recruits aged 19-31 years [(}] and a further 47 from children aged 9 IS
years who did not have meningococcal disease.
METHODS
Antibiotic sensitivities to penicillin (FX), erythromycin (ER). tetracycline (T(')-
sulphamcthoxazole (SI"), rifampiein (RF). cefaclor (CF) and ciprofloxacin (CP)
were determined by the agar dilution method. A range of twofold dilutions from
259 to 0-015 mg/1 of each antibiotic in Mueller Hinton medium was examined. The
breakpoints used for penicillin (^ 0-125 mg/1). tetracycline 1 mg/1). erythro¬
mycin (^0*5 mg/1). rifampiein mg/1). ciprofloxacin 1 mg/1) and the
cephalosporin cefaclor (^4 mg/1) were based on those recommended by the
working party of the British Society for Antimicrobial Chemotherapy for
Branhamella catarrhalis and Haemophilus influenzae [7], The break point of
10 mg/1 for sulphamethoxazole (SC) was that used by the Neisseria Reference
Laboratory (Scotland) [Dr R. J. Fallon, personal communication]. Beta-
laetamase production was assessed during the rapid carbohydrate fermentation
test for identification of each isolate [8].
Serogroup was determined by slide agglutination with commercially available
antisera (Wellcome Diagnostics): serotype and subtype were determined by whole
cell enzyme-linked immunosorbent assays with monoclonal antibodies from Dr
J. T. Poolman (RIVM Bilthoven. The Netherlands) [9].
RESl'LTS
Table 1 compares the proportion of resistant isolates among the three groups
examined. Among 31 isolates obtained from children with meningococcal disease,
none was resistant to rifampiein or ciprofloxacin. Nearly half the isolates were
penicillin-insensitive (48 3%) and all grew on 1 or 2 mg/1 tetracycline.
Among the 47 isolates from school-children the pattern of resistance to
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(n = 31) (n =47) (n = 472)
Penicillin G 48-3 19 1 36-7
Sulphamethoxazole 16 1 10-6 356
Rifampicin — 64 7
Tetracycline too 64 91
Erythromycin 25-8 61-7 82-2
Cefaclor 9-7 6-4 23 7
Ciprofloxacin — — 0-2
ciprofloxacin, cefaclor and sulpharnethoxazole was similar to that of isolates from
patients. The proportion resistant to erythromycin (617%) was over twice that
among isolates from patients (25 8%) (^2 = 8 27, df = 1 .P— < 0 005); and there
were some rifampicin resistant strains (6 4%). Compared with the isolates from
patients, the proportion resistant to tetracycline was much less (6-4 %) (;^2 = 62-83.
df = 1, P= <00005) as was the proportion with decreased sensitivity to
penicillin (191 %) (x2 = 7 61, df = 1, P = < 001).
The proportions of 472 isolates from recruits resistant to tetracycline or
penicillin were similar to those of isolates from patients. The proportions of
isolates from recruits resistant to erythromycin or to rifampicin were similar to
that for isolates from children who were carriers. Compared with the other two
groups, there was a higher proportion of isolates from recruits resistant to
sulphamethoxazole and cefaclor. There were 112 isolates (237%) with
MIC ^ 4 mg/1 cefaclor and 32 isolates (6-8%) with MIC ^ 8 mg/1. Of the latter 32
isolates, 27 (84%) had decreased sensitivity to penicillin. There was one isolate
with MIC ^ 1 mg/1 ciprofloxacin. None of the 550 isolates from patients and
carriers produced beta-lactamase.
Geographical distribution of resistant isolates
In the two major population centres, Eastern Macedonia and Athens, the
proportions of penicillin-insensitive isolates were 33 and 40% respectively. The
highest proportions of such isolates were found in Thrace (50%), Crete (52%) and
the Aegean and Ionian Islands (50%). The lowest proportion was obtained from
recruits who lived abroad but who had returned to Greece for their compulsory
military service (9%). Analysis of the serogroups, serotypes, subtypes and
sensitivities to other antibiotics indicate that the isolates within a particular
geographical area with decreased sensitivity to penicillin are not related (Table 2).
Analysis by antigenic phenotypes
Meningitis strains
Among the isolates from patients with meningitis. 50% of group B, 37-5% of
group C and 60% of the non-groupables were penicillin-insensitive. Sulphonamide
resistance was found in 17% of the group B isolates and 25% of group C but in
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Table 2. Proportion of antibiotic-resistant isolates obtained from recruits from
different regions of Greece
Percent
resistant
Region Number tested PX SU RF CP
Thrace 14 50 79 7 —
VV. Macedonia 38 26 42 5 —
E. Macedonia 96 33 35 7 —
Epirus 23 48 30 4 —
Thessaly 46 34 48 6 —
Central Greece 32 32 44 9 —
Athens 127 40 39 7 0-8
Peloponnese 40 35 30 10 —
Crete 31 52 39 3 —
Aegean Islands 10 50 70 10 —
Ionian Islands o 50 — 50 —
Foreign 11 9 22 — —
Table 3. Antibiotic resistances of serogroups
Percent
resistant
Serogroup No. PX SU RF
A 17 41 41 12
B 114 35 37 5
C 19 42 42 10-5
W135 2 0 50 0
Y 8 625 25 0
Z 4 25 0 0
NG 300 36 40 7
none of the non-groupable isolates. Of the 9 2b serotype isolates, 7 (78%) were
penicillin-insensitive as were 8/18 (44%) of the non-typables. The 4 isolates
expressing other serotypes (2a, 14 and 15) were sensitive to penicillin and to
sulphamethoxazole. Resistance to sulphamethoxazole was found for only 2/9
serotype 2b isolates and 3/18 non-typable isolates. Of the 9 isolates expressing the
Pi. 10 subtype, 7 (78%) were penicillin-insensitive though only 1 was resistant to
sulphamethoxazole. The second most common subtype was Pi.9. Only 1 of the 5
Pi.9 isolates was penicillin-insensitive, but 2 were sulphonamide resistant.
Carrier strains
There were sufficient numbers of isolates from the recruits for analysis of
antibiotic resistances by serogroup, serotype and subtype (Tables 3-5). Among the
serogroups, the highest proportion of penicillin-insensitive isolates was found for
group Y (62-5%) while rifampicin resistance was greatest in groups A (12%) and
C (10-5%) (Table 3).
Penieillin-insensitivity was highest among serotypes 2a and 15 and lowest in
type 4, which, however, had the highest proportion of strains resistant to
sulphamethoxazole. Rifampicin resistance was observed most frequently among
serotypes 4 and 15 (Table 4).
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Table 4. Antibiotic resistances among serotypes
Percent
resistant
Serotype No. PN SU RF
1 15 27 20 7
2a 7 57 43 0
2b 22 •27 32 45
4 9 11 56 11
14 66 42 28 9
15 16 56 19 12 5
Table 5. Antibiotic resistances among subtypes
Percent
resistant
>group No. PN SU RF
1 41 39 34 25
■7 72 43 22 155
4 7 43 29 0
6 28 32 68 0
7 30 43 63 13
9 45 27 38 2-4
10 29 45 28 14
12 8 25 375 0
14 8 62-5 25 0
15 16 375 19 0
16 13 38 70 23
Xo particular subtype antigen was associated with an unusual degree of
antibiotic resistance (Table 5).
DISCUSSION
Although sulphonamide resistance has been associated with strains causing
outbreaks of meningococcal disease in northern Europe [10. 11], only 16% of the
isolates from Greek patients had MIC > 10 mg/1 to sulphamethoxazole ; however,
nearly half had reduced sensitivity to penicillin and all grew in the presence of
1 or 2 mgm/1 tetracycline.
In contrast, while the proportions of penicillin-insensitive and of tetracycline-
resistant isolates from carrier children were both significantly lower, the
proportion of erythromycin isolates was significantly increased.
Among isolates from the recruits, the proportion of penicillin-insensitive strains
was significantly greater than that from children who were carriers (^2 = 5T26.
df = 1. P < 0-025) but not compared with those from children with disease. The
proportion of sulphonamide-resistant isolates among those from recruits (35-6%)
was over twice that of the other two groups, carriers (10-6 %) (x2 = 10 882, df = 1.
P < 0005) or patients (16%) (/y2 = 4 06. df = 1. P < 0-05) (Table 1).
Although penicillinase-producing isolates of Neisseria gonorrhoeae are not
uncommon in Greece (18%) [12], none of the 550 meningococcal isolates tested
produced beta-lactamase.
IT-2
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isolated. Although the sulphonamide and rifampicin resistances were highest
among subtype Pi.16. the two resistances were not found together in the Pi.16
strains. The higher rate of rifampicin resistance among isolates expressing Pi. 10.
the subtype found most frequently among meningococci isolated from patients,
and among isolates expressing Pi.2, the most common subtype among carriers,
needs to be further investigated.
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Susceptibility to infection in relation to SIDS
C C Blackwell, A T Saadi, M W Raza, J Stewart, D M Weir
Summary
Because there is little evidence that inva¬
sive bacterial diseases contribute to cot
deaths, most studies on Infectious causes
of SIDS have focused on viruses or toxin
producing bacteria.
Although epidemiological studies found
marginally significant associations
between influenza virus and SIDS, respi¬
ratory syncytial virus (RSV) was isolated
from 90% of older infants with SIDS.
There are conflicting reports that some
toxigenic bacteria (Clostridium hotuli-
num, Clostridium difficle, enterotoxi¬
genic Escherichia coli and Staphylococcus
aureus) might be implicated in cot deaths.
5 aureus are common micro-organisms
and their toxins are very powerful. As the
pyrogenlc toxic shock syndrome toxin ofS
aureus can kill a previously healthy adult,
it might easily kill a small infant.
Based on our studies on susceptibility of
infants to other infections, we suggest the
following might be factors leading to colo¬
nisation of infants by toxin producing 5
aureus:
• The Lewis* blood group antigen
appears to act as a receptor for some
micro-organisms. Epithelial cells ex¬
pressing high concentrations of Lewis*
bound appreciably more toxin produc¬
ing 5 aureus than cells expressing low
concentrations of the antigen.
• Lewis* is expressed in secretions of
nearly 90% of infants aged 3 months,
the peak age for SIDS.
• RSV infects about 50% of infants by the
first year of life and it is often isolated
from infants with SIDS. Studies in our
laboratory indicate that RSV infected
HEp-2 cells bind more toxin producing
5 aureus than uninfected controls.
For many years it has been suggested that
micro-organisms might be involved in the
aetiology of SIDS; several of the factors identi¬
fied in epidemiological studies of SIDS are
associated with increased susceptibility of
infants to infectious diseases. SIDS is asso¬
ciated with the vulnerable period when mater¬
nal antibodies have decreased, and the infant's
immune system is immature. Deaths from
SIDS occur more frequently during the winter
months when respiratory viral infections are
most prevalent. Both occur frequently in famil¬
ies in which socio-economic conditions are
poorer. One of the factors identified in the
New Zealand studies on cot death was mater¬
nal smoking habit.1 Smoking is, however,
related to socio-economic group. In the United
Kingdom the proportion of women who smoke
increases as social class decreases from pro¬
fessional to partly skilled or unskilled cate¬
gories.' Smoking and passive exposure to
cigarette smoke have been associated with
susceptibility to respiratory infections.' Smok¬
ers are also more likely to be asymptomatic
carriers of potential pathogens such as menin¬
gococci.4 ' Breast feeding protects infants in
this age range from gastrointestinal and respi¬
ratory illnesses, and SIDS is claimed to be
more frequently associated with bottle feed¬
ing.*
Viruses
Much of the work on the role of infectious
agents in SIDS has concentrated on viruses.
Various respiratory viruses have been impli¬
cated; chapters 6 and 7 provide critical reviews
of the evidence for viral infection as a cause of
SIDS. Although viruses have been isolated
from infants with SIDS, it has been difficult to
establish a direct link for viral infection with
these deaths.
Bacteria
Generally, bacteria cause disease in two ways,
by invading the host or by producing a toxin.
There has been no substantial evidence for
invasive baaerial infections in SIDS.7* Post¬
mortem studies have isolated several toxin
producing bacteria from these infants (table
1). Infant botulism has been reported to be
responsible for 4% of cot deaths in the United
States and up to 16% of those in Sweden.9""
This pattern has not been found in the United
Kingdom."
Toxins A and B of C difficile produce death in
monkeys that is pathologically consistent with
SIDS,14 and these baaeria have been isolated
from some infants at necropsy.Entero¬
toxigenic strains of E coli have also been
implicated in some studies"; the evidence for
the involvement of intestinal toxigenic bacteria
has, however, been inconsistent.
TabU 1 Taxin producing bacuria implicxxud in SIDS
Specie3 Team Reference
C bondhmtm A, B, C, F, G 6 11-14
C ixffurit A, B 16-18
E cob En(fro.arm 17
5 aureus A, B.CD, TSST-1 * 19 22
Toxic ihock syndrome.
S*Kiptobdity to mfetson in rtiation to SIDS 2I
TabU 2 Blood pvup antigens an ct&s and m body fluids
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pyrogenic toxins similar to those of staphylo¬
cocci. A variety of toxin producing staphy-
toccoci, including that associated with toxic
shock syndrome, have been isolated from
infants with SIDS.20 We chose these bacteria as
the model for our investigations.
* Pwenl ID tnrmbk qmnmxv
The pyrogenic toxins of Staphylococcus aur¬
eus such as that associated with toxic shock
syndrome can kill previously healthy adults, so
they might easily kill a small infant." One of
the characteristics of disease caused by these
toxigenic bacteria is high fever (>38 5*C).
Among 24 infants who died suddenly and
whose rectal temperatures were measured
immediately before refrigeration, 10 had tem¬
peratures above 38"C and five above 40"C."
The pyrogenic toxins produced by the Gram
positive bacteria S aureus and group A Strepto¬
coccus pyogenes have similar properties. They
are potent inducers of fever, perhaps by direct
action on the hypothalamus or through their
induction of interleukin 1 (EL-1) and rumour
necrosis factor (TNF) from mononuclear pha¬
gocytes. These toxins are mitogenic for lym¬
phocytes. They can non-specifically suppress
immunoglobulin production and enhance
delayed type hypersensitivity, these are prob¬
ably not important functions in SIDS, how¬
ever, as the infants have little specific immunity
at this time. The toxins can alter liver clearance
function and enhance endotoxic shock. An
important fact to note is that they are produced
at 37-40*C, and more toxin is produced at the
higher temperatures."
The study by Telford and colleagues pub¬
lished in 1989™ led us to consider how toxin
producing strains of5 aureus might cause some
cot deaths. Although the proportion of infants
with SIDS from whom S aureus was isolated
was greater than the controls, the difference
was not significant. The proportion of strep¬
tococci isolated from infants with SIDS was
significantly higher; none of these, however,
was a group A S pyogenes which produces
lit
Subjects
Fieure 1 Binding of monoclonal ann-Lems* antibody to buccal epithelial cells from
nvn->**.r*ton. -.ere»vr..>rj and L*wis->uf<2mx Sonort.
Secretor status and susceptibility to
Infectious agents
Our research team has been examining a
genetic factor associated with the susceptibility
of individuals to several infectious diseases.
This is non-secTetion, the inability of an
individual to secrete the glycoprotein form of
his ABO blood group antigens. The first
association between non-secretion and infec¬
tious diseases was noted in the 1950s and
1960s among patients with rheumatic fever.
Non-secretors were over-represented among
patients with rheumatic fever and also among
asymptomatic carriers of group A 5 pyo¬
genes.2'
Traditionally, secretor status is determined
by detection of ABO blood group antigens in
saliva by a haemagglutination inhibition test,
but it can also be determined by the Lewis
blood group antigen. Non-secretors can ph>-
duce only Lewis"; while secretors can have
varying quantities of Lewis", they predom¬
inantly express Lewis'." We have developed
enzyme linked immunosorbent assays (ELISA)
for detection of H antigen2' and Lewis anti¬
gens24 in body fluids such as saliva or nasal
secretions so that, even if we do not have red
blood cells, we can still determine the Lewis
blood group of a subject. The distribution of
ABO and Lewis blood group antigens on cells
and in body fluids of secretors and non-
secretors is outlined in table 2.
One hypothesis we suggested to explain the
increased susceptibility of non-secretors to
some infectious agents was that the Lewis"
antigen, present in greater quantities on epi¬
thelial cells of non-secretors, might act as a
receptor for some strains of bacteria." The
idea is not novel; a variety of blood group
antigens have been shown to act as receptors
for micro-organisms. For example, the Duffy
blood group acts as a receptor for Plasmodium
vivaoc in populations expressing this anti¬
gen."
By flow cytometry we measured the amount
of monoclonal anti-Lewis* antibody bound to
epithelial cells from non-secretors, secretors
and subjects who lack the Lewis gene. Cells
from non-secretors consistently bound high
concentrations of anti-Lewis"; those from
secretors bound highly variable amounts; while
those from Lewis-negative subjects consis¬
tently bound very low amounts of the antibody
(fig 1).
The peak of SIDS at 2-3 months of age
suggests that cot deaths might be associated
with a critical phase of development during
which either all or a subgroup of babies are at
risk.27 There are differences in maturation or
efficiency of the products of the secretor gene
and the Lewis gene during this period in the
infants' development.




tgurr 2 Derrvatwn of ABH ami Lewis antigens from type I precursor chains.
The enzymes coded for by the secretor and
Lewis genes act on type 1 precursor chains
attached for the most part to glycoproteins in
body fluids. The enzyme coded by the secietor
gene adds fucose to the terminal sugar of the
type 1 precursor and that coded for by the
Lewis gene adds fucose to the subterminal
sugar of the type 1 precursor. If the secretor
enzyme adds the fucose first, the structure can
act as a substrate for the Lewis enzyme to form
Lewis" antigen. If the Lewis enzyme adds
fucose to the subterminal sugar first to form
Lewis', the secretor gene cannot use the Lewis"
as a substrate to form Lewis" (fig 2). In infants
the enzyme coded by the secretor gene does
not mature as rapidly as the one coded by the
Lewis gene. The result is that infants, even
though they are secretors, express considerable













When we looked at the figures published for
percentage of infants expressing Lewis', it was
obvious that the curve mirrored that for SIDS
(fig 3) When we examined secretions from 89
infants with SIDS by the ELISA method, we
found Lewis" antigen in 63 (71%).
In a series of experiments we tested the
hypothesis that some strains of toxin producing
5 aureus, bind in greater numbers to cells
expressing large amounts of Lewis". Because
we could not use cells from infants, we
examined epithelial cells from adult secretors
and non-secretors matched as closely as poss¬
ible for ABO blood group, sex, and age for
their abilities to bind strains of 5 aureus
obtained from different sources (table 3).
Attachment of fluorescein labelled bacteria to
buccal epithelial cells obtained from matched
pairs of secretor and non-secretor donors was
assessed by flow cytometry'0 and analysed by
the computer program Immunoanalysis (Coul¬
ter). The binding index of each sample (per¬
centage of fluorescent cells multiplied by the
mean fluorescence) was calculated.
In figs 4 and 5 the data are represented as a
difference in the percentage of the binding
between secretor and non-secretor cells, each
point representing the results for one pair of
donors. If there was no difference the point is
on the line (0%). The points above die line
represent those pairs in which the non-secretor
cells bound more bacteria than cells from the
secretor: the points below the line represent
those pairs in which the secTetor cells bound
more than those from the non-secretor.
Five of the eight toxin-producing strains and
the non-toxigenic strain showed no difference
in binding to cells of secretors compared with
non-secretors. Figure 4 represents the type of
pattern observed with these strains. For three
of the toxigenic strains, including one produc¬
ing TSST-1, there was significantly more bind¬
ing to the cells on non-secretors (fig 5). This
indicates that some but not all strains bind in
greater numbers to cells of non-secretors.
If some toxin-producing strains use Lewis'
as one of the host cell receptors, the results
suggest that at the age of 2 to 3 months infants
might be more susceptible to colonisation by
these bacteria.
Interactions between viruses and
bacteria
There is clinical, epidemiological, and experi¬
mental evidence that virus infections predis¬
pose people to some bacterial diseases and
enhance colonisation by potentially pathogenic
Table 3 Staphylococcus aureus isolates examined
Figure 3 Analysis by age of expression of Lewis' antigen
and prev alence of SIDS.
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Figure f Binding of \ umgenu S aureus
epithelial ctUs of secrtton and non-tecretors.
bacteria, such as influenza followed by
invasive pneumococcal disease. Some of the
interactions that might lead to secondary
bacterial disease include: immunosuppression;
decreased phagocytosis; loss of mucociliary
function; local oedema formation and tissue
injury; and increased binding to virus infected
cells.
Toxic shock syndrome caused by toxin
producing staphylococci has been identified as
a complication of influenza or influenza-like
illness.2* In our studies we tested the hypoth¬
esis that cells infected with RSV bind more
bacteria than uninfected cells. We chose RSV
as a model system for these studies because it is
an important, ubiquitous respiratory pathogen
causing infection in young infants during the
winter months when SIDS is most common.20
It has been isolated often from infants with
SIDS.11 By the age of 12 months half of all
infants have been infected with the virus. It can
be grown in an epithelial cell line of human
origin. Finally, our studies on two bacterial
species that cause invasive disease among
children in the age range affected by SIDS,
Neisseria meningitidis and type b Haemophilus
influenzae, found that cells infected with RSV
bound significantly more of these bacteria than
uninfected cells (Raza MW, Ogilvie MM,
Blackwell CC, ei al. Abstract presented at
120th meeting of Society for General Micro¬
biology).
A flow cytometry method was adapted to
examine attachment of bacteria to tissue cul¬
ture cells derived from human epithelial cells
(HEp2) cells which can be infected with RSV.
The results from our preliminary experiments
with staphylococci closely paralleled those
found with the other two species of bacteria.
Compared with the uninfected cells the infec¬
ted cells bound more staphylococci with both
the toxin producing strain (10655) and the
non^toxigenic strain tested (8325) (fig 6).
If toxin producing staphylococci are respon¬
sible for some of these infant deaths, our
studies suggest two factors that might contrib¬
ute to colonisation by these bacteria: expres¬
sion of abnormally high concentrations of
Lewis" in infants under the age of 12 months;
and enhanced binding of these bacteria to
infected cells. The following scheme attempts
to incorporate the factors identified in epi¬
demiological studies with our experimental
work.
First, maternal smoking, which has been
identified as a risk factor for SIDS, could
enhance exposure of the infant to staphylo¬
cocci in two ways. Epithelial cells from smok¬
ers bind significantly more staphylococci than
cells from non-smokers.12 Smoking also
enhances susceptibility to respiratory viral
infections; epithelial cells from patients .with
natural or experimental viral infections bound
more staphylococci compared with cells from
people who were not infected with a virus.11
Factors that might enhance colonisation of
infants by toxigenic staphylococci include pas¬
sive exposure to cigarette smoke which decrea¬
ses mucociliary clearance. Infants in the age
range affected by SIDS have little or no
mucosa] or systemic immunity to staphylo¬
cocci or their toxins. The effect of breast
feeding on colonisation by staphylococci is not
known, but breast fed infants are less suscept¬
ible to toxigenic strains of C botulinum.* Infants
in the 2-3 month age group express large
amounts of Lewis", which we postulate, some
isolates of toxigenic staphylococci might use as
a receptor on epithelial cells. Respiratory viral
infections have been shown to enhance binding
of staphylococci to epithelial cells from 8%
among uninfected people to 43% among those
with infection11; our laboratory finding indi¬
cate that the common paediatric virus, RSV,
can also enhance binding to epithelial cells in
vitro.
In most infants colonisation by staphy¬
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Figure 6 Binding of umn-producing S aureus (10655)
to uninfected HEp-2 cells and HEp-2 cells infected wuh
RSV
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toxigenic S Aureus
Figure 7 Propoted tents of rtfnxi by which bactena
producing pyrogtmc toxins might cause tome cot deaths.
factors are probably required to precipitate cot
death. In some infants the series of events
outlined in fig 7 might occur. The temperature
of the infant colonised by the toxigenic bacteria
is increased, whether by virus infection or by
environmental overheating. The higher tem¬
perature enhances the amount of toxin pro¬
duced by the bacteria," and the toxin diffuses
into the bloodstream to increase the tem¬
perature of the infant further. This synergistic
effect between increased temperature and
toxin production might account for the un¬
usually high temperatures recorded for some of
these infants at necropsy."The actual cause of
death might be shock due to the fever or other
as yet unrecognised effects of the toxin on the
respiratory or cardiac systems.
Our studies suggest three areas for further
investigation. The first is already underway; to
identify the receptors on the cells of non-
secretors that contribute to the enhanced
binding of staphylococci and the components
on RSV infected cells that enhance binding of
bacteria. From this we will try to identify the
adhesions on the bacteria and to determine
whether they can elicit an immuned response
in infants in this vulnerable age group. The
second set of studies requires development of
assays for detection of pyrogenic toxins to
determine whether these are found in some
infants with SIDS at necrospy. Last is epi¬
demiological studies of the effects of parental
smoking and viral infections on the carriage of
staphylococci among infants during the first
year of life, which we are trying to organise in
conjunction with our studies on meningitis.
Toxigenic bacteria might have a role in some
cot deaths. Colonisation by toxigenic strains is
probably not uncommon. In most infants this
colonisation does no harm and induces pro¬
tective antibodies to the bacteria. We suggest
that in most instances in which these pyrogenic
toxins might be involved, there must be other
factors such as viral infection or overheating
that create conditions in which these bacteria
produce enough toxin to have a lethal effect.
The studies planned will allow us to obtain
evidence to support or refute the hypothesis.
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Serogroups, serotypes and subtypes of Neisseria
meningitidis isolated from patients and carriers in Greece
G. TZANAKAKI, C. C. BLACKWELLV J. KREMASTINOU+, D. M. WEIR', A. MENTIS and
R. J. FALLON*
National Meningitis Reference Laboratory. Hellenic Institute Pasteur. Athens, Greece, 'Department of Medical
Microbiology, University of Edinburgh Medical School. Teviot Place. Edinburgh EH8 9AG, tAthens School of Public
Health and \Meningococca! Reference Laboratory (Scotland). Ruchill Hospital. Glasgow
Summary. The increase in the number of cases of meningococcal disease reported to the
Ministry of Health in Athens since 1989 prompted the present study to determine if isolates
from patients or carriers expressed the same phenotypic characters as those in other parts of
Europe. None of the isolates from patients (31) or carriers (547) expressed the antigenic
combinations associated with outbreaks in northern Europe, i.e., B: 15: PI. 16 or B: 4: P1.15.
The majority of the Greek isolates did not react with any of the six monoclonal serotype
reagents tested; however, most reacted with one or more of the 11 monoclonal subtype
antibodies. The results suggest that additional serotype reagents are needed for epi¬
demiological studies in southeastern Europe and that vaccines based on serotype antigens
developed against outbreak strains in northern Europe would not be effective in Greece.
Introduction
The increase in the number of cases of meningo¬
coccal disease reported to the Ministry of Health in
Athens prompted the present study.1 As the last major
epidemiological survey of Neisseria meningitidis in
Greece was published in the 1970s before the avail¬
ability of serotype and subtype reagents,2 the study
had three main objectives; firstly, to determine
whether the serotype and subtype reagents used in
northern Europe and America can discriminate
between isolates of meningococci from south-eastern
Europe; secondly, to find out if serogroups, serotypes
and subtypes of isolates from patients with meningo¬
coccal disease or carriers in northern Europe3"' are
prevalent among Greek isolates; and thirdly to see if
particular phenotypes are associated with different
regions of Greece.
Materials and methods
Thirty-one isolates from children aged 1 month-11
years with meningococcal disease were obtained from
the microbiology laboratory of Aglaia Kyriakou
Paediatric Hospital, Athens. The isolates were from
sporadic cases that occurred during 1989-1991. Fifty-
one isolates from school children aged 5-18 years who
Received 4 March 1992; accepted 21 April 1992.
'Correspondence should be sent to Dr C. C. Blackwell
were carriers were obtained in surveys undertaken in
Athens between Dec. 1990 and Jan. 1991.8 A series of
496 isolates from military recruits aged 16-30 years
were obtained during July 1990 and Jan. 19911 within
3-5 days of the arrival of the recruits at the camps;
recruits from all regions of Greece were represented.
The isolates were grown on modified New York
City medium9 and characterised by Gram's stain, the
oxidase test and by the rapid carbohydrate utilisation
test (RCUT).10 Serogroups were determined by slide
agglutination with polyclonal antisera to serogroups
A, B, C, W135, X, Y and Z (Wellcome Diagnostics).
Serotype and subtype were determined by a whole-cell
enzyme-linked immunoassay (ELISA) with mono¬
clonal antibody11 reagents supplied by Dr J. T.
Poolman (RIVM, Bilthoven, The Netherlands).
Information obtained from each recruit regarding
area of residence and socio-economic status was coded
and entered into a Data Base 3 Plus program together
with the results of the throat swab and the serogroup,
serotype and subtype of the isolates.1 Similar data
bases were prepared for information obtained from
questionnaires returned by parents of school children
participating in the surveys.8 Written informed consent
was obtained from each of the recruits or from the
parent or guardian of the children.
The results from the school children were compared
with those obtained in a Scottish secondary school,
where there was an outbreak of disease caused by a
sulphonamide-resistant serogroup B serotype 4 sub¬
type 15 (B:4: P1.15) strain,' and results from the
recruits were compared with published results for 133
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isolates obtained from carriers among Norwegian
military recruits.8





The antigenic phenotypes of isolates from patients
are shown in table I. The most prevalent serogroup
was B (58%) followed by group C (26%) and non-
groupable isolates (15%). The majority of isolates
(58%) did not react with any of the serotype anti¬
bodies. The most common serotype was 2b (9 of 31,
29%), and the most common subtype was PI. 10 (11 of
31, 35%). The most common serotype-subtype com¬
bination was 2b:P1.10 (7 of 31, 23%).
Carriers
Among school children there was no predominant
antigenic phenotype. Of the 19 (37%) serogroupable
isolates, 10 belonged to group B, two to each of
serogroups A, C, W135 and Y and one to group Z. As
with the isolates from patients, the majority (65 %) did
not react with any of the serotype antibodies; however,
most (75%) reacted with one or more subtype re¬
agents. Two isolates (4%) obtained from secondary
school pupils expressed the 2b:PI. 10 combination
found among those from patients (tables II and III).
Of the 496 isolates from recruits, 36% were sero¬
groupable: 24% were group B, 5% group C and 4%
group A. Most isolates (69%) were not serotypable,
but 64% reacted with one or more of the subtype
antibodies. The most common serotype was 14(16%),
and the most common subtype was P 1.2 (16%) (tables
II and III). The most prevalent combination of
serotype-subtype antigens was 14:PI.2 {n = 24) fol¬
lowed by 14: P1.7 (n = 13). None of the isolates from
the recruits expressed the 2b:PI. 10 combination pre¬
dominant among children with meningococcal disease.
None of the 2a or 2b isolates from carriers reacted with
any of the subtype antibodies.
Geographic areas
The major regions of Greece are shown in the figure
together with the proportion of recruits from whom
meningococci were isolated. Meningococci were ob¬
tained most frequently from recruits from the north¬
east of Greece: Thrace (37 %), West Macedonia (33 %)
and East Macedonia (30%). Because military service
is compulsory, even for individuals who live abroad,
there were 33 subjects who were not normally resident
in Greece. Among these, 33% were carriers.
There were no unusual distributions of serogroups
among the different regions. The most common
serotype (14) was found in equal proportions (15%)




B - PI 1 1
B - PI.9 4
B - PI 10 2
B . PI.14 1
B 2 b: P1.9 1
B 2 b: PI. 10 4
B 14: P1.15 1
B IS: PI.6 1
C . PI.6 2
C - PI.10 3
C - PI.14 1
C . PI.16 1
C *> b:P1.2 1
NG 2a:PI 6 1
NG 2b:Pl.10 3
NG 14:PI. 10 1
Table II. Comparison of serotypes of isolates from carriers in
Greece with those from carriers in northern Europe
Percentage of isolates from
Serotype
recruits school children
Greece Norway Greece Scotland
in = 485) (i= 133) = 51) s II K>
1 4 5 8 9
2a 1 5 6 0
2b 5 0 8 5
4 2 22 8 36
14 16 16 2 13
15 3 8 4 8
21* 8 7
Non-typable 69 28 64 22
•Not tested in this study.
Table III. Comparison of subtypes of isolates from carriers
in Greece with those from carriers in northern Europe
Percentage of isolates from
Subtype
recruits school children
Greece Norway Greece Scotland
in = 489) (#i = 133) (1 = 51) (» = 121)
Pl.l 9 5 14 3
PI.2 16 16 8 17
PI.3* 13
PI.4 1 0 0 0
PI .6 6 0 8 8
PI.7 6 0 4 7
PI.9 9 0 18 0
PI.10 6 0 10 0
PI.12 2 0 4 0
PI.14 2 0 0 0
PI.15 4 19 8 23
PI.16 3 8 0 4
Non-typable 36 39 26 38
*Not tested in this study.




Figure. Proportion of carriers among recruits from different regions
of Greece.
population, greater Athens and East Macedonia. Over
20% of the isolates from Thessaly (22%), the Pelo-
ponnese (21 %), Crete (25%) and the Aegean Islands
(30%) expressed the type 14 antigen.
Isolates representative of all the 11 subtypes ex¬
amined were found among those from recruits from
greater Athens, East Macedonia and Crete. More
isolates that did not react with the subtype antibodies
were obtained from recruits from the north of Greece:
Thrace. Macedonia and Epirus.
Discussion
The first two objectives of the study were to
determine if the serotype and subtype reagents used
for epidemiological studies in northern Europe and the
Americas could be used in epidemiological studies in
Greece, and if the serotype and subtype combinations
associated with disease in other populations were
found in Greece. The proportion of non-serotypable
isolates from the Greek recruits (69%) and school
children (64%) was greater than the proportion of
non-serotypable isolates obtained from carriers among
Norwegian recruits (28 %)' or Scottish school children
(22%). The proportion of serotype 14 isolates was
similar for Greek (16%) and Norwegian (16%)
recruits and Scottish school children (13%) but was
much lower (2%) among Greek children. The pro¬
portion of 2b serotypes was similar for the Greek
recruits and Scottish school children. Serotype 4 was
the most prevalent type among the Norwegian (22 %)'
and Scottish (36%) isolates compared with 2-8% of
the Greek isolates. Serotype 15 was found in 8% of
isolates from north Europeans compared with 3-4%
of the Greek isolates. This suggests that other serotype
reagents need to be developed for epidemiological
studies of meningococci from Greece and that the
serotypes associated with recent outbreaks in Britain
and Scandinavia are uncommon in Greece.
The proportion of isolates from the Greek recruits
(36%) and school children (26%) that did not react
with any of the subtype reagents was similar to that of
isolates from the Norwegian recruits (39 %)' and from
Scottish school children (38%). The proportion of
subtype PI.2 isolates was similar for Greek (16%)
and Norwegian (16%) recruits and Scottish school
children (17%) but was lower among Greek school
children (8%). The proportion of subtype PI.15 was
similar among the Norwegian (19%)' and Scottish
(23%) isolates but was greater than that found in the
Greek isolates (4-8%). The subtype reagents appear
to discriminate between strains from Greek carriers as
effectively as between carrier strains from northern
Europe; however, the proportions of subtypes asso¬
ciated with outbreaks in northern Europe are lower.
Combinations of serotype and subtype antigens
15:PI. 16, 4:PI. 15 and 2a:PI.2 associated with out¬
breaks in northern Europe4 5 were not found among
any of the isolates in this study. Although PI .2 was the
most common subtype found in the study there was
only one patient isolate with this subtype, C:2b:P1.2
(table I). In contrast, the 2a:P1.2 and 2b:P1.2 com¬
binations are found frequently among Scottish group
C12 and French serogroup B isolates and 2a.PI.2 is
found frequently among French serogroup C iso¬
lates.13 The only report of meningococcal serotypes
from southeast Europe is that of the C:2a phenotype
associated with disease in Italy.14 None of the sero¬
group C isolates expressed this serotype.
The third objective was to determine if there were
antigenic phenotypes associated with different areas of
Greece, e.g., those in which there are large numbers of
foreign tourists or foreign military personnel or areas
such as the northeast were there is a significant Muslim
population some of which might have visited Saudi
Arabia; however, there was no unusual distribution of
serogroups or serotypes in the different regions of
Greece.
The results of the study suggest that vaccines based
on serotypes and subtype combinations associated
with disease in northern Europe such as the one being
developed and tested in Norway will not be appro¬
priate for Greece.
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SUMMARY
Non-secretors of ABO blood group antigens are over-represented among
patients with meningococcal diseases. Lower levels of secretory IgA reported for
non-secretors have been suggested to compromise mucosal defences. Total serum
and salivary IgG, IgA and IgM and levels of these isotypes specific for Neisseria
lactamica and five isolates of meningococci were determined by ELISA for 357
pupils and staff of a secondary school in which an outbreak of meningitis occurred.
There were no differences in total or specific levels of serum IgG. IgA or IgM or
salivary IgG or IgA of secretors compared with non-secretors. Non-secretors had
significantly lower levels of salivary IgM (P = 0-022) A similar pattern was
observed for levels of IgM specific for A', lactamica and five meningococcal isolates.
The significance of these results is discussed with reference to the role of secretory
IgM in protection of mucosal surfaces in infants.
INTRODUCTION
The ability of the host to resist infection or colonization by microorganisms is
partly dependent on the presence of a fully functional mucosal immune system.
Although IgA is the most abundant immunoglobulin in exocrine secretions such
as tears, saliva and milk, IgG and IgM are also found in these fluids [1, 2], IgM can
also function as a true secretory immunoglobulin [3], reaching the mucosal surface
by the identical secretory-component mediated transcellular pathway that
transports IgA. The full protective potential of secretory IgA is not present in the
infant at birth [4, 5]. Adult levels of secretory IgA are not reached until after 1
year of age [6. 7]. It has been suggested that in infants the presence of IgM
compensates partially for the low levels of IgA [7]. IgM to poliovirus and
Escherichia coli has been found in infants [7. 8],
Protective immunity to disease due to Neisseria meningitidis is associated with
the presence of an intact complement system and opsonizing or bactericidal
antibodies specific for the invading strain [9-11], These antibodies can be formed
through nasopharyngeal carriage of meningococci [12]. The majority of individuals
This work was presented at the 120th meeting of the Society for General Microbiology.
Nottingham. UK. 27-29 August 1991.
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who develop invasive disease lack protective antibody to the pathogen [9. 10]. The
age range in which meningococcal infection is most prevalent (6 months to 45
years) reflects the natural development of antibodies to these pathogens.
Xon-secretors of ABO blood group antigens are over-represented among
patients with disease due to A', meningitidis [13. 14] and among carriers of this
bacterium [15], The lower immunoglobulin levels found in non-secretors compared
with secretors have been used to explain the increased susceptibility of non-
secretors to rheumatic fever and rheumatic heart disease [16, 17]. In later studies,
non-secretors were reported to have lower levels of both serum [18] and salivary
[19] IgA. It was suggested that specific immune responses at the mucosal surfaces
of non-secretors might be compromised compared with that of secretors. The aims
of the present study were to determine:
(1) if there is a difference in the amount of total serum and salivary IgA. IgG
and IgM between secretors and non-secretors;
(2) if there is a difference in the levels of isotypes specific for A*, lactamica and
N. meningitidis in serum or saliva of secretors and non-secretors;
(3) if there is a correlation between levels of specific anti-meningococcal
antibodies in secretions and in serum;
(4) if carriage of meningococci affects the levels of antibody to these bacteria
found in secretors and non-secretors.
MATERIALS AND METHODS
Subjects
Sera and whole saliva specimens (357) were obtained from staff and pupils (most
within the 12-18 years age group) of a school in which there was an outbreak of
meningococcal disease due to a serogroup B, serotype 4, subtype PI. 15
sulphonamide resistant strain (B:4:P1.15). Information regarding carriage of
meningococci, secretor status, ABO and Lewis blood group antigens were reported
in a previous study [15]. Informed consent to participate in the survey was
obtained from parents or guardians of the children.
Isolates of neisseria
An isolate of A', lactamica and five different isolates of A', meningitidis expressing
different serogroup. serotype and subtype antigens were obtained from the freeze-
dried strains in the collection of the Infection and Immunity Laboratory. Medical
Microbiology Department. L'niversity of Edinburgh. The outbreak strain and a
B: 15:Pi. 16 sulphonamide resistant isolate were obtained from Dr R. J. Fallon.
Meningococcus Reference Laboratory (Scotland). Ruchill Hospital. Glasgow
(Table 1). The bacteria were grown on Modified New York City (MXYC) agar [20]
for 24 h in a humidified atmosphere with 10% C02.
Determination of total immunoglobulin isotype levels
The total amount of IgM and IgA were assayed by a capture ELISA method.
IgG from serum and saliva was coated directly onto ELISA plates. For the
measurement of total IgM and IgA, the wells of polystyrene microtitre plates were
coated overnight at 4 °C with either 100 p\ of mouse monoclonal anti-human IgM
Secretor status and antibody responses
Table 1. Bacterial isolates



























Clone Xo. MB-11. lot 69F-4807 (1/500) (Sigma. Poole. Dorset. UK) or mouse
monoclonal anti-serum IgA Clone No. GA-112. lot 99F-4803 (1/500) (Sigma)
diluted in coating buffer (15 m\i XaC03. 35 m.M XaH2C'03. 3 m.vi XaX3: pH 9 6).
The coated plates were washed three times with phosphate buffered saline (PBS)
(016 m-XaCl. 8 m.m-XaP2HP04. 1 m.M-KH2P04. 3m>i-KCl: pH 7-2) containing
0-01 % bovine serum albumin (BSA) and Tween 20 (0-05% v/v) (PBS-Tween) and
blocked w ith BSA (1 %) in PBS (blocking buffer) for 30 min. After washing. 50 p\
of serum (1/2000) or saliva (1/10) diluted in blocking buffer were added and
incubated for 2 h at room temperature. Plates for detecting IgM were washed and
50 /d of sheep //-chain-specific anti-human IgM (1/80) (Scottish Antibody
Production Unit. Lanarkshire. Scotland) (SAPU) were added. After washing.
50 fi\ of horseradish peroxidase conjugated (HRP) donkey anti-sheep/goat IgG
(1/20) were added to the plates for 1 h. For IgA plates. 50/d HRP rabbit anti-
human /r-chain-specific IgA (1/500) (Dako. High Wycombe. Bucks. L'K) were
added to the plates and incubated for 2 h.
Finally, the plates were washed and 50 /d of phosphate citrate buffer (01 m-
XaHP04. 0T m citric acid) containing the substrate O-phenylene-diamine
(0 4 mg/ml. pH 5 0) activated by 0-02% H202 (30% v/v). The colour was allowed
to develop in the dark and the reaction was stopped after 20-30 min by adding
50 (i\ of H2S04 (125%).
To determine total IgG. 100 /d of serum (1/50000) or saliva (1/2) diluted in
coating buffer were added to the microtitre plates and the plates incubated
overnight under the conditions used, none of the reagents was at a limiting
concentration. After washing. 50 //I of HRP sheep anti-human IgG (1/20) (SAPl")
diluted in blocking buffer were added for 2 h. The plates were then treated as for
IgA and IgM.
Optical density (OD) at 490 nm was determined by an ELISA plate reader
(Dynateeh) and corrected by subtracting the OD of the corresponding blank.
Samples were tested in duplicate and the readings averaged. ELISA readings were
converted to mg/ml by extrapolation from the curve that was constructed
from readings obtained with standard human serum: IgG = 1140 mg/dl;
IgA = 250 mg/dl: IgM = 114 mg/dl (Behring lot no. 041024). A series of twofold
dilutions of standard human serum (Behring, London. LTK) containing known
concentrations of immunoglobulin (mg/ml) were tested with the specimens from
the children.
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Whole cell enzyme linked immunosorbent assay
Sera and saliva were examined for anti-meningococcal antibodies by a whole
bacterium ELISA. A", meningitidis and A*, lactamica were cultured overnight on
MNYC agar at 37 °C. Large batches of microtitre plates were coated with bacteria
to minimize variations due to different antigen preparations and coating
procedures. Plates were coated overnight at 4 °C with 100 /d of one of the six
bacterial isolates (6 6 x 107 bacteria/ml). The plates were washed and blocked with
PBS containing BSA (1%). The buffer was removed and plates washed with
washing buffer. Undiluted serum or saliva (50 p\) was added to the wells and
incubated at room temperature for 2 h. The assay was continued in the same way
as ELISA for total antibodies. The assay for total and specific antibodies were
determined at the same time under the same conditions.
Statistical methods
The statistical analysis of the data was performed with the package SPSS/PC + .
The results were summarized by geometric means, since the logarithmic values
were more normally distributed than the raw data. The significance levels for
differences between groups were examined with the Mann-Whitney U test and a
P value of < 005 was regarded as significant. The association between levels of
antibodies in serum and in saliva was assessed by Spearman rank correlation.
RESULTS
Total IgA. IgG and IgM antibodies of secretors and non-secretors
The specificity of the ELISA for detection of IgM, IgG and IgA was assayed
with purified IgM. IgG and IgA (data not shown). There was no cross reaction
between IgA, IgG and IgM. There was no marked difference in total
immunoglobulin levels between sera from secretors and non-secretors. Non-
secretors had higher levels of serum IgM antibody compared with secretors, but
the difference was not statistically significant. There was no difference in the levels
of IgA or IgG in the saliva from secretors compared with non-secretors; but, there
was significantly more total IgM in the saliva of secretors (P = 0-0274) (Table 2).
There was no difference in serum or salivary immunoglobulin levels of smokers
(37) compared with non-smokers (320).
Specific immune responses to Neisseria species
There was no marked difference in antibody levels to the isolates in sera of
secretors compared with non-secretors, except for IgM to the non-groupable
serotype 4 isolate (Table 2).
There were significant differences in the mean specific salivary IgAI immuno¬
globulin levels of secretors and non-secretors. Non-secretors had significantly
lower levels IgM for A7, lactamica and each of the meningococcal isolates tested
(Table 2). Statistical comparison of IgA and IgG antibody levels in saliva was also
performed, but there was no difference between secretors and non-secretors. For
both secretors and non-secretors, the highest levels of IgM were observed for the
NG :4 isolate.
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Table 2. Geometric mean levels of total and specific IgM of secretors and
non-secretors
Xon-secretors Secretors P
Serum (n = 107) (n = 171
Total IgM* 1 27 108 0-05
Specific
A" lactamica 9-7 i ' 1 0-12
B : 15: PI 16 10-5 8-5 0-15
C: 4 6-0 53 0-25
B:4 22-4 14 7 0-11
XG:4 26-8 22 2 0-03
B4P1.15 5-2 4-8 0-48
Saliva (a = 129) (a = 208)
Total IgM 63-0 87-0 0-027
Specific
A", lactamica 1-8 2-5 0-0000
B:15:PI 16 21 3 1 0-0000
C: 4 29 36 0-040
B: 4 2-2 35 0-0000
XG:4 4-7 5-9 0-017
B 4P1.15 1-9 2-9 00008
* Unit for mean total serum IgM levels are expressed in mg/ml; unit for mean total and
specific salivary IgM levels and specific serum IgM levels expressed in /cg/ml.




Carriers (a) Xon-carriers (n ) P
Serum
Isotvpe strain
IgA C: 4 18-0 (67) 13 0 (209) 0-03
IgA B:4:PI. 15 9-5 (66) 8-4 (207) 002
IgM C':4 12-4 (68) 41 (210) 0-0000
IgM B:4 PI.15 8-3 (66) 6-5 (207) 0-002.5
IgG* C:4 5-3 (68) 4-2 (205) 0-01
IgG B :4: Pl.15 7-2 (64) 6 1 (207) 00033
Saliva
IgA XG:4 9-7 (89) 6-6 (243) 001
IgM XG: 4 6-5 (89) 5 1 (243) 0-03
* Unit for mean total serum IgG are expressed in mg/ml.
The correlation between serum and salivary antibodies
Analysis by Spearman correlation test found no correlation between the levels
of IgG. IgA and IgM antibodies in serum and saliva (P > 0-05). This suggests that
the increased levels of secretory IgM found among secretors are due to locally
produced immunoglobulins.
Carriage of meningococci and immunoglobulin levels
Compared with non-carriers, carriers of meningococci had significantly higher
levels of salivary IgA and IgM to a XG.4 strain and serum antibodies to the
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outbreak strain and to a C:4:- isolate (Table 3); however, analysis with respect
to both secretor status and carriage revealed that immunoglobulin levels still
differed according to secretor status when carriage was taken into account.
There was no difference in salivary immunoglobulins to the outbreak strain; but
there were significantly higher levels of IgA and IgM to the XG:4 isolate.
DISCUSSION
An association between non-secretion and meningococcal disease has been
reported in studies of patients in Scotland. Iceland and Nigeria [13. 14]. In this
study we tested the hypothesis that there might be differences in the humoral
immune responses of secretors and non-secretors that could contribute to the
apparent increased susceptibility of non-secretors to meningococcal disease. Both
serum and salivary immunoglobulin levels were examined.
Conflicting results have been reported for the differences in immunoglobulin
levels between secretors and non-secretors; however, most of these studies
measured total amounts of immunoglobulin in serum and saliva [18. 19.21].
Lower levels of both serum [19] and salivary IgA [18] were reported for non-
secretors. suggesting that specific immune responses at the mucosal surfaces of
non-secretors might be reduced compared with secretors. Blackwell and her
colleagues [21] did not confirm the earlier observation with single radial
immunodiffusion; higher levels of IgA were associated with the presence of
meningococci in the individuals from whom the saliva was obtained. There was no
difference in the mean levels of total IgA in the saliva of secretors compared with
non-secretors from whom no Neisseria spp. were isolated.
There was no difference between secretors and non-secretors in total or specific
levels of salivary IgA or IgG; however, non-secretors had significantly less total
IgM in their saliva compared with secretors. These differences were also observed
for salivary IgM to N. lactamica and to five isolates of meningococci expressing
different combinations of serogroup. serotype and subtype antigens. There was no
correlation between levels of serum IgM and secretory IgM in saliva, suggesting
that salivary IgM is locally produced and has not leaked from the serum. Although
serum and saliva of carriers had significantly higher levels of antibodies to some
of the neisseria isolates, the effect of secretor status on IgM remained after
adjustment for the effect of carriage.
A major biological role of high molecular weight, polyvalent IgA and IgM
secretory antibodies might be to provide a first line of defence against particulate
and polyvalent antigens such as bacteria. Individuals with IgM deficiency appear
at risk of disseminated meningococcal disease [22. 23]. It has been demonstrated
that locally produced IgM in IgA-deficient patients exhibits anti-virus activity
[24].
The lower levels of secretory IgM in non-secretors might contribute to
susceptibility to colonization, particularly among infants under the age of 12
months in whom secretory IgM is the major class of antibody on mucosal surfaces.
The presence of secretory IgM in early infancy has been suggested to compensate
for the absence of secretory IgA [7], IgM had been detected in saliva of infants who
w ere as young as one month of age [25]. If secretory IgM provides a crucial host
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defence during this period of life the lower levels of secretory IgM found for non-
secretors might contribute to their apparent susceptibility to meningococcal
disease. This hypothesis is under investigation at present.
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SUMMARY
A total of 439 individuals with diabetes mellitus were examined for carriage of
yeasts by the oral rinse and palatal swab techniques. Eighteen genetic or
environment variables were assessed for their contribution to carriage of yeasts.
The factor contributing to palatal and oral carriage of yeasts among individuals
with insulin dependent diabetes mellitus (IDDM) was age (P < 001). The factor
contributing to palatal carriage of yeasts among individuals with non-insulin
dependent diabetes mellitus (NIDDM) was poor glvcaemic control (glycosuria
P<0-01): carriage in the oral cavity as a whole was influenced additionally
by non-secretion of ABH blood group antigens (P < 0.05). Introduction of a
denture altered the above risk factors. For individuals with IDDM. oral carriage
was associated with the presence of retinopathy (P < 0-05): palatal carriage was
influenced by poor glycaemic control (HbA, P<0-01. plasma glucose levels
P < 0-05) and age (P < 005). For those with NIDDM, palatal carriage was
associated with continuous presence of the denture in the mouth (P < O01): oral
carriage was associated with plasma glucose levels (P < 0-05).
INTRODUCTION
Oral candidiasis is most prevalent as chronic atrophic candidiasis [1],
Individuals with diabetes are prone to infection: and chronic atrophic candidiasis
has been reported to be more prevalent among diabetic individuals compared with
non-diabetic controls [2]. Since disease is frequently preceded by colonization, it
is important to identify factors which predispose to colonization. Few studies have
examined the factors which predispose to colonization of diabetic patients by
Candida albicans; and none of these specifically analysed patients with insulin
dependent diabetes mellitus (IDDM) separately from those with non-insulin
dependent diabetes mellitus (NIDDM) [2-6].
Both genetic [7. 8] and environmental factors [9] have been reported to affect
carriage of Candida species. Group A /Miaemolytie Streptococcus pyogenes are
isolated more frequently from the pharynx of individuals who are non-secretors of
ABH antigens [10] and non-secretors were significantly over-represented among
carriers of meningococci [11]. Among non-diabetic individuals and individuals
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with NIDDM non-secretors of blood group 0 are over-represented among carriers
of C. albicans compared with secretors [7. 8].
Environmental factors variably reported to be associated with carriage of
yeasts include: presence of a denture; continuous wearing of a denture; denture
fit. occlusion, trauma, hygiene and age; smoking; and control of diabetes [3, 12]
This was the first study designed to compare the factors contributing to carriage
of yeasts in individuals with IDDM or NIDDM; its aims were:
(1) To compare the oral rinse technique with the palate swab method for
isolating yeasts.
(2) To compare the species of yeasts isolated from patients with IDDM or
NIDDM.
(3) To assess the association between secretor status and carriage taking into
account denture status.
(4) To dissect the contributions of the following variables to the carriage of
yeasts and, specifically, C. albicans: age; sex; type of diabetes; control of
diabetes as measured by glycosylated haemoglobin As (HbA,), random
plasma glucose levels, persistent glycosuria and albuminuria: diabetic-
complications - retinopathy. neuropathy, nephropathy; antibiotic usage:
corticosteroid treatment; smoking; alcohol consumption; presence of the
denture in the mouth at night; denture fit, extension, occlusion hygiene and




A total of 439 subjects attending for routine follow up examination at the
diabetic out-patient clinic. Royal Infirmary. Edinburgh were sampled. An initial
pilot study examined 80 individuals and was followed by a stud}7 that sampled 359
individuals between September 1988 and March 1989. The method of selection was
stratified random selection according to sex and type of diabetes.
Clinical history
Each subject was classified as insulin dependent (IDDM) or non-insulin
dependent (NIDDM) according to family history of diabetes, clinical history of
onset, requirement for insulin, progression of the disease. Three of the 439 subjects
sampled could not be classified.
A full medical history including the presence of diabetic complications
(retinopathy, neuropathy and nephropathy) was obtained during interview and
from the patients' records. A history of medications, with particular reference to
antibiotics or corticosteroid-containing preparations, within the past 6 months
was noted. A social history of alcohol consumption and smoking was recorded.
Subjects were questioned about history of superficial infections due to Candida.
Glycosuria and albuminuria were recorded as persistent if subjects had positive
urine samples on more than two consecutive appointments at the clinic. None of
the subjects used any oral preparations containing antiseptics within the previous
6 months.
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Clinical examination
A thorough oral examination of both soft and hard tissues was carried out. The
occlusion, fit, extension and hygiene of a denture where present was recorded as
'good' or 'poor'. The age of the denture was recorded as well as whether it was left
out of the mouth at night.
Samples
Venous blood was obtained for ABO blood grouping and Lewis antigen
determination. Routine analyses for glycosylated haemoglobin (HbA,) and
random plasma glucose were recorded. Swabs were obtained from five sites
(palate, tongue, floor, right and left angles of the mouth) and inoculated
immediately into malt broth. Each subject provided a fresh, unstimulated sample
of saliva which was collected in a sterile L'niversal container.
Subjects were requested to rinse with 10 ml of sterile phosphate buffered saline
(PBS) for 1 min and to return the contents to a sterile L'niversal container.
Laboratory analysis
ABO blood group was determined by slide agglutination with monoclonal anti-
A and anti-B antibodies (Scottish National Blood Transfusion Service). Secretor
status was determined by the presence of Lew is antigen on red blood cells by tube
agglutination with monoclonal anti-Le* and anti-Leb antibodies (Scottish National
Blood Transfusion Service). The haemagglutination inhibition method with boiled
saliva was used to confirm the Lewis antigen results for 159 individuals [13].
The Corning electrophoresis method was used for measuring HbAl (normal
range 4-5-80%, coefficient of variance = 4%).
The swabs in malt broth were incubated at 37 °C for 36-48 h to enrich for
C. albicans, plated onto malt agar and incubated for a further 36-48 h.
The mouth rinse was concentrated by centrifugation and resuspended in 1 ml of
PBS; 20 pi of the suspension were inoculated onto malt agar plates and incubated
at 37 °C for 36-48 h. The number of colonies per sample were recorded.
Pure colonies were subcultured and identified with the API 20C Auxanogram
(API Systems S.A., France). All were also identified by the conventional methods
of germ-tube production in horse serum, urease test and hyphae production on
corn-meal agar following incubation at 28 °C for 48 h [14].
Statistical analysis
All results were coded and a computerized database was set up to facilitate
analysis by the SPSSX. LTnivariate analysis was by the \1 (with Yates' correction)
or YVilcoxon rank sum tests. MacNemar's test for paired alternatives was used to
compare the results of the oral rinse and the palate swab.
Stepwise linear discriminant analysis (Wilk's method) was used to identify
which combinations of factors best predicted yeast carriage. During the analysis,
predictor variables can be added or removed in a stepwise manner, each variable
being selected on the basis of an F level of 4 for entry or removal, corresponding
to P = 0 05.
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RESULTS
Table 1 summarizes the characteristics of the population sampled with respect
to their diabetic status. Individuals with IDDM were younger, had a higher mean
value of HbAj; and they had a higher proportion of non-secretors (36-4%)
compared with individuals with XIDDM (22%) (x2 = 10-15: P < 0005). The
mean number of cigarettes per day smoked by subjects with IDDM or XIDDM
were similar.
Mycological profile of the ■sample population
Only 29% (128/439) of the individuals examined had no yeasts in any of the five
sites swabbed; this compared well with the oral rinse technique in which 34% of
the individuals were culture negative. The concordance between the results
obtained by these methods was 85%. By MacXemar's test for paired alternatives,
there was no significant difference between the discordant pairs obtained by the
two sampling methods (P > 01). Table 2 compares the species of yeasts cultured
from swabs of the five sites of the mouth with those obtained from the oral rinse
from individuals with IDDM or XIDDM.
Univariate analysis of factors affecting carriage
Tables 3-8 present analysis of factors examined for their association with
carriage of yeasts: similar results were obtained when carriage of C. albicans was
analysed separately.
Isolation ofyeasts from the palate or from the oral rinse was not associated with
secretor status when the results were analysed by type of diabetes and/or denture
status.
Blood group was not associated with palatal carriage. When carriage was
assessed by the oral rinse, however, individuals with XIDDM who wore dentures
and who were of 0 blood group were more likely to be carriers than those of blood
group A (x2 — "'93. P = 0-05) (Table 3). Comparisons with B and AB were not
done because of the small numbers of individuals with these blood groups.
Analysis of secretor status with reference to blood group revealed a significant
association between non-secretion and increased frequency of carriage of yeasts
among individuals with IDDM who were blood group A and who wore dentures;
there were 9/19 A-secretor carriers compared with 12/12 A-non-secretor carriers
(x2 = 7-07. P = 0-008).
Yeasts were isolated significantly more frequently from the palate of patients
with IDDM with or without dentures (Table 4). Similar results were obtained by
the oral rinse method.
Increase in age was significantly associated with a decreased frequency of
isolation of yeasts from the palate of patients with IDDM but not those with
XIDDM (Table 5). Similar results were obtained by the oral rinse technique.
The HbAj values of palatal carriers were higher compared with non-carriers:
particularly among individuals with IDDM (Table 6). Results from the oral rinse
technique showed a similar trend but did not attain significance at P < 0-05 for
individuals with IDDM or XIDDM.
The mean number of cigarettes per day was a highly significant factor
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Table 1. Characteristics of the sample population.
Age HbA,
Type of a a Smokers Cigarettes Non-secretors Secretors
diabetes mean (s.D.) mean (s o.) (%) per day <%) <%)
IDDM 40-3 (16-0) 10-3 (2 1) 41 17 3 (11 1) 364 636
(n = 231)
NIDDM 58 1 (9-3) 9-8 (2-3) 34 17 3 (11 7) 22-0 780
(n = 205)
Table 2. Species of yeast isolated from individuals with IDDM or SIDDM with or
without dentures (percentages)
Patient
category Sample None C. albicans C. tropicalis Oth.
No dentures
IDDM Oral rinse 33 47 2 0 18
(n = 150) Palate 44 48 I 1 6
Tongue 38 54 ••> 0 6
Floor of mouth 41 54 1 1 3
Right angle 56 38 0 0 5
Left angle 60 35 0 0 5
NIDDM Oral rinse 40 28 2 0 31
(n = 70) Palate 63 28 0 0 9
Tongue 63 32 0 0 5
Floor of mouth 70 27 0 0 3
Right angle 68 27 0 0 5
Left angle 75 24 0 0 2
Dentures
IDDM Oral rinse 24 43 4 0 29
(n = 79) Palate 33 47 9 •1 9
Tongue 37 49 5 2 8
Floor of mouth 34 49 5 3 8
Right angle 50 29 9 1 10
Left angle 42 41 6 2 9
N'lDDM Oral rinse 41 24 6 3 27
(n " 135) Palate 51 29 6 3 12
Tongue 51 34 8 2 6
Floor of mouth 53 31 7 3 7
Right angle 54 25 9 3 9
Left angle 58 24 10 3 6
Table 3. Blood groups and carriage of yeasts assessed by the oral rinse technique
Non-carriers Carriers
Blood At i r"' A
C'ategory group no. (%) no. (%)
IDDM O 22 (39) 34 (61)
No dentures A 11 (26) 32 (74)
IDDM 0 5(16) 26 (84)
With dentures A 10 (31) 22 (69)
NIDDM O 9(33) 18(67)
No dentures A 7 (44) 9 (56)
NIDDM O 17(32) 36 (68)
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Category no. (%) no. (%)
All
IDDM 70 (39) 108 (61)
NIDDM 101 (55) 82 (45)
Without dentures
IDDM 48(44) 62 (56)
NIDDM 40 (62) 24 (38)
With dentures
IDDM 22 (33) 44 (67)








* All yeasts including C. albicans.
iP value refers to comparisons between IDDM and NIDDM






























*P determined by Mann-Whitney test.
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Category presence no. (%) no. (%)
All Yes 30 (40) 45 (60)
No 32 (65) 17 (35)
IDDM Yes 10 (32) 21 (68)
No 5(38) 8(62)
NIDDM Yes 20 (45) 24 (55)





associated with carriage of the whole population sampled (Mann-Whitney
P < 0 001). When results were analysed with respect to types of diabetes and
denture status, smoking was of marginal significance (P = O051) only among
denture wearers with NIDDM (Table 7).
Yeasts were isolated more often from the palate of subjects who left their
dentures in the mouth at night; however, this was observed only among
individuals with NIDDM (Table 8). This pattern was not found when carriage was
assessed by the oral rinse method.
The following variables were not associated with frequency of carriage of yeasts
by either isolation technique; sex; duration of diabetes; complications -
neuropathy, nepthropathy and retinopathy; alcohol consumption; contraceptive
pill; sjstemic corticosteroid treatment; topical corticosteroid application;
antibiotics; fit, occlusion or hygiene of denture; persistent albuminuria; or history
of superficial Candida infections. Denture status was not significantly associated
with frequency or density of colonization by yeasts.
Multivariate analysis
Univariate analysis might incorporate dependent variables which need prior
knowledge to control for their effect. The multivariate analysis identified factors
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Diabetes Dentures Yariables isolated predicted
IDDM No Age (P < 0-05) 61
(n = 110)
IDDM Yes HbA, (P < 001)
(n — 51) Age (P < 0-05) 71
Plasma glucose (P < 0 05)
XIDDM No Glycosuria (P < 0"01) 78
(n = 49)
NIDDM Yes Continuous wear of denture 64
(n = 80) (P < 0.01)




Diabetes Dentures Variables isolated predicted
IDDM No Age (P < 0 01) 68
(n = 97)
IDDM Yes Retinopathy- (P < 005) 76
(n = 71)
NIDDM No Glycosuria (P < 0-01)
(n = 43) plasma glucose (P < O05) 67
Non-secretion (P < 005)
NIDDM Yes Plasma glucose (P < 0-05) 48
{n - 78)
which contribute to carriage of yeasts among individuals with IDDM or NIDDM
who wear dentures and those without dentures. Tables 9 and 10 summarize the
results obtained from the palate swab and oral rinse techniques respectively.
Similar results were obtained when carriage of C. albicans was analysed separately.
The percentage of carriers correctly predicted by the isolated variables indicates
their prognostic value.
Individuals with IDDM who did not wear dentures were best segregated on the
basis of their age into non-carriers and carriers of yeasts; carriage decreased with
increased age. This was true when carriage was assessed by either technique. The
univariate analysis of this group of patients showed similar associations; younger
individuals were more prone to carriage of yeasts.
Among individuals with IDDM who wore dentures, an increase in the frequency
of palatal carriage of yeasts was associated with an increase in HbAj level
(P < 0-01); younger individuals (P < 0-05) and increased random plasma glucose
levels (P < 0-05). The variable which was the most efficient predictor of carriage
assessed by the oral rinse technique was, however, the presence of retinopathy
(P < 0-05). Univariate analysis of this group of patients showed age to be
associated with palatal carriage.
Individuals with XIDDM who did not wear dentures were more likely to be
palatal carriers of yeasts if they had persistent glycosuria (P < 005). Carriage
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assessed by the oral rinse method was influenced by persistent glycosuria
(P < OOl). higher random plasma glucose levels (P < OOo) and non-secretion of
blood group antigens (P = 005). Univariate analysis of this group revealed an
association between persistent glycosuria and carriage among individuals with
XIDDM (x* = 5 32, P = 0-02).
Individuals with XIDDM who wore dentures were at risk of palatal carriage of
yeasts if they wore their dentures continuously (P = 0-01). Carriage of yeasts
assessed by the oral rinse technique was best predicted by an increased random
plasma glucose levels (P < 0-05). Comparison with univariate analysis showed
that continuous wearing of dentures was a significant factor only when carriage
was assessed by palatal swab.
DISCUSSION
The results are discussed in the context of the objectives of the study. The first
objective of the study was to compare isolation of yeasts by the oral rinse
technique with those obtained by the palate swab. The oral rinse technique
compared well with the results of the swab technique; there was 85 % concordance
between the results obtained with the two methods.
C. albicans was the species most frequently isolated from the swabs while species
other than C. albicans were isolated more often from the oral rinse. This might be
due to incubation of swabs in the malt broth suppressing other species of yeasts.
By the swab technique, yeasts were isolated most frequently from the tongue
followed by the palate, floor of the mouth and the angles of the mouth. Similar
results have been reported [3]. This supports the suggestion that the tongue might
act as a reservoir for yeasts [15]. For future work, the technique appropriate for
the objectives of the study should be employed. The oral rinse technique can be
used where quantitative and overall carriage of yeasts are required; swabs can be
used for examination of specific sites for carriage.
In this study, 66% of the diabetics were carriers of yeasts by the oral rinse
technique, a figure slightly higher than those reported in previous studies of
diabetics (41-62%) [2, 3. 5, 6, 16].
The second objective was to compare isolation of yeasts from patients with
IDDM compared with those with XIDDM. C. glabrata and C. tropicalis were
isolated more frequently from patients with either IDDM or XIDDM who wore
dentures. There were significantly more carriers among individuals with IDDM
compared with XIDDM subjects; no other study has found this association [2. 3,
16]. This might be due to the smaller sample sizes of other studies, differences in
populations sampled and their distinction of IDDM from XIDDM based solely on
treatment of the diabetic condition. In this study subjects were classified as IDDM
or XIDDM according to family history of diabetes, clinical history of onset,
requirement for insulin and progression of the disease.
By the API identification system, some studies have found 97 % of isolates to
be C. albicans [5. 17]. In this study only 54 % of the isolates were C. albicans (Table
2); this figure includes the proportion that was not identified by API 200 Aux as
C. albicans but found to be so by conventional methods. These results are similar
to studies which found 60% of isolates from diabetics to be C. albicans [3, 16]. This
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emphasizes the need for accurate identification as patients with diabetes are more
likely to carry and to have disease due to species other than C. albicans [18] which
might not be sensitive to routinely prescribed oral antifungal agents [19].
The third objective was to assess the association between secretor status and
carriage of yeasts among individuals with IDDM separately from those with
NIDDM. In most diseases the influence of blood group or secretor status is
marginal; sample sizes need to be large enough to discern such relationships with
confidence [20]. By univariate analysis, other studies found a relationship between
non-secretion of blood group antigens and carriage of yeasts among diabetics [8.
17]. These studies did not take into account the denture status [8] or type of
diabetes [17] of the sample population. Another study did not report an
association between secretor status and carriage of yeasts or development of
disease [2]; however, the number of subjects was much smaller, denture status and
type of diabetes were not considered.
Among individuals with NIDDM, the results of the multivariate analysis show
that non-secretion of blood group antigens was a marginally significant factor
influencing carriage in the oral cavity as a whole. Palatal carriage of yeasts was
not dependent on secretor status. Density of colonization reflected in the
quantitative carriage of yeasts assessed by the oral rinse is influenced by secretor
status; carriage per se does not depend on secretor status.
The fourth objective of the study was to dissect the contribution of various
other factors to carriage of yeasts. The following factors were not associated with
carriage by either univariate or multivariate analyses: sex; duration of diabetes;
diabetic complications of neuropathy or nephropathy; alcohol consumption;
contraceptive pill; systemic corticosteroid treatment; topical corticosteroid
application; antibiotic usage; fit, occlusion or hygiene of denture; persistent
albuminuria; or history of superficial Candida infections. Those for which
significant associations were found are discussed below with reference to previous
reports.
The prevalence of yeasts in the adult mouth has been shown to rise with age.
The effects of age are not always easily separated from disease and medical
treatment [21, 22]. Age was not related to isolation of yeasts from diabetics [2, 3,
17]. In a Canadian study [6], diabetics over 50 years of age had a higher density
of yeasts compared with those less than 50 years old. Age was not isolated as a
significant factor in the multivariate analysis, and the authors suggested that
carriage in the older age group might be due to the higher number of denture
wearers. In the study reported here, increase in age was associated with a decrease
in the frequency of carriage especially among non-denture wearers with IDDM
(Tables 5 and 9). This was unexpected; one explanation might be that decreased
isolation of yeasts with increasing age reflects the efficiency of the mucosal
immune defences against yeasts with increased frequency of challenge. Studies on
vaginal carriage of yeasts found an inverse correlation between isolation of yeasts
and levels of serum anti-candida IgA [23]. Secretory anti-candida IgA has been
reported to correlate with levels of serum IgA [24]. Analysis of secretory and
humoral immune responses of the study population to yeasts are needed to obtain
evidence for this hypothesis.
Poor glycaemic control (HbA, and plasma glucose) was a significant factor
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associated with palatal carriage of yeasts among patients with IDDM who wore
dentures. Carriage assessed by the oral rinse was not associated with HbAt levels;
similar results were reported in other studies [2, 5]. The single study in which
multivariate analysis was used found an association between HbA, level and
colonization determined by palate or denture base swab; however, this study did
not differentiate individuals with IDDM from those with NIDDM [6], Further
evidence that diabetic control is associated with carriage was the significant
association between carriage and plasma glucose levels or persistent glycosuria
among patients with NIDDM who did not wear dentures. Studies on other
diabetic populations reported similar results [16], but the majority did not find
this association [2, 3, 6. 17].
Retinopathy was of marginal significance as a predictor of carriage among
denture wearers with IDDM. This complication results from microvascular
changes associated with diabetes which might also impair immune response
through inadequate diffusion of tissue mediators and indicates that systemic
changes associated with diabetes predispose to colonization.
Studies in non-diabetic populations reported a positive correlation between
smoking and carriage of bacteria [25, 26] and yeasts [27]. Among diabetics,
smoking was a significant factor influencing carriage of yeasts; however, the type
of diabetes and denture status were not taken into account [3]. Although similar
association was found in this study, this association was not significant when
results were analysed with respect to type of diabetes and denture status.
In contrast to other studies which reported a higher prevalence and/or density
of yeasts among diabetics who wore dentures [2, 3, 5, 6], we found no correlation
with frequency or quantity of yeasts isolated with either technique. Similar results
w ere reported by Darwazeh and colleagues [17], There is no obvious explanation
for these discrepancies. Continuous presence of the denture might influence
analysis of denture status results; however, we found this association only for
palatal carriage among patients with NIDDM (Tables 8 and 9). Other studies
found continuous presence of dentures associated with increased frequency and
density of yeasts [3, 17].
The contribution of factors such as antibiotics and corticosteroids to carriage of
yeasts is not easily differentiated from that of the underhung illness. Most of the
studies in which associations between carriage and these treatments were found
were carried out on hospitalized patients. The present study examined out¬
patients. the majority of whom were not on either of these treatments; therefore,
no inferences can be made on the role of these therapies on oral carriage.
REFERENCES
1. Odds FC. Factors that predispose the host to candidiasis. In: Candida and candidiasis: a
review and bibliography. 2nd edn. Bailliere Tindall. 1988: 93-114.
2. Lamey PJ, Darwazeh A, Fisher B.M. Samaranayake LP. McFarlane T\V. Frier BM. Secretor
status, candidal carriage and candidal infection in patients with diabetes mellitus. J Oral
Pathol 1988; 17: 354-7.
3. Tapper-Jones LM. Aldred MJ. Walker DM. Hayes TM. Candidal infections and populations
of Candida albicans in mouths of diabetics. J Clin Pathol 1981 : 34: 705-11.
4 Barlow AJE, Chattaway FW. Observations on the carriage of C. albicans in man. Br J
Dermatol 1969 ; 81: 103—6.
518 F. Z. Aly and others
5. Fisher BM. Lamey P-J. Samanayake LP. MacFarlane TW. Carriage of Candida species in
the oral cavity in diabetic patients: relationship to glvcaemic control. J Oral Pathol 1987 :
16 282 4
6. Hill LVH. Tan MH. Pereira LH. Embil JA. Associations of oral candidiadis with diabetic
control. J Clin Pathol 1989; 42 : 502-5.
7. Burford-Mason AP. VVelsby JCP. VVilloughby JMT. Oral carriage of C. albicans, ABO blood
group and secretor status in healthy individuals. J Med Veter Mycol 1988 : 26 : 49-56.
8. Blackwell CC, Aly FZM, James VS. et al. Blood group, secretor status and oral carriage of
yeasts among patients with diabetes mellitus. Diabetic Res 1989: 12 101—4.
9. Ryley JF. Review article: Pathogenicity of Candida albicans with particular reference to
the vagina. J Med Vet Mycol 1986: 24: 5-22.
10. Haverkorn MJ. Goslings VVRO. Streptococci. ABO blood groups and secretor status Am J
Hum Genet 1969: 21: 360-75.
11. Blackwell CC. Genetic susceptibilitv to infectious agents. Proc Rov Coll Phvs Edin 1989:
19 129-35.
12. Budtz-Jorgensen E. Bertram V. Denture stomatitis. I. The etiology in relation to trauma
and infection. Acta Odontol Scand 1970; 28: 71-92.
13. Mollison PL. Blood transfusion in clinical medicine. 6th ed. Oxford: Blackwell Scientific
Publications, 1976; 414-82.
14. Milne LJR. Fungi. In: Practical medical microbiology. 13th ed. Edinburgh: Churchill
Livingstone. 1988: 675-99.
15. Soammes JV, Southam JC'. Infections of the oral mucosa. In: Oral pathology. Oxford:
Oxford L'niversity Press. 1985: 153-8.
16. Odds FC. Evans EGV. Taylor MAR. Wales JK. Prevalence of pathogenic yeasts and
humoral antibodies to Candida in diabetic patients. J Clin Pathol 1978: 31: 840—4.
17. Darwazeh AMG. Lamey PL. Samaranayake LP. et al. The relationship between
colonization, secretor status and in vitro adhesion of Candida albicans to buccal epithelial
cells from diabetics. J Med Microbiol 1990: 33: 43-9.
18. Aly FZM. Blackwell CC. Mackenzie DAC. et al. Chronic atrophic oral candidiasis among
patients with diabetes mellitus - role of secretor status. Epidemiol Infect 1991: 106:
355-63.
19. Dick JD. Xerz WG, Saral L. Incidence of polyene-resistant yeasts recovered from clinical
specimens. Antimicrob Agents Chemother 1980; 18 158-63.
20. Mourant AE Kopec AC, Domaniewska-Sobczak K. Blood groups and diseases. Oxford:
Oxford L'niversity Press, 1978.
21. Marples MJ. Microbiological studies in Western Samoa. II The isolation of yeast-like
organisms from the mouth with a note of some dermatophytes isolated from lesions of Tinea
corporis. Trans Roy Soc Trop Med Hyg 1960; 54: 166-70.
22. Smits BJ. Prior AP. Alabaster PG. Incidence of Candida in hospital in-patients and the
effect of antibiotic therapy. Br Med J 1966; 1: 208-10.
23. Schonheyder H, Melbye M. Biggar RJ. Ebbesen P. Neuland CY. Stenderup A. Oral yeast
flora and Candida albicans in homosexual men. Mykosen 1984 : 27 : 539—44.
24. Warnock DW, Hilton AL. Value of the indirect immunofluorescence test in the diagnosis
of vaginal candidiasis. Br J Vener Dis 1976; 52: 187-9.
25. Blackwell CC. Weir DM. James VS et al. Secretor status, smoking and carriage of Aeisseria
meningitidis. Epidemiol Infect 1990; 104: 203-9.
26. Blackwell CC, Tzanakaki G, Kremastinou J, et al. Factors affecting carriage of Neisseria
meningitidis among Greek military recruits. Epidemiol Infect. In press.
27. Arendorf TM. Walker DM. Kingdom RJ, Rous JRS, Xewcombe RG. Tobacco smoking and
denture wearing in oral candidal leukoplakia. Br Dent J 1983; 155: 340-3.
55
EFFECT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION ON BINDING OF
NEISSERIA MENINGITIDIS AND HAEMOPHILUS INFLUENZAE TYPE B TO A HUMAN
EPITHELIAL CELL LINE (HEP-2)
M.W. RAZA1, M.M. OGILVIE1, C.C. BLACKWELL*1, J. STEWART1,
R.A. ELTON2 and D.M. WEIR
1 ... ? . ...
Department of Medical Microbiology and Medical Statistics Unit,
Department of Public Health Sciences, University of Edinburgh
Medical School, Teviot Place, Edinburgh EH8 9AG





It has been suggested that individuals might be more readily colonized
with bacteria that cause meningitis through enhanced binding of the
bacteria to virus-infected epithelial cells. As respiratory syncytial
virus (RSV) affects infants and children in the age group also
susceptible to bacterial meningitis, we tested the hypothesis that
infection of HEp-2 cells by RSV might enhance binding of Neisseria
meningitidis or Haemophilus influenzae type b (Hib). Attachment of
fluorescein-labelled bacteria to HEp-2 cells was measured by flow
cytometry, and RSV-infected cells bound significantly more
meningococci (p < 0.001) and Hib (p < 0.01) than uninfected cells.
Although the isolates expressed different antigenic characteristics (3
meningococci and 5 Hib), all showed a similar pattern of binding. The
results are discussed with reference to the methods used for detection
of bacterial binding and to interactions that might explain the
increased binding to RSV-infected cells.
3
INTRODUCTION
Clinical, epidemiological and experimental evidence indicates that
virus infections can be predisposing factors for invasive bacterial
diseases and carriage of potentially pathogenic bacteria [1-6].
Factors considered to contribute to this effect include: immune
suppression [7-9]; diminished phagocytosis by polymorphonuclear
leucocytes [10], local oedema formation and tissue injury; loss of
mucociliary function and decreased bacterial clearance [11]; formation
of exudates that enhance bacterial growth [7]; and increased bacterial
binding to virus infected cells [7], Most investigators have studied
associations of influenza virus and bacteria such as Streptococcus
pneumoniae [12], Staphylococcus aureus [13] and Haemophilus influenzae
[14,15]. Coincident upper respiratory tract infections with viruses or
mycoplasma have been reported to be risk factors for epidemic disease
due to group A Neisseria meningitidis [16]; and there is recent
epidemiological evidence for an increase in meningococcal disease
following epidemics of influenza A [17],
Human respiratory syncytial virus (RSV) is a ubiquitous respiratory
tract pathogen which infects 50% of children in their first year of
life and virtually all by the age of two [18]. Much of the invasive
disease due to meningococci and H. influenzae type b (Hib) occurs in
this age group [19].
Although animal models have been used to study disease caused by
meningococci and Hib, we chose to use a human epithelial cell line
which expresses surface antigens, H and Lewis*3 postulated to be
involved in bacterial binding [20]. HEp-2, a non-ciliated human
epithelial cell line, can be infected with RSV, and uninfected cells
have been used for bacterial attachment studies [21,22], In the
present study we tested the hypothesis that HEp-2 cells infected with




HEp-2 cells (Flow Laboratories) were used between passages 400 to 420
for the binding assays. Cell growth medium (GM) consisted of Eagle's
minimal essential medium (Gibco) supplemented with 10% foetal calf
serum (FCS) (Gibco), NaHCO^ (0.85 g/1), L-glutamine (2mM),
streptomycin (200 pg/ml) and penicillin (100 IU/ml).
Virus
RSV (Edinburgh strain) [23] was used at the 5th to 7th passages to
infect the HEp-2 cells. Stock aliquots of supernatant fluid from
infected cell lysates were stored at -70°C and contained from 1 x 10
- 5 x 10 plaque forming units (pfu)/ml.
Bacteria
Three strains of meningococci were used: C:2b:P1.2; NG:-:P1.9;
Y:14:P1.2. Pilate and non-pilate isolates of Y:14:P1.2 were tested.
Hib isolates from Icelandic children were kindly provided by Dr K.
Jonsdottir, University of Iceland [Table 1], Serogroup, serotype and
subtype of the meningococcal isolates were determined by Dr. R.J.
Fallon, Meningococcus Reference Laboratory (Scotland). Cultures were
prepared by reconstituting the lyophilized bacteria in distilled
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water; meningococci were grown on modified New York City (MNYC) medium
[24] and Hib on boiled blood agar. For some experiments meningococci
were grown on boiled blood agar or GC agar (Difco, UK) containing 10%
lysed horse blood, 2.5% yeast dialysate and 10% glucose to examine the
effect of growth medium on attachment. Bacteria were grown overnight
at 37°C in 5-10% CO2 in air. Dulbecco's phosphate buffered saline
solution A (DPBSA) was used for washing the bacteria and the cells.
The bacteria were harvested, washed three times in DPBSA by
centrifugation at 2500 g for 15 min and resuspended in MM without
antibiotics by vigorous pipetting to disperse clumps. The bacterial
concentration was determined by measuring optical density (OD) at 540
nm. The linear relationship between OD reading and total count was
determined for each strain.
Binding of meningococci to HEp-2 cells in suspension
Overnight monolayer cultures of HEp-2 cells in culture flasks (25 cm )
were infected with RSV at different multiplicities of infection (MOI)
ranging from 0.001 - 1.0 pfu/cell. Virus (1 ml in MM) was adsorbed
for 1 hour, replaced with 10 ml MM and incubated overnight at 37"C.
Cultures were rinsed twice with DPBSA, then ethylenediaminetetra-
acetic acid ( EDTA) (0.05%) was applied, 1 ml per flask at 37°C for 5-
10 min to produce a cell suspension. MM (5 ml) was then added to the
cells to counteract EDTA activity. After centrifugation at 460 g for
7 min, the cells were resuspended in MM without antibiotics, counted
and adjusted to 1 x 10 cells/ml. The cell suspensions were gently
rotated at 37°C whilst the bacteria were prepared. The time from end
of viral adsorption to addition of bacteria was 24 h (+ 1 h).
The bacterial suspensions were labelled with fluorescein
isothiocyanate (FITC) (Sigma) freshly prepared as a 0.4% solution in
Nal^CO^ ( 0.05M) and NaCl (0.1M) (pH 9.2). The washed bacterial pellet
obtained from two culture plates was suspended in 2 ml of the FITC
solution by gentle shaking at 37°C for 20 min [25]. FITC-labelled
bacteria were washed three times in DPBSA and resuspended in MM
without antibiotics. The pilate isolate was incubated at 37°C for 2 h
to allow pili to regenerate. The concentration of the suspension was
determined by OD at 540 nm and adjusted to provide a range of ratios
of bacteria per cell. The bacterial suspensions (200 pi) were
incubated with equal volumes of HEp-2 cells at 37°C at 60 rpm in an
orbital incubator (Gallenkamp). At the end of each incubation period,
the cells were washed three times by centrifugation at 460 g for 7
min. The cells were resuspended in 200 pi of DPBS and fixed with 100
pi of 10% buffered paraformaldehyde (Sigma). The samples were kept in
the dark at 4°C until analysed within 3 days of the assay.
Analysis of binding bv flow cytometry
Each sample was analysed by flow cytometry with an EPICS-C (Coulter
Electronics, Luton, UK) equipped with a 5 watt laser with a power
output of 200 mw at 488 nm. The cells were selected from a display
of forward angle light scatter (size) versus 90° light scatter
(granularity) by means of a bitmap. The bitmap included the main
population of the cells excluding unbound bacteria, debris and clumps
from further analysis. The percentage of cells with fluorescence
greater than background level was recorded on a one parameter
histogram (H-%) measuring fluorescence on a logarithmic scale. The
mean fluorescence channel values for the positive cells were obtained
from a one parameter histogram measuring fluorescence on a linear
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scale. After subjecting the H-% histograms to Immunoanalysis
(Coulter), a computer programme that subtracts the values of the
control population from the test population at each channel of the two
H-% histograms, the binding index (BI) of each sample was calculated
by multiplying the percentage of fluorescent cells by the mean
fluorescence.
RSV infected cells were reacted with mouse monoclonal antibody to RSV-
F protein (Kindly supplied by Prof. P.J. Watt, Southampton University)
for 30 min at 37°C. After washing, 20 pi of FITC-label led antimouse
IgG antibody (Fab fragment, adsorbed with human serum protein) (Sigma)
was added and incubated for 30 min. The cells were washed and fixed
in paraformaldehyde and the proportion of cells binding the
monoclonal anti-F antibody was determined by flow cytometry.
Binding of H. influenzae to HEp-2 cells
The same method was used to investigate the binding of H, influenzae
to HEp-2 cells infected with RSV at MOI 1.0. The bacteria (Table 1)
were grown on boiled-blood agar medium for 48 h. FITC-labelled
bacteria were incubated with cells in ratios of 50, 200 and 800
bacteria per cell for 2 h, the incubation period recommended by St.
Geme and Falkow [26], The cells were analysed by flow cytometry as
described above.
Statistical methods
The results were analysed with the statistical package 'Minitab' using
multiple regression on the logarithms of the Bis of the samples. For
experiments with meningococci, dummy variables were included to adjust
for daily variations and different ratios of viruses and bacteria/
cell. The coefficients from this analysis were used to estimate
binding relative to that found with 10 bacteria/uninfected cell by
taking antilogarithms. Examination of the distribution of residuals
from the fitted models suggested that the logarithmic transformation
had given an acceptable fit to a normal distribution. A sign test was
used to test for consistency of excess binding of H. influenzae to RSV
infected cells in repeated experiments.
RESULTS
Detection of RSV infected cells
The percentage of RSV infected cells at 24 h post inoculation for each
MOI was determined. This ranged from <10% (MOI = .001) to >80% (MOI =
1) at the time of the attachment assay. No cytopathic effect was
noted at this stage.
Attachment of meningococci to cells in suspension assessed by flow
cytometry
The effect of RSV infection on binding of meningococci to HEp-2 cells
is shown in Figures 1 & 2. The left hand peak in the figures
represents fluorescence recorded with uninfected cells following
incubation with 320 bacteria/cell. The right hand peak represents
fluorescence observed with cells infected with MOI of 0.1 (fig 1) and
1.0 (fig 2) following incubation with 320 bacteria/cell.
Table 2 summarises the results obtained by flow cytometry assays to
assess the effect of viral infection at various MOI on binding of
bacteria. The results for 11 assays were combined using analysis of
6
variance and Table 2 shows the derived estimate of the ratios of the
binding index obtained with 10 bacteria per uninfected cell taken as
1. The results indicate that prior infection of the cells with RSV at
MOI of 0.1 and 1.0 enhanced the binding of N. meningitidis at ratios
>80 bacteria/cell as illustrated in figure 3 (F(2.51) = 37.37 P <
0.001).
At ratios of 10-20 bacteria/cell, the presence of virus infection at
any level did not change the binding level significantly. The cells
infected with an MOI of 0.001 demonstrated decreased bacterial binding
compared with uninfected cells; (F(1.45) = 5.48, P < 0.05) (figure
4).
The figures and Table 2 were obtained with one strain (C:2b:P1.2) of
meningococcus; however, similar results were found with other strains
which expressed different serogroup, serotype and subtype surface
antigens. Growth on boiled blood agar or GC agar did not alter the
pattern of binding obtained when the bacteria were grown on NYC
medium. Presence of pili demonstrated by an haenagglutination assay
had no effect on the binding pattern.
Attachment of H. influenzae to cells in suspension
Cells infected with RSV at MOI 1.0 bound significantly more Hib than
uninfected cells. Although the effect varied widely between
experiments, the mean of log differences was positive in all 10
experiments with strain H14 ( P < 0.01, sign test). RSV infection of
the cells enhanced bacterial binding at all the ratios of bacteria to
cell tested (Table 3). In 7 additional assays, 4 strains of
Haemophilus with different antigenic and biotype characteristics
showed a similar increase in binding to RSV-infected cells compared
with uninfected cells at each bacteria 1:ce11 ratio tested.
DISCUSSION
Increased susceptibility to secondary bacterial disease following
viral infection has been recognized for many years [27]. Among the
factors suggested to contribute to susceptibility to secondary
infections, the enhancement of bacterial binding to virus-infected
cells might be an important initial step.
In initial experiments, binding of meningococci to HEp-2 cells and
RSV-infected cells was assessed by light microscopy. The method was
not used for quantitative studies because of wide variation in the
counts obtained (data not shown) and the time needed for the assay.
The experiments were, however, helpful to demonstrate binding of the
bacteria to the cells and to determine optimal incubation periods
before cytotoxic effects occurred. These efects might be the direct
effect of the bound bacteria [21] or of the release of
lipopolysacchride from the bacteria [28]. Although increased binding
of bacteria to RSV infected cells was observed with this technique,
results were not reliably reproducible. In our studies, measuring
fluorescein-labelled bacteria on the surface of cells by flow
cytometry is a more sensitive and precise method than microscopy. More
cells can be counted in a short period of time and there is no
subjectivity in the values recorded.
The finding that in the cell samples with <10% infected cells (MOI
0.001) meningococcal binding is significantly decreased compared with
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uninfected cells was not expected (figure 4). The RSV-infected cells
might be secreting a soluble factor such as interferon which results
in reduced bacterial binding to neighbouring uninfected cells in the
sample. Compared with controls, total bacterial binding was not
significantly altered for the samples containing 20-30% infected cells
(MOI 0.01). This might reflect the mixed population of infected cells
and uninfected cells.
Enhanced binding of meningococci and haemophilus to cells infected
with RSV at MOI > 0.1 pfu/ml 24 hours previously suggests four
possibilities. RSV infection might enhance the expression of existing
receptor(s) for the bacteria. It might induce expression of a new
cell receptor. The filaments observed on the surface of RSV-infected
cells might trap the bacteria [29] . The F or G viral glycoproteins
expressed on the infected cells might act as additional receptors for
the bacteria. Because Hep-2 cells infected with RSV express viral
glycoproteins F and G on their surface at the time used in these
experiments, the last hypothesis is currently under investigation.
The results of this study suggest virus infection might be a
predisposing factor for bacterial colonization of epithelial cells.
Epidemiological investigations are underway to assess the influence of
RSV infection on carriage of meningococci or Hib.
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Table 1. Isolates of w. meningitidis examined
serogroup Serotype Subtype Source
C 2b PI.2 patient
NG - PI.9 carrier
Y* 14 PI.2 carrier
* This strain was used in both pilate and non-pilate forms.
Table 2. Isolates of type b Haemophilus Influenzae examined
Strain no. Source Enzyme type Biotype QKP type LPS type
14 Edinburgh - - - -
20 Reykjavik 4b I NT 1
21 Reykjavik 1 I 2 9
25 Reykjavik 12 I 1 1
29 Keflavik 1 — — —
NT = non typable
Table 3. Effects of Infection of HEp-2 cells with RSV on binding of
H. ranlnqltldla




Amount of virus added (MOI)
0 0.001 0.01 0.1 1.0
10* 100* 60 69 125 -
20 79 89 123 102 117
40 194 123 125 239 213
80 316 190 323 331 407
160 575 380 467 776 1288
320 1000 588 1148 1905 3311
640 1318 - - 2818 5248
1000 2238 - - 5623 11220
(* mean for KOI « 0 and 10 bacteria per cell tafcen as 100%)
Figure 1. Binding of FITC labelled N. meningitidis to HEp-2 cells
infected with RSV (MOI 0.1) (B) and uninfected cells (A).
Figure 2. Binding of FITC labelled N. meningitidis to HEp-2 cells
infected with RSV (MOI 1.0) (B) and uninfected cells (A).
Figure 3. Effect of infection of HEp-2 cells with RSV at MOI of 0.1
and 1.0 on binding of Neisseria meningitidis to the cells.
Figure 4. Effect of Infection of HEp-2 cells with RSV at MOI of
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Toxigenic strains of Staphylococcus aureus have been suggested to play a
role in Sudden Infant Death Syndrome (SIDS). In this study we examined
two factors that might enhance binding of toxigenic staphylococci to
epithelial cells of infants in the age range in which cot deaths are
prevalent: expression of the Lewis3 antigen and infection with respiratory
syncytial virus (RSV). By flow cytometry we demonstrated that binding of
three toxigenic strains of aureus to cells from non-secretors was
significantly greater than to cells of secretors. Pre-treatment of
epithelial cells with monoclonal anti-Lewis3 or anti-type 1 precursor
significantly reduced bacterial binding (P < 0.01); however, attachment of
the bacteria correlated only with the amount of Lewis3 antigen detected on
the cells (P < 0.01). HEp-2 cells infected with RSV bound significantly
more bacteria than uninfected cells. These findings are discussed in
context of factors previously associated with SIDS (mother's smoking,
bottle feeding and the prone sleeping position) and a hypothesis proposed
to explain some cases of SIDS.
3
INTRODUCTION
The suggestion that microorganisms are involved in the aetiology of some
cases of sudden infant death syndrome (SIDS) is based on evidence from a
variety of epidemiological and pathological studies. SIDS occurs during
the period when maternal antibodies have declined and the infant immune
system is immature. There is a marked seasonal variation in SIDS; the risk
increases in autumn and winter when respiratory infections are more common
[1,2]. There is often a history of upper respiratory tract infection in
these infants [3]. Mother's smoking was identified as a factor for SIDS in
the New Zealand studies [4] . Smoking and passive exposure to cigarette
smoke have been associated with increased risk of respiratory tract
infections [5] and with carriage of potentially pathogenic microorganisms
[6,7], At post mortem examination, there is often evidence of minor
inflammation and infection of the respiratory tract in many SIDS infants
[8],
There are conflicting results on the role of viruses [9,10] and toxigenic
intestinal bacteria in SIDS [11-15], Recently, it has been suggested that
nasopharyngeal colonization by toxigenic strains of Staphylococcus aureus.
particularly those producing the toxic shock syndrome toxin 1 (TSST-1),
might be involved in some of these infant deaths [16]. Pyrogenic toxins
are produced by many strains of S_t. aureus , and similar ones are found among
some strains of group A beta-haemolytic Streptococcus pyogenes. These are
"superantigens" that have significant physiological effects such as
induction of fever (> 38°C) , possibly by direct action on the hypothalamus
or by their induction of tumor necrosis factor (TNF) and interleukin 1 by
monocytes [17], iL. aureus was isolated from a higher proportion of SIDS
infants (41.3%), compared with a control population (28.3%) [18]. In this
study we examined two factors that might enhance density of colonization by
toxigenic staphylococci in infants during the period when they are at risk
of SIDS: expression of the Lewis3 blood group antigen, and infection with
respiratory syncytial virus (RSV).
Non-secretion, the genetically controlled inability of an individual to
secrete the glycoprotein form of his/her ABO blood group antigens, is
associated with susceptibility to a number of bacterial diseases and with
asymptomatic carriage of some potentially pathogenic microorganisms [19],
including group A streptococci [20] . The secretor gene also influences
expression of the Lewis blood group antigens; non-secretors produce only
Lewis3; secretors produce Lewis'5 predominantly but also variable amounts of
Lewis3. The amount of Lewis3 present in secretors depends on the relative
activities of the fucosyl transferases coded for by the secretor gene and
the Lewis gene. If the secretor fucosyl transferase acts first on the
precursor chain, the Lewis enzyme can add fucose to the subterminal sugar
of the chain to produce Lewis'5. If the Lewis fucosyl transferase acts on
the precursor first, the Lewis3 molecule cannot act as a substrate for the
secretor enzyme.
One of the hypotheses proposed to explain the increased proportion of
non-secretors among carriers of some potentially pathogenic bacteria and
yeasts is that the Lewis3 antigen is one of the host cell receptors for
some microorganisms [19,21,22], In this context, the reported high
proportion of infants expressing Lewis antigens during the first year of
life was of particular interest [23], Among infants, the enzyme coded for
by the secretor gene appears to be less efficient than that coded for by
the Lewis gene. Although the majority of infants are secretors (75-80%),
during the first year of life they will express easily detectable amounts
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of Lewis3. The peak in the proportion of infants expressing Lewis3 is 2-4
months, similar to the highest incidence of cot deaths.
It has been reported that both natural and experimental viral infections
enhance colonization by Sj. aureus [24] . RSV infected cells bind greater
numbers of Neisseria meningitidis and type b Haemophilus influenzae
compared with uninfected cells [25]. As RSV infects almost half of all
infants by the age of 12 months and is most prevalent in the winter months
[26] , it is an obvious candidate for investigation of the role viruses
might play in enhanced colonization by toxigenic bacteria.
These observations prompted the following questions:
1. Is Lewis3 detected in SIDS infants?
2. Do strains of toxigenic aureus bind in greater numbers to
non-secretor cells expressing larger amounts of Lewis3 ?
3. As some viral infections increase carriage of staphylococci, do tissue
culture cells infected with RSV bind greater numbers of staphylococci than
uninfected cells?
The results of these investigations are discussed in the context of
epidemiological data on the role of microorganisms in SIDS.
5
SUBJECTS AND KETHODS
Respiratory tract secretions (89) obtained from SIDS infants during autopsy
were provided by Dr. J.N. Inglis and Dr. P. Molyneaux (Regional Virus
Laboratory, City Hospital, Edinburgh) and by Dr. A. Gibson (Royal Hospital
for Sick Children, Glasgow). These were examined for presence of H [27]
and Lewis antigens [28] by enzyme-linked immunoassays (ELISA) described
previously.
aureus strains NCTC 10652, NCTC 10654, NCTC 10655, NCTC 10656, NCTC
10657, NCTC 11965, and NCTC 8532 were obtained from Dr. A. Wieneke Central
Public Health Laboratory, Colindale. Strains 40654 and 41206 were kindly
provided by Dr. J. Medcraft, Public Health Laboratory Service, Department
of Microbiology, Reading, Berkshire. The strains and the toxins they
produced are listed in Table 1. The bacteria were grown on nutrient agar
or for some experiments on blood agar to examine the effect of medium on
binding to epithelial cells
Buccal epithelial cells (BEC) were obtained from pairs of healthy secretor
and non-secretor donors matched as closely as possible for ABO blood group,
age and sex. ABO groups of the donors were determined by slide
agglutination of erythrocytes with monoclonal anti-A and anti-B antibodies
(Scottish National Blood Transfusion Service). Secretor status was
determined from saliva by haemagglutination inhibition assays [29],
initially confirmed by tube agglutination with monoclonal anti-Lewis3 or
anti-Lewis^ antibodies (Scottish National Blood Transfusion Service) and
later by ELISA's for H and Lewis antigens.
BEC were collected by rubbing the inside of the cheeks with cotton swabs.
To remove the cells, the swabs were agitated in 10 ml phosphate buffered
saline (PBS) (pH 7.2). They were washed twice in PBS in a Sorvall RT 6000
centrifuge (300g for 10 minutes) and the concentration adjusted to 2 x 10^
ml~^ after determination of the number of cells microscopically in an
improved Neubauer haemocytometer.
Bacteria were labelled with fluorescein isothiocynate (FITC) by a
modification of the method of Wright and Jong [30]. A heavy suspension of
bacteria in PBS was prepared and washed twice by centrifugation at 1000 g
for 20 minutes. The bacterial pellet was resuspended in 4 ml of a freshly
prepared 0.04% solution of FITC in sodium carbonate (0.05M) and sodium
chloride (0.1M) (pH 9.2). The mixture was incubated at 37°C for 20 min and
washed twice with PBS. The pellet was resuspended in PBS and filtered
through a Millipore membrane filter (5um pore size) to remove clumps of
bacteria.
The bacterial concentration was determined by measuring the optical density
of the suspension at 540 nm. The linear relationship between optical
density and total count was determined for each strain.
Binding of bacteria to BEC of secretors and non-secretors
BEC (200 ul) were mixed with 200 ul of the FITC-labe 1 led bacteria at the
following ratios of bacteria per cell: 80:1, 160:1 and 320:1. The
mixtures were incubated at 37°C for 30 min with gentle shaking in an
orbital incubator (Ga11enkamp). The cells were washed twice with PBS by
centrifugation at 300g for 10 minutes to remove unattached bacteria. The
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samples were resuspended in 300 ul 17. buffered paraformaldehyde (Sigma) and
stored in the dark at 4*C until analysed.
Analysis of binding assays
Each sample was analyzed by flow cytometry with an EPICS-C (Coulter
Electronics, Luton, UK) equipped with a 5 watt laser with a power output of
200 mw at 488 nm. Cells were selected from a display of forward angle
light scatter (size) versus 90* light scatter (granularity) by means of a
bitmap. The bitmap included the main population of the cells and excluded
debris and clumps from further analysis. The percentage of cells with
fluorescence greater than background level was recorded on a one parameter
histogram which measured fluorescence on a lograthraic scale. The mean
fluorescence channel values for positive cells were obtained from a one
parameter histogram measuring fluorescence on a linear scale. The results
were analyzed by Immunoanalysis (Coulter), a computer programme that
subtracts the values of the control population from the test population at
each channel of the two histograms. The binding index (BI) of each sample
was calculated by multiplying the percentage of fluorescent cells by the
mean fluorescence channel value.
Inhibition of bacterial binding
BEC obtained from secretors or non-secretors were treated with monoclonal
anti-Lewis3 (LM112/161 .8, kindly supplied by Dr. R.H. Fraser, Law Hospital,
Carluke) or monoclonal antibody to the type 1 precursor chain
(anti-precursor type 1) (clone no. 619/102, Russel Fine Chemicals, Chester)
for 60 min at 37°C. After washing twice by centrifugation at 300g for 10
min, the attachment assay was performed and analysed as described above.
Binding of bacteria to HEp-2 cells
Methods for assessment of binding of Staph. aureus strains NCTC 8532 and
NCTC 10655 to uninfected and RSV-infected HEp-2 tissue culture cells and
analysis of results were as described for H. influenzae [25].
Detection of Levisa and type 1 precursor antigens on BEC of secretor and
non-secre tor donors.
Buccal epithelial cells (200 ul, 2 x lO^ml"*) from seven secretors, seven
non-secretors and three secretor donors whose erythrocytes were not
agglutinated by either anti-Lewis3 or anti-Lewis*5 monoclonal antibodies
(Scottish National Blood Transfusion Service) (Lewis-negative individuals)
were incubated with 200 ul of monoclonal antibodies to Lewis3 (1/5) or
precursor type 1 (1/10) for 60 min at 37°C. The cells were washed twice
with PBS at 300 g for 10 min and incubated with 200 ul rabbit anti-mouse
IgM conjugated with FITC (1/200) (Sigma). The FITC-labe1led antibody was
also added to 200 ul of cells which had not been treated with the first
antibody as a control. After 30 min incubation in an orbital shaker at
37°C, the cells were washed twice with PBS. They were resuspended in 300
ul 1% buffered paraformaldehyde and stored in the dark at 4*C until
analysed. The cells were analysed on an EPICS-C flow cytometer as
described above and the binding indices calculated as before.
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Statistical methods
All analyses were carried out on the logarithms of the binding indices
which conformed more closely to a normal distribution than the raw values.
Differences between groups were tested by paired or unpaired t-tests as
appropriate, and confidence limits for the mean values in one group were
expressed as a percentage of those in the other by taking antilogarithms.
Analysis of covariance was used to test whether binding levels were
associated with the amount of anti-Lewis3 in secretors and non-secretors
tested on different days, while the association in a similar experiment
with anti-precursor on a single day was tested by Pearson correlation.
Three-factor analysis of variance was used to test whether RSV infection




Detection of Levis3 antigen in body fluids of SIDS infants
Lewis3 antigen was detected in 63/89 (71%) of the specimens from SIDS
infants.
Binding of S. aureus to epithelial cells of secretors and non-secretors
The results of the binding assays are presented in Table 1 as the 95%
confidence limits for binding of the bacteria to non-secretor cells
expressed as a percentage of binding to cells from matched secretors.
Confidence intervals for which both values are above 100 indicate
significant evidence that cells from non-secretors bound more staphylococci
than cells from secretors. There was no significant difference in binding
to cells of non-secretors compared with binding to cells of secretors
observed for the non-toxigenic strain NCTC 8532 or five of the toxin
producing strains: 41206, 40654, NCTC 10654, NCTC 10656 and NCTC 10652.
Three of the toxigenic isolates NCTC 10655, NCTC 11965 and NCTC 10657,
showed higher binding to cells from non-secretors compared with binding to
cells from secretors (Table 1). There was significantly higher binding of
NCTC 10655 and NCTC 10657 to non-secretor cells at all ratios of
bacteria:ce1Is tested, while for strain NCTC 11965 there was significantly
higher binding to cells of non-secretors only with the lowest ratio of
bacteria.
Binding of anti-Lewis3 or anti-precursor antibody to epithelial cells of
secretors and non-secretors
The epithelial cells from the 3 individuals whose erythrocytes were not
agglutinated by either anti-Lewis3 or anti-Lewis'3 (Lewis-negative) bound
consistantly low levels of anti-Lewis3. Cells from non-secretors bound
high levels of the antibody. While the mean binding index for secretors
(36,707) was approximately half that for non-secretors (79,148), there was
considerable variation in the amount of antibody bound by individual
secretors (Figure 1). There was no consistent pattern of binding of the
anti-precursor monoclonal to cells of secretors, non-secretors or
Lewis-negative individuals
Inhibition of bacterial binding
Binding of aureus NCTC 10655 to BEC obtained from seven secretors or
seven non-secretors treated with anti-Lewis3 antibody was significantly
lower compared with binding of the bacteria to untreated cells from the
same donors (t=-4.46, df=13, P <0.001 95% CI 55% - 81%). A similar pattern
was observed for binding of NCTC 10655 to cells of seven non-secretors and
ten secretors treated with monoclonal anti-precursor type 1 compared with
untreated cells (t = 8.19, df = 16, P < 0.001; 95% CI 58% - 72%).
Binding of aureus NCTC 8532 to the cells from the same donors treated
with anti-Lewis3 antibody was significantly lower compared with binding of
the bacteria to untreated cells (t = -4.97, df = 11, P < 0.001 95% CI 43% -
72%). Inhibition of NCTC 8532 with anti-precursor was not examined
because of the limited amount of antibody.
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Binding of bacteria with reference to detection of Levisa antigen or
precursor antigen
Binding of aureus NCTC 10655 was correlated with the amount of
monoclonal anti-Lewis3 antibody detected on the BEC of secretors and
non-secretors (df = 12, t = 5.03, P < 0.001). A similar pattern was found
with NCTC 8532 (t - 4.24, df = 12, P < 0.001). There was no significant
correlation between the amount of anti-precursor detected on epithelial
cells and binding of NCTC 10655 or NCTC 8532.
Binding of £L. aureus to RSV infected cells
Strains NCTC 8532 and NCTC 10655 were assessed in seven experiments to
compare binding of bacteria to HEp-2 cells and RSV-infected HEp-2 cells.
For both isolates the binding indices were greater for the virus infected
cells: NCTC 8532 (P < 0.001, 95% CI 117% - 155%), NCTC 10655 (p < 0.05, 95%
CI 109% - 155%).
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DISCUSSION
The results provided information for the three questions to be investigated
in this study. Lewis3 antigen was detected in secretions of 71% of SIDS
infants examined. There was increased binding of some toxigenic strains of
S. aureus to epithelial cells from non-secretor donors; and RSV-infected
cells bound more staphylococci than uninfected cells.
The lack of relevant control populations is a major criticism of
epidemiological studies of cot deaths. There is, however, evidence from
several surveys that £_u aureus is isolated from the nasopharynx of
approximately 35-40% of SIDS infants [16,18,31] compared with 28% from
healthy infants [18]. TSST-1 has been demonstrated in the renal tubular
cells of some SIDS infants but not in a comparison group of infants who
were not cot death victims [32], The pyrogenic toxins of Sj. aureus and
group A streptococci are powerful "superantigens" that can induce release
of cytokines that might trigger a cascade of events leading to shock or
damage to the respiratory or cardiac systems [17].
Because density of colonization might be an important consideration in the
hypothesis that these toxins play a role in some cot deaths, factors
suggested to enhance colonization were assessed in the study reported here.
Non-secretors of ABO blood group antigens are over-represented among
carriers of group A streptococci [20]. We tested the hypothesis that
epithelial cells from non-secretor donors might bind greater numbers of
toxigenic staphylococci than cells from secretors. Three of the eight
toxigenic strains, including one producing TSST-1, did show significantly
higher binding to non-secretor cells.
Attachment of strain 10655 which bound in greater numbers to non-secretor
cells was significantly inhibited by pretreatment of the host cells with
either monoclonal anti-Lewis3 antibody or monoclonal anti-precursor type 1
antibody. Anti-precursor type 1 antibody was examined because it has been
suggested that bacteria might bind to the precursor portion of the ABO or
Lewis blood group antigens; and glycosylation of the precursor to H or
Lewis antigens decreased the accessibility of the binding site [33]. There
was a significant correlation between binding of 10655 and binding of
anti-Lewis3 antibody to the host cell, but there was no correlation between
binding of this strain with the amount of anti-precursor antibody detected
on the cells. As the anti-precursor monoclonal was prepared by immunization
with Lewis 3 antigen, the inhibition of bacterial binding observed
following pretreatment of cells with anti-precursor might be due to
cross-reactivity with Lewis3 although none was indicated by the
manufacturer.
Although NCTC 8532 did not bind in greater numbers to non-secretor cells
compared with secretor cells, its binding was inhibited by treatment of the
epithelial cells with anti-Lewis3 and there was a significant correlation
between its binding to the donor cells and the amount of anti-Lewis3
antibody bound by the cells. From figure 1, it is apparent that some
secretors bind as much anti-Lewis3 as most non-secretors. For the
experiments comparing the binding of staphylococci to cells from secretors
and non-secretors, the donors were matched only according to sex, age and
ABO blood group; and the same pairs of secretor/non-secretor donors were
not available for each experiment. At that time there was no information
on the amount of anti-Lewis3 bound by the cells of individual donors.
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Early experimental work suggested that there are multiple receptors for
staphylococci on human epithelial cells [34], If Lewis3 is one of the
receptors for some strains of staphylococci or group A streptococci
capable of producing pyrogenic toxins, the expression of this antigen among
young infants might enhance their colonization by these bacteria. Viral
infections have been shown to enhance carriage of staphylococci (24); and
disease due to TSST-1 has been reported to follow influenza or "flu-like"
illnesses [35] . Binding of both meningococci and type b JL. influenzae to
tissue culture cells derived from human epithelium (HEp-2) was
substantially increased if the cells were infected with RSV [25]; and, in
this study, both the toxigenic and non-toxigenic strain tested bound in
greater numbers to the RSV infected cells. If there are similar
interactions in vivo. infection with RSV common during the first year of
life might also enhance colonization by these bacteria.
These studies suggest two factors that might enhance staphylococcal
colonization of young infants; however, all infants who become colonized do
not become SIDS victims. The following hypothesis is an attempt to
correlate our laboratory findings with factors identified in
epidemiological studies of cot deaths in New Zealand: mother's smoking,
prone sleeping position and bottle feeding [4],
Mother's smoking which was associated with carriage of meningococci among
children [36] might increase the risk of initial exposure to potentially
pathogenic bacteria in two ways. First, epithelial cells from smokers have
been shown to bind greater numbers of staphylococci than cells from
non-smokers [37], Smoking also enhances susceptibility to respiratory
viral infections; and epithelial cells from indiviudals with natural or
experimental viral infections bound more staphylococci compared with those
from individuals who were not infected with a virus [37],
In addition to the two factors examined in the present study, others that
might enhance density of colonization of infants by staphylococci include
passive exposure to cigarette smoke which decreases mucocilary clearance.
Infants in the age range in which the peak of SIDS occurs have little or no
mucosal or systemic immunity to staphylococci or to the pyrogenic toxins.
The effect of breast feeding on carriage of staphylococci or susceptibility
to these toxins is unknown; however, in studies on the possible role of
toxigenic Clostridia in cot deaths, Clostridium difficile was isolated from
significantly fewer breast fed infants compared with formula fed infants,
and C1 . difficile toxin was detected only in the faeces of formula fed
infants [38].
The pyrogenic toxins are produced between 37-40° C; and they are produced
in greater quantities at the higher temperatures [17], Three factors
associated with SIDS might increase the infant's temperature and thereby
enhance toxin production: respiratory infection; overwrapping with
clothing or bedding; and the prone sleeping position. In the prone
sleeping position, infants lose less heat than in the supine position.
[39,40,41]. The synergistic effect between increased temperature and
increased toxin production might account for the high temperatures recorded
for some of these infants at autopsy. Among 24 infants who died suddenly
and whose rectal temperatures were measured immediately before
refrigeration, 10 had temperatures > 38°C and 5 were > 40°C [42]. In
addition to the heat shock hypothesis of cot death, the increased release
of IL-1 induced by the toxins might contribute to prolonged sleep apnoea as
suggested by Guntheroth [43].
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Studies are underway to assess levels of Lewis3 in saliva of infants,
exposure to cigarette smoke and presence of RSV on carriage of toxigenic
staphylococci and streptococci. Results of these studies should provide
evidence to refute or confirm the scheme proposed.
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Figure 1 : Binding of monoclonal anti-Lewis3 antibody to epithelial
cells of non-secretors, secretors and Lewis3"*5' secretors.
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Table 1. 95Z confidence limits for binding of Staphylococcus aureus to
non-secretor cells expressed as a percentage of binding to ce
from matched secretors.
Bacteria per cell
Strain Toxin 80 160 320
produced
NCTC 8532 - 66-145 69-146 31-182
NCTC 10652 A 63-198 63-227 50-301
NCTC 10654 B 67-153 75-185 75-206
NCTC 10655 C 138-22 8"*" 107-249* 107-237*
NCTC 10656 D 61-136 79-175 67-178
NCTC 10657 A, B 110-197* 101-161* 117- 165+
NCTC 11965 A.TSST-l 102-201* 92-192 81-203
40654 A 82-182 54-189 91-222
41206 B 74-147 75-172 74-158
* P < 0.05
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Summary
Toxigenic bacteria have been implicated in some cases of Sudden Infant Death Syndrome
(SIDS). Although there is not much evidence that Clostridia spp. are associated with SIDS in
Britain, strains of Staphylococcus aureus producing pyrogenic toxins have been isolated from
significant numbers of these infants at autopsy. The pyrogenic toxins, produced by some
strains of group A Streptococcus pyogenes as well as staphylococci, are powerful
"superantigens" that have significant physiological effects including induction of fever
> 38* C. In this article, interactions between genetic and environmental factors that might
enhance colonization of epithelial surfaces by toxigenic staphylococci are analyzed: infant's
expression of Lewis* antigen which acts as a receptor for some microorganisms; viral
infections; the effect of mother's smoking on susceptibility to respiratory infection. Based
on epidemiological findings and laboratory investigations, a hypothesis is proposed to explain
how bacteria producing pyrogenic toxins might contribute to some cot deaths.
2
Introduction
Epidemiological studies indicate that infectious agents might be involved in some cases of
Sudden Infant Death Syndrome (SIDS). At autopsy there can be evidence of minor
inflammation and infection of the respiratory tract in many of these infants [1). The deaths
are more frequent during the period when maternal antibodies are declining and the immune
system of the infant is immature. The risk of SIDS increases during autumn and winter
months when respiratory infections are more common [2,3]. There is often a history of minor
upper respiratory tract infection in these infants [4] and histological evidence of viral
infection or inflammation in the lung has been reported [5,6]. Both smoking and passive
exposure to cigarette smoke have been associated with increased risk of respiratory infection
[7], and maternal smoking is one of the factors identified in the New Zealand studies of SIDS
[8], In some series, SIDS is more frequent in families in which socio-economic conditions
are poorer, and smoking is also related to socio-economic status. In the United Kingdom, the
proportion of women who smoke increases as social class decreases from "professional" to
"partly skilled" or "unskilled" categories [9], Breast feeding protects infants in this age
range from gastrointestinal and respiratory illnesses, and SIDS is reported by some workers to
be more frequent among bottle fed babies [8].
Microorganisms investigated for their associations with SIDS
By definition, invasive bacterial diseases are excluded from deaths diagnosed as SIDS. As a
result, the role which respiratory virus infections might play in these infant deaths has been
investigated [10,11], however, there is little evidence for direct associations between viral
infections and SIDS [12,13]. Toxin-producing bacteria have been isolated from autopsy
material. Infant botulism has been suggested to contribute to 4% of cot deaths in the United
States and up to 16% of those in Sweden [14-17], This pattern has not been observed in the
United Kingdom [18]. Toxins of Clostridium difficile can produce death in monkeys with
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features that are pathologically consistent with SIDS (19). These bacteria and
enterotoxigenic Escherichia coli have been isolated from a few infants (20,21], however, the
evidence for involvement of intestinal toxigenic bacteria has been inconsistent.
One of the more recent hypotheses regarding sudden infant death syndrome (SIDS) is that
nasopharyngeal colonization by toxigenic strains of Staphvlococccus aureus might contribute to
some of these cases [22]. These bacteria remain localized on the mucus membranes but their
toxins disseminate into the circulation. In one series, these bacteria were isolated from the
nasopharynx of approximately 40% of SIDS infants [23]. The toxic shock syndrome toxin of Si.
aureus can kill a previously healthy adult, so it might easily kill a small infant.
Pyrogenic toxins are produced by some strains of Si. aureus and also by some strains of group
A beta-haemolytic Streptococcus pyogenes. These families of toxins are associated with
staphylococcal food poisoning, toxic shock syndrome and also with the rash that accompanies
scarlet fever. These substances are powerful "superantigens" that have significant
physiological effects such as induction of fever (>38"C), possibly due to direct action on the
hypothalamus or through their induction of tumor necrosis factor (TNF) and interleukin 1 by
monocytes (Table 1). The bacteria can produce these toxins at temperatures between 37-40*C,
but the amount of toxin produced increases with increasing temperature (24],
Factors contributing to susceptibility to infectious agents
Our research group has been investigating both genetic and environmental factors affecting
susceptibility to infectious agents, in particular the secretor gene (Se) located on
chromosome 19. The gene is inherited in a Mendelian dominant pattern and there are two
phenotypes, secretors and non-secretors. Secretors which comprise 75-80% of most
populations, have the antigens of their respective ABO blood group determinants in their body
fluids. The minority 20-25% who are non-secretors do not have these antigens in their body
fluids. The secretor gene is in the same linkage group as the gene for the Lewis blood group
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antigens (Lt), and the secretor gene controls expression of the Lewis blood group antigens.
Non-secretors can produce only Lewis4 while secretors produce predominantly Lewis6 and
also variable amounts of Lewis4 (25]. The distribution of the ABO and Lewis antigens on cells
and in body fluids of secretors and non-secretors is summarized in Table 2.
Susceptibility to bacterial diseases and superficial yeast infections appears to be associated
with the non-secretor phenotype, as does asymptomatic carriage of group A streptococci (26],
meningococci (27), and Candida species (28-30). Susceptibility to respiratory viral diseases
(31] and to acquisition of the human immunodeficiency virus (HTV) through heterosexual
intercourse (32] appear to be associated with the secretor phenotype .
When we examined these phenotypes among SIDS infants, the distribution of secretors and
non-secretors did not differ significantly from that observed for the general population.
There was, however, a high proportion of these infants in whose secretions the Lewis4 antigen
was detected, 63/89 (71%) (33]. This was not unexpected; compared with adults and children
over the age of 18 months, Lewis4 antigen is detected in a much higher proportion of infants.
The peak incidence for the detection of Lewis4 on erythrocytes of infants is 2-3 months
(80-90%) (34], coincident with a high incidence of SIDS (Figure 1).
The production of Lewis substances is due to the interactions between two fucosyl
transferases, one coded for by the secretor gene and one coded for by the Lewis gene. Both
these enzymes add fucose to the type 1 precursor chain from which most of the ABO and
Lewis antigens in secretions is derived. If the secretor transferase adds fucose to the
terminal sugar in the precursor chain, the Lewis enzyme can add fucose to the subterminal
sugar to produce Lewis6. If the Lewis enzyme adds fucose to the subterminal sugar first to
produce Lewis4, the secretor enzyme cannot use this structure as a substrate and Lewis4 is the
final product (35). In infants, the Lewis enzyme is more efficient than the secretor enzyme.
As a result, infants express easily detectable amounts of Lewis4 even though the amount of
this antigen might be greatly reduced as the child becomes older.
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One of the hypotheses proposed to explain the higher proportion of non-secretors found
among patients with bacterial or yeast infections was that there are adhesins on some strains
of microorganisms that can bind to the Lewis* antigen usually present in greater quantities
on epithelial cells of non-secretors {36]. This might enhance the probability of
colonization or the density of colonization by bacteria or yeasts expressing adhesins that use
Lewis* as a receptor. Evidence for this hypothesis was obtained initially from studies of
Candida species [37-38], a^d there is evidence that the Lewis* antigen is a receptor for the
pertussis toxin [39].
If there are strains of toxigenic bacteria with adhesins that can bind to Lewis', infants
might be easily colonized if they are exposed to these bacteria. In the age range in which
SIDS occurs, they have little serum or secretory antibodies that might reduce colonization by
these bacteria or activities of their toxins.
We have tested the hypothesis that there are adhesins on SL aureus that bind Lewis*. Binding
of 3 strains of aureus producing pyrogenic toxins (including one producing the TSST-1
toxin) to epithelial cells of non-secretors was significantly higher than to cells from
secretors. As in the experiments with yeasts, pre-treatment of cells with monoclonal
anti-Lewis* significantly reduced the binding of the toxigenic strain tested. It also
significantly reduced the binding of the non-toxigenic strain which bound equally well to
cells of secretors or non-secretors [40].
This apparent discrepancy was solved by examining the amount of Lewis* on epithelial cells
of individual secretor and non-secretor donors. When assessed semiquantitatively by flow
cytometry, binding of monoclonal anti-Lewis* antibody to cells of non-secretors was
uniformly high while binding of the antibody to cells from donors who lack the (Lewis gene)
Lewis-negative was barely detectable [33]. Binding of the antibody to cells of secretors was
highly variable, some as low as that observed for the Lewis-negative cells (i.e. Le*"b"), some
as high as that for non-secretors and some between these two extremes (Figure 2). The
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binding of the bacteria was significantly correlated with the amount of anti-Lewis* antibody
detected on the epithelial cells regardless of secretor status [40].
Viral infections as predisposing factors for colonization by bacteria
Although there is no direct evidence for viruses causing cot deaths, they might be
predisposing factors for colonization by toxigenic bacteria. Much of the work in this area
has been done on influenza virus and superinfections by staphylococci or pneumococci [41],
We have also found that cells infected with respiratory syncytial virus (RSV) in. vitro bind
significantly more meningococci and type b Hi influenzae [42.43]. A condition similar to
toxic shock syndrome caused by staphylococci has been identified as a complication of
influenza or influenza-like illness [44], RSV is a common cause of disease among infants.
Its peak prevalence occurs during the winter months [43] when SIDS is most common. By flow
cytometry assays, we demonstrated that binding of a variety of bacteria including one
non-toxigenic and one of the toxigenic strains of staphylococci to HEp-2 cells was
significantly enhanced in RSV infected cells [40] (Figure 3).
If toxigenic staphylococci are responsible for some cot deaths, we have identified 2 factors
that might contribute to increased colonization or density of colonization by these bacteria:
expression of Lewis* in this age range; infection with RSV. Since the majority of infants who
become colonized by these bacteria suffer no ill effects, there must be additional factors
that precipitate the chain of events leading to cot deaths. From our results and the
epidemiological data reported, we have suggested the following hypothesis illustrated in
Figure 4.
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Exposure to and colonization by staphylococci or streptococci
Mother's smoking might enhance exposure of the infant to S* aureus. Smokers are more
frequently carriers of potentially pathogenic microorganisms (30,46] and epithelial cells of
smokers bind significantly more staphylococci than those of non-smokers (47]. Smoking also
enhances susceptibility to respiratory viral infection, and epithelial cells from individuals
with natural or experimental viral infections bound more staphylococci than those from
uninfected controls (47,48]. Passive exposure to cigarette smoke decreases mucociliary
clearance. The effect of breast feeding on staphylococcal or streptococcal carriage is not
known, however, breast fed infants are less susceptible to toxigenic strains of £L botulinum
(49].
Enhancement of toxin production
If an infant becomes heavily colonized with bacteria producing pyrogenic toxins and
environmental factors raise the body temperature, this might increase the quantity of toxin
produced. Body temperature might be increased by concurrent minor respiratory viral
infection, over-wrapping or placing the infant in the prone sleeping position (50,51]. The
toxin produced diffuses into the blood stream to increase the temperature of the infant and
further enhance toxin production. This synergistic effect might account for the unusually
high temperatures recorded for some cases of SIDS (52]. The actual cause of death might be
heat shock or increased frequency or duration and depth of sleep due to induction of IL-1
which has been proposed as the link between respiratory infections and fatal sleep apnoea
(51].
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Detection of Lewis* antigen on cells of infants and incidence of SIDS.
Figure 2
Variability in binding of monoclonal anti-Lewis* to epithelial cells of non-secretors,
secretors and Lewis-negative individuals.
Figure 3
Binding of Staph, aureus to HEp-2 cells and HEp-2 cells infected with RSV.
Figure 4
Factors proposed to affect colonization of infants by toxigenic Staph, aureus and to
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Since 1989 there has been a steady increase in the numbers of cases of
meningococa1 disease reported to the Ministry of Health in Athens (1).
In December 1990 and January 1991 primary (324) and secondary (713)
pupils in two areas of Athens were screened to determine if there was an
increase in the rate of carriage of Neisseria meningitidis and to assess
genetic and environmental factors previously associated with carriage of
meningococci in northern European populations: age [2]; sex (2,3);
secretor status (4); smoking or passive exposure to cigarette smoke
(1,4,5,6); lower socioeconomic conditions (2); upper respiratory tract
infections (7,8).
The effect of cigarette smoke was of particular interest because of the
strong association between smoking and carriage observed among Greek
military recruits (1) and the proportion of recruits who were smokers
(62%) was higher than than among men of similar age in Britain (40%)
(9).
Results
Children in two areas of Athens were screened for carriage of
meningococci. In area A socioeconomic indicators, housing costs and the
educational level of the parents (Table I) were significantly lower.
Over half the parents in area A had less than 7 years of formal
education (category 1); only 5% had received technical training
(category 4) and 27. had attended university (category 5).
Table I. Educational (socioeconomic) Levels of Parents in Areas A and B
Category
7.
1 2 3 4 5
Area
A (n=1122) 52 21 19 5 2
B (n=937) 18 14 31 8 29
(P < 0.0005)
The overall carriage rate was 60/1038 (5.8%), for area A 30/565 (5.3%)
for Area B 30/473 (6.3%) .
Univariate analysis found no association between carriage and sex, viral
infection or secretor status. There was no associaton between carriage
and educational level of either parent or numbers of individuals per
household in either area.
Carriage was increased among secondary pupils who smoked, but this was
significant only in Area A: 5/30 smokers (17%) were carriers compared
with 16/352 non-smokers (4.5%) (P <0.025).
Carriage rates were higher among children from households where adults
smoked. Only 6/214 (2.8%) of children from non-smoking households were
carriers compared with 28/360 (7.8%) (P < 0.025) from households where
the mother smoked or if grand parents smoked (11/129, 8.5%, P <0.05).
The increase associated with the father's smoking was not significant
(38/571, 6.7%). When figures were assessed after elimination of
children who smoked, 20/38 (52.6%) carriers who were non-smokers had
mothers who smoked. In area A the proportion of father's who smoked was
significantly higher (345/560, 61%) than in Area B (223/472, 47%) ( P <
0.0005). These differences were not observed for mothers in Area A
(33%) compared with Area B (38%).
Multiple logistic regression analysis identified only age (P <0.01) and
maternal smoking (P < 0.05) to be significant factors associated with
carriage. Older children and those whose mothers smoked were more
likely to be carriers (Table II).





smoker 1/66 (1.5) 5/99 (5.1) 22/195 (11.3)
mother
non-smoker 5/118 (4.2) 8/321 (3.5) 19/329 (5.8)
Discussion
The proportion of carriers among school children was within the
expected range, 5-10%. Several factors associated with carriage in
studies in northern Europe were not identified in this study. The two
significant factors were age and mother's smoking.
The isolation rate in different age bands followed a pattern similar to
that found in the Stonehouse study (2); there were more carriers the
15-19 year age range.
In contrast to the Stonehouse survey in which isolation rates of both
the outbreak strain and non-outbreak strains were greater in the parts
of the town where socioeconomic indicators were lower, there was no
difference between the isolation rates for the two areas of Athens.
Patterns of smoking in the two countries might explain these
differences. As in the United Kingdom (9), smoking among Greek men is
correlated socioeconomic level. A similar pattern is observed for
British women, but not for Greek women; among the mothers in the study,
there was no significant association between smoking and educational
level (Table III) .
Table III. Sex, Smoking and Educational Level of Parents
educational category
X
1 2 3 4 5
women
smoker (n=329) 35 38 39 30 25
men
smoker (n=568) 62 59 55 53 38
women (P > 0.05)
men (P < 0.0005)
The observation that carriage was also associated with smoking by adults
other than the father might reflect the structure of many Greek
families; grandparents often live with families with young children and
are closely involved in child care.
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Introduction
Following the epidemic of meningitis in the 1960's, there was a steady
decrease in the numbers of cases reported to the Ministry of Health in
Athens until 1988. In 1989, the numbers began to increase, and members
of the Athens School of Public Health and the Hellenic Institute Pasteur
invited our group to help organize studies on meningococcal carriage and
the characteristics of Neisseria meningitidis circulating in the Greek
population (1) . The last major surveys on meningococci had been
undertaken before serotype and subtype antibodies were available (1);
and, there was no information on antibiotic sensitivities. In contrast
to northern Europe, there had been no studies on genetic and
environmental actors affecting carriage of meningococci (3,4,5)
Environmental factors suggested to affect meningococcal carriage include
smoking or passive exposure to cigarette smoke (4,6). Several groups
have suggested viral infections might be predisposing factors for
meningococcal disease (7
factors or carriage of
objectives of the surveys
,8); and viral infections are predisposing
potentially pathogenic bacteria (9). The
were to answer the following questions:
1. Is there an increase in the proportion of carriers among recruits
or school children?
2. Are factors associated with carriage in Greece the same as those in
northern Europe?
3. Can the available serotype and subtype reagents differentiate Greek
strains?
4. Are the antigenic phenotypes associated with outbreaks in north and
west European countries prevalent among patients or carriers in
Greece ?
5. Are there higher proportions of penicillin-insensitive strains or
strains resistant to other antibiotics compared with northern
countries?
Results
Carriage of meningococci among military recruits
Greek military recruits (993) from two camps, one near Athens (Haidari)
(Camp A) and one near Avlona 50 km north of Athens (Camp B) , were
examined for carriage of meningococci during the third week of July
1990. The specimens and information obtained from the recruits are
summarized in Table I.
Table I. Specimens and Information Obtained from Recruits
Subj ects:
Specimens:
993 recruits in 2 military camps








Meningococci were isolated from 247 (25 %) of the recruits; however,
between the two camps, there were significant differences in the
carriage rates and other factors examined. The carriage rate for Camp
B (30%) was significantly higher than that for camp A (18%) (P <
0.0005); and in Camp B there were significantly higher proportions of
non-secretors (P < 0.0005), those with less than 7 years of schooling (P
< 0.0005), younger recruits (<19 years of age) (P <0.001) and heavy
smokers (> 30 cigarettes / day) (P <0.0005) (1,9).
By univariate analysis, smoking and the number of cigarettes smoked per
day were associated with carriage of meningococci (P < 0.0005). By
multivariate analysis, carriage was associated with smoking (P < 0.001),
the younger age group (<19 years) (P < 0.01) and the camp (P < 0.01).
In Camp B, although the carriage rate was 30%, it was 40% among recruits
that had viral infections. These studies were carried out in July when
the respiratory infections are not common. They were repeated in the
same camps in January 1991 to examine carriage rates at a time when
respiratory infections were more common. Although the proportion of
(1,9).
recruits with symptoms of colds was increased, the overall proportion
of carriers was increased by only 27. from 25 to 27% (Table II).













Carriage of meningococci among school-age children
In December 1990 and January 1991 school children in two areas of Athens
were screened in a survey similar to that carried out among the recruits
(Table III)
Table III. Specimens and Information Obtained from School-age Children
Subjects: 1038 primary and secondary pupils in two areas of Athens;
In Area A socioeconomic indicators were lower than in B






educational level of mother and father
no. members of household
who smokes in household
In Area A, the housing costs were lower and the educational level of
both parents were significantly lower than in Area B (P < 0.0005). The
carriage rates for the two areas were similar, A = 5.3% and B = 6.3%.
Univariate analysis found no association between age, sex, secretor
status, area of residence, educational level of parents, numbers of
members per family, school attended or respiratory tract infection.
Carriage was associated with the mother's smoking or smoking by a member
of the household other than the father. By multivariate analysis, the
age of the child and mother's smoking were found to be significantly
associated with carriage (Table IV).











multivariate analysis age (15-19) <0.01
mother's smoking <0.05
Among fathers, smoking was significantly more prevalent among those with
less formal education (P < 0.0005), a pattern similar to that observed
for men in the United Kingdom (10). Although a similar association
between smoking an socioeconomic indicators is found among women in
Britain, this was not observed among women in Greece; there was no
association between educational level and smoking (11). If the
mother's smoking is a significant factor associated with carriage, this
might explain the similar isolation rates for the two areas of Athens.
The observation that carriage was associated with smoking by adults
other than the father might reflect the structure of many Greek
families; grandmothers often live with families with young children and
and are closely involved in child care.
Antigenic characteristics of meningococcal isolates from patients and
carriers
The majority of isolates from patients or carriers did not react with
any of the monoclonal serotype reagents examined; however, most reacted
with one or more of the subtype reagents (12,13). The results suggest
that new serotype reagents need to be developed for epidemiological
studies in Greece and possibly other countries in eastern Europe.
Nearly 600 isolates have been examined; only 1 strain obtained from a
school child in Athens expressed antigenic combinations associated with
outbreaks in northern Europe. This was a B:4:P1.15 strain, but it was
not resistant to sulphonamide. The predominant serotype/subtype
combination found among patient isolates was 2b:P1.10; however, only 4%
of isolates from children who were carriers expressed this phenotype but
none of those from the recruits (12).
Antibotic resistance
In 1991, the proportion of penicillin insensitive (PI) isolates among
recruits who were carriers (37%) was lower than that among patient
isolates (48%) but higher than that obtained from school children who
were carriers (19%). The proportion of isolates resistant to
sulphamethoxazole, tetracycline erythromycin and cefaclor wre higher in
the recruits compared with the children who were carriers (14,15).
February 1992, the proportion of PI isolates had increased to 37% as had
all the other resistances except tetracycline.
Discussion
The results are discussed in the context of the questions posed in the
Introduction. The proportion of carriers was not above that expected
for the two populations examined, military recruits and school children.
In both populations, smoking or exposure to cigarette smoke were factors
associated with carriage as was age. In both populations, the rate of
carriage was highest in the 15-19 year age range; similar results were
reported for the Stonehouse survey (16). While the subtype reagents
were able to differentiate the strains from both carriers and patients,
the serotype antibodies did not react with the majority of strains.
Only 1 out of nearly 600 isolates examined expressed antigenic
phenotypes associated with epidemics of group B meningococcal disease in
northern Europe. This indicates new serotype reagents need to be
developed for studies in Greece and that vaccines presently under trail
in Norway would not be appropriate for this population. Penicillin
insensitive isolates, particularly those from carriers, are more common
in southern European countries such as Greece and Spain (17) where
antibioitic usage is less well regulated.
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